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Abstract 
 
During DNA replication, forks often stall upon encountering obstacles blocking 
their progression. Cells will act to speedily remove or overcome such barriers, 
thus allowing complete synthesis of chromosomes. This is the case for R-
loops, DNA/RNA hybrids that arise during transcription. One mechanism to 
remove such R-loops involve DNA/RNA helicases. 
 
Here, I have shown that one such helicase, Sen1, associates with replisome 
components during S phase in the model organism S. cerevisiae. I 
demonstrate that the N-terminal domain of Sen1 is both sufficient and 
necessary for the interaction of the protein with the replisome. I also identified 
Ctf4 as one of at least two replisome interactors of Sen1. By mutational 
analysis, a mutant of Sen1 (Sen1-3) that cannot interact with the replisome 
was created. This mutant is healthy on its own but is lethal in the absence of 
both RNase H1 and H2. Overexpression of the sen1-3 allele from the 
constitutive ACT1 promoter is able to suppress this synthetic lethality, 
suggesting that Sen1 travels with replisomes in order to be quickly recruited 
at sites of R-loops that impair fork progression so as to remove those R-loops. 
 
In some cases, cells exploit fork stalling for biologically important processes. 
This is the case in Sz. pombe, where an imprint prevents complete DNA 
replication, triggering cell-type switching. This imprint is dependent on Pol1, a 
component of the replisome. Importantly, a single imprinting-defective allele 
of pol1 has been identified to date. Using in vitro assays, I have shown that 
this Pol1 mutant has reduced affinity for its substrates and is a correspondingly 
poor polymerase. By generating novel alleles of pol1, I have also 
demonstrated that switching-deficiency correlates with the affinity of Pol1 for 
its substrates in vivo. Finally, two interactors of Pol1 (Mcl1Ctf4 and Spp1Pri1) 
have been shown to have switching defects. 
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Note on Nomenclature Conventions 
  
S. cerevisiae and Sz. pombe have similar yet distinct genetic nomenclature 
conventions. Given that both model organisms were used in this study, it is 
important to highlight the conventions for both organisms to prevent confusion. 
 
In S. cerevisiae, wildtype gene names are expressed as a three letter, 
uppercase and italic name followed by a number (e.g. SEN1). The three letter 
name often corresponds to the screen through which the gene in question was 
originally identified. Mutants are generally designated with the same three 
letter but in lower case (unless the mutant is dominant) and with an allele 
designation (e.g. sen1∆, sen1-1 and sen1-2). Because of historical context, 
the allele designations vary in format (e.g. leu2-3,112 is a mutant of LEU2). 
Protein names are given as a three letter name with the first letter in uppercase 
(e.g. Sen1). This is also true for mutant proteins, with the added allele 
designation (e.g Sen1-1 and Sen1-2). In this study, I have generated 
constructs of the SEN1 gene and these constructs are referred to as SEN1 
(X-Y), where X and Y refer to the first and last residues being encoded for. 
The corresponding proteins are referred to as Sen1 (X-Y). Different promoters 
have been used and, where appropriate, the promoters are expressed 
similarly to their wildtype gene names (e.g. GAL1, SEN1 and ACT1). 
 
In Sz. pombe, wildtype gene names are expressed as a three letter, 
lowercase and italic name followed by a number (e.g. pol1). Mutants are 
generally designated in the same format but with an allele designation. Like in 
S. cerevisiae, the allele designation varies widely (e.g. pol1-1, pol1-H4 and 
pol1-ts13). Additionally, because of the historical context, some (but not all) 
alleles of pol1 are referred to as swi7 to reflect the fact that they are defective 
for cell-type switching. Similar to the situation in S. cerevisiae, proteins names 
are given as a three letter name with the first letter in uppercase for both 
wildtype and mutants (e.g. Pol1 and Swi7-1). Sometimes, for the sake of 
comparison, genes or proteins are referred to their S. cerevisiae orthologues 
(e.g. swi1TOF1 and Swi1Tof1, respectively). 
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Several protein tags have been used in this study. When written in gene form, 
they were written in capital letters and italicized, irrespective of the host (e.g. 
5FLAG) and when in protein form, they were written in capital, irrespective of 
the host (e.g. 5FLAG). 
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Chapter 1: Introduction 
 
DNA replication is essential for cell viability. When cells duplicate their 
chromosomes, the information needs to be fully and faithfully duplicated. To 
do so, cells must be able to unwind the entirety of DNA molecules, thus 
overcoming the many proteins bound to the DNA and the secondary structures 
that single-stranded DNA can assume. Mounting evidence indicates that a 
major obstacle to fork progression are DNA/RNA hybrids formed during RNA 
transcription. Understanding how this occurs will be one of the major focus of 
this thesis. DNA/RNA hybrids, however, are also essential for DNA replication, 
since DNA synthesis requires an RNA primer. These primers are removed 
before the end of DNA replication as RNA molecules are more labile than DNA 
and stretches of RNA might impede the enzymatic activities of processive 
DNA polymerases. Some organisms, however, have evolved to use RNA 
nucleotides incorporated into the genome as a marker for programmed DNA 
recombination. A notable example of this phenomenon occurs at the mating 
type locus (mat1) in Schizosaccharomyces pombe. The mechanisms used to 
establish this marker and the role of DNA Polymerase α in this process is also 
a major focus of this thesis. 
 
In this introduction, I will briefly introduce the eukaryotic cell cycle, before 
focusing on the S phase and the process of DNA replication. I will introduce 
several components of the replication machinery (the replisome) and will then 
go on to describe several obstacles to DNA replication that forks must 
overcome during DNA synthesis. I will focus particularly on (1.) programmed 
replication fork DNA-protein barriers and (2.) DNA/RNA hybrids as 
barriers. As an example of the former, I will introduce the mating-type 
switching mechanism of Sz. pombe and how cells use such a barrier to 
create an RNA imprint (or marker) that causes DNA recombination in the 
subsequent cell cycle. As an example of the latter kind of barriers, I will focus 
on the obstacle represented by RNA transcription to fork progression. I will 
describe how cells cope with R-loops (an intermediate of the transcription 
process), and focus on the function of the DNA/RNA helicase Sen1. Finally, I 
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will describe the known functions of Sen1 including in transcription termination 
and in maintenance of genome stability.  
 
1.1 The Cell Cycle and DNA Replication 
 
The life cycle of a cell follows an ordered and pre-programmed pattern of 
events known as the cell cycle. Cells are fated to follow this sequence of 
events unless under special circumstances. These include quiescence (such 
as in terminally-differentiated neurons) and loss of genetic material (such as 
erythrocytes). The emergence of the cell cycle in evolution is ancient and 
serves the crucial purpose of quality-controlling newly-duplicated DNA prior to 
irreversible division of genetic material between two sister cells. 
Notwithstanding quiescence (G0), the cell cycle can be divided in interphase 
and mitosis where DNA is packaged in chromosome pairs that can be 
conveniently divided. Interphase can be further divided in G1 (pre-DNA 
synthesis gap), S phase where cells duplicate their DNA and G2 (post-DNA 
synthesis gap). The boundaries between the different phases are not always 
easily discernible. For instance, whilst cytokinesis coincides with the end of 
the mitotic cycle in most organisms, in the fission yeast, Schizosaccharomyces 
pombe, cytokinesis is delayed until the end of the subsequent S phase (Fig 
1.1).
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Figure 1.1. The cell cycle follows a patterns of events that is species-
specific. The duration of the cell cycle also varies according to the species 
and, in multicellular organisms, according to cell types. Typically, human cells 
will complete one cell cycle in 24 h whilst the model organisms S. cerevisiae 
and Sz. pombe will go through several cell cycles in a day. 
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Progression from one phase of the cell cycle to the next is stringently regulated 
and is mediated through the interplay of activation of cyclin-dependent protein 
kinases (CDK) and their inactivation by the anaphase-promoting 
complex/cyclosome (APC/C). The protein kinases are made up of two 
components: a cyclin-dependent kinase and its cyclin co-factor. Several 
phase-specific cyclins have been identified. In the model organism 
Saccharomyces cerevisiae, the cyclin-dependent kinase that regulates the cell 
cycle is Cdc28 and it is activated by nine different cyclins (Clb1-6 and Cln1-3) 
(Mendenhall  and Hodge 1998).  
 
Three of these cyclins (Cln1, Cln2 and Cln3) are required at the G1-S 
boundary. Cln1 and Cln2 are strictly G1-specific and are involved in the 
decision to commit cells to the mitotic cell cycle, cell growth, degradation of 
the kinase inhibitor Sic1 and other functions. Unlike both CLN1 and CLN2, 
CLN3 is expressed throughout the cell cycle but its transcription is slightly 
raised at the M-G1 boundary (Tyers et al., 1993). In fact, Cln3-Cdc28 is 
required for transcription of CLN1, CLN2, CLB5 and CLB6. However, Clb5-
Cdc28 and Clb6-Cdc28 are inactivated by Sic1 until the latter is degraded by 
Cln1-Cdc28 and Cln2-Cdc28. This allows Clb5 and Clb6 to initiate S phase. 
Two other cyclin genes, CLB3 and CLB4, are transcribed optimally at the 
onset of S phase and plateau until late anaphase. Clb3-Cdc28 and Clb4-
Cdc28 seem to contribute partially to the initiation of S phase but are also 
involved in spindle formation. A final pair of cyclin genes (CLB1 and CLB2) 
exist whose transcriptions peak prior to anaphase. Both Clb1-Cdc28 and Clb2-
Cdc28 contribute, albeit to different extents, to the mitotic event.  
 
Besides cyclin-dependent kinases, the APC/C is another major player in cell 
cycle progression. The APC/C is an essential, multi-subunit (5 subunits in 
Drosophila melanogaster, 12 subunits in vertebrates and 13 subunits in S. 
cerevisiae) E3 ubiquitin ligase (Peters, 2006). The APC/C influences 
progression through the cell cycle by polyubiquitinating cyclins, targeting them 
for degradation by the 26S-proteasome. Importantly, the APC/C requires a co-
factor to be functional. Indeed, by metaphase, the APC/C is phosphorylated 
by CDK, allowing it to associate with one of its co-factors, Cdc20 (Peters, 
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2006). APC/CCdc20 selectively tags S phase and mitotic cyclins for 
polyubiquitination. This inactivates the CDK, allowing its substrates to undergo 
dephosphorylation, a critical event for the progression of mitosis. APC/CCdc20 
also mediates the degradation of securin. Securin is an inhibitor of separase, 
a protease that digests a subunit of cohesin (a complex that holds sister 
chromatids together). As such, the APC/C is essential for the transition from 
metaphase to anaphase. Cyclin degradation leads to dephosphorylation of the 
APC/C. This promotes its dissociation from Cdc20, thus permitting its 
association with a different co-factor, Cdh1. APC/CCdh1 degrades Cdc20, 
promoting origin licensing in G1. Once cells enter S phase however, 
phosphorylation of APC/C mediates the dissociation of Cdh1 from the 
cyclosome, greatly reducing its activity in S phase (Peters, 2006).  
 
Successful completion of the cell cycle necessitates the satisfactory 
completion of individual phases within the cell cycle prior to progression to 
subsequent phases. For instance, fusing of S and G2 cells triggers premature 
condensation and mitotic entry of S phase nuclei, leading to chromosomal 
fragmentation (Rao and Johnson, 1970). Meanwhile, defects in chromosome 
attachment to the spindle lead to aneuploidy and stalling of replication forks 
can lead to un-replicated stretches of DNA, eventually causing non-disjunction 
between sister chromatids and DNA double-stranded breaks. Thus, to ensure 
that the different processes within the cell cycle occur in the correct order and 
with tolerably low levels of error, cells have evolved several monitoring points 
known collectively as cell cycle checkpoints. Checkpoints involve delaying the 
entry into a subsequent phase of the cycle until some threshold is reached or 
until a particular problem is dealt with. For example, cell size checkpoints 
depend on cells reaching a certain critical size and these are known to exist in 
G1 and G2, but their position within the cycle is species-specific (Barnum and 
O'Connell, 2014). The intra-S phase checkpoint plays a crucial role at stalled 
replication forks by regulating and protecting them, and preventing the 
progression into the G2/M phases of the cell cycle. The DNA damage 
checkpoint, similarly, stalls entry into the following phase of the cell cycle until 
damaged DNA is repaired. Finally, the mitotic spindle checkpoint prevents 
premature degradation of cyclins and securin via the APC/CCdc20 upon 
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unproductive occupation of kinetochores in metaphase. The different 
checkpoints are summarized in (Barnum and O'Connell, 2014). Whilst the 
discovery of cyclins was made in sea urchin eggs by Timonthy Hunt (Evans et 
al., 1983), the CDK was originally identified and cloned in Sz. pombe by Paul 
Nurse (Nurse and Bissett, 1981) and mutants of the genes required for cell 
cycle control (cdc) were originally identified in S. cerevisiae by Leyland 
Hartwell (Hartwell et al., 1973). Hunt, Nurse and Hartwell would go on to share 
the 2001 Nobel Prize in Physiology or Medicine for their discoveries of key 
regulators of the cell cycle.   
 
Interestingly, the S phase represents the most dangerous part of the cell cycle. 
During replication, DNA is unwound by means of the replicative helicase and 
single-stranded DNA (ssDNA) is stabilized by recruitment of the replication 
protein A (RPA). This prevents re-annealing prior to DNA duplication. 
However, in this configuration, the DNA is especially prone to damaging 
agents. Indeed, in yeast, a marker for DNA damage, Rad52-foci, is elevated 
several fold in S phase compared to other parts of the cell cycle (Lisby et al., 
2001). Nonetheless, DNA replication is an absolute necessity as it duplicates 
genetic material to be shared precisely equally between two sister cells. 
 
In the following chapter, I will illustrate how eukaryotic cells ensure the 
complete and faithful duplication of their chromosomes.  
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1.2 DNA Replication 
 
1.2.1 Origin Firing 
 
Prior to entering S phase, origins of replication (loci within the genome from 
which replication is initiated) need to be licensed. In eukaryotes, the origin 
recognition complex (ORC) consisting of Orc1-6 is recruited at origins. 
Eukaryotic origins, contrary to their bacterial and plasmid counterparts, cannot 
be defined by specific consensus sequences but for the notable exception of 
S. cerevisiae. Nonetheless origins can be defined empirically, for example by 
using different thymidine analogs to label origins in two successive cell cycles 
(Patel et al., 2006) or through mapping of ORC1 binding sites using chromatin 
immuno-precipitations (ChIPs) (Dellino et al., 2013). Genome-wide 
identification of Okazaki fragments can also pinpoint the location of origins. 
Indeed, in a landmark work, (Smith and Whitehouse, 2012) exploited a DNA 
ligase mutant in S. cerevisiae to enrich for Okazaki fragments, enabling their 
identification throughout the genome of the yeast. In vertebrates, rapidly 
decreasing levels of a protein called geminin (of which there seems to be no 
orthologues in either budding or fission yeasts) and concomitant increases in 
levels of Cdt1 enable stepwise recruitment of Cdc6 (Cdc18 in Sz. pombe) and 
Cdt1 at ORC-enriched origins. Importantly, Cdt1 forms a hetero-heptamer with 
MCM2-7 (minichromosome maintenance) (Tanaka and Diffley, 2002) that is 
required for loading of MCM2-7 at origins. This enables the sequential loading 
of two hexamers of MCM2-7 at origins with the double hexamers facing one 
another head-to-head (Evrin et al., 2009, Gambus et al., 2011, Remus et al., 
2009).  
 
The MCM2-7 complex is made of six related but non-identical subunits that 
are evolutionarily conserved. These genes were identified through the 
isolation of hypomorphic alleles that were unable to propagate 
minichromosomes (artificial chromosomes containing a centromere and a 
single origin of replication) but did not affect the replication of natural 
chromosomes or minichromosomes with multiple origins (Tye, 1999). The 
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Mcm proteins are part of the AAA+ ATPases family (Forsburg, 2004). The 
MCM2-7 double hexamer loads onto dsDNA but the single hexamer can bind 
ssDNA with high affinity (Bochman and Schwacha, 2008). Moreover, the 
MCM2-7 complex has demonstrable helicase activity in vitro (although it is a 
less processive enzyme than the replicative helicase of which it is a 
constituent) and it has a gate between its Mcm2 and Mcm5 subunits that 
allows the complex to assume a closed or opened conformation on the loaded 
DNA (Bochman and Schwacha, 2008).     
 
In eukaryotes, origin licensing and firing are de-coupled to prevent 
troublesome cases of re-replication and they occur in G1 and S phase 
respectively. Entry in S phase is mediated by activation of S phase dependent 
kinases. In budding yeast, cyclins Clb5 and Clb6 associate with Cdc28 to form 
the CDKs that promote efficient entry into the mitotic S phase (Epstein and 
Cross, 1992, Schwob and Nasmyth, 1993). In fission yeast, two S phase 
cyclins Cig1 and Cig2/Cyc17 associate with Cdc2 to promote the mitotic S 
phase (Bueno and Russell, 1993, Connolly and Beach, 1994, Obara-Ishihara 
and Okayama, 1994) although cells can fire origins by using only the mitotic 
cyclin Cdc13 associated to Cdc2. Defects in S phase progression are 
observable only upon deletion of the cig1, cig2/cyc17 and cdc13 genes (Fisher 
and Nurse, 1996). 
 
The CDK phosphorylates several components required for replisome 
assembly including Sld2 and Sld3-Sld7. This promotes the formation of a 
complex made up of Sld2 (bound to GINS and Polymerase ε), Sld3-Sld7 
(bound to Cdc45) and Dpb11 that is important for productive origin licensing. 
A second kinase, known as the Dbf4-dependent kinase (DDK), consisting of 
Dbf4-Cdc7 in S. cerevisiae and Dfp1-Hsk1 in Sz. pombe, is also critical for 
replisome assembly. Notably, DDK is responsible for the phosphorylation of 
MCM2-7 that is a pre-requisite for recruitment of Cdc45 complexed to Sld3-
Sld7. Phosphorylated Sld2 is required for the recruitment of GINS. The latter 
is made up of Sld5, Psf1, Psf2 and Psf3 (GINS: Go, Ichi, Ni, San are the 
Japanese equivalent of five, one, two and three respectively) (Takayama et 
al., 2003). This enables the co-localization of Cdc45, GINS and MCM2-7, 
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leading to the formation of the CMG helicase. Whilst sub-complexes of MCM2-
7 and the MCM2-7 hexamer itself have demonstrable helicase activity in vitro, 
the replicative helicase is the CMG (Ilves et al., 2010). Sld2 also recruits 
Polymerase ε. The CMG associates with Polymerase ε to form the CMGE 
holoenzyme. The polymerase and helicase within the CMGE co-operate 
functionally (Langston et al., 2014) but little is known about the role 
Polymerase ε could play in unwinding of the double helix. The CMG itself is at 
the centre of a dynamic machinery used to replicate genomes called the 
replisome. Subunits of the replisome associate with one another with different 
affinities under physiological conditions. 
 
The exact molecular functions of Cdc45 and of the GINS complex within the 
CMG are yet to be elucidated. GINS is required for bridging Cdc45 and the 
MCM2-7 complex and for binding of the CMG helicase to Ctf4 (Gambus et al., 
2006, Gambus et al., 2009). In vitro analysis indicate that the only subunit of 
the CMG capable of binding to Ctf4 in isolation is Sld5 (Tanaka et al., 2009a). 
 
Association of GINS and Dpb11 to origins are mutually dependent (Takayama 
et al., 2003) and the interaction between GINS and Dpb11 is important for 
efficient initiation at origins (Tanaka et al., 2013). The Dpb2 subunit of 
Polymerase ε was shown to physically interact with Psf1 in a yeast-two-hybrid 
assay (Takayama et al., 2003) and in vitro assays using the Polymerase ε and 
GINS purified from Xenopus cell extracts revealed that GINS potentiates the 
catalytic activity of the polymerase (Shikata et al., 2006). Y2H, IPs and in vitro 
reconstitution assays suggest that N-terminus of Dpb2 interacts with the C-
terminal B-domain of Psf1 in yeast (Sengupta et al., 2013). This enables 
tethering of Pol ε to the CMG helicase and, thus, to the rest of the replisome. 
In fact, when a variant of Dpb2 lacking the N-terminus (first 158 residues) is 
expressed after depletion of endogenous Dpb2 in G1-arrested cells, the CMG 
cannot be assembled and cells are unable to sustain replicative synthesis of 
DNA (Sengupta et al., 2013). By contrast, depletion of endogenous Dpb2 in 
G1-arrested cells followed by expression of Dpb2 (1-168) led to formation of 
the CMG and progression in S phase once the cells were released from G1-
arrest. Moreover, once the CMG is assembled, Dbp2 but not Dpb2 (159-689) 
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can associate with the CMG. As such, the N-terminal domain of Dpb2 is 
required not only for CMG assembly at origins but is also important for Pol ε 
to load onto on-going forks during S phase, at least in yeast. Both functions 
require the Psf1 subunit of GINS. Cdc45 is more enigmatic still. It is a homolog 
of the bacterial RecJ ssDNA exonuclease and is structurally very similar to 
RecJ in spite of limited similarity in primary sequence (Simon et al., 2016). 
However, of four active site-motifs, three are inactivated in Cdc45 (Simon et 
al., 2016). This contributes to the lack of exonuclease activity of the protein in 
vitro (Krastanova et al., 2012). Due to its similarity with RecJ, Cdc45 binds to 
long ssDNA (80-120 bases long) antagonizing its interaction with the MCM2-
7 complex (Bruck and Kaplan, 2013). This may be useful for fork pausing. 
Cdc45 also interacts with RPA, at least in humans (Szambowska et al., 2017). 
In gel shift assays, Cdc45 did not bind to ssDNA in isolation but enhanced the 
binding of RPA to ssDNA. Removal of residues spanning positions 154-164 
or 137-188 in Cdc45 led to a complete loss of Cdc45-dependent RPA loading 
on ssDNA. Cdc45 also binds to branched DNA and mediates limited passive 
unwinding of 3’-overhanged substrate (Szambowska et al., 2014). The authors 
of the study go on to suggest that Cdc45 could work as a wedge, facilitating 
unwinding by the replicative CMG helicase. Cdc45 specifically interacts with 
the leading strand extended by the CMG helicase. Mutations that abrogate 
this interaction lead to diminished CMG activity (Petojevic et al., 2015). The 
authors suggest that Cdc45 prevents slippage of DNA from the opened 
channel between Mcm2 and Mcm5 when the MCM2-7 is in its opened 
conformation.  
 
Although the exact contribution of the individual subunits of CMG remains to 
be determined, the formation of the CMG allows the rearrangement of the 
inactive MCM2-7 double hexamer (arranged previously head-to-head by virtue 
of interactions between the N-terminal domains of their constituent proteins) 
into two 5’-3’ DNA helicases. Mcm10 is also required for activation of the CMG 
helicase. Depletion of Mcm10 does not affect CMG assembly but prevents the 
CMG from moving along forks (Kanke et al., 2012, van Deursen et al., 2012, 
Watase et al., 2012). Mcm10 participates in remodelling of the CMG to a 
functional helicase by either triggering a conformational change in Mcm2, 
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exposing a buried segment of the protein or by recognizing and binding to this 
segment (Lõoke et al., 2017). The activated CMG can unwind chromosomal 
DNA and translocate away from origins. Several models are now proposed for 
the mechanism of movement of the CMG derived from high resolution cryo-
EM images of CMG from yeast and Drosophila (Abid Ali et al., 2016). 
 
The unwound DNA is then used as a template for synthesis of new DNA. The 
enzymes responsible for DNA synthesis are the replicative DNA B-family 
polymerases: Polymerase α, Polymerase δ and Polymerase ε (see Section 
1.3). In vitro work in John Diffley’s lab indicates that cooperative action 
between the CMG and DNA polymerases is sufficient for basal replication at 
slow, non-physiological rates (Yeeles et al., 2017). Moreover, a minimal 
leading replisome made up of Pol ε, RFC, PCNA, and RPA from S. cerevisiae 
can only achieve rates of 0.26 kb/min on average (Georgescu et al., 2014) 
while in vivo speeds of replisome movement have been measured between 1-
2 kb/min (Conti et al., 2007, Hodgson et al., 2007, Sekedat et al., 2010). 
However, in the presence of the fork protection complex (Csm3, Mrc1 and 
Tof1) and the clamp loader, PCNA, in vitro replisome speeds of up to 1.9 
kb/min can be achieved, comparable to physiological speeds (Yeeles et al., 
2017). Intriguingly, PCNA would seem to speed up both leading and lagging 
strand synthesis.   
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1.3 Diverse Roles for Polymerase α 
 
DNA Polymerase α, Polymerase δ and Polymerase ε are multi-subunit 
enzymes required for the duplication of eukaryotic genomes. Their multiple 
subunits are mostly conserved (Fig 1.2) and the largest subunit from each 
enzyme is responsible for polymerizing DNA from deoxyribonucleotides 
(dNTPs). These subunits are all from the B-family polymerases and they adopt 
a right-hand conformation. In brief, their structure consists of palm domain that 
houses the catalytic site, the fingers domain that interacts with incoming 
dNTPs and a thumb domain that holds the nucleic acid substrate close to the 
catalytic site (Perera et al., 2013).  
 
 
Figure 1.2. The replicative polymerases are multi-subunit enzymes and 
are conserved across eukaryotes. 
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Uniquely, Polymerase α also has primase activity mediated by its Pri1 (Spp1 
in Sz. pombe and Prim1 in humans) and Pri2 (Spp2 in Sz. pombe and Prim2 
in humans) subunits. The primase is responsible for synthesis of a small 
stretch of RNA (~10 nucleotides long) called the RNA primer prior to an 
intramolecular hand-off to the catalytic Pol1 subunit of Pol α (Perera et al., 
2013). Synthesis of RNA primers is crucial as DNA polymerases cannot 
synthesize DNA de novo. Indeed, the Pol1 subunit recognizes and binds to 
the DNA/RNA hybrid left over after priming as the DNA/RNA substrate adopts 
an A-DNA conformation. Upon synthesis of DNA at the 3’ end of the DNA/RNA 
hybrid, the substrate gradually adopts a conformation between A- and B-DNA, 
increasingly constraining Pol1’s grip as the enzyme translocates to the newly 
synthesized 3’-end of the substrate until the latter adopts a fully B-DNA 
conformation and can no longer be used as a substrate by Pol1 (Perera et al., 
2013). This feature probably acts as a molecular cue for replication to switch 
to a more processive enzyme. All the DNA polymerases replicate in a 5’ to 3’ 
direction. Consequently, on the leading strand then, Pol α is theoretically 
needed only once upon origin firing whilst, on the lagging strand, it is 
continuously required for repeated priming and extension of primers (Fig 1.3). 
Limited synthesis of DNA by Polymerase α leads to small stretches of DNA 
that are handed over to a more processive enzyme that go on to synthesize 
around 200 bases or more. These longer stretches of DNA are known as 
Okazaki fragments. After extension, these Okazaki fragments are processed 
by the removal of the RNA primer and their substitution with corresponding 
DNA segments. Although juxtaposed, the resulting DNA fragments have nicks 
between their 5’ and 3’ ends that need to be healed by ligases (Cdc9 and 
Cdc17 in budding and fission yeast respectively). Deletion of the POL1/pol1 
gene is lethal in both budding and fission yeasts (Francesconi et al., 1993) 
and depletion of Pol1 in fission yeast using the AID degron leads to a tight 
arrest in early S phase, similar to treatment with HU (Kanke et al., 2011).  
 
In budding yeast, Polymerase α has been shown to interact with Cdc13 and 
abrogation of this interaction leads to lengthening of telomeres (Sun et al., 
2011). Meanwhile, in fission yeast, Pol1 was also found to be necessary for 
both imprinting at a specific locus in the genome and is involved in silencing 
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of donor loci (Ahmed et al., 2001, Singh and Klar, 1993, Nakayama et al., 
2001a). Both the silencing and imprinting processes are important for cell-type 
switching in this yeast. This will be discussed further in Section 1.9. 
 
 
 
Figure 1.3. Polymerase α is differently enriched on the leading and 
lagging strands. On leading strands, the enzyme is required at origins. 
However, because polymerases synthetize DNA in a 5’ to 3’ direction, lagging 
strand synthesis occurs discontinuously, so that more molecules of 
Polymerase α are required on lagging strands.  
 
  
	 29	
1.4 The Processive DNA Polymerases δ and ε 
 
After synthesis of the RNA primer and a small stretch of DNA, there is 
intermolecular hand-off of the nucleic acid substrate from Polymerase α to 
more processive enzymes, notably DNA Polymerases δ and ε. The catalytic 
subunits of DNA Polymerases δ and ε are Pol3 and Pol2 respectively. As well 
as their polymerization site, these proteins also possess 3’-5’ exonuclease 
activities that ensure high fidelity duplication of the DNA template by removing 
nucleotides incorrectly incorporated into the DNA molecule. Both enzymes 
then are well suited for processive DNA synthesis but the division of labour 
between the two of them, based solely on their structures, has been difficult to 
predict. To determine which of the two proteins synthesized the leading and 
lagging strands, mutagenic alleles of POL2 and POL3 with specific mutation 
signatures were used to replicate the URA3 marker gene in S. cerevisiae, 
placed in close proximity to an origin, in both orientations. Using this assay, it 
was determined that Polymerases ε synthesizes primarily the leading strand 
whilst Polymerases δ is mainly functional at lagging strands. Results using 
alleles of the enzymes that encode for variants of the proteins without their 
exonuclease activities also suggest this particular configuration of labour 
division. This is reviewed in (Kunkel and Burgers, 2008). A similar experiment 
was conducted in Sz. pombe, using mutagenic cdc20/pol2 and cdc6/pol3 
alleles that incorporate elevated levels of ribonucleotides in the genome 
(Miyabe et al., 2011). Using theses alleles, it was found that Pol ε synthesizes 
the leading strand of a reporter gene whilst Pol δ synthesizes its lagging 
strand. This suggests that the division of labour between these two enzymes 
is conserved evolutionarily (Miyabe et al., 2011). Moreover, a technique was 
created where the global incorporation of ribonucleotides within the genome 
of Sz. pombe could be assessed (Keszthelyi et al., 2015). Using this method 
in strains carrying either the mutagenic cdc20/pol2 and rnh201Δ or the 
mutagenic cdc6/pol3 and rnh201Δ, it was shown that the Pol ε synthesizes 
leading strands and Pol δ synthesizes lagging strands throughout the genome 
of Sz. pombe (Daigaku et al., 2015). At efficient origins, however, it was 
determined that there is a bias for Pol δ to initiate leading-strand replication, 
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followed by an exchange for Pol ε (Daigaku et al., 2015). Purely in vitro work 
also suggests that Pol δ and ε function at lagging and leading strands 
respectively (Yurieva and O’Donnell, 2016). 
 
Yet, deletion of the N-terminus of Pol2 in both S. cerevisiae and Sz. pombe is 
not lethal (Dua et al., 1999, Feng and D’Urso, 2001). The N-terminus encodes 
the catalytic activity of the protein, suggesting that Polymerase δ can, at least 
under such circumstances, replicate both leading and lagging strands in both 
model organisms. Moreover, in human cells infected with the SV40 virus, Pol 
δ in conjunction with Pol α, but not Pol ε were found to crosslink to the viral 
DNA (Waga et al., 1994). Some genetic evidence also seems to indicate that 
Pol δ is the major replicative polymerase that synthesizes both leading and 
lagging strands of DNA whilst Pol ε is mostly involved in correcting mistakes 
on the leading strand (Johnson et al., 2015). Nevertheless, the current 
consensus is that Pol ε and Pol δ synthesize the leading and lagging strands 
respectively. 
 
Both DNA Polymerases δ and ε are known to bind to PCNA (Chilkova et al., 
2007). PCNA itself is a conserved protein that forms a homotrimeric complex 
that acts as a clamp by encircling DNA (Krishna et al., 1994, Yao et al., 1996). 
It is loaded onto DNA by RFC1 (replication factor C) and the RFC2-5 complex 
(Majka and Burgers, 2004). PCNA also binds to a number of proteins and, in 
doing so, it tethers these proteins to the DNA. There are differences between 
the interaction of these two polymerases with PCNA. Surface plasmon 
resonance studies have revealed that Pol ε interacts weakly with PCNA whilst 
Pol δ interacts strongly with it. This is offset by the fact that Pol ε has a strong 
affinity for dsDNA, ssDNA and primed DNA whilst Pol δ does not. In vitro 
primer extension assays also demonstrated that binding to PCNA stimulates 
Pol ε processitivity ~6-fold whilst binding to PCNA stimulates Pol δ 
processitivity at least ~100 fold (Chilkova et al., 2007), suggesting that PCNA 
is critical for the functioning of Pol δ.  
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Proteins that interact with PCNA are known to do so through their respective 
PIP box (PCNA interacting peptide) (Warbrick, 1998). Besides polymerases, 
other proteins also encode PIP boxes, including the Flap endonucleases Fen1 
and the DNA damage protein Rad2 (Yu et al., 2014). In yeast, the Pol2 subunit 
of Pol ε contains a PIP box but point mutagenesis of the motif does not affect 
growth, suggesting that the putative physical interaction between Pol2 and 
PCNA is not essential for Pol ε’s functions during replication (Dua et al., 2002). 
However, any difference in binding-affinity to PCNA between wildtype Pol2 
and its PIP box mutants was not tested (Dua et al., 2002). Interestingly, unlike 
both Pol α and δ, Pol ε has a P domain that allows it to encircle dsDNA on its 
own (Hogg et al., 2014). Evolution of this novel P domain might perhaps 
compensate for the inactivation of the PIP box within Pol ε. PCNA, however, 
is still important to achieve maximal rates during leading-strand synthesis 
(Yeeles et al., 2017). Meanwhile, in Pol δ, the Pol32 subunit contains a PIP 
box whilst a cysteine motif (CysA) in the Pol3 subunit also enables direct 
interaction with PCNA (Johansson and Dixon 2013, Netz et al., 2011). This 
dual method of Pol δ to interact with PCNA highlights the functional importance 
of this interaction during DNA replication.  
 
The inner surface of the PCNA clamp is lined with lysine- and arginine-rich α-
helices and it is ~35 Å wide whilst the double helix which it encircles is ~24 Å 
wide (Wing et al., 1980). The DNA is threaded through PCNA at a 15° tilt (De 
March et al., 2017). Crystallographic data suggest that five basic residues 
(K20, K77, R149, H153 and K217) from one of the PCNA isomer as well an 
additional basic residue (K80) on the adjacent isomer within the same trimer 
form polar interactions with five consecutive phosphate in one strand of the 
DNA backbone (De March et al., 2017). Simulations also suggest that the 
PCNA trimer can stably interact with both strands of DNA where the protein 
will rotate in a cogwheel-like fashion shifting interactions between its residues 
from antecedent or succeeding phosphates on the DNA backbone to the 
phosphates immediately adjacent (De March et al., 2017). As such, when in 
this coupled state to DNA, the PCNA trimer will move by 1 base pair at a time, 
contrary to its uncoupled state where it freely slides over DNA (Yao et al., 
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1996). The coupled state enables Pol δ to translocate quickly enough for 
processive synthesis of DNA. 
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1.5 Other Proteins that assist DNA Replication 
 
The CMG is at the centre of a dynamic assembly of proteins known as the 
replisome. The identity of the proteins within the replisome were initially 
identified by consecutive immuno-precipitation of GINS and MCM2-7 followed 
by mass spectrometric analysis of the immuno-precipitated proteins (Gambus 
et al., 2006, Gambus et al., 2009). Given the nature of screens however, it is 
likely that other replisome components exist. Table 1.1 lists some of the 
replisome proteins identified. For brevity, I will focus on components of the fork 
protection complex (Csm3, Mrc1 and Tof1), as well as Ctf4 that forms a 
homotrimeric complex and works as a hub to tether proteins to the CMG 
helicase (Simon et al., 2014). As such, the recruitment of accessory replisome 
components can be thought as either Ctf4-dependent or Ctf4-independent.  
 
Table 1.1. Accessory proteins of the replisome 
Identity Orthologue 
(Sz. pombe) 
Cft4-dependent 
Ctf4 Mcl1 Not applicable.  
Top1 Top1 No 
Tof1 Swi1 No. Physically interacts with Top1. Also 
interacts with phosphorylated CMG and 
MCM2-7. GINS dependent. 
Csm3 Swi3 No 
Mrc1 Mrc1 No 
Mcm10 Mcm10 No (Via Pol α and MCM2-7) 
Spt16 Spt16 No  
Pob3 Pob3 No  
Dna2 Dna2 Yes 
Tof2 Not identified Partially. Also interacts with Top1.  
Dpb2 Dpb2 Partially. (Note: Dpb2 is a subunit of Pol ε 
but it can also function as an accessory 
protein). Also interacts with Psf1. 
Chl1 Chl1 (predicted) Yes. 
Dia2 Pof3 Partially. Also interacts with Mrc1. 
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Mms22 Mus7 Yes. Interacts with WD40 domain. 
 
 
Ctf4 was originally isolated as a binding partner of Pol1 in S. cerevisiae (Miles 
and Formosa, 1992b). Both Ctf4 and its interaction with Pol1 are conserved 
as seen with the Sz. pombe orthologue, Mcl1 (Williams and McIntosh, 2002, 
Williams and McIntosh, 2005) as well as with the vertebrate orthologue, AND-
1 (Zhu et al., 2007). Interestingly, whilst ctf4∆ is viable in S. cerevisiae, mcl1∆ 
is conditionally lethal in Sz. pombe and the depletion of the vertebrate 
orthologue of Ctf4 (AND-1) leads to incomplete DNA replication in Xenopus 
(Zhu et al., 2007) and in humans (Bermudez et al., 2010). Besides a role in 
DNA duplication and metabolism, Ctf4 is also required for genome stability 
and for sister chromatid cohesion (Bermudez et al., 2010, Gosnell and 
Christensen, 2011, Hanna et al., 2001, Kouprina et al., 1992, Miles and 
Formosa, 1992a, Tanaka et al., 2009b, Williams and McIntosh, 2002, Zhou 
and Wang, 2004, Zhu et al., 2007). 
 
In yeast, Ctf4 is made up of three subunits, consisting of a WD40 domain in 
its N-terminus spanning residues 2-383 (Gambus et al., 2009), a six-bladed β-
propeller domain as well as an α-helical bundle at its C-terminus (Simon et al., 
2014). Noteworthy is a second WD40 predicted in the C-terminal half of the 
protein (Simon et al., 2014). Crystallographic data have revealed that Ctf4 
trimerizes by virtue of its central β-propeller domain. This trimer is soluble and 
both the WD40 and α-helical domains extend away from the plane formed by 
the β-propeller trimer, primed for interaction with a host of proteins and 
perhaps with DNA (Simon et al., 2014). Ctf4 interacts with both Pol1 and Sld5 
by virtue of its C-terminus (Gambus et al., 2009, Tanaka et al., 2009a). The 
corresponding domain in AND-1 is also required for interaction with PolA1 but 
not does not interact with human Sld5 in vitro (Guan et al., 2017). Both Pol1 
and Sld5 requires a CIP box (Ctf4 Interacting Peptide) to interact with Ctf4 
(Simon et al., 2014). The CIP box is composed of the ‘DDIL’ residues at its 
core. Two other proteins have been shown to interact with Ctf4 through their 
CIP box; the flap endonuclease Dna2 that is important in the processing of 
Okazaki fragments (Villa et al., 2016) and the Chl1 DNA helicase that is 
	 35	
important for sister chromatid cohesion (Samora et al., 2016). A second group 
of proteins with a divergent CIP box also bind to Ctf4 (Simon et al., 2014). 
These include the Dpb2 subunit of Polymerase ε and the rDNA-associated 
protein Tof2. Crystallographic data has shown that the two types of CIP boxes 
bind to different residues within the C-terminus of Ctf4. Whether all physical 
interactors of Ctf4 require one of the two types of CIP box however is not 
known but improbable. By virtue of forming a trimer and through its interaction 
with Sld5, Ctf4 acts as a hub that tethers several proteins to the CMG helicase, 
including Pol1. Deletion of CTF4 prevents Pol1 from binding to other 
components of the replisome in S phase and mutation of CIP box of Pol1 also 
abrogates interaction between Pol1 and the replisome (Gambus et al., 2009, 
Simon et al., 2014). This suggests alternative mechanisms that allow Pol α to 
coordinate with forks. Alternatively, Pol α simply needs not coordinate with 
forks.  
 
The fork protection complex (FPC) is a sub-complex of the replisome (Bando 
et al., 2009). It is made up of Csm3, Mrc1 and Tof1. Tof1 was originally 
identified as an interactor of the topoisomerase/gyrase Top1 (Park and 
Sternglanz, 1999). All three proteins are conserved. In Sz. pombe, the 
orthologues are known as Mrc1, Swi1Tof1 and Swi3Csm3 whilst in humans they 
are known as ClaspinMrc1, TimTof1 and TipinCsm3. The association of Csm3 and 
Tof1 to the replisome is co-dependent whilst Mrc1 requires both Csm3 and 
Tof1 to associate efficiently with replisomes (Bando et al., 2009). Conversely, 
Mrc1 is not required for either Csm3 or Tof1 to bind to other components of 
the replisome. In Sz. pombe, Swi1Tof1 and Swi3Csm3 form a complex (Noguchi 
et al., 2004) and are mutually dependent for stability (Shimmoto et al., 2009). 
Mrc1 interacts with Swi1 and Swi3 independently of Swi3 and Swi1, 
respectively. The difference between the Mrc1 orthologues of these two yeasts 
can be attributed to a conserved helix-loop-helix motif in the DNA-binding 
domain of Sz. pombe Mrc1 that is not present in the S. cerevisiae orthologue 
(Zech et al., 2015) so that this motif of Mrc1 is exploited for formation of the 
FPC in fission yeast. 
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The FPC is required for efficient replication barrier activities in several 
organisms, including in both budding and fission yeasts as well as in humans. 
For instance, it is required for pausing and stalling at the MPS1 and RTS1 loci 
in Sz. pombe. These are pre-requisite for cell-type switching in the organism. 
The FPC is also required for fork arrest prior to entry at the highly-transcribed 
rDNA loci. This is a conserved function, first identified in budding yeast 
(Mohanty and Bastia, 2004, Kobayashi, 2003) but later expanded to other 
organisms. This is reviewed in (Bastia and Zaman, 2014). The FPC is also 
required for efficient arrest at fork barriers at centromeres and telomeres and 
is involved in sister chromatid cohesion (Xu et al., 2007, Smith-Roe et al., 
2011).  
 
Interestingly, Mrc1 is also involved in the intra-S phase checkpoint. In the 
event of replication stress such as fork stalling as a result of obstacles or 
depressed pools of dNTPs (as seen upon hydroxyurea-treatment), cells 
activate a signal transduction pathway that delays exit from S phase until cells 
completely replicate their DNA (Allen et al., 1994, Weinert et al., 1994). This 
is known as the intra-S phase checkpoint. Besides delaying entry into mitosis, 
this checkpoint delays firing of late origins by hyper-phosphorylating the Dbf4 
component of DDK and by phosphorylating Sld3 (Lopez-Mosqueda et al., 
2010, Weinreich and Stillman, 1999, Zegerman and Diffley, 2010) and causes 
global changes in transcriptional activity to promote DNA repair and to reduce 
replication stress (Gasch et al., 2001), such as in the CRT1 gene, an inhibitor 
of transcription of the RNR genes in S. cerevisiae that are responsible for 
synthesis of dNTPs from rNTPs (Huang et al., 1998). The intra-S phase 
checkpoint also serves the purpose of preventing damage-induced fork 
catastrophe (Desany et al., 1998, Lopes et al., 2001, Tercero and Diffley, 
2001). The intra-S phase checkpoint involves an upstream checkpoint kinase, 
Mec1 (Rad3 in Sz. pombe and ATR in humans). Meanwhile, the effector 
downstream kinase Rad53 (Cds1 in Sz. pombe and Chk1 in humans) is 
activated by hyperphosphorylation in response to DNA damage and stress 
(Iyer and Rhind, 2017). 
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Mrc1 is a known mediator of the intra-S checkpoint and works at an 
intermediate step between Mec1 and Rad53 but is phosphorylated by both 
kinases (Alcasabas et al., 2001, Osborn and Elledge, 2003, Tanaka and 
Russell, 2001). Mutations in the MRC1 allele can cause delayed but persistent 
Rad53 activation and further deletion of the RAD9 gene (a mediator that 
activates Rad53 in response to DNA damage) completely abrogates Rad53 
phosphorylation. Depending on the background used, deletion of both MRC1 
and RAD9 is lethal but this can be suppressed by overexpression of RNR1, 
similar to rad53∆ (Alcasabas et al., 2001, Redon et al., 2006). As such, Mrc1 
is required for Rad53 phosphorylation in response to DNA stress and, when 
this pathway is impeded, Rad53 is phosphorylated solely in response to DNA 
damage occurring behind replication forks. This signalling pathway is 
conserved in fission yeast (Zhao et al., 2003). Triple cdc13-1 mrc1∆ tof1∆ 
mutants are characterized by pronounced growth defects, not associated with 
either the cdc13-1 mrc1∆ or cdc13-1 tof1∆ double mutants, highlighting an 
additive effect of the MRC1 and TOF1 deletions as checkpoint mediators 
(Grandin and Charbonneau, 2007). Similarly, in Sz. pombe, both swi1∆ and 
swi3∆ (Noguchi et al., 2003, Noguchi et al., 2004) lead to a pronounced but 
comparable decrease in Cds1 activation upon HU addition whilst mrc1∆ 
reduces Cds1 activation beneath detectable levels in HU-treated cells 
(Tanaka and Russell, 2001).  
 
Taken together, the three components of the FPC (Csm3, Mrc1 and Tof1) 
have distinct roles, especially as mediators of cell cycle checkpoints where 
Mrc1 has a more prominent role. However, they do share some overlapping 
functions such as in stabilizing stalled forks upon encounters with replication 
barriers. These barriers occur throughout the genome and can either be pre-
programmed or arise stochastic. Fork barriers can also be made up completely 
of nucleic acids or be composed of nucleic acid-protein complexes. The 
following chapters will be devoted to these fork barriers, how they challenge 
the process of DNA replication, how forks respond to them and how cells can 
actually use such barriers to their advantage. 
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1.6 Barriers to the Replication Process  
 
During DNA replication, forks do not proceed freely through genomes but 
instead encounter several barriers that can cause fork stalling or even 
replication termination. Some replication fork barriers (RFBs) consist of 
nucleic acids. Often, they will form secondary structures that physically impede 
fork progression. A subset of such nucleic acid fork barriers is made of both 
DNA and RNA and arises during transcription. These are known as R-loops. 
Other fork barriers are composed of DNA-protein complexes. Interestingly, 
cells seem to exploit such barriers at pre-programmed locations to mediate 
useful cellular events such as pausing at the rDNA loci.      
 
1.6.1 Nucleic acid Barriers 
 
There are several subtypes of nucleic acid barriers (Fig 1.4) (Mirkin and Mirkin, 
2007). One of these are hairpins that arise because of inverted repeats. 
Seminal work from the DePamphilis lab has shown that phage DNA encoding 
sequences that lead to hairpin formation can promiscuously cause replication 
termination of Pol α from CV-1 cells (derived from monkey kidney tissue), 
HeLa cells and calf thymus tissue in vitro (Weaver and DePamphilis, 1982). 
These sequences also terminated replication driven by the T4 DNA 
polymerase. In fact, the authors estimated that 28% of replication arrests were 
attributed to such hairpin structures. Similarly, in a study using Pol α extracted 
from D. melanogaster embryos to replicate murine mtDNA cloned into the 
single-stranded M13 vector, it was shown that hairpins structures can cause 
replication stalling (Kaguni and Clayton, 1982).  
 
G-quadruplexes represent a different subtype of nucleic acid barriers. They 
consist of four guanine bases where each guanine forms hydrogen bonds with 
two other guanine bases. The structure is stabilized by cations, chiefly K+. G-
quadruplexes have also been shown to hinder the replication progression. 
Indeed, in vitro assays where G-quadruplexes are stabilized (in the presence 
of K+ ions) cause replication stalling but this pausing is alleviated when the K+ 
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ions is substituted with Na+ or NH4+ or when cations are removed completely 
(Usdin and Woodford, 1995, Woodford et al., 1994, Weitzmann et al., 1997). 
 
A third type of nucleic acid fork barrier is the triplex H-DNA that arises because 
of mirror repeats within DNA. (Mirkin and Mirkin, 2007). The barrier activity of 
H-DNA was demonstrated using in vitro assays where (TCTCTC)n and 
(GAGAGA)n mirror repeats tracts were cloned into the M13 vector. Replication 
of these substrates by either calf thymus Pol α, the Klenow fragment or Taq 
polymerase was prematurely terminated in the middle of the individual tracts. 
However, either using analogs of dNTPs unable to form hydrogen bonds with 
other bases or pre-incubating templates with single-stranded DNA binding 
protein from E. coli prevented the premature replication termination of the 
template (Baran et al., 1991, Lapidot  et al., 1989). This is consistent with a 
mechanism whereby the single-stranded part of the template folds back and 
anneals to the newly synthesized DNA, sand-witching and effectively trapping 
the polymerase extending the mirror repeat. 
 
Yet another type of nucleic species that hinders fork progression are the 
DNA/RNA hybrids. These include R-loops that will be the focus of future 
sections in this chapter. DNA/RNA hybrids also include RNA primers 
synthesized by the primase subunit of Pol α hybridized to their template 
(Joyce, 1997, Nick McElhinny et al., 2010a, Nick McElhinny et al., 2010b). So 
far, no reports have yet implicated these RNA primers as barriers to replication 
forks, perhaps on account that they are efficiently removed by the flap 
endonucleases Fen1 and Dna2 (Rossi and Bambara, 2006). However, primer 
release on the lagging strand is rate-limiting in the T7 replisome-mediated 
lagging strand synthesis (Hernandez et al., 2016) whilst T7 primase has been 
shown to act as a brake to prevent leading-strand synthesis from synthesizing 
exceedingly ahead of the lagging strand (Lee et al., 2006). In neither study 
however have RNA primers themselves been shown to physically impede fork 
progression and it is unlikely that RNA primers can obstruct fork progression 
as in vitro DNA synthesis by Pol δ on naked DNA is essentially unrestricted 
and the polymerase efficiently displaces the RNA primer in the process 
(Devbhandari et al., 2017).  
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Ribonucleotides incorporated into the genome constitute yet another type of 
DNA/RNA hybrid that can act as fork barriers. Indeed, whilst replicative 
polymerases can polymerize past a ribonucleotide incorporated within the 
template DNA in vitro, a subpopulation of forks will terminate at those 
ribonucleotides (Watt et al., 2011). As for ribonucleotides inserted in the 
genome in vivo, they are efficiently removed by the RNase H2 endonuclease 
(Nick McElhinny et al., 2010b). Absence of RNase H2 leads to genome-wide 
instability in yeast (O'Connell et al., 2015). Moreover, yeast strains carrying 
both the pol2-M644G (an allele that encodes for a Pol2 variant that 
incorporates ribonucleotides in the genome 11-times more frequently than its 
wildtype counterpart) and the rnh201∆ alleles (a deletion mutant of one subunit 
of RNase H2) progress slowly in S phase. The triple pol2-M644G rnh1∆ 
rnh201∆ mutant is not viable, suggesting that RNase H1 is also involved in 
removal of individual ribonucleotides inserted into the genome (Lazzaro et al., 
2012). The rnh1∆ rnh201∆ mutants are characterized by hyper-
phosphorylated Rad53 upon hydroxyurea treatment, indicative of replication 
stress (Lazzaro et al., 2012). As such, ribonucleotides can constitute a barrier 
to replication forks. In fact, in Sz. pombe, two ribonucleotides incorporated at 
a particular locus in the genome (MPS1, mat1-pausing site 1) is thought to 
stall replication, leading to fork reversal and, eventually, to synthesis-
dependent strand annealing (Vengrova and Dalgaard, 2004, Vengrova and 
Dalgaard, 2006). This contributes to cell-type switching in this yeast.
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Figure 1.4. Nucleic acid fork barriers assume secondary structures that are refractory to fork progression. Several non-B 
DNA nucleic acid can act as fork barriers. These include, but are not limited to: (A) Inverse repeats within the genome that can form 
hairpins and cruciform structures, (B) G-rich sequences that can be appropriate substrates for the formation of G-quadruplexes, (C) 
Mirror repeats that give rise to H-DNA that can trap replisomes during DNA synthesis.  
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1.6.2 DNA-Protein Complexes as Replication Fork Barriers   
 
Several DNA-protein complexes that act as barriers to forks have also been 
identified and these complexes have diverse roles. In prokaryotes, replication 
termination depends on such DNA-protein complexes. Replication begins at a 
single origin (oriC) and proceeds in a bi-directional manner, halving the 
genome in two replichores. In theory, because of the different contents of each 
replichore in terms of DNA accessibility and the stochastic nature of DNA 
damage, the two leading strands (and their associated replisomes) need not 
meet at the opposite pole to the oriC and the forks can fuse at any place other 
than the oriC itself. In actuality, this scenario is averted by the presence of 
replication termination sites (Ter) that form a replication trap where forks can 
travel past a point in one direction (permissive end) but not in the opposite 
direction (non-permissive end). In E. coli, monomeric trans-acting Tus proteins 
(terminus utilization substance) bind to each of ten 23 bp Ter sites (TerA-J) 
arranged in two opposite orientations and these Ter-Tus DNA-protein 
complexes somehow enable polar arrest of replication by counteracting the 
activity of the replicative helicase (DnaB) in an orientation-specific manner (Fig 
1.5A) (Mirkin and Mirkin, 2007). Three different mechanisms have been 
suggested to account for this polar termination. Firstly, the crystal structure of 
the Tus protein complexed to Ter DNA was obtained and revealed that the 
Tus protein has two protruding α-helical regions and forks stall when 
approaching on the side of those protrusions (Kamada et al., 1996). The Tus 
protein has another asymmetric feature, notably its L1 loop, and forks stall 
when approaching on the side of this loop. Thus, this L1 loop could also 
contribute to polar fork termination.  
 
An alternative or complementary model originated from the observations that, 
although binding to the Ter sites was absolutely necessary for replication 
arrest, there were some point mutants of TerB to which the Tus protein 
retained wildtype affinity but where those TerB mutants were nonetheless 
characterized by defects in replication termination in vivo (Coskun-Ari and Hill, 
1997). Moreover, the interaction between Tus and TerB was differently 
affected by mutations depending on their location relative to the site of fork 
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arrest (Neylon et al., 2000). In fact, in vitro experiments have shown that the 
helicase activity of the DnaB helicase causes efficient dissociation between 
Tus and TerB when approaching from the permissive end of the arrest site. 
But, when the DnaB helicase approaches from the non-permissive end, it 
causes a newly unwound cytosine to flip and bind within a cleft within the Tus 
protein (Mulcair et al., 2006). Importantly, this cytosine is stringently conserved 
in the different Ter sequences. In the flipped base configuration, the DnaB 
would seem to be unable to displace the Tus protein anchored to its Ter site 
on the DNA, leading to polar fork arrest. Interestingly, cloning arrays of TerB 
as well as the Tus gene (under the GAL1 promoter) in S. cerevisiae leads to 
a polar pausing event in S phase that is independent of either Tof1 or Rrm3. 
Contrary to E. coli’s DnaB however, the CMG helicase is not permanently 
arrested at the ectopically-cloned Ter sites (Larsen et al., 2014). 
 
In B. subtillis, a similar mechanism is used to prevent collisions between two 
replisomes. The B. subtilis genome carries nine 29 bp Ter sites (TerI-IX) 
located at the opposite pole to its oriC. These Ter sequences do not share 
sequence homology with E. coli’s Ter sites nor are they predicted to adopt 
similar secondary structures (Wilce et al., 2001). The Ter sequences are 
conserved amongst themselves and consist of two functional sites (A and B) 
to which their cognate binding partner can bind. This protein is known as the 
replication terminator protein (RTP). RTP shares no primary, secondary or 
tertiary similarity with E. coli’s Tus protein. In B. subtilis, two copies of RTP 
form a dimer that binds to both functional sites within the Ter sequence. 
Should incoming forks travel proximal to the A site, the fork will be allowed to 
proceed unhindered whilst forks travelling proximal to the B site will be 
arrested (Fig 1.5B) (Griffiths et al., 1998, Vivian et al., 2007). It would seem 
that these two similar systems have evolved separately in E. coli and B. subtilis 
(Wake, 1997). As such, it can be theorized that restricting replication 
termination to a small region of the chromosome is beneficial in organisms 
with circular genomes. Indeed, in E. coli, the dif site is located within this region 
of the genome. This locus is required for decatenation and efficient 
segregation of sister chromatids, enabling a smooth transition between DNA 
replication and cell division (Wake, 1997). It is also possible that restricting the 
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site of replisome collision/fusion to a relatively small, gene-sparse region of 
the genome is beneficial for chromosomal stability.  
 
1.6.3 DNA-Protein Replication Barriers in Eukaryotes       
 
In eukaryotes, the best studied example of RFBs are the ones found within 
non-transcribed spacer regions between rDNA repeats, regions of DNA that 
encode for the 25-28S, 16-18S and the 5.8S rRNA that constitute ribosomes. 
These were initially discovered in S. cerevisiae where replication 
intermediates of the ~200 tandem repeats of rDNA on chromosome XII were 
visualized on 2D-gels (Brewer and Fangman, 1988). The 2D-gels 
demonstrated that forks approaching distally from the promoter from which 
RNA Pol I transcribes the rDNA genes were arrested in a polar fashion. 
However, forks approaching proximally were not, so that replication of the 
rDNA locus only occurs in one orientation (Fig 1.5C). The barrier activity was 
found to depend on a cis-acting sequence within a non-transcribed region 
known as RFB and on a trans-acting factor, Fob1 (Kobayashi and Horiuchi, 
1996). Within the RFB locus, there exist three discrete sites RFB1, RFB2 and 
RFB3. RFB1 is sufficient for fork arrest whilst RFB2 and RFB3 co-operate as 
a second, minor fork arrest site (Kobayashi, 2003). It has been suggested that 
the roles of these barriers is to prevent head-on collisions between the 
replication machinery and transcribing complexes. Indeed, in a FOB1-
defective strain where the copy number of rDNA genes was also reduced to 
around 20, increased collisions between the replication fork and transcribing 
complexes eventually led to production of extrachromosomal rDNA circles and 
shortened lifespans (Takeuchi et al., 2003). Two other factors are essential for 
fork arrest at the Fob1-RFB site. These are Tof1 and Csm3. Deletion mutation 
of either gene leads to loss of pausing signal on 2D gels at the RFB (Calzada 
et al., 2005). On the other hand, the third component of the FPC, Mrc1, is 
dispensable for fork arrest at RFB. 
 
Replication barriers at rDNA genes have also been discovered in other 
species, including in peas (López-Estraño et al., 1999), the ciliate 
Tetrahymena thermophile (MacAlpine et al., 1997), Xenopus (Maric et al., 
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1999) and humans (Little et al., 1993). Interestingly, the human RFB is non-
polar and forks are paused in both directions, as seen on 2D gels (Little et al., 
1993). Replication arrest occurs at multiple (up to five) Sal box elements (T1- 
T5) to which the protein TTF-1 binds (transcription termination factor 1) to 
mediate arrest. The T2 and T3 boxes are inactivated and it was found that 
TTF-1 does not bind to either of them nor can they mediate fork arrest 
(Pfleiderer et al., 1990). The T1 box mediates fork arrest distally from the rDNA 
promoter. Whilst individual Sal boxes do not demonstrate fork arrest proximal 
to the promoter, T4 and T5 cooperatively caused fork arrest in either direction, 
suggesting that they act with one another to form a heterochromatic region 
that  impedes fork progression, leading to the peculiarity of non-polar fork 
arrest (Akamatsu and Kobayashi, 2015). Knockdown of TimTof1 by siRNA 
correlated with reduced barrier activity, suggesting a conserved function of the 
FPC in efficient fork arrest (Akamatsu and Kobayashi, 2015). Interestingly, 
TTF-1 also participates in transcription termination. 
 
In Sz. pombe, there are four fork barriers at the rDNA loci (RFB1-4). RFB4 
seems to play a minor role unless the barrier activity of RFB1-3 are 
compromised (Krings and Bastia, 2004). The Sz. pombe orthologue of TTF-1, 
Reb1, has been shown to bind to RFB2 and RFB3 and reb1∆ abolishes fork 
arrest at both sites (Sánchez-Gorostiaga et al., 2004). RFB1 is the strongest 
arrest site, to which a homodimer of the essential Sap1 protein binds (Krings 
and Bastia, 2005). RFB1-3 also requires the activity of all three components 
of the FPC (Swi1, Swi3 and Mrc1) for optimal barrier activity (Krings and 
Bastia, 2004, Zech et al., 2015). As mentioned earlier, Mrc1 from Sz. pombe 
contains a conserved helix-loop-helix motif that may help it to contribute to the 
fork barrier activity. Interestingly, the FPC is also required for optimal barrier 
at two other loci, namely at the replication termination site 1 (RTS1) and at the 
mat1- pausing site 1 (MPS1). Notably, at RTS1, two other trans-acting factors, 
Rtf1 and Rtf2 are also required (Codlin and Dalgaard, 2003). Rtf1 is a paralog 
of Reb1 as well as an orthologue of mammalian TTF-1 (Eydmann et al., 2008). 
Fork arrest at RTS1 and fork pausing at MPS1 are critical for changing the 
gene expressed at the mating-type locus, mat1. This leads to a parent of a 
particular cell-type (or mating-type) having progenies of different cell-types. 
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This pattern of mitotic division is known as asymmetric cell division. This will 
be described in more detail in Section 1.7.       
 
Several other replication fork barriers (RFBs) have been described and have 
been reviewed elsewhere (Dalgaard et al., 2011, Gadaleta and Noguchi, 
2017, Labib and Hodgson, 2007, Mirkin and Mirkin, 2007). These include 
RFBs present at centromeric and telomeric loci. Centromeric RFBs lead to 
non-polar replication stalling in early S phase again seemingly to prevent 
conflicts between DNA replication and transcription. In addition, telomeric 
DNA at the ends of chromosomes are difficult to replicate by virtue of their 
repetitive nature as well as other local features such as the propensity to form 
T-loop structures. In Sz. pombe, the repetitive nature of the telomeric DNA 
leads to fork stalling. Pausing may be required for the stabilization of telomeres 
as abolition of pausing in swi1∆ strains leads to loss of the telomeric repeats 
(Gadaleta et al., 2016). 
 
One interesting feature of pre-programmed fork barriers is that they seldom 
lead to profound genome instability and that cells do not activate any 
checkpoint in response to forks stalling at such barriers. Instead, cells seem 
to respond with limited and controlled instability before resolution of the conflict 
(Dalgaard et al., 2011). For instance,  in S. cerevisiae, neither the absence of 
MEC1 nor that of RAD53 affects the stability of replisomes at stalled forks  
(Calzada et al., 2005). Similar conclusions can be derived from experiments 
conducted in Sz. pombe. In one study, two copies of fork arrest site (RTS1) 
were cloned on either side of a ura4 reporter gene (Lambert et al., 2005). 
Importantly, resolution of fork arrests at this construct required proteins 
involved in homologous recombination but not proteins involved in checkpoint 
function (including Cds1Rad53, Chk1 or Rad3Mec1). That is not to say that pre-
programmed RFBs cannot be dangerous to cells. For instance, the TerB in E. 
coli when cloned in otherwise stable plasmid vectors were found to be a site 
of deletion hotspot, leading to progeny plasmids smaller than their parental 
plasmid (Bierne et al., 1991). Thus, there must be a mechanism that 
counteract this deletion hotspot characteristic of TerB in the E. coli genome to 
prevent loss of genetic material. 
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Figure 1.5. DNA-protein barriers are exploited productively by cells. In both E. coli (A) and B. subtilis (B), terminator proteins 
bind to terminator sequences to terminate DNA replication within a relatively small expanse of the genome. At the rDNA locus, polar 
and non-polar replication termination prevents head-on collisions between transcription and replication. This barrier is conserved as 
seen in humans (C), S. cerevisiae (D) and Sz. pombe (E), although neither the cis-acting elements nor the trans-acting factors need 
not be completely similar.
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1.7 Asymmetric Cell Division 
 
Asymmetric cell division denotes a phenomenon whereby daughter cells 
derived mitotically from the same mother undergo distinct cellular fates 
despite having the same genotype. Such cell divisions are important for the 
life-cycles of both multicellular and unicellular organisms.   
 
In C. elegans, upon fertilization, the zygote undergoes five asymmetric cell 
divisions within the first four cell cycles to produce six founder cells: AB, MS, 
E, C, D and P4 (Fig 1.6) (Kipreos, 2005). These founder cells are critical in 
blueprinting the correct axial development of the embryo. In B. subtilis, 
environmental stimuli can trigger cells to undergo spore formation in a process 
that is dependent on asymmetric cell division (Fig 1.6) (Errington, 2003). 
Derivation of a multitude of different cell-types from toti- and pluripotent stem 
cells in humans is yet another example of asymmetric cell division. Meanwhile, 
some homothallic (self-fertile) yeasts, including S. cerevisiae and Sz. pombe, 
have acquired the ability to undergo asymmetric cell division to switch between 
cell-types (Fig 1.6). This is unique in nature as, typically, differentiated cells 
cannot switch to different cell-types although it is possible to artificially de-
differentiate cells into induced pluripotent stem cells or to artificially reprogram 
differentiated cells through forced trans-differentiation (Riddle et al., 2017). 
 
The molecular mechanism underpinning reversible cell-type switching in Sz. 
pombe and the dependence of this process on fork barriers will be explored in 
the next two sections of this chapter.  
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Figure 1.6. Examples of asymmetric cell type switching. (A) In C. elegans, 
asymmetric cell division gives rise to six founder cell types that are critical for 
development. (B) In B. subtilis, asymmetric cell division allows formation of 
spores. Cell-type switching in (C) S. cerevisiae and (D) Sz. pombe are also 
examples of asymmetric cell divisions. In this diagram, Mu and Pu cells carry 
mat1M and mat1P alleles respectively but are not imprinted whilst Ms and Ps 
cells also carry mat1M and mat1P alleles respectively and are imprinted. 
Imprinted cells carry a mark at the MPS1 locus. 
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1.8 Cell-Type Switching in Schizosaccharomyces 
pombe 
 
The ability to switch cell-types allows isolated cells to recapitulate a mixed 
population of cells. Similar to S. cerevisiae (see Info Box 1), Sz. pombe cells 
spontaneously switch between h+ and h- cell-types and these two cell-types 
are sexually compatible. Under nutrient depletion, cells of opposite cell-types 
will mate to form a zygote that will rapidly undergo sporulation. Switching cell-
types favours in-crossing by virtue of proximity suggesting that the ability to 
switch cell-types emerged evolutionarily not to provide genetic diversity but 
either as a survival tactic (spore formation) or to allow DNA repair via meiotic 
DNA recombination. It should be noted that S. cerevisiae and Sz. pombe have 
evolved from a common multicellular ancestor and acquired uni-cellularity 
independently from one another. Given that reversible switching between cell-
types in multicellular organisms would seem to serve no purpose, the two 
yeast species have probably acquired the ability to switch cell-types 
independently (Hanson and Wolfe, 2017). Cell-type switching then might be 
pervasive for unicellular life-styles in eukaryotes and the underlying 
mechanisms could underpin our understanding of other molecular processes 
such as immunoglobulin class switching and, indeed, asymmetric cell division 
in higher eukaryotes.  
 
The molecular mechanisms underpinning cell-type switching in S. cerevisiae 
and Sz. pombe are superficially similar (see Info Box 1). In Sz. pombe, the 
cell-type is determined by the identity of the gene cassette at the mat1 locus 
with two transcriptionally-silenced donor loci located distally on chromosome 
II. These donor loci can be copied onto the mat1 locus. Unlike budding yeast, 
switching is not dependent on any endonucleases, but is dependent on the 
configuration of the donor loci. Self-fertile (homothallic) h90 cells, for instance, 
include the mat2P and mat3M donor and are able to switch cell-type by 
replacing the mat1 locus with either of the silenced mat2P or mat3M loci (Fig 
1.7A). Heterothallic (non-self-fertile) strains however have different 
configurations at the donor loci and, hence, lose the ability to switch cell-types. 
	 52	
The most commonly used heterothallic strains are the h-S that has lost the 
mat2P donor and the h+N that has duplicated the entirety of the mat2P-K-
mat3M region and substituted it for the mat1 locus (Fig 1.7A). Heterothallic 
strains occur spontaneously in the wild, perhaps as a result of erroneous 
recombination events. When expressed at the mat1 locus, the P- and M-
cassettes express two transcripts each (Pm and Pc for the P-cassette and Mm 
and Mc for the M-cassette). Pc and Mc are required for conjugation between 
cells of opposite cell-types whilst Pm and Mm are required for meiosis within a 
diploid. Unlike S. cerevisiae, these haploid-genes when expressed at the mat1 
locus are not suppressed in diploids. Switching can occur within diploids and 
these can, in turn, mate to form a tetraploid or mate with a haploid to form a 
triploid (Egel, 1989, Gutz, 1967). 
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Info Box 1: Cell-type switching in budding yeast. In S. cerevisiae, cells switch 
between a and α cell-types that are sexually-compatible. This predispose cells 
to a sexual life cycle as sexually-compatible S. cerevisiae haploids readily mate 
to form a stable diploid that can undergo sporulation. Mating-type (or cell-type) 
is determined by genes expressed at the mating-type (MAT) locus. This locus is 
flanked by two (HML and HMR) transcriptionally silenced loci. At the HML locus, 
the silenced α1 and α2 are saved whilst, at HMR, the a1 gene is housed. In a-
type cells, the MATa1 gene that encodes for the homeodomain protein a1 is 
expressed but removal of the MAT locus also pheno-copies a-type cells.  By 
contrast, α-type cells encode the MATα1 and MATα2 genes that activate 
transcription of α-specific genes and repress transcription of a-specific genes 
respectively. In both haploids, haploid-specific genes are also transcribed. 
Switching between the two different cell-types can occur one cell cycle after 
germination. In cells that have divided at least once, a G1-specific pulse of HO 
endonuclease creates a double stranded break (DSB) within a junction at the 
MAT locus. This break is repaired by a synthesis-dependent strand annealing 
(SDSA) mechanism where forks use information at the donor loci to repair the 
DSB. To limit futile switching, a donor bias is implemented. In a-type cells, a 
recombination enhancer (RE) sequence favours HML as a donor whilst, in α-
type cells, the α2 product prevents HML to be used as a donor enabling HMR 
bias (Haber, 2012, Hanson and Wolfe, 2017). 
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Figure 1.7. Cell-type switching in Sz. pombe and cis-acting elements 
requirement at the MPS1 locus for imprinting. (A) Cell-type switching in 
Sz. pombe depends on the configuration of donor loci at mat2 and mat3. 
Heterothallic strains cannot use their donor loci to substitute them for the gene 
at the expressed mat1 locus. (B) Switching also depends on imprinting at 
mat1. This imprint is dependent on a number of cis-acting elements, including 
SAS1, SAS2, SS2 and SS13. Resolution of switching requires other cis-acting 
elements, including H1 and H2.  
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1.9 Exploiting the asymmetric nature of DNA 
Replication and Polar Fork Barriers to Imprint 
DNA at MPS1 as a marker for Cell-Type Switching 
 
A newly germinated homothallic Sz. pombe cell cannot switch cell-type 
irrespective of the mating cassette at mat1. However, upon cell division one 
of the daughter cells inherits a mark, historically referred to as an imprint. The 
nature of this imprint is subject to debate: it has been reported to be either a 
nick (Arcangioli, 1998) or two ribonucleotides incorporated at the mat1 pausing 
site 1 (MPS1) (Vengrova and Dalgaard, 2006). 
 
Establishment of the imprint requires fork termination at the replication 
termination site 1 (RTS1) locus and fork pausing at MPS1. Both barriers 
require components of the FPC, Swi1Tof1, Swi3Csm3 and Mrc1 for optimal 
barrier activity (Dalgaard and Klar, 2000, Dalgaard and Klar, 2001, Zech et al., 
2015). Pausing at MPS1 is necessary but not sufficient for imprinting and the 
two processes have been isolated genetically (Dalgaard and Klar, 2000, 
Sayrac et al., 2011). In wildtype cells, the imprint is degraded during 
purification of genomic DNA, leading to a double stranded break at mat1. 
Consequently, Southern blotting of a HindIII fragment that includes this imprint 
leads to three distinct DNA fragments: the intact fragment and two fragments 
that arise because of breakage. By contrast, strains that are defective for 
imprinting do not undergo breakage at mat1 and only the intact HindIII 
fragment is observable in Southern blots (Singh and Klar, 1993). Through 
Southern blotting of the HindIII fragment at mat1, it was shown that a mutant 
of pol1, swi7-1 (pol1G116E), is defective for imprinting whilst not affecting 
pausing at MPS1 on 2D gels (Singh and Klar, 1993, Dalgaard and Klar, 2000). 
Given that Pol α also contains primase subunits (Spp1Pri1 and Spp2Pri2), it is 
thus tempting to suggest that the imprint is indeed RNA in nature. If this is the 
case, it would suggest that there is a protective mechanism that prevents 
displacement of the ribonucleotides at MPS1, especially by Pol δ. This putative 
protective mechanism may take the form of heterochromatin that is known to 
impede DNA synthesis by Pol δ that otherwise synthesizes DNA continuously, 
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in an uninterrupted fashion (Devbhandari et al., 2017). In fact, binding of Sap1 
(also involved at the rDNA RFB1) and of a histone demethylase, Lsd1 within 
the vicinity of the imprint are required for stable imprinting at MPS1 (Arcangioli 
and Klar, 1991, Holmes et al., 2012) (Fig 1.7B). These may contribute to a 
chromatin architecture that is favourable for protecting ribonucleotides at 
MPS1. Beyond its effects on cell-type switching and on the S phase response 
to alkylation damage (Koulintchenko et al., 2012), the swi7-1 allele is ill-
characterized. The allele is also known to confer a mutator phenotype and is 
characterized by hypersensitivity to both HU and MMS. However, the strength 
of interaction between the Swi7-1 protein with different proteins such as Mcl1 
or other subunits of Pol α (with the exception of Swi6) and how it differs from 
its wildtype counterpart has not been determined. 
  
Once the cells are imprinted, the imprint itself is stabilized for one cell cycle. 
In the subsequent S phase, the imprint at MPS1 blocks leading strand 
replication. Given that forks are still terminated at the RTS1 locus, the entirety 
of mat1 locus and its immediate surrounding cannot be replicated 
conventionally (Dalgaard and Klar, 2001). Instead, forks are reversed at MPS1 
and a ‘chicken foot’ intermediate is observable on 2-D gels. This intermediate 
is resolved by the RecQ-like helicase Rqh1 (Vengrova and Dalgaard, 2004).  
 
Fork reversal seems to precede fork invasion of either the mat2P or mat3M 
loci. Homology is provided by the H1 and H2 sequences that allow intra-
chromosomal recombination between the newly copied donor and the 
cassette at mat1. Sequences not found between the H2 and H1 sites seem to 
be digested. This would explain why the mat1 locus does not contain the H3 
site although both donor loci do. This synthesis-dependent strand annealing 
(SDSA) mechanism was verified in vivo by using artificial mat2P and mat3P 
alleles (Yamada-Inagawa et al., 2007). Resolution of the recombination 
between the mat1 and its donor loci is resolved by concerted action of 
Msh2Swi8, Msh3Swi4, Rad16Swi9 and Swi10 (Arcangioli and de Lahondès, 2000). 
Puzzlingly, absence of donor loci does not lead to cell death suggesting that 
the lack of replication between RTS1 and MPS1 can be compensated for by 
inter-chromosomal repair using the intact sister chromatid as a template (Klar 
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and Miglio, 1986). The various steps involved in cassette-switching at mat1 
are summarized in Fig 1.8. 
 
It should be noted that mutants that are defective in cell-type switching are not 
necessarily defective for imprinting (Gutz and Schmidt, 1985). Whilst 
switching-defective mutants can be distinguished by iodine staining, 
imprinting-defective mutants are characterized by non-breakage of the mat1 
cassette during purification of genomic DNA.
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Figure 1.8. Cell-type switching in Sz. pombe requires two fork barriers. In the first cell cycle, forks approaching proximally (from 
cen2) are terminated at RTS1 and forks approaching distally are paused at MPS1. Pausing and termination both require Swi1, Swi3 
and Mrc1. The pausing event is required for Pol1-dependent imprinting at MPS1. In the following cell cycle, the imprint act as a 
second terminator site so that the DNA between RTS1 and MPS1 is not replicated conventionally. Instead, it needs to be copied from 
information stored at either one of two donor loci (mat2P or mat3M). This leads to cassette switching.  
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Like in S. cerevisiae (see Info Box 1), futile switching of cell-types is prevented 
by means of donor preference. Indeed, from a newly germinated cell, one of 
four the grand-daughter cells has an about 90% chance of switching cell-type 
(Miyata and Miyata, 1981). Donor preference is mediated by both cis- and 
trans acting-sequences (Thon and Klar, 1993, Jakočiūnas et al., 2013). In cells 
carrying the M-cassette at mat1 (mat1M), donor preference for mat2P is 
mediated by relatively high concentrations of Swi2 (and its partner, Swi5) and 
by the SRE2 enhancer region found distally to mat2P. Conversely, in cells 
expressing the P-cassette at the mat1 locus (mat1P), mat3M donor bias is 
mediated by the enhancer SRE3 found distally to mat3M and by relatively 
lower expression of swi2 and swi5 (Jakočiūnas et al., 2013).  
 
Importantly, the donor loci at mat2 and mat3 are silenced by virtue of a 
combination of cis-acting elements found proximal to the donor loci (Thon et 
al., 1994, Thon et al., 1999) and trans-acting factors, among which the HP1-
like chromodomain protein Swi6 (Nakayama et al., 2000) and the H3K9 
methyltransferase Clr4 (Nakayama et al., 2001b). Swi6 has been shown to 
interact physically with both Dfp1Dbf4 (Hayashi et al., 2009) and Cdc18Cdc6 (Li 
et al., 2011), modulating replication at heterochromatin-rich sites in the Sz. 
pombe genome. The mat2 and mat3 loci are replicated early in S phase (Kim 
et al., 2003). Both the early replication and lack of transcription at these loci 
could be a result of the compactness of the DNA there.  
 
Intriguingly, switching-defective alleles of swi1 (swi1-111), swi3 (swi3-146) 
and pol1 (swi7-1) were found to de-suppress silencing at the donor mat2 and 
mat3 loci. Higher levels of de-suppression were observed with the swi7-1 
allele (Nakayama et al., 2001a). It was determined that recombinant Pol1 
interacts with Swi6 by virtue of its C-terminus (residues 1032-1405) in vitro 
and that endogenous Pol1, but not Swi7-1, interacts with Swi6 ex vivo. 
Moreover, swi7-1 strains were characterized by reduced levels of Swi6 at the 
silenced donor loci, centromeres and telomeres (Nakayama et al., 2001a). 
This indicates that Swi6 is enriched at heterochromatin-rich DNA in a Pol1-
dependent manner and that Swi7-1 cause de-suppression of the silenced 
donor loci by virtue of reduced interaction with Swi6. A similar silencing defect 
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was seen in strains harbouring a temperature-sensitive of pol1 with checkpoint 
defects (Murakami and Okayama, 1995), pol1-H4 (pol1G889D) (Ahmed et al., 
2001). Similar to the Swi7-1, Pol1-H4 has reduced interaction with Swi6 and 
Swi6 levels at the silent donor loci are much reduced in strains harbouring the 
pol-H4 allele. Interestingly, both the temperature-sensitive and cycle defects 
of pol1-H4, but not its silencing defect, were suppressed by co-expression of 
either wildtype pol1 or cds1 (Ahmed et al., 2001, Murakami and Okayama, 
1995). This would suggest that the silencing defect was dominant, perhaps 
reflecting a gain of function. The pol1-H4 mutant, as well as two other 
temperature-sensitive mutants, pol1-ts11 and pol1-ts13, show observable 
silencing defects when crossed in strains carrying the heterothallic mat1-
Msmt0 mutation (Ahmed et al., 2001). Strains carrying the swi7-1 and mat1-
Msmt0 mutations did not present these defects unless also deleted for a 1.5 
kb BglII-BssHII fragment proximal to mat2P. As such, it is tempting to suggest 
that the overlapping phenotypes between swi7-1 and pol1-H4 might be 
underpinned by un-identical mechanisms at the molecular level. 
 
Consequently, the exact role of Polymerase α in the mating-type switching of 
fission yeast, especially in imprinting at the MPS1 locus is still unknown. 
Elucidating this problem could inform us about the role of DNA polymerases 
in response to pre-programmed fork barriers, perhaps in relation to fork restart 
after stalling. This will be the focus of Chapter 3 of this thesis.  
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1.10 The Transcription Process as a barrier to DNA 
Replication 
 
Both DNA replication and transcription are fundamental processes for life and 
represent central pillars of molecular biology. Whilst DNA replication is 
restricted to S phase, transcription can occur throughout the cell cycle. Indeed, 
in human cells, transcription of longer genes can span the better part of a cell 
cycle or can even last longer than one cell cycle. For instance, transcription of 
the human dystrophin gene (DMD) lasts around 16 h (Tennyson et al., 1995) 
whilst transcription of the longest human gene, CNTNAP2 (functional in the 
nervous system) takes between 9 to 35 h to complete (Helmrich et al., 2011). 
On the other hand, the fast-growing HeLa cells have a doubling time of about 
23 h. DNA replication and transcription then can overlap temporally. Moreover, 
both processes utilize the same substrate (the double helix) to which they 
impose transient but significant architectural alterations. Such altered DNA are 
not ideal substrates for either DNA replication or transcription, and can halt 
their respective progression. Importantly, collisions between DNA replication 
and transcription, especially head-on collisions, lead to genomic instability (Fig 
1.9) (Liu and Alberts, 1995, Helmrich et al., 2011, Helmrich et al., 2013, Prado 
and Aguilera, 2005). 
 
In prokaryotes, forks originate from a single origin. This neatly halves bacterial 
chromosomes in two replichores. It has been established that the direction of 
transcription of operons on either replichore are biased so that replication forks 
and transcription complexes encounter in a mostly co-directional fashion. This 
suggests an evolutionary advantage to reducing the frequency of head-on 
collisions between the two processes. For example, in E. coli, the genome is 
organized so that 55% of protein coding genes align with the direction of 
replication whilst all seven of the ribosomal RNA operons and 53 out of 86 
tRNA genes (62%) also align with the direction of forks (Blattner et al., 1997). 
Operons of highly transcribed genes are also more likely to be orientated so 
that the 5’ end of the genes occur proximal to the origin (Brewer, 1988). The 
bias is starker in B. subtilis where the genome is organized in such a way that 
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75% of the predicted genes are transcribed co-directionally with DNA 
replication (Kunst et al., 1997). Beyond genome organization, there are 
several lines of evidence that demonstrate that the transcription process 
represents a potent barrier to fork progression. For example, in asynchronous 
cultures of E. coli, rifampicin treatment leads to increased replication speeds 
(Pato, 1975). Rifampicin works by preventing synthesis of novel transcripts but 
does not interfere with the elongation of nascent mRNA molecules. Thus a 
reduction in the number of transcribing complexes correlates with increased 
fork speeds. In the same study, the author also found that streptolydigin 
treatment leads to reduced fork speeds (Pato, 1975). Streptolydigin also 
affects transcription but by slowing down the process (Brewer, 1988). As such, 
stabilizing transcribing complexes on the genome correlates with reduced fork 
speeds. This fork barrier activity of the transcription process can be 
reproduced in vitro (Liu and Alberts, 1995). Interestingly, replication pauses 
for longer when the two processes undergo head-on rather than co-directional 
collisions (Liu and Alberts, 1995). 
 
Head-on collisions between transcription and DNA replication have also been 
shown to be more deleterious than co-directional collisions in eukaryotes. 
Using a plasmid-based assay, Prado and Aguilera have shown that head-on 
collisions between replication forks and transcribing complexes lead to 
increased levels of recombination compared to co-directional collisions in S. 
cerevisiae (Prado and Aguilera, 2005). The authors also showed that the 
extent of recombination was highest when the promoter of the transcription 
module was S phase specific (HHF1 promoter). Similar studies have been 
carried out at genomic loci. One notable example involved using isogenic 
yeast strains carrying the GAL1-lys2frameshift construct in the presence or 
absence of Gal80 (Datta and Jinks-Robertson, 1995). The GAL80 gene 
supresses transcription from the GAL1 promoter in the absence of galactose 
so that strains carrying the gal80∆ allele constitutively express from the GAL1 
promoter. The cells were grown in medium lacking galactose. Cells with 
constitutive expression of the GAL1 promoter were more likely to undergo 
LYS2 reversion demonstrating that transcriptionally active DNA is 
characterized by increased recombination, perhaps by hindering other 
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processes such as DNA replication (Datta and Jinks-Robertson, 1995). In a 
similar study where the lys2frameshift mutant was expressed under the control of 
a repressible promoter, it was determined that the extent of LYS2 reversion 
was directly proportional to the levels of transcription (Kim et al., 2007). The 
authors also found that mutational signature was co-dependent on the 
orientation of the lys2frameshift allele relative to closest origin from which it was 
cloned (ARS306) and its expression level. When the 5’ end of the gene was 
found distal to the origin, large deletions were more likely at low transcription 
levels whilst complex indels (as well as other mutants) were more prevalent at 
high transcription levels. As such, conflicts between DNA replication and 
transcription can lead to deleterious recombogenic events, distinct from those 
arising when forks do not meet transcribing complexes.  
 
It is evident that the transcription process need not impede DNA replication 
directly. Indeed, it has been suggested that supercoils accumulating ahead of 
the replication fork and transcription machinery might provide a topological 
constrain that leads to fork reversal and genomic instability (Helmrich et al., 
2013). Moreover, the transcription process generates an intermediate known 
as the R-loop that impedes replication forks. The following chapter will be 
devoted to R-loops and the factors that contribute to their formation and 
stability within genomes. 
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Figure 1.9. DNA replication and transcription can interfere with the 
progression of one another. Collisions between the two processes can 
occur co-directionally. In eukaryotes, the two processes have comparable 
speeds, but either forks or transcribing complexes may pause. This creates 
the opportunity for co-directional collisions. Head-on collisions may also 
happen if forks travel towards transcribing complexes. The two types of 
collisions trigger different DNA damage responses and appear to resolved 
differently (Hamperl et al., 2017). Importantly, head-on collisions are more 
harmful for cells (Prado and Aguilera, 2005). 
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1.11 R-loop Biology 
 
The R-loop is a three-stranded nucleic species made up of both DNA and 
RNA. This hybrid consists of a nascent transcript reannealing to its template 
DNA, with the non-template strand displaced as ssDNA (Fig 1.10) (Mirkin and 
Mirkin, 2007, Aguilera and García-Muse, 2012). 
 
 
 
Figure 1.10. The R-loop is a three-stranded DNA/RNA hybrid that arises 
as an intermediate of the transcription process. It is made up of a nascent 
RNA molecule bound to its template, with the non-template strand displaced. 
 
Importantly, R-loops are thermodynamically more stable than their equivalent 
dsDNA by virtue of the hybrid interaction between RNA and DNA molecules 
(Lesnik and Freier, 1995, Roberts and Crothers, 1992) and need to be 
removed enzymatically. Structural studies suggest that R-loops adopt a 
conformation that is intermediate to that of A- and B-form DNA (Shaw and 
Arya, 2008). This may have implications for the homeostasis of the nucleic 
species and could underpin its nature as a fork barrier. Whilst it has been 
established that R-loops arise as by-products of the transcription process, the 
precise mechanism through which they are formed is unknown. It is thought 
that R-loops are formed through a ‘thread-back’ model where the nascent 
mRNA molecule reanneals to its template strand once it exists its RNA 
polymerase (Fig 1.11). This would fit crystallographic data that shows that the 
template strand and nascent mRNA are extruded through different passages 
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within eukaryotic RNA polymerases (Westover et al., 2004). Moreover, R-
loops synthesized in vitro using the prokaryotic T7 RNA polymerase are 
susceptible to RNase T1 (an enzyme that degrades single-stranded RNA at 
G-residues) added during transcription but not after completion of the 
transcription process, consistent with the thread-back model (Roy et al., 2008). 
However, it is not impossible that, under some conditions, the nascent 
transcript might not disengage from its template but instead exit the 
polymerase as a hybrid, promoting R-loop formation (Fig 1.11).  
 
 
 
Figure 1.11. Two models have been proposed for the formation of R-
loops. In the thread-back model, the nascent transcript and template strand 
are extruded via different channels. However, the transcript then reanneals 
with the template strand, displacing the non-template strand. Empirical data 
favours this model. An alternative model suggests that the nascent transcript 
emerges bound to its template from the RNA polymerase, promoting R-loop 
formation.  
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R-loop formation is favoured by a number of factors, as reviewed in (Aguilera 
and García-Muse, 2012) (Fig 1.12). Firstly, the nature of the DNA needs to be 
favourable. Indeed, GC skew (or strand asymmetry) at either the 5’ end of 
genes (immediately downstream of the promoter) or at their 3’ end has been 
found to promote R-loop formation (Ginno et al., 2012, Ginno et al., 2013). The 
strength of the promoter also correlates positively with R-loop formation 
(Huertas and Aguilera, 2003, Hamperl et al., 2017). Importantly, the replication 
process also plays a critical part in R-loop homeostasis. In a recent paper from 
the Cimprich lab, it was shown that head-on, but not co-directional, collisions 
between replication forks and transcribing complexes favoured the formation 
of R-loops (Hamperl et al., 2017). In fact, head-on and co-directional collisions 
between the replication fork and transcribing complexes were found to lead to 
distinct types of genomic instability that are also resolved through distinct 
pathways (Hamperl et al., 2017). Head-on collisions on substrates prone to 
form R-loop were found to trigger robust phosphorylation of γH2AX and 
ATRS428 as well as phosphorylation of ATR targets RPA32S33 (a component of 
the human replication protein A), and Chk1S345 suggesting that head-on 
collisions trigger and are resolved by the ATR pathway in human cells. 
Conversely, co-directional collisions were seen to lead to robust auto-
phosphorylation of ATMS1981 as well as phosphorylation of ATM targets 
KAP1S824, Chk2T68 and RPA32S4/8 (Hamperl et al., 2017). This would provide 
a rationale on how head-on collisions would favour formation of R-loops whilst 
co-directional collisions would lead to R-loop removal. Interestingly, 
substituting the substrate for one that is not susceptible for R-loop formation 
does not lead to ATR and ATM activation upon head-on and co-directional 
collisions respectively (Hamperl et al., 2017). Taken together, this would 
suggest that spontaneously-arising R-loops trigger genomic instability upon 
collisions between the replication and transcription process and that, in the 
case of head-on collisions, this leads to accumulation of R-loops, potentially 
forming a positive feedback that would lead to profound genomic instability. 
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1.12 The Physiological Importance of R-loops 
 
As illustrated above, R-loops occur naturally. Yet they may be harmful for 
genome stability and integrity (Aguilera and García-Muse, 2012). It is intriguing 
then why cells have not evolved to completely prevent R-loop formation in their 
genomes. In actuality, several lines of evidence suggest that R-loops are 
physiologically useful in several pathways, including in immunoglobulin class 
switching in B-cells and in DNA replication. 
 
In E. coli, in vivo replication of ColE1 plasmids has been shown to be 
dependent on both the primase dnaA and polymerase polA. Remarkably, 
replication of ColE1 plasmids was inhibited by treatment with the transcription-
inhibitor rifampicin in vivo (Tomizawa, 1975). Likewise, in vitro replication of 
ColE1 plasmids (unlike that of chromosomal DNA) was also inhibited by 
rifampicin and was dependent on the presence of rNTPs (Sakakibara and 
Tomizawa, 1974). These observations strongly suggested that transcription is 
also necessary for DNA replication of ColE1 plasmids. In vitro assays were 
also used to demonstrate that a transcription initiation site found some 550 
base pairs upstream of the ColE1 origin of replication produces an R-loop that 
is processed by the RNase H1 endonuclease (rnhA) to produce a 3’-hydroxyl 
end (Itoh and Tomizawa, 1980). The R-loop, then, is effectively processed into 
an RNA primer that can be used to initiate the replication process. 
Interestingly, whilst dnaA is an essential gene in E. coli (Baba et al., 2006), 
inactivation of either dnaA or of the chromosomal origin of replication, oriC, is 
not lethal in rnhA mutants, presumably by virtue of increased stability of R-
loops (Kogoma and von Meyenburg, 1983, Kogoma, 1997). This suggests 
that, at least in prokaryotes, loss of priming on chromosomal DNA can be 
compensated for by the presence of R-loops.  
 
Replication of mitochondrial DNA also requires R-loops. This is true for the 
circular human mitochondrial DNA where transcripts lead to the formation of 
RNAse H-sensitive R-loops whose 3’ ends map to the origins of replication in 
the mitochondrion (Xu and Clayton, 1996). Electron microscopy data also 
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suggests that stable R-loops are intermediates of the replication process in 
human as well as other mammalian mitochondria (Pohjoismäki et al., 2010). 
More surprisingly, R-loops were also found to be important for replication of 
the linear mitochondrial genome in S. cerevisiae. Yeast mtDNA has several 
origins (seven to eight) (Foury et al., 1998).  Work focusing on two of those 
origins (ori1 and ori5) found that, Aspergillus nuclease S1-insensitive but 
RNase-sensitive nucleic species were required for DNA replication initiation at 
those loci (Baldacci et al., 1984). The S1 nuclease digests single-stranded 
nucleic acid species (both DNA and RNA), suggesting that R-loops participate 
in DNA replication at mitochondrial origins in yeast despite yeast mtDNA being 
linear. As such, R-loops are not precluded from initiating replication in linear 
genomes and could participate in the replication of eukaryotic genomes.  
 
R-loops are involved in gene expression. In Arabidopsis, differences in 
flowering phenotypes can be attributed to the relative expression and 
suppression of the floral repressor gene, FLOWERING LOCUS C (FLC) that 
is receptive to changes in temperature. Several pathways contribute to 
changes in the levels of FLC transcription but one involves stabilizing R-loops 
whereby these then compete with long non-coding RNA (lncRNA) at the FLC 
locus. LncRNA contribute to the epigenetic silencing of the FLC locus so that 
R-loops effectively act as positive regulators of FLC expression in Arabidopsis 
(Csorba et al., 2014, Sun et al., 2013). R-loops might also regulate gene 
expression by mediating changes in chromatin. Indeed, work in the Aguilera 
lab found that increasing the levels of R-loops by using deletion mutants of 
RNH1 and RNH201 or HPR1 led to a concomitant increase in the levels of the 
heterochromatin marker H3S10 in S. cerevisiae along the lengths of most 
ORFs (Castellano-Pozo et al., 2013). The enrichment of the H3S10 marker 
was most marked at centromeric and pericentromeric loci (Castellano-Pozo et 
al., 2013). Counterintuitively, H3S10 also acts as a marker for highly 
transcribed regions at euchromatin (Sawicka and Seiser, 2012). As such, 
dysregulation of R-loops leads to global changes in the accessibility of DNA 
and, consequently, to altered transcription profiles globally in the cell. In the 
same study, the authors also showed that elevating levels of R-loops in the 
nematode C. elegans and in HeLa cells led to the enrichment of the H3S10 
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marker, suggesting that the mechanism linking R-loop to chromatin 
rearrangement is conserved across eukaryotes. Meanwhile, R-loops arising 
from antisense transcription were found to mediate the formation of dsRNA in 
human as well as in murine cells (Skourti-Stathaki et al., 2014). dsRNA is an 
intermediate in the recruitment of the H3K9me2 chromatin marker. As such, 
some R-loops affect gene expression through chromatin silencing. By 
contrast, other R-loops inhibit the methylation (and silencing) of the CpG island 
promoters of several genes (Ginno et al., 2012).  
 
R-loops also contribute to gene expression through transcription termination 
(Ginno et al., 2013). In fact, failure to remove R-loops at the 3’-end of genes 
leads to termination read-through of transcripts (Mischo et al., 2011, Skourti-
Stathaki et al., 2011). However, in human cells, complete removal of R-loops 
by overexpressing RNase H1 also leads to transcription termination defects 
(Skourti-Stathaki et al., 2011). These apparently contradictory results could be 
reconciled by envisaging a threshold of R-loops that is required for 
transcription termination in human cells but enrichment beyond a certain level 
can be detrimental to the cell. An observation apparently in support of such a 
model is that the overexpression of RNase H1 leads to synthetic defects, 
presumably by removing R-loops below a certain physiologically beneficial 
threshold (Paulsen et al., 2009).  
  
R-loops are also implicated in telomere dynamics. Telomeres cannot be 
replicated and are progressively shortened in each successive round of DNA 
synthesis, unless acted upon by telomerase, a reverse transcriptase. This 
leads to replicative senescence and has been linked to the both the Hayflick 
limit and ageing (Bekaert et al., 2005, Olovnikov, 1996). Remarkably, 
telomeric length can be preserved in spite of compromised telomerase activity, 
such as in a Rad52-dependent manner in S. cerevisiae (Lundblad and 
Blackburn, 1993). R-loops- in the form of TERRAs (telomeric-repeat-
containing RNAs)- naturally form at telomeres. The abundance of these R-
loops increase upon deletion of components of the THO/TREX complex that 
are involved in mRNA processing (including HPR1 and THO2) (Pfeiffer et al., 
2013) or of the RNase H enzymes (RNH1 and RNH201) (Balk et al., 2013) 
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and upon shifting strains encoding the temperature-sensitive rat1-1 (Rat1 is 
involved in transcription termination) to non-permissive temperatures (Luke et 
al., 2008). R-loops at telomeres trigger recombination, presumably by acting 
as fork barriers. The resolution of this recombination is important for the 
maintenance of telomeric length in wildtype cells but would seem to accelerate 
telomere shortening and cellular senescence in recombination-compromised 
cells (Balk et al., 2013). As such, R-loops are involved in telomerase-
independent telomere maintenance. In fact, in telomerase-deficient cells, R-
loops promote recombination preferentially at critically shortened telomeres 
(Graf et al., 2017). It should also be noted that, in strains defective for both 
telomerase and recombination, rad5∆ causes additional defects (Fallet et al., 
2014). Rad5 is part of the error-free DNA-damage tolerance pathway. It is an 
E3 ubiquitin ligase and also possesses DNA-dependent ATPase activity (Xu 
et al., 2015). Both enzymatic activities are necessary for error-free DNA-
damage tolerance. Rad5 is recruited at telomeres, enabling error-free repair 
at those loci. Given that rad5∆ causes synthetic defects in strains defective for 
both telomerase and recombination, it is possible that R-loops are involved in 
the Rad5-dependent repair of telomeres. 
 
Given the role of R-loops in the Rad52-driven recombination at telomeres, it 
is not surprisingly to note that R-loops promote recombination at other loci in 
the genome. This was illustrated in an elegant study in the Storici lab where 
yeast cells were constructed to contain two chimeric HIS3 genes. At the 
endogenous locus on chromosome XV, the HIS3 gene was disrupted with a 
site that can be specifically digested to a double-stranded break by the HO 
endonuclease whilst a second HIS3 allele was introduced at an ectopic site 
on chromosome III. This second HIS3 allele was disrupted with an artificial 
intron and under the control of the GAL1 promoter so that an antisense his3 
transcript can be used to repair the endogenous HIS3 gene after having 
undergone splicing. Alternatively, a single chimeric HIS3 allele was used on 
chromosome III where the HO site was introduced in the artificial intron, still 
under control of the GAL1 promoter so as to generate an antisense transcript. 
In this case, the transcript was tested for the ability to self-heal the DNA from 
which it was transcribed (Keskin et al., 2014). Histidine prototrophs were 
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recovered in wildtype but not in spt3∆ cells. Removal of Spt3 leads to a 
reduction of transcription of Ty transposons that could reverse-transcribe the 
antisense spliced his3 transcript to HIS3 cDNA. The latter could then be used 
instead of the transcript for recombination. As such, in wildtype strains, 
recombinants were exclusively a result of the presence of HIS3 cDNA. 
However, histidine prototrophs were obtained in strains triply deleted for SPT3, 
RNH1 and RNH201, suggesting that R-loops can lead to repair of double-
stranded break directly without having to recourse to reverse-transcription first 
(Keskin et al., 2014). This repair pathway was also shown to be dependent on 
Rad52 but not Rad51.  
 
Finally, R-loops are important for immunoglobulin class-switching in activated 
B-cells, leading to the synthesis of immunoglobulins other than IgM 
(Chaudhuri and Alt, 2004, Yu and Lieber, 2003). Class-switching involves an 
atypical recombination named class switch recombination (CSR) that eschews 
recombination based on homology between different DNA loci and instead 
makes use of DSBs to excise portions of the genome that encode for antibody 
heavy chains. After excision, the DNA between the DSBs assembles itself in 
a promoter-less circular DNA and is presumably lost by the cell. The remaining 
DNA is repaired by non-homologous end joining (NHEJ). Inversion of the 
donor Sγ1 locus in mice, promoting anti-parallel transcription, was found to 
severely impair isotype switching to IgG1 (Shinkura et al., 2003), suggesting 
that transcription-related intermediates are important for CSR. Cell-free 
transcription of the donor Sμ, Sγ2b and Sγ3 loci led to nucleic species that 
migrated slowly on agarose gels and that were RNase A-insensitive but 
RNase H-sensitive (Daniels and Lieber, 1995). In fact, the nature of the DNA 
at class switch donor sequences was found to be ideal for R-loop formation 
(Roy et al., 2008). Although the precise mechanism through which R-loops are 
used for CSR is yet to be established, a seductive hypothesis is that R-loops 
could stabilize the non-template strand of DNA, the latter being a substrate for 
activation-induced cytidine deamination where cytidines are deaminated to 
uridines. Uridines occurring on the non-template strand would then be prone 
to digestion, promoting abasic DNA and eventually DSBs. 
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1.13 R-loops as a Source of Genome Instability and 
The Mechanisms of R-loop Removal in Eukaryotes 
 
R-loops were previously considered to be rare by-products and transient 
intermediates of the transcription process. Consequently, the impact of R-
loops, beyond their very specific uses (as illustrated in Section 1.12) on the 
genome was deemed negligible. It is quickly becoming apparent however that 
R-loops are generated much more frequently than previously envisaged 
(Aguilera and García-Muse, 2012). Given also that R-loops are more stable 
than their dsDNA counterpart, that the displaced non-template DNA is more 
susceptible to damage and that they can plausibly interfere both with fork 
progression and the transcription process, R-loops are increasingly being 
appreciated for the threat they pose to both genomic integrity and to gene 
expression.  
 
In theory, there are several ways through which R-loops could contribute to 
genome instability. By virtue of their structural nature alone, the non-template 
strand in R-loops are exposed as ssDNA and prone to chemical modifications. 
Some of these such as activation-induced deamination in B-cells could be 
programmed and beneficial whilst other modifications could contribute to 
unwanted transcription-associated mutagenesis (TAM). Indeed, C-G to T-A 
transition mutations occur 140 times more frequently in ssDNA than in dsDNA 
(Frederico et al., 1990) whilst, in E. coli, C-G to T-A mutations that trigger 
reversion of a reporter kanamycin gene are favoured when the target cytosine 
is present in a non-template strand (Beletskii and Bhagwat, 1996). These 
observations are consistent with the notion that R-loops promotes TAM. R-
loops mediated TAM have also been established as intermediates of both 
DSBs and transcription-associated recombination (TAR) (Chavez and 
Aguilera, 1997, Huertas and Aguilera, 2003, Wimberly et al., 2013). 
Meanwhile, nucleotide excision repair (NER) proteins have been found to 
engage in the metabolism of R-loops in human cells into potentially dangerous 
DSBs (Sollier et al., 2014).  
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R-loops can also be deleterious by interfering with transcription. As described 
in Section 1.12, R-loops can participate in chromatin re-modelling that possibly 
interferes with global gene expression (Ginno et al., 2012, Castellano-Pozo et 
al., 2013, Skourti-Stathaki et al., 2014). This could affect the expression of 
repair and replication genes that could have far-ranging consequences for 
genome integrity. R-loops can also affect transcription directly by impeding its 
progression (Hamperl et al., 2017), affecting gene dosage. R-loop-dependent 
transcription silencing may also be important for the pathophysiology of 
diseases with repeat instability. Repeat instability refers to the characteristic 
of some DNA repeats to expand or be reduced, causing an unstable number 
of repeats. Usually, the instability involves expansion of trinucleotide repeats, 
perhaps as such mutations would not cause frameshifts. However, the repeats 
involved need not be limited to protein-coding regions (Li et al., 2008). Repeat 
instability leads to several diseases, including the Fragile X syndrome and 
Friedreich Ataxia (Castel et al., 2010). Interestingly, transcription of repeat 
nucleotides responsible for Friedreich Ataxia in E. coli led to R-loop formation 
that impeded further transcription (Grabczyk et al., 2007). In the same study, 
in vitro transcription of the same repeat nucleotides using the T7 RNA 
polymerase also led to R-loop formation and subsequent inhibition of 
transcription. More recently, R-loops were found to accumulate at repeat 
nucleotides in patients of both Friedreich Ataxia and Fragile X Syndrome, 
promoting gene silencing (Groh et al., 2014, Groh and Gromak, 2014). 
Whether R-loops actually cause the repeat instability is unknown but these 
findings suggest that it is involved in the pathophysiology of at least a sub-set 
of the associated disorders. 
 
R-loops also contribute to genome instability by interfering with fork 
progression. Although the replication process itself seem to be important for 
generating or stabilizing R-loops on the genome (Hamperl et al., 2017), R-
loops may strengthen the interaction between the transcription machinery and 
its DNA substrate, impeding fork progression. Whether these collisions involve 
direct physical contact between the replication and transcription machineries 
or are mediated indirectly through super-coiling in the DNA substrate is subject 
to debate. Another plausible scenario is that TAM, TAR and DSBs generated 
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by R-loops (or the repair proteins recruited as a consequence) could act as 
fork barriers. In fact, R-loops are enriched on longer genes in human cells at 
common fragile sites (CFSs), loci characterized as hotspots for DNA breaks 
and where collisions between replication forks and transcription complexes 
occur at anomalously high frequencies (Helmrich et al., 2011). Consequently, 
R-loops could contribute to the pathophysiology of diverse ailments, including 
Duchenne and Becker muscular dystrophy as well as juvenile Parkinsonism 
as the genes responsible for these diseases (DMD and PARK2 respectively) 
are both characterized by high numbers of CFSs (Mitsui et al., 2010). 
Alternatively, R-loops could impede fork progression independently of the 
transcription machinery or other protein or protein-nucleic acid complexes. 
Whatever the precise context through which R-loops inhibit fork progression, 
fork stalling and collapse might ensue, leading to genomic instability. Finally, 
persistent R-loops at the rDNA locus in yeast can be used as primers for the 
initiation of non-canonical DNA replication, contributing to dangerous re-
replication events (Stuckey et al., 2015). It should be stressed, however, that 
R-loops by and of themselves are not sufficient for genome instability (García-
Pichardo et al., 2017). This was demonstrated when the authors identified 
histone mutants that led to accumulation of R-loops, but with limited genome 
instability, unlike in hpr1Δ and sen1-1 cells. Moreover, these mutants led to 
reduced levels of H3S10 phosphorylation and also suppressed the levels of 
genomic instability in both hpr1Δ and sen1-1 cells (García-Pichardo et al., 
2017). The authors concluded that, upon formation of R-loops, a second 
epigenetic step (either limited to or including H3S10 phosphorylation) was 
necessary for R-loop mediated genome instability. 
 
Given the various ways through which R-loops can compromise genome 
integrity, it is not surprising to note that cells have evolved several pathways 
to rid the genome of R-loops when required. In fact, cells seem to adopt a 
simplistic approach to dealing with R-loops. Firstly, mechanisms are in place 
to prevent the enrichment of R-loops beyond levels that are physiologically 
beneficial for the cells. On the other hand, once stable R-loops have been 
generated, mechanisms distinct form those involved in R-loop prevention are 
utilized to remove them from the genome (Fig 1.12).
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Figure 1.12.  Summary of factors that are important for the homeostasis of R-loops. The nature of the DNA being transcribed 
is important for R-loop formation. For instance, GC skew favours the formation of R-loops. Moreover, DNA left behind the transcription 
machinery is negatively supercoiled, also favouring R-loop formation. Because of the potentially deleterious consequences of stable 
R-loops in the genome, cells employ several pathways to prevent R-loop formation in the first place. For instance, topoisomerases 
alleviate negative supercoiling behind RNA polymerases. Nascent transcripts are also efficiently exported out of the nucleus using 
the THO/TREX complex, preventing R-loop formation. Once R-loops are formed, however, cells have at their disposal several 
nucleases that they employ to remove them. These include the RNase H endonucleases and the conserved DNA/RNA helicase, 
Sen1.  
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Efficient processing of transcripts is a major factor in preventing the formation 
of R-loops. In S. cerevisiae, deletion of the HPR1 gene (part of the THO/TREX 
complex that is used to process transcripts out of the nucleus) led to the 
enrichment of R-loops in vivo. These cells were also characterized by hyper-
recombination (Huertas and Aguilera, 2003). These observations highlight a 
possible link between stable R-loop formation and genome instability. In DT40 
chicken cells, depletion of ASF/SF2 (an enzyme involved in transcript splicing) 
by using a tetracycline-repressible promoter led to a subpopulation (~10%) of 
cells acquiring tetracycline resistance (Li and Manley, 2005). Further analysis 
revealed that tetracycline insensitivity was induced by R-loop dependent 
hyper-recombination that also caused gene expression from an inactivated 
promoter. Another line of evidence highlighting the role of efficient transcript 
processing in the prevention of R-loop formation comes from studies in the 
pathophysiology of some cancers. This includes cancer-formation in immuno-
depressed individuals infected by the Kaposi's sarcoma-associated 
herpesvirus (KSHV). Studies suggest that a viral protein from KSHV impedes 
normal functioning of the human TREX complex, leading to stable formation 
of R-loops that contributes to DSBs (Jackson et al., 2014). Another example 
involves FIP1L1, an oncogene involved in leukaemia (Stirling et al., 2012). The 
FIP1L1 gene-product is a subunit of the human cleavage and polyadenylation 
specificity factory (CPSF) that is required for 3’-end processing and 
transcription termination. Depletion of FIP1L1 causes chromosome breakage, 
possibly due to R-loop enrichment (Stirling et al., 2012). Importantly, truncation 
mutants as well as temperature-sensitive mutants (grown at non-permissive 
temperatures) of the yeast homolog of FIP1L1 (FIP1) lead to both enrichment 
of R-loops and increased genomic instability (Stirling et al., 2012). 
 
Negative super-coiling favours R-loop formation (Roy et al., 2010). In vivo, this 
favourable coiling arises behind transcription complexes. Unsurprisingly then, 
topoisomerases have been implicated in the prevention of R-loop formation. 
Indeed, in yeast, absence of topoisomerases Top1 and Top2 led to R-loop 
enrichment at the rDNA locus (El Hage et al., 2010). Moreover, R-loop 
enrichment at that locus in top1∆ top2∆ double mutant cells interfered with 
RNA Pol I transcription. In human cells, treatment with topoisomerase 
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inhibitors (campothecin and topotecan) results in accumulation of R-loops at 
the appropriate DNA substrates (Powell et al., 2013, Sollier et al., 2014, Sordet 
et al., 2009).  
 
Once R-loops have been formed, they need to be removed from genomes. 
One of the main pathway of R-loop removal involves the two RNase H 
endonucleases. The substrate requirements between RNase H1 and H2 
differ. Current evidence suggests that RNase H1 recognizes and binds to both 
the RNA and DNA portion of DNA/RNA hybrids but it requires the hybrids to 
comprise of at least four consecutive ribonucleotides in order to process them. 
On the other hand, RNase H2 can recognize and cleave single ribonucleotides 
incorporated into the genome (Cerritelli and Crouch, 2009). Thus, both 
enzymes can remove R-loops. In fact, in mutant cells that otherwise stabilize 
R-loops, overexpression of RNase H1 or H2 can suppress R-loop 
accumulation (Huertas and Aguilera, 2003, Mischo et al., 2011). Moreover, 
sensitivity to RNase H treatment in vitro is a diagnostic for the presence of R-
loops (Li and Manley, 2005, Roy et al., 2008, Roy and Lieber, 2009). In 
humans, mutations in the subunits of the RNase H2 enzyme lead to an 
autoimmune inflammatory disorder named Aicardi-Goutières syndrome 
(AGS). As such, a decrease in RNase H-mediated R-loop processing could 
contribute in part to the pathophysiology of AGS (Groh and Gromak, 2014). In 
fact, the autoimmune nature of AGS is linked to the inappropriate 
accumulation of nucleic acids that is thought to trigger aberrant type I 
interferon signalling and, hence, chronic inflammation (Crow et al., 2014).  
 
R-loops are also targeted by specific helicases. In human cells, depletion of 
the DNA/RNA helicase Aquarius (AQR) led to the accumulation of R-loops and 
DSBs, indicating that Aquarius participates in R-loop removal (Sollier et al., 
2014). Overexpression of RNase H1 reduces the enrichment of R-loops in 
cells depleted for the Aquarius. Interestingly, Aquarius is part of a subfamily of 
DNA/RNA helicases that possesses a DEAxQ-like catalytic domain. Another 
protein with this DEAxQ-like domain in humans is Senataxin (SETX) (Sollier 
et al., 2014). Depletion of Senataxin also causes R-loop enrichment that can 
be remediated by the overabundance of RNase H1 (Skourti-Stathaki et al., 
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2011). Mutations in the Senataxin gene can lead to one of two neurological 
diseases; ataxia with oculomotor apraxia type 2 (AOA2) and juvenile-onset 
amyotrophic lateral sclerosis type 4 (ALS4). Whether R-loops contribute to 
these pathologies remain to be seen. Unlike AGS, neither AOA2 nor ALS4 
have been recognized as autoimmune diseases yet. However, depletion of 
Senataxin in human cells have been shown to lead to increased transcription 
of antiviral genes upon infection of the cells with the influenza A virus (Miller 
et al., 2015). Cells derived from individuals with AOA2 and cells from Setx-/- 
mice were also characterized by increased transcription of anti-viral genes 
upon infection using the influenza A and the Sendai virus (murine para-
influenza virus) defective-interfering RNA respectively (Miller et al., 2015). 
This may lead to chronic inflammation. In fact, both AOA2 patients and Setx-/- 
mice are hyper-responsive to infection, suggesting that chronic inflammation 
may contribute to the pathophysiology of AOA2 (Becherel et al., 2015). 
Meanwhile, a murine model of ALS (but not specific to ALS4) were 
characterized by the upregulation of interferon-stimulated genes in the 
astrocytes surrounding motor neurons (Wang et al., 2011), suggesting that 
chronic inflammation may also contribute to the pathophysiology of ALS4.  
 
Senataxin, but not Aquarius, is conserved in eukaryotes. Its yeast orthologue, 
Sen1 (Splicing endonuclease 1) was originally isolated as a protein important 
in the homeostasis of tRNA precursors (DeMarini et al., 1992). Increasingly 
however, Sen1 is being regarded as an important player in both R-loop 
removal (Mischo et al., 2011) and in non-canonical transcription termination. 
Sen1 also functions at forks, at the interface of transcription and DNA 
replication (Alzu et al., 2012). In fact, the role of Sen1 at forks will be a major 
focus of this thesis. The different functions of Sen1 will be discussed in more 
detail in later sections. Presently, however, the mechanism of canonical 
transcription termination in eukaryotes will be described and this mechanism 
will later be contrasted with the non-canonical, Sen1-dependent mechanism 
of transcription termination. 
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1.14 Canonical Transcription Termination in 
Eukaryotes 
 
Transcription is the process through which RNA polymerases synthesize 
transcripts, using the genome as a template. Eukaryotic transcription differs 
tremendously from its prokaryotic counterpart in that it occurs in the nucleus, 
in the absence of the translation machinery. In eukaryotes, three RNA 
polymerases operate. These enzymes are related structurally and functionally 
but they have undergone specialization and each transcribes different RNA 
molecules using distinct loci of the genome as templates (Table 1.2) 
 
Table 1.2. The eukaryotic RNA polymerases. Here, some of the most common 
products of the eukaryotic RNA polymerases are given (Richard and Manley, 
2009). This list is non-exhaustive and the sedimentation of the corresponding 
rRNA molecules are different between yeast and mammals. 
 
Enzyme 
 
Transcripts 
 
RNA Pol I 
• 25-28S rRNA 
• 16-18S rRNA 
• 5.8S rRNA 
 
 
 
 
RNA Pol II 
• Spliceosomal small nuclear RNA (involved in splicing/RNA 
processing) 
• Small nucleolar RNA (a subtype of snRNAs involved in the 
chemical modification of RNA molecules, including rRNA, 
tRNA, and snRNA) 
• MicroRNA precursors (miRNA are involved in RNA 
silencing and post-transcriptional regulation of gene 
expression. 
• CUT (cryptic unstable transcripts, products of non-
productive transcription). 
• Long non-coding RNA (regulation of gene expression) 
• Messenger RNA 
 
RNA Pol III 
• Transfer RNA 
• 5S rRNA 
• U6 spliceosomal snRNA 
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Independently of the identity of the transcripts being synthesized, transcription 
need to be terminated reproducibly. This is especially true for protein coding 
genes. Failure to do so will lead to read-through transcription. Beyond the 
obvious futile and costly energy expenditure in transcription beyond the limits 
of a certain gene of interest, read-through transcription from an upstream gene 
can proceed to the promoter of an immediately downstream gene, interfering 
with the activity of the second promoter. This phenomenon, called transcription 
interference, may result in decreased transcript levels from the downstream 
gene and correspondingly impact on the protein levels encoded by that gene, 
as evidenced by experiments in S. cerevisiae at the GAL10 and GAL7 genes 
(Greger and Proudfoot, 1998). Notably, the two genes are transcribed co-
directionally and the GAL7 gene is found downstream of the GAL10 gene. 
Deletion of the termination sequence of the GAL10 gene led to complete shut-
off of GAL7 expression whilst, concomitantly, a bi-cistronic GAL10-GAL7 
transcript was highly enriched.  
 
Transcription from a certain gene will often generate several mRNA 
populations varying in length. Some of these isoforms arise from alternative 
splicing whilst others are a product of using different polyadenylation signals 
(PASs) that signal for transcription to be terminated (Proudfoot, 2011). Indeed, 
mutations that inactivate PASs lead to transcription hundreds of bases beyond 
the PAS, leading to suboptimal levels of the genes being transcribed. In fact, 
this defect underpins the pathophysiology of two different thalassaemias 
(blood disorders characterized by incorrect blood counts) (Higgs et al., 1983, 
Orkin et al., 1985, Whitelaw and Proudfoot, 1986).  
 
Passage through PASs is sensed by RNA Pol II. In fact, RNA Pol II differs 
from either RNA Pol I and III by virtue of an additional protein segment that is 
formed from the carboxyl-terminal domain (CTD) of its largest subunit, Rpb1 
(Vannini and Cramer, 2012). This CTD consists of repeats of a seven residue-
stretch of amino acid (consensus Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7) and the 
number of these repeats varies from 26 in S. cerevisiae and 29 in Sz. pombe 
to 52 in vertebrates (Schwer and Shuman, 2011). Using recombinant 
expression of murine Pol II in human cells, it was found that truncating the 
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number of the heptad repeats from 52 down to five resulted in decreased 
transcription termination (McCracken et al., 1997). The authors also found that 
the heptads were required for binding to components of the cleavage and 
polyadenylation (CPA) complex. Importantly, the different residues within the 
heptad can be modified and different modifications are thought to enable 
distinct interactions with diverse complexes and to mediate distinct molecular 
events (Buratowski, 2003). Canonical transcription termination of Pol II genes 
in vivo seems to depend on concomitant de-phosphorylation of Tyr1 
(Schreieck et al., 2014) when RNA Pol II reaches a PAS and continued Ser2 
phosphorylation (Ahn et al., 2004). These modifications seemingly enable 
recruitment of Pcf11 (a component of the CPA complex) and Rtt103 (Kub5-
Hera in humans) that participate in 3’-end processing and transcription 
termination respectively (Schreieck et al., 2014). It is likely however that the 
effects of modifications of the heptad repeats on transcription termination are 
nuanced. For instance, in Sz. pombe, mutagenesis of Tyr1 to either alanine or 
leucine is lethal but mutation to its non-phosphorylable surrogate, 
phenylalanine, is not (Schwer and Shuman, 2011). This suggests that Tyr1 
phosphorylation is not an absolute requirement for termination. Likewise, 
mutagenesis of Ser2 to alanine or threonine was viable but mutation to the 
phospho-mimetic glutamic acid was found to be lethal. Although the viable 
mutants were temperature-sensitive, suggesting some defects, these results 
indicate that Ser2 phosphorylation is not necessary for the termination of 
transcription of RNA Pol II genes. 
 
Transient pausing of RNA Pol II after passing the PAS has also been 
implicated in transcription termination and this pausing has been shown to be 
dependent on the PAS itself and not on other cis-acting elements (Orozco et 
al., 2002). This pausing is stochastic and leads to the gradual termination of 
transcription.  Pausing may also be dependent on the recruitment of the CPA 
complex at or near the PASs. Indeed, depletion of components of the CPA 
complex in human cells leads to defects in pausing at PASs (Nojima et al., 
2015). R-loops and heterochromatin may also contribute to pausing of the 
RNA Pol II enzyme (Proudfoot, 2016). Stalling of RNA Pol II is thought to 
coincide with conformational changes in the protein, prompting transcription 
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termination. The CPA then polyadenylates the 3’-end of the transcript, leading 
to mature mRNA. These molecules can then be exported out of the nucleus 
whilst the RNA Pol II can be recycled and used anew for transcription. This 
model has been dubbed the allosteric model of termination (Fig 1.13).  
 
An alternative pathway for canonical transcription termination involves the 
Rat1 5’-3’ endonuclease in budding yeast (Dhp1 in fission yeast and XRN2 in 
vertebrates). In this model, the 3’-end of the nascent transcript is still cleaved 
when RNA Pol II passes through a PAS and the transcript is polyadenylated. 
However, in this model, RNA Pol II goes on to transcribe beyond the PAS. 
Simultaneously, the Rat1 endonuclease is recruited at the PAS and degrades 
the read-through transcript until it catches up with the processive RNA 
polymerase and torpedoes it off the chromosome (Fig 1.13). Indeed, yeast 
strains carrying the temperature-sensitive rat1-1 allele grown at non-
permissive temperatures are characterized by transcription termination 
defects and increased stability of transcripts downstream of their PASs (Kim 
et al., 2004). Likewise, rai1∆ cells (Rai1 forms a complex with Rat1) are also 
characterized by termination defects and enhanced stability of transcripts 
beyond their PAS (Kim et al., 2004). In HeLa cells, depletion of XRN2 using 
the siRNA technology also leads to termination defects (West et al., 2004). 
These observations suggest a non-species specific function for Rat1/XRN2 in 
transcription termination.  
 
Back-tracking may play an intriguing role in transcription termination. RNA Pol 
II has an intrinsic exonuclease activity to which the transcription factor TFIIS 
is a co-enzyme (Proudfoot, 2016). Backtracking favours removal of incorrectly 
transcribed RNA molecules but the enzyme might encounter secondary 
structures within the transcript during back-tracking that promotes 
transcription termination. In vitro experiments using endogenous S. cerevisiae 
RNA Pol II and recombinant Rat1-Rai1 indicate that misincorporation of 
dNTPs in the transcript by RNA Pol II promotes Rat1-Rai1 dependent 
degradation, suggesting a role for backtracking in termination (Park et al., 
2015). Interestingly, substituting Rat1-Rai1 with human XRN2 also leads to 
degradation of nascent transcripts upon misincorporation of dATP.  Given the 
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similarity between RNA Pol I, II and III, it is interesting to note that Rat1 is 
required for productive termination of transcription of RNA Pol I although the 
latter lacks a CTD (El Hage et al., 2008) whilst backtracking has been 
implicated in termination of transcription of RNA Pol III (Nielsen et al., 2013).  
 
It is possible that the allosteric and alternative (torpedo) models of transcription 
termination are mediators of the same (canonical) pathway. In this scenario, 
choosing one pathway of termination over the other would depend on some 
threshold being crossed or reached. For example, it is possible that, when 
RNA Pol II does not pause sufficiently at several PASs, the Rat1/Rai1 complex 
is recruited instead. As such, at any particular locus, either model of canonical 
termination could be used. It should be noted however that transcription can 
be terminated in a non-canonical manner. Often, this will involve abrupt arrest 
of RNA Pol II instead of pausing. Such arrests have been triggered by 
chemical damage. Once the RNA Pol II has been arrested, the enzyme is poly-
ubiquitylated and targeted for degradation by the 26S proteasome (Svejstrup, 
2007). The arrest also acts as a signal for transcription-coupled repair (TCR) 
using the nucleotide-excision repair (NER) pathway (Svejstrup, 2002). 
Although it is not known whether such arrests do occur under physiological 
conditions, it has been proposed that, in the event of collisions between forks 
and R-loop stabilized transcription complexes, RNA Pol II arrest could be used 
to forcefully terminate transcription (Proudfoot, 2016). Interestingly, in yeast, 
a protein involved in non-canonical transcription termination, has been shown 
to associate with forks (Alzu et al., 2012). The protein in question is the 
DNA/RNA helicase, Sen1 (Fig 1.13). 
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Figure 1.13. In S. cerevisiae, cells can terminate RNA Pol II-mediated 
transcription in one of two ways. The main mechanism involves the 
cleavage and polyadenylation of the nascent transcript once the RNA 
polymerase has reached a terminator sequence named PAS. Passage 
through the PAS coincides with changes in the conformation of the enzyme 
that can no longer bind to its substrate. The enzyme is then recycled. If the 
polymerase does not disengage, the Rat1 endonuclease is recruited and the 
latter torpedoes the polymerase off the genome. An alternative, non-canonical 
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pathway to  terminate transcription involves the NNS complex where Nrd1 and 
Nab3 enable recruitment of the DNA/RNA helicase that torpedoes the 
polymerase, similar to Rat1 (Porrua and Libri, 2013).  The NNS interacts with 
the exosome and this interaction may be important in NNS-dependent 
transcription termination. Interestingly, Sen1 may also be involved in canonical 
transcription, independently of Nrd1 and Nab3.
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1.15 Non-canonical/ Premature Transcription 
Termination by the NNS Complex in S. cerevisiae 
 
In S. cerevisiae, transcripts synthesized by RNA Pol II shorter than 1000 bases 
are typically terminated by a mechanism that is not dependent on the cleavage 
and polyadenylation of the 3’-end of the transcript. Instead, these transcripts 
are terminated by the NNS complex made up of Nrd1, Nab3 and Sen1. The 
substrates of the NNS termination pathway include snRNA (Steinmetz et al., 
2001), snoRNA (Kim et al., 2006) and cryptic unstable transcripts (CUTs) 
(Arigo et al., 2006), although it is likely that several substrates of the NNS 
complex remain to be identified as such.  
 
Nrd1 and Nab3 are two sequence-specific RNA binding proteins that form a 
heterodimer on the nascent transcript (Nrd1 binds to GUAA and Nab3 binds 
to UCUU) (Carroll et al., 2007, Conrad et al., 2000). Single-base mutations of 
the Nrd1 and Nab3 binding sites to GCAA and UCGU respectively were 
sufficient to reduce the binding affinity of the Nrd1-Nab3 dimer to its RNA 
template 10 to 20-fold in vitro (Carroll et al., 2007). In vivo, these mutations 
lead to termination read-through. As such, the ability of the Nrd1-Nab3 dimer 
to dock onto nascent transcripts is critical for the NNS-dependent transcription 
termination. The primary sequence of the N-terminal region of Nrd1 has 
similarity with the RNA Pol II CTD-interacting domains (CIDs) of both Pcf11 
and Rtt103 and was shown to also interact with the CTD of RNA Pol II 
(Vasiljeva et al., 2008) and the nrd1-101 allele, that encodes for a mutation in 
the CID of Nrd1, leads to termination defects (Conrad et al., 2000). Unlike 
Pcf11 and Rtt103, however, Nrd1 preferentially interacts with the RNA Pol II 
CTD when the Ser5 but not the Ser2 is phosphorylated (Vasiljeva et al., 2008). 
As such, occupancy on RNA Pol II by Nrd1 and by either Pcf11 or Rtt103 
would seem to be mutually exclusive. Indeed, a simplistic model suggests that 
Ser5 is phosphorylated when RNA Pol II is close to the 5’-end of genes but, as 
it elongates, Ser5 is dephosphorylated whilst Ser2 is phosphorylated (Hsin and 
Manley, 2012). To complicate matters however, the Nrd1-Nab3 dimer can bind 
to the 3’-UTR (untranslated regions) of several genes (Webb et al., 2014).  
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Importantly, neither Nrd1 nor Nab3 can bind stably to mRNA in isolation of one 
another (Carroll et al., 2007) and removal of the residues of Nrd1 responsible 
for interaction with Nab3 abrogates interaction between the CTD of RNA Pol 
II and Nrd1 (Vasiljeva et al., 2008). Intriguingly, neither the deletion of Nrd1’s 
CID nor that of the residues required for interaction with Nab3 cause lethality 
in S. cerevisiae. However, the NRD1 gene is essential for viability and deletion 
of both domains without interfering with the RNA-binding domain is lethal 
suggesting that these two domains serve to perform overlapping, if not entirely 
redundant, functions (Vasiljeva et al., 2008). 
 
Nab3 is also essential for viability but its function remains unclear. Whether 
Nab3 is functional in isolation is also unclear. Work in the Corden lab has 
shown that Nab3 overexpression correlates with increased phosphorylation of 
Nrd1 possibly as Nrd1 needs to form a dimer in order to be phosphorylated 
(Conrad et al., 2000). Yeast-two-hybrid experiments have also shown that 
Nab3, but not Nrd1, can physically interact with a Sen1 construct spanning 
residues 1890 to 2092 (Nedea et al., 2008). As such, current evidence points 
to a direct interaction between Nab3 and Sen1, forgoing any such interaction 
with Nrd1. This interaction is important for recruitment of the Sen1 protein at 
nascent transcripts. Moreover, immuno-precipitations suggest that full-length 
Sen1 forms a complex with Nrd1, Nab3 and Glc7 (a subunit of CPF, the 
cleavage and polyadenylation factor, used in mRNA cleavage and 
polyadenylation) (Nedea et al., 2008). Nrd1-Nab3 forms a stable sub-complex 
within this tetrameric complex and may serve to stabilize it.   
 
The final component of the NNS complex is Sen1. The SEN1 gene encodes 
a 253 kDa (2231 amino acid) DNA/RNA helicase that belongs to the Upf1-like 
superfamily 1 helicases (Jankowsky, 2011). Deletion of the gene is lethal in 
yeast and the essential region has been mapped to the C-terminal domain of 
the protein (DeMarini et al., 1992). This region encodes the helicase domain 
of the protein. The precise mechanism through which Sen1 mediates 
termination is still being elaborated. An elegant in vitro study has 
demonstrated that Sen1 disengages the transcription machinery in a manner 
reminiscent of the bacterial Rho termination factor (Porrua and Libri, 2013). 
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Indeed, Sen1 binds to transcripts and uses its ATPase activity to translocate 
along the RNA molecule in the 5’ to 3’ direction until it reaches the DNA/RNA 
region. There, it unwinds the transcript from its template. This termination was 
not dependent on the presence of Nrd1 and Nab3 and was carried to 
completion whether the RNA Pol II was actively transcribing or was stalled by 
the Reb1 protein. Using non-hydrolysable ATP or a mutant of Sen1 incapable 
of ATP-hydrolysis (Sen1G1747D) did not lead to productive transcription 
termination suggesting that ATP hydrolysis was important for Sen1-dependent 
transcription termination. Meanwhile, both recombinant full-length Sen1 and 
Sen1 (1095-1876) have demonstrable helicase activity in vitro and are 
capable of unwinding both RNA and DNA substrates (Martin-Tumasz and 
Brow, 2015, Leonaitė et al., 2017). As such, Sen1 may mediate two possibly-
distinct enzymatic activities from its helicase domain. At non-permissive 
temperatures, sen1-1 strains exhibit strong termination defects and increased 
levels of R-loops. These defects were alleviated by expression of Sen1 
constructs expressing the helicase domain expressed under the control of the 
strong ACT1 promoter (Mischo et al., 2011). Which of the helicase or 
transcription terminator functions of Sen1 is absolutely necessary for cell 
survival and whether these functions can be separated genetically are 
important avenues of future research.  
 
To enable transcription termination, Sen1 needs to be brought close enough 
to a transcribing RNA Pol II enzyme. However, the mechanism through which 
Sen1 interacts with RNA polymerases is not clear. It has been established 
that, like the Rat1 endonuclease, Sen1 is able to terminate transcription 
mediated by RNA Pol II but not by E. coli RNA polymerase (Park et al., 2015, 
Porrua and Libri, 2013). This indicates species- or polymerase-specificity. 
Surprisingly, however, using a variant of RNA Pol II lacking its CTD did not 
impair Sen1-dependent termination in vitro (Porrua and Libri, 2013). This is at 
odds with yeast-two-hybrid assays that indicate that Sen1 interacts 
preferentially with phosphorylated Ser2 in the CTD of RNA Pol II, 
independently of Nrd1 and Nab3 (Chinchilla et al., 2012). Indeed, a Sen1 
mutant (Sen1R302W) that has decreased affinity to phosphorylated Ser2 in 
the CTD of RNA Pol II has a different Chip-chip trace compared to wildtype 
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Sen1 at both non-coding and protein-coding loci. Taken together, this 
suggests that Sen1 interacts with the CTD terminal of RNA Pol II but that it 
can also interact with a non-CTD domain of RNA Pol II. In fact, IPs experiment 
have shown that Sen1 interacts with RNA Pol I, II and III (Yüce and West, 
2013). Unlike RNA Pol II, both RNA Pol I and III lack a CTD. This strengthens 
the hypothesis that Sen1 interacts with RNA Pol II in at least two different 
ways. 
 
Transcription speeds play a critical part in Sen1-dependent transcription 
termination, as illustrated in (Hazelbaker et al., 2013). The authors used two 
mutant alleles of RPB1 (the gene that encodes the largest subunit of RNA Pol 
II): rpb1E1103GFAST that leads to increased transcription speeds and is 
characterized by increased defects in transcription termination and 
rpb1N488DSLOW that is characterized by reduced transcription speeds with no 
defects in transcription termination (Hazelbaker et al., 2013). Temperature 
sensitive-alleles of SEN1 (sen1-1 and sen1-E1597K) were shown to have 
different responses to these two mutant alleles of RPB1. At semi-permissible 
temperatures, rpb1N488DSLOW was shown to suppress the growth defects 
associated with sen1-1 and sen1-E1597K whilst rpb1E1103GFAST 
accentuated the growth defects of the SEN1 mutants. Moreover, at semi-
permissive temperatures, rpb1N488DSLOW suppressed the termination defects 
of the SEN1 mutants whilst rpb1E1103GFAST led to increased termination 
defects. The increased defects can be accounted for by additive effects of the 
rpb1E1103GFAST and SEN1 mutants. However, the synthetic suppression of 
SEN1 mutants by rpb1N488DSLOW suggests that there is an interplay between 
the speeds of RNA Pol II and Sen1-dependent transcription termination. 
 
Several interactors of Sen1 could play a role in NNS-dependent transcription 
termination. Sen1 interacts physically and genetically with Rnt1, a homolog of 
E. coli RNase III, that is required for processing the 3’-end of U2 and U5 
spliceosomal RNA (Chanfreau et al., 1997, Elela and Ares, 1998, Ursic et al., 
2004). In fact, Rnt1 promotes transcription termination by enabling Rat1 to 
access RNA Pol I (El Hage et al., 2008, Kawauchi et al., 2008) and Pol II 
(Ghazal et al., 2009). As such, Sen1 could compete with Rat1 for Rnt1-
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dependent recruitment to RNA polymerases. Both Rat1 and Sen1 have been 
found to be important for transcription termination of RNA Pol II at the PAS of 
a reporter gene. Moreover, cells carrying both the rat1-1 and sen1-1 alleles 
showed additive defects in transcription termination at PAS (Kawauchi et al., 
2008). This suggests that Sen1 is able to terminate transcription both though 
the canonical and non-canonical pathways. 
 
Sen1 also interacts with Glc7 (Nedea et al., 2008). Sen1 is thought to present 
Glc7 to the Nrd1-Nab3 dimer, in proximity to nascent transcripts. In yeast, the 
CPF consists of several sub-complexes, one of which is known as the APT 
(Associated with Pta1) complex (Nedea et al., 2003). APT is made up of seven 
proteins, namely: Glc7, Pta1, Pti1, Ref2, Ssu72, Swd2 and Syc1. Deletion of 
either SWD2 and REF2 destabilizes the APT complex so that Glc7 no longer 
associates with the complex, triggering cell lethality. Over-expression of Sen1 
can synthetically suppress the lethality associated with swd2∆ and ref2∆ in 
W303 strains (Nedea et al., 2008). Importantly, although overexpression of 
Sen1 constructs suppress lethality in swd2∆ and ref2∆ cells, they do not 
prevent the destabilization of the APT complex. Moreover, suppression of 
lethality was dependent on residue F256 found in the C-terminal region of Glc7 
and a KHVCF motif in Sen1 spanning residues 1999-2003 (Nedea et al., 
2008). These allow for a direct physical interaction between Sen1 and Glc7, 
enabling the formation of a stable tetramer made up of the NNS complex and 
Glc7. This may serve the purpose to bring Glc7 to the vicinity of transcribing 
polymerases. Glc7 is a phosphatase that could potentially dephosphorylate 
Sen1, contributing to Sen1-dependent termination. Elsewhere, Glc7 has been 
shown to dephosphorylate Tyr1 in the CTD of RNA Pol II. Failure to 
dephosphorylate Tyr1 prevents recruitment of termination factors such as 
Pcf11 and Rtt103, contributing to termination defects (Schreieck et al., 2014). 
Finally, Sen1 physically interacts with Smd3, a protein involves in intron 
splicing (Fromont-Racine et al., 1997). It is unknown whether this interaction 
is useful for transcription termination. 
 
As mentioned earlier, sen1-1 strains are characterized by the enrichment of 
R-loops. These trigger hyper-recombination at significantly higher levels than 
	 92	
in hpr1∆ and rat1-1 cells at semi-permissive temperatures (Mischo et al., 
2011). By using different direct-repeat recombination substrates, the extent of 
recombination was also found to be dependent on both the length of the 
substrate (or duration of transcription) and the rate of transcription (Mischo et 
al., 2011). As such, transcription termination defects in the presence of Sen1-
1 is favourable for R-loop enrichment on the genome. This illustrates how 
disrupting the terminator function of Sen1 can lead to genomic instability.  
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1.16 The Exosome may be Important for NNS-
Dependent Transcription Termination 
 
The NNS complex interacts with the exosome complex. The latter is 
conserved and exists in both the cytoplasm and nuclei of eukaryotes. It is 
important for RNA metabolism and homeostasis (Bonneau et al., 2009). The 
core cytoplasmic exosome complex is composed of 10 essential subunits, 
including the 3’-5’ RNase Dis3 (Chlebowski et al., 2013) whilst the nuclear 
exosome complex is made up of those 10 subunits and another 3’-5’ RNase, 
Rrp6 (Chlebowski et al., 2013). Besides the RNase subunits, the exosome 
complex is made up of a hexameric core (composed of Mtr3, Rrp41, Rrp42, 
Rrp43, Rrp45 and Rrp46) onto which sits a cap composed of Csl4, Rrp4 and 
Rrp40. ssRNA is treaded into the channel formed by the core, that presumably 
allows for optimal enzymatic activity from the RNase subunits (Chlebowski et 
al., 2013). 
 
Interaction of the NNS with the exosome complex is mediated chiefly through 
Nrd1. Nrd1 co-precipitates with several components of the RNA exosome 
complex, including Rrp6 (Vasiljeva and Buratowski, 2006). Notably, the 
interaction between the exosome and Nrd1 depends on the latter’s CID, 
suggesting a link between Nrd1’s ability to bind to RNA Pol II and its ability to 
target transcripts for exosomal degradation/processing (Heo et al., 2013, Kim 
et al., 2016). Moreover, two cofactors of the exosome, Mpp6 and Trp4 interact 
with Nrd1 in a mutually exclusive fashion (Kim et al., 2016). Trp4 is part of the 
TRAMP complex (Trp4/5-Air1/2-Mtr4 polyadenylation) and stimulates the 
exosome into either trimming or degrading RNA in a Rrp6-dependent (Kilchert 
et al., 2016). Interestingly, overexpression of Nab3, but neither of Nrd1 nor of 
Sen1, supresses thermosensitive air1/2 mutants at semi- and non-permissive 
temperatures, and Nab3 also interacts with Rrp6 independently of Nrd1 
(Fasken et al., 2015). This suggests that the whole NNS complex and not Nrd1 
alone is important to couple transcription termination to exosomal processing 
of transcripts.  
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It is likely that targeting transcripts for exosomal processing is an important 
step for transcription termination. Indeed, delayed processing of transcripts 
could favour on-going transcription. This was illustrated in yeast cells where 
rrp6∆ leads to defects in NNS-dependent transcription termination at several 
loci, including those transcribed by RNA Pol II (Fox et al., 2015). 
 
Taken together, the NNS complex likely participates in transcription 
termination through several, perhaps overlapping pathways. The NNS 
complex is firstly a co-factor for the exosome in S. cerevisiae, whereby Nrd1 
and Nab3 bind to transcripts and target them for degradation or an alternative 
form of processing. It is not known whether transcription needs to be stalled in 
order for the NNS to act as an exosomal co-factor but it would seem likely. If 
the transcripts are not degraded promptly, this may lead to the resumption of 
transcription. 
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1.17 Conservation of the Subunits of the NNS 
complex 
 
The Sen1 protein is expressed at low levels in cells and Nrd1 and Nab3 
docking onto transcripts would enable localized and fine-tuned recruitment of 
Sen1 onto transcripts. Overexpression of Nrd1 leads to increased premature 
termination, possibly by over-enriching for Sen1 (Arigo et al., 2006). Once 
recruited at actively-transcribing sites, Sen1 can torpedo RNA Pol II off the 
chromosome, by interacting with the CTD of RNA Pol II. Alternatively, Sen1 
could make use of its DNA/RNA helicase activity to remove both R-loops and 
transcripts from their templates. The complex function of the NNS is reflected 
by the fact its individual components have different localization profiles on 
chromosomes (Alzu et al., 2012, Webb et al., 2014). Moreover, point mutants 
of Nrd1, Nab3 and Sen1 have different transcriptomes from their wildtype 
counterparts and amongst themselves (Chen et al., 2017). Whilst some of 
these differences could be ascribed to the severity and penetrance of the 
different mutations, their effect on protein stability and differing effects on 
complex formation, at least some of the differences reflect the non-overlapping 
functions of Nrd1, Nab3 and Sen1 in transcription termination (Chen et al., 
2017). 
 
It should be noted that the components of the NNS complex are conserved. In 
Sz. pombe, the Sen1 protein has two orthologues; Dbl8 (~222 kDa) and Sen1 
Sz.pombe (~193 kDa), both of which share 31% sequence identity with S. 
cerevisiae Sen1. dbl8∆ and sen1∆ are viable in fission yeast, perhaps as a 
result of redundancy. Like its yeast orthologue, Sen1Sz.pombe has been shown 
to possess both DNA and RNA helicase activities (Kim et al., 1999). 
Additionally, Sen1Sz.pombe has been shown to alleviate topological stress in the 
genome at RNA Pol III genes in fission yeast by antagonizing Pol III-
dependent transcription (Legros et al., 2014). Nrd1 and Nab3 are also 
conserved in fission yeast (Seb1 and Nab3, respectively) and both seem to 
have RNA recognition motifs (RRM), indicating a possible functional 
conservation. However, the RNA-binding protein Mmi1 seems to fulfil a role 
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comparable to that of the NNS complex in targeting mRNA molecules to the 
exosome complex in Sz. pombe, suggesting some divergence in functionality. 
In humans, the homolog of Sen1, Senataxin (SETX) (Chen et al., 2004) binds 
to the RRP45/EXOSC9 subunit of the human exosome complex in a 
SUMOylation-dependent manner. Mutations that impede the SUMOylation of 
SETX leads to a recessive neurological disorder, known as AOA2 (Richard et 
al., 2013). Mutations of SETX can also lead to a different neurological disorder 
known as ALS4. Both AOA2 and ALS4 will be discussed in more detail in 
Section 1.20. Paralogues of Senataxin include Aquarius, IGHMBP2, RENT1 
and ZNFx1 (Bennett and La Spada, 2015, Chen et al., 2004, Sollier et al., 
2014). 
 
SCAF8/RBM16 is the likely mammalian homolog of Nrd1 and has been found 
to promiscuously interact with both phosohorylated Ser2 and Ser5 at the CTD 
of RNA Pol II (Becker et al., 2008, Corden, 2013, Patturajan et al., 1998, 
Yuryev et al., 1996). The human RALY protein’s RRM share 31% identity with 
that of Nab3 and overexpression of the RALY gene, similarly to that Nab3 in 
yeast, can suppress thermosensitive air1/2 mutants (Fasken et al., 2015). The 
biological function of the RALY protein has remained elusive however and 
polyadenylation-independent transcription termination as mediated by the 
yeast NNS complex has yet to be identified in humans (Corden, 2013). Like 
Sen1 however, SETX appears to be involved in canonical, Xrn2-dependent 
transcription termination (Skourti-Stathaki et al., 2011).  
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1.18 A Prominent Role for Sen1 in Transcription-
Coupled Repair 
 
Given its role in the removal of transcription-mediated R-loops and in 
transcription termination, it is not surprising to note that the Sen1 helicase is 
also involved in transcription-coupled repair. In fact, the first 975 residues of 
Sen1 was shown to interact with Rad2 in a yeast-two-hybrid assay (Ursic et 
al., 2004). Using the sen1-1 and rad2∆ alleles, it was also shown that the two 
genes also interact genetically. Rad2 is a single-stranded DNA endonuclease 
involved in nucleotide excision repair (NER) (Habraken et al., 1993) where it 
is absolutely required for incision at the 3’ end of lesions. NER, itself, is 
primarily important for the removal of UV-induced DNA damage such as 
pyrimidine dimers and can be sub-divided in two pathways: global genome 
NER (GG-NER) and transcription coupled repair (TCR). These differ in the 
substrate they recognize. GG-NER scans the genome for helix-distorting 
lesions whilst TCR primarily recognizes damage that impede RNA polymerase 
progression during transcription (Marteijn et al., 2014). However, after 
damage-recognition, the mechanisms of damage-removal and gap-filling in 
GG-NER and TCR are identical.  
 
In S. cerevisiae, the DNA-dependent ATPase, Rad26, is important for TCR 
(van Gool et al., 1994). However, in the absence of TCR repressors such as 
Rpb4 (a dispensable subunit of RNA Pol II) (Li and Smerdon, 2002), as well 
as the transcription elongation factors Spt4 (Jansen et al., 2000) and Spt5 
(Ding et al., 2010), Rad26 is dispensable for TCR. This suggests that there 
are at least two sub-pathways for TCR in budding yeast, one of which is 
dependent on Rad26. In fact, deletion of both RBP9 (Rbp9 is another 
dispensable subunit of RNA Pol II) and RAD26 abolishes TCR (Li and 
Smerdon, 2002), indicating that there are only two such sub-pathways. 
Interestingly, IPs of Sen1-TAP reveal that the protein interacts with elongation 
factors Spt5 and Spt6 and RNA Pol II subunits, including Rpb4 (Yüce and 
West, 2013). 
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Direct evidence for a role of Sen1 in TCR was provided when removal of either 
the first 1088 or last 373 residues of the protein led to defects in TCR (Li et al., 
2016). Moreover, ablation of the last 373 residues led to milder TCR defects, 
suggesting that the N-terminal domain of Sen1 plays a more prominent role in 
TCR than its extreme C-terminal residues. The Sen1E1597K mutant, 
defective for its ATPase-helicase activity, only showed minor defects in TCR, 
suggesting that the catalytic activity of the protein is dispensable for its role in 
TCR. In addition, deletion of SPT4 does not fully suppress the TCR defect 
associated with the SEN1(1089-2231) allele. This suggests that Sen1 works 
in the Rbp9-dependent pathway of TCR. 
 
Sen1 could also play a role in non-TCR and non-NER repair pathways. 
Indeed, the triple rad7∆ rad26∆ SEN1(1089- 1929) mutant is more susceptible 
to UV compared to the double rad7∆ rad26∆ mutant. Rad7 is required for GG-
NER. This suggests that Sen1 repairs UV-mediated damage through at least 
two repair pathways, one of which is not involved in NER. This role of Sen1 in 
repair of DNA damage may be conserved. Indeed, in humans, Senataxin co-
localizes with 53BP1, a marker signalling response to DNA damage (Yüce and 
West, 2013). 
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1.19 Sen1 at the Interface of DNA Replication and 
Transcription 
 
Besides its role in transcription, the human homolog of Sen1, Senataxin has 
also been implicated in DNA replication. In fact, both human epithelial U2OS 
cells and HeLa cells form nuclear Senataxin foci primarily when they replicate 
their genomes (Yüce and West, 2013). Moreover, treating cells with the B-
DNA polymerase specific inhibitor aphidicolin, that works by docking at the 
active site of polymerases preventing dCTP incorporation (Baranovskiy et al., 
2014), led to an increase in the number of Senataxin foci. Conversely, 
successive treatment of cells with aphidicolin and RNase H1 or treatment with 
the transcription-inhibitor α-amanitin led to a decrease in the number of 
Senataxin foci (Yüce and West, 2013). These observations indicate that 
Senataxin molecules are enriched on the genome especially when forks and 
transcription complexes are more likely to encounter one another and at sites 
of R-loop formation. Senataxin then may be important for fork progression past 
R-loops and transcription complexes.  
  
In yeast, the first evidence for a possible role of Sen1 in DNA replication was 
provided when ChIP-chip analysis revealed that Sen1 is enriched at origins 
(Alzu et al., 2012). Moreover, at highly-transcribed RNA Pol II genes, such as 
PDC1, rapid depletion of Sen1 leads to enrichment of R-loops and Rfa1 (a 
subunit of the replication protein A) in the genome as determined by ChIP-
qPCR. 2D gels also revealed the presence of gapped-forks following Sen1-
depletion, indicative of incomplete DNA replication. As such, in yeast, Sen1 
co-localizes with forks, enabling the completion of DNA replication. The 
authors also found that growing cells expressing the temperature-sensitive 
sen1-1 allele at non-permissive temperatures led to the lengthening of S 
phase as well as terminal arrest in G2. The sen1-1 allele also triggers activation 
of Rad53 at non-permissive temperatures, suggesting that forks stall in the 
absence of a functional Sen1.  
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Sen1-1 also interacts genetically with several components of the replisome 
including CTF4, MRC1 and TOF1, as well as genes involved in DNA repair 
including RAD50 and SGS1 (Alzu et al., 2012). Meanwhile, IPs of the CMG 
helicase has revealed that Sen1 interacts with the replisome (Giacomo De 
Piccoli, unpublished). Whether Sen1 directly binds to the replisome or 
interacts with the latter indirectly remains to be seen. The biological 
significance of this interaction is also an important aspect that needs 
addressing. These two questions will be a major focus of this thesis. 
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1.20 The Domains of Sen1 and Senataxin, and their 
Role in Human Diseases 
 
As mentioned earlier, the essential region of Sen1 has been mapped to the C-
terminal domain of the protein (DeMarini et al., 1992) and this has been 
winnowed to residues 1084-1907, provided the presence of a chimeric nuclear 
localization sequence (NLS) (Chen et al., 2014). Analysis of the primary 
sequence of the C-terminal domain of Sen1 reveals that the portion of the 
protein spanning residues 1147-1857 has ~30% identical sequence with 
isoforms of its human homolog. This region corresponds to the helicase 
domain of the protein, suggesting some conservation of function. The crystal 
structure of this domain of Sen1 was recently published (Leonaitė et al., 2017). 
Like other Upf1-family helicases, Sen1 is made up of a subdomain 1B that 
forms a stalk and a barrel, and a subdomain 1C that forms a rigid prong. The 
latter extends atop a RecA1 domain. The authors suggest that once nucleic 
species enter between subdomains 1B and 1C, the subdomains close leading 
the prong to slice through the nucleic species, overcoming van der Waals 
forces between complementary bases, effectively causing melting. 
Interestingly, Sen1, contrary to other Upf1-like helicases, seem to have a 
unique structure that the authors call a brace that modulates the positioning of 
the barrel. Importantly, residues within this brace structure (1097-1149) are 
conserved in Senataxin (Leonaitė et al., 2017). 
 
In silico analysis of the N-terminus of Sen1 suggests an abundance of α-
helices. Whilst this domain is conserved in other yeasts (~31% identical 
sequence compared to both Sen1 and Dbl8 in Sz. pombe), it is not conserved 
in humans. However, this domain is conserved in aquatic vertebrates such as 
Danio and Xenopus (Bennett and La Spada, 2015). The N-terminal domain of 
Sen1 then underwent strong divergent evolution, especially in mammals. 
Given however that the N-terminal domain is not a separate protein, it is 
plausible that some of its functions are conserved (Bennett and La Spada, 
2015). IPs of C-terminally FLAG-tagged Senataxin transiently transfected in 
HeLa cells revealed that the protein interacts with RNA Pol II subunits (RPB1, 
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RPB2 and RPB3), transcription elongation factors as well as with proteins 
involved in DNA repair such as MRE11 and RAD50 (Yüce and West, 2013). 
As such, like the N-terminal domain of Sen1, Senataxin can interact with RNA 
Pol II but, unlike Sen1, there is no evidence that Senataxin interacts with 
human RNA Pol I or III. Moreover, unlike Sen1, current evidence does not 
indicate Senataxin’s involvement in TCR or NER in human cells.  
 
Senataxin has been implicated in two distinct neurological disorders; ataxia 
with oculomotor apraxia type 2 (AOA2) and juvenile amyotrophic lateral 
sclerosis (ALS4) (Bennett and La Spada, 2015). AOA2 is an early-onset (10- 
22 years), progressive debilitating disease characterized by atrophied 
cerebellar matter, oculomotor apraxia (loss of or defective control of voluntary 
eye movements) and damage to the peripheral nervous system (Le Ber et al., 
2004, Moreira et al., 2004). Of the original 15 mutations first described, 10 are 
nonsense mutations that lead to truncated proteins (Moreira et al., 2004), 
plausibly affecting the catalytic activity of the enzyme. Mutations that lead to 
AOA2 occur throughout the SETX gene, except at its extreme C-terminus 
(Chen et al., 2014). A study in the Brow lab exploited the conserved helicase 
domain of Sen1 to reproduce AOA2 point mutations in the yeast Sen1 protein 
(Chen et al., 2014). Of the 13 mutations tested, only two were indistinguishable 
from wildtype. The other mutations conferred either recessive or dominant 
transcription termination defects, temperature-sensitivity or were lethal. Four 
of those mutants were characterized by both temperature-sensitivity and 
defects in transcription termination. The N-terminal of Senataxin is 
SUMOlyated and this modification is a requisite for Senataxin’s interaction with 
the exosome through its RRP45 subunit in human cells (Richard et al., 2013). 
This interaction is important for Senataxin to target the exosome to sites of 
DNA damage. Three AOA2 mutations were found to abolish the SUMOlyation 
of the N-terminus of Senataxin, thus inhibiting its interaction with RRP45. 
Notably, Senataxin and RRP45 colocalize at nuclear foci in S phase and these 
foci are sensitive to overexpression of RNase H1 (Richard et al., 2013, Yüce 
and West, 2013). Taken together, this suggests that AOA2 mutations are often 
loss of function mutations. Indeed, AOA2 mutations are recessive and carriers 
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do not present any phenotypes associated with the disease (Le Ber et al., 
2004, Moreira et al., 2004).  
 
Unlike AOA2, ALS4 is a dominant disease, suggesting gain of function 
mutations. ALS4 is much rarer than AOA2 potentially underlying a more 
specific and obscure pathophysiology. ALS4 is an early-onset disease, 
characterized by progressive degeneration of motor neurons in the cortex, 
brain stem and spinal cord. Analysis of unrelated pedigrees of the disease 
highlighted only four causal mutations: T3I, L389S and R2136C/H (Chen et 
al., 2004, Chen et al., 2014). Intriguingly, two of the mutations occur in the N-
terminal domain of Senataxin whilst the other residue occurs in the helicase 
domain but is not conserved in Sen1 (Chen et al., 2014). The L389S mutation 
has been studied extensively. In a yeast-two-hybrid screen using a human 
brain cDNA library, and either Senataxin (1- 650) or SentaxinL389S (1- 650) as 
bait, the mutant fragment was seen to interact specifically with a peptide 
translated from an antisense transcript of a brain-specific, non-coding RNA 
known as BCYRN1 (Bennett et al., 2013). Whether this interaction is critical 
for the pathophysiology of ALS4 is yet to be determined. However, it is 
possible that ALS4 mutations lead to artificial interactors of the protein, directly 
antagonizing its useful, physiological roles in cells.  
 
A Setx knock-out murine model was generated by crossing Setx+/- 
heterozygotes but this line of mice is both viable and displays neither ataxia 
nor neuronal degeneration phenotypes (Becherel et al., 2013). The male mice 
are infertile as a result of R-loops accumulating in germ cells, promoting 
apoptosis and hampering spermatogenesis. On the other hand, R-loops were 
not found to accumulate in post-mitotic cells (Yeo et al., 2014). This may 
underpin the discrepancy in the Senataxin-dependent development of 
neurological disorders between the murine model and humans. It is possible 
that, unlike in mice, R-loops could form in the human nerves encoding 
Senataxin mutants, contributing to the pathophysiology of AOA2 and/or of 
ALS4. Whilst not yet formally proven, it is possible that both AOA2 and ALS4 
are characterized by chronic inflammation, similar to the autoimmune disorder, 
the Aicardi-Goutières syndrome. 
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1.21 Aims of the Thesis 
 
The goal of this thesis is to broaden our understanding of how forks deal with 
barriers in eukaryotes. For that purpose, I have used two different systems. 
 
The first one involved the cell- or mating-type switching of Sz. pombe, where 
a fork barrier (MPS1) mediates fork pausing that is required for incorporating 
ribonucleotides at that specific locus (an event referred to as imprinting). 
Importantly, the Pol1 subunit of Polymerase α is required for this imprinting 
process. However, the mechanism through which Pol1 participates in the 
synthesis of the imprint has not yet been solved. Here, I have attempted to 
characterize the difference between pol1 and its imprinting-defective mutant 
swi7-1. In order to do so, I have cloned recombinant variants of Pol1 and Swi7-
1 and have assayed their properties in vitro. 
 
The second system I was interested in involved the DNA/RNA helicase Sen1 
travelling with forks in S. cerevisiae. Depletion of Sen1 leads to slow fork 
progression and activation of Rad53, suggesting that forks are stalled at a 
higher frequently in the absence of Sen1. Here, I sought to characterize the 
interaction between Sen1 and the replisome in S. cerevisiae. I have identified 
one replisome interactor of Sen1 as well as the domain through which Sen1 
interacts with the rest of the replisome. I have also created an allele of SEN1 
that encodes for an isotype of the protein incapable of binding to the replisome 
in order to tease out the biological relevance of this interaction. 
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 CHAPTER 2: Materials and Methods 
 
2.1 Yeast Specific Methods 
 
Both budding and fission yeasts are powerful model organisms for 
fundamental research. Of note, since the beginning of the 21st century, no less 
than six people have been awarded the Nobel Prize in Physiology or Medicine 
based on their work using either budding or fission yeast. They include Sir 
Paul Nurse and Leland Hartwell (2001) for their discoveries of key regulators 
of the cell cycle, Elizabeth Blackburn and Jack Szostack (2009) for their work 
on telomeres and telomerases, Randy Schekman (2013) for his involvement 
in the discovery of machinery regulating vesicle trafficking and Yoshinori 
Ohsumi (2016) for this work on autophagy.  
 
Both species are attractive models for research for several reasons. Firstly, 
yeasts can be generated within a short time. Indeed, whilst human cell cycles 
last approximately 24 h, wildtype haploid strains of budding yeast complete an 
entire cell cycle within approximately 90 min in rich medium whilst wildtype 
haploid strains of fission yeast go through one cell cycle within 2-4 h. 
Consequently, a large number of cells can be generated relatively quickly for 
both organisms enabling rapid isolation of both nucleic acid and protein matter. 
 
It is also easy and inexpensive to grow and maintain these two yeasts under 
laboratory conditions. Both organisms are widely used in research so that a 
wide range of techniques and reagents are available for use with either 
organism. Several techniques are applicable to both yeasts, with minor 
alterations required for optimal efficiency.  Genetic manipulation is tractable, 
enabling gene deletion and disruption, as well as gene tagging with protein 
markers, degrons as well as reporter genes. Targeted mutagenesis is also 
possible. Unlike bacteria, budding and fission yeast can exist both as haploids 
and as diploids after mating between individuals of different and 
complementary mating/cell-types. As such, the phenotypes of recessive 
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alleles can be easily observed in haploid strains whilst heterozygous diploids 
deleted or disrupted for essential genes can also be constructed.   
 
S. cerevisiae and Sz. pombe have both a rich history as model organisms in 
the study of DNA replication. Several proteins involved in the DNA replication 
process have been identified and characterized first in budding and fission 
yeast prior to the discovery of the human orthologue. Differences between the 
two yeasts and human cells do exist. For instance, neither budding nor fission 
yeast encode a geminin orthologue whilst S. cerevisiae has uniquely defined 
origins amongst eukaryotes. Notwithstanding such evolutionary quirks, the 
process of DNA replication is well conserved across eukaryotes so that 
studying the process in S. cerevisiae and Sz. pombe has direct implications 
for our understanding of DNA replication in humans. In this study, both yeasts 
were used as model organisms. Table 2.1 and 2.2 details the genotypes of the 
S. cerevisiae and Sz. pombe strains generated in this work respectively. 
 
2.1.1 Yeast strains and Media 
 
S. cerevisiae strains were grown from 25% (v/v) glycerol suspensions (kept at 
−80°C) onto solid non-selective medium (YPD) at either 25°C for heat-
sensitive strains or 30°C for all other strains. For Sz. pombe strains, cells were 
also grown from 25% (v/v) glycerol solutions (kept at −80°C) onto solid non-
selective YEA medium at either 25°C for heat-sensitive strains or 33°C for all 
other strains. To select for antibiotics resistance conferred by the kanMX and 
hphNT cassettes, strains were grown on either YPD or YEA supplemented 
with G418 (Geneticin) and Hygromycin B respectively to a final concentration 
of 200 μg/ml. For selection of autotrophy, strains were growth onto synthetic 
medium supplemented with the required amino acids. 
 
For loss of the URA3 gene in S. cerevisiae or ura4 gene in Sz. pombe, cells 
were grown in synthetic medium supplemented with FOA (5-fluoroorotic acid) 
to a final concentration of 0.1% (w/v). Yeasts cells carrying constructs cloned 
under the inducible GAL1 promoter were grown on solid YPD medium or in 
liquid YP-Raff to suppress induction of the constructs or on solid or liquid 
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YPGAL for expression of the constructs. Table 2.3 gives detailed recipe of the 
media used (for growth of both yeasts and bacteria) in this study. 
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Table 2.1. List of S. cerevisiae strains used in this study. All strains were 
derived from and are isogenic to strain W303-1 (ade2-1 ura3-1 his3-11,15 
trp1-1 leu2-3,112 can1-100 rad5-535), unless stated otherwise. 
 
ID Genotype Source 
CS1 MATa Laboratory 
collection. 
CS6 MATα Laboratory 
collection. 
CS44 MATa top1Δ::kanMX Laboratory 
collection. 
CS55 MATa/MATα Laboratory 
collection. 
CS74 MATa pep4Δ::ADE2+ Laboratory 
collection. 
CS114 MATa/MATα ade2-101/ade2-101 his3/his3-D200 
leu2-3,112/ leu2-3,112 trp1-901/trp1-901 ura3-
52/ura3-52 gal4Δ/gal4-452 gal80Δ/gal80-538 
LYS2/lys2-801::GAL1UAS-GAL1TATA-HIS3 
URA3::UASGAL1-LacZ, (met-)/URA3:: GAL4 
17mers (X3)-CyC1TATA-LacZ 
Hybrigenics (not 
isogenic with 
W303). 
CS1125 MATa TAP-SLD5 (kanMX) SEN1-9MYC (hphNT) 
pep4Δ::URA3+ ADE2+ 
This study. 
CS1126 MATa SEN1-9MYC (hphNT) pep4Δ::URA3+ 
ADE2+ 
This study. 
CS1134 MATa DPB2-TAP (kanMX) SEN1-9MYC (hphNT) 
pep4Δ::URA3+ ADE2+ 
This study. 
CS1187 MATa TAP-SLD5 (kanMX) SEN1-9MYC (hphNT) 
pep4Δ::URA3+ ADE2+ ctf4Δ::kanMX 
This study. 
CS1217 MATa TAP-SLD5 (kanMX) SEN1-9MYC (hphNT) 
pep4Δ::URA3+ ADE2+ tof1Δ::HISMX 
This study. 
CS1353 MATa SEN1-TAP (kanMX) pep4Δ::ADE2+ This study. 
CS1403 MATa POL12-TAP (kanMX) SEN1-9MYC (hphNT) 
pep4Δ::ADE2+  
This study. 
CS1416 MATa TAP-MCM3 (kanMX) SEN1-9MYC (hphNT) 
pep4Δ::ADE2+ 
This study. 
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CS1534 MATa TAP-SLD5 (kanMX) SEN1-9MYC (hphNT) 
pep4Δ::URA3+ ADE2+ mrc1Δ::hphNT 
This study. 
CS1561 MATa TAP-SLD5 (kanMX) SEN1-9MYC (hphNT) 
pep4Δ::URA3+ ADE2+ csm3Δ::hphNT 
This study. 
CS1671 MATa POL12-TAP (kanMX) SEN1-9MYC (hphNT) 
pep4Δ::ADE2+ ctf4Δ::kanMX 
This study. 
CS1676 MATa TAP-SLD5 (kanMX) SEN1-9MYC (hphNT) 
pep4Δ::URA3+ ADE2+ top1Δ::kanMX 
This study. 
CS1711 MATa TAP-MCM3 (kanMX) GAL1-3HA-ø (LEU2+) 
pep4Δ::ADE2+ 
This study. 
CS1714 MATa TAP-MCM3 (kanMX) GAL1-3HA-SEN1 (2-
931) (LEU2+) pep4Δ::ADE2+ 
This study. 
CS1852 MATa GAL1-TAP-ø (LEU2+) pep4Δ::ADE2+ This study. 
CS1933 MATa GAL1-TAP-SEN1 (1095-2231) (LEU2+) 
pep4Δ::ADE2+ 
This study. 
CS1941 MATa GAL1-TAP-SEN1 (2-2231) (LEU2+) 
pep4Δ::ADE2+ 
This study. 
CS1942 MATa GAL1-TAP-SEN1 (2-1901) (LEU2+) 
pep4Δ::ADE2+ 
This study. 
CS1943 MATa GAL1-TAP-SEN1 (931-2231) (LEU2+) 
pep4Δ::ADE2+ 
This study. 
CS1956 MATa GAL1-TAP-SEN1 (2-1103) (LEU2+) 
pep4Δ::ADE2+ 
This study. 
CS1957 MATa GAL1-TAP-SEN1 (2-931) (LEU2+) 
pep4Δ::ADE2+ 
This study. 
CS2030 MATa TAP-MCM3 (kanMX) GAL1-3HA-SEN1 (2- 
622) (LEU2+) pep4Δ::ADE2+ 
This study. 
CS2032 MATa TAP-MCM3 (kanMX) GAL1-3HA-SEN1 
(410- 931) (LEU2+) pep4Δ::ADE2+ 
This study. 
CS2056 MATα td-MYC-sen1-1 (K.l.TRP1+) GAL1-UBR1 
(HISMX) GAL1-TAP-	ø (LEU2+) 
This study. 
CS2058 MATα td-MYC-sen1-1 (K.l.TRP1+) GAL1-UBR1 
(HISMX) GAL1-TAP-	SEN1 (2-931) (LEU2+) 
This study. 
CS2061 MATα td-MYC-sen1-1 (K.l.TRP1+) GAL1-UBR1 
(HISMX) GAL1-TAP-	SEN1 (2-1901) (LEU2+) 
This study. 
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CS2062 MATα td-MYC-sen1-1 (K.l.TRP1+) GAL1-UBR1 
(HISMX) GAL1-TAP-	SEN1 (1095-2231) (LEU2+) 
This study. 
CS2145 MATa TAP-MCM3 (kanMX) GAL1-3HA-SEN1 
(410- 913) (LEU2+) pep4Δ::ADE2+ 
This study. 
CS2146 MATa TAP-MCM3 (kanMX) GAL1-3HA-SEN1 
(410- 761) (LEU2+) pep4Δ::ADE2+ 
This study. 
CS2147 MATa TAP-MCM3 (kanMX) GAL1-3HA-SEN1 
(410- 501) (LEU2+) pep4Δ::ADE2+ 
This study. 
CS2148 MATa TAP-MCM3 (kanMX) GAL1-3HA-SEN1 
(501- 931) (LEU2+) pep4Δ::ADE2+ 
This study. 
CS2149 MATa TAP-MCM3 (kanMX) GAL1-3HA-SEN1 
(761- 931) (LEU2+) pep4Δ::ADE2+ 
This study. 
CS2150 MATa TAP-MCM3 (kanMX) GAL1-3HA-SEN1 
(622-931) (LEU2+) pep4Δ::ADE2+ 
This study. 
CS2184 MATα td-MYC-sen1-1 (K.l.TRP1+) GAL1-UBR1 
(HISMX) GAL1-TAP-	SEN1 (2-1103) (LEU2+) 
This study. 
CS2188 MATα td-MYC-sen1-1 (K.l.TRP1+) GAL1-UBR1 
(HISMX) GAL1-TAP-	SEN1 (2-2231) (LEU2+) 
This study. 
CS2276 MATa hrp1Δ::kanMX Laboratory 
collection. 
CS2334 MATa/MATα SEN1/SEN1 (1-410, 411-2231 
Δ)::URA3-CP 
This study. 
CS2335 MATa/MATα SEN1/SEN1 (1-622, 623-2231 
Δ)::URA3-CP 
This study. 
CS2403 MATa/MATα SEN1/SEN1 (SEN1promoter-930 
Δ)::URA3-CP 
This study. 
CS2404 MATa/MATα SEN1/SEN1 (SEN1promoter-912 
Δ)::URA3-CP 
This study. 
CS2451 MATα td-MYC-sen1-1 (K.l.TRP1+) GAL1-UBR1 
(HISMX) GAL1-TAP-	SEN1 (931-2231) (LEU2+) 
This study. 
CS2457 MATa/MATα SEN1/SEN1 (913-2231) (HISMX) This study. 
CS2458 MATa/MATα SEN1/SEN1 (931-2231) (HISMX) This study. 
CS2582 MATa sen1Δ::URA3-CP ACT1-3HA-SEN1 (931-
2231) (LEU2+) 
This study. 
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CS2584 MATa sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-
2231) (LEU2+) 
This study. 
CS2586 MATa sen1Δ::URA3-CP SEN1-3HA-SEN1 (2-
2231) (LEU2+) 
This study. 
CS2603 MATa GAL1-TAP-SEN1 (2-931) (LEU2+) 
pep4Δ::ADE2+ ctf4Δ::kanMX 
This study. 
CS2607 MATa sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-
2231)	W773A E774A W777A (LEU2+) 
This study. 
CS2609 MATa sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-
2231) D850A E851G V852A L853G L854A 
(LEU2+) 
This study. 
CS2617 MATa sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-
2231) V746G D747G P748G I749G (LEU2+) 
This study. 
CS2623 MATa sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-
2231) L656A S657A K658A I659A L660 (LEU2+) 
This study. 
CS2636 MATa sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-
2231) L656A S657A K658A I659A L660A NRD1-
9MYC (HIS3MX) pep4Δ:: ADE2+ TAP-MCM3 
(kanMX)   
This study. 
CS2638 MATa sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-
2231)W773A E774A W777A NRD1-9MYC 
(HIS3MX) pep4Δ:: ADE2+ TAP-MCM3 (kanMX)   
This study. 
CS2640 MATa sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-
2231) D850A E851G V852A L853G L854A NRD1-
9MYC (HIS3MX) pep4Δ:: ADE2+ TAP-MCM3 
(kanMX)   
This study. 
CS2642 MATa sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-
2231) V746G D747G P748G I749G NRD1-9MYC 
(HIS3MX) pep4Δ:: ADE2+ TAP-MCM3 (kanMX)   
This study. 
CS2656 MATα sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-
2231) (LEU2+) top1Δ::kanMX 
This study. 
CS2659 MATa sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-
2231) L656A S657A K658A I659A L660 (LEU2+) 
top1Δ::kanMX 
This study. 
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CS2661 MATa sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-
2231)	W773A E774A W777A (LEU2+) 
top1Δ::kanMX 
This study. 
CS2668 MATα sen1Δ::URA3-CP ACT1-3HA-SEN1 (931-
2231) (LEU2+) top1Δ::kanMX 
This study. 
CS2669 MATa sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-
2231) NRD1-9MYC (HIS3MX) pep4Δ:: ADE2+ 
TAP-MCM3 (kanMX)   
This study. 
CS2670 MATa sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-
2231) NRD1-9MYC (HIS3MX) pep4Δ:: ADE2+  
This study. 
CS2696 MATa sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-
2231)	W773A E774A W777A hrp1Δ::kanMX 
This study. 
CS2702 MATa sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-
2231) L656A S657A K658A I659A L660 (LEU2+) 
hrp1Δ::kanMX 
This study. 
CS2729 MATa sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-
2231) D850A E851G V852A L853G L854A 
(LEU2+) hrp1Δ::kanMX 
This study. 
CS2734 MATa rnh1Δ:: hphNT rnh201Δ::HISMX This study. 
CS2735 MATα rnh1Δ:: hphNT rnh201Δ::HISMX This study. 
CS2736 MATa rnh1Δ:: hphNT rnh201Δ::HISMX 
sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-2231)	
W773A E774A W777A (LEU2+) 
This study. 
CS2738 MATa rnh1Δ:: hphNT rnh201Δ::HIS3MX 
sen1Δ::URA3-CP ACT1-3HA-SEN1 (2-2231)	
D850A E851G V852A L853G L854A (LEU2+) 
This study. 
CS2791 MATa td-sld3-7 (kanMX) GAL1-UBR1 (HIS3MX) 
GAL1-TAP-SEN1 (2-931) (LEU2+) pep4Δ:: ADE2+  
This study. 
CS2798 MATa CTF4 (1-367)-9MYC (kanMX) pep4Δ:: 
ADE2+ 
This study. 
CS2799 MATa CTF4 (1-367)-9MYC (kanMX) pep4Δ:: 
ADE2+ GAL1-TAP-SEN1 (2-931) (LEU2+) 
This study. 
CS2800 MATa CTF4-9MYC (kanMX) pep4Δ:: ADE2+ 
GAL1-TAP-SEN1 (2-931) (LEU2+) 
This study. 
CS2801 MATa CTF4-9MYC (kanMX) pep4Δ:: ADE2+ This study. 
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CS2802 MATa 9MYC-CTF4 (kanMX) pep4Δ:: ADE2+ 
GAL1-TAP-SEN1 (2-931) (LEU2+) 
This study. 
CS2803 MATa 9MYC-CTF4 (kanMX) pep4Δ:: ADE2+ This study. 
CS2804 MATa 9MYC-CTF4 (351- 927) (kanMX) pep4Δ:: 
ADE2+ GAL1-TAP-SEN1 (2-931) (LEU2+) 
This study. 
CS2805 MATa 9MYC-CTF4 (351- 927) (kanMX) pep4Δ:: 
ADE2+  
This study. 
CS2806 MATa CTF4 (1- 841)-9MYC (kanMX) pep4Δ:: 
ADE2+ GAL1-TAP-SEN1 (2-931) (LEU2+) 
This study. 
CS2903 MATa td-sld3-7 (kanMX) GAL1-UBR1 (HIS3MX) 
GAL1-TAP-SEN1 (2-931) (LEU2+) (kanMX) 
pep4Δ:: ADE2+ ctf4Δ:: kanMX 
This study. 
CS2853 MATa SEN1-TAP (kanMX) pep4Δ:: ADE2+ This study. 
CS2854 MATa SEN1 (W773A E774A W777A)-TAP 
(kanMX) pep4Δ:: ADE2+ 
This study. 
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Table 2.2. List of Sz. pombe strains used in this study. All strains were derived 
either from the homothallic (self-fertile) 968 h90 strain or from the heterothallic 
(non-self-fertile) strains 972 h- and 975 h+ originally isolated by Urs Leupold.  
 
ID Genotype Source 
 
JZ1 
 
 
h90 ade6-M210 leu1-32 ura4-D18 
 
Laboratory 
collection. 
 
SV46 
 
 
h90 ade6-216 leu1-32 ura4D-18 
 
Laboratory 
collection. 
 
FMA3 
 
 
h90 ade6-216 leu1-32 ura4D-18  
loxP-ura4-loxP-pol1 
 
 
This study. 
 
FMA4 
 
 
h90 ade6-216 leu1-32 ura4D-18 
loxP-pol1 
 
 
This study. 
 
FMA8 
 
 
h90 ade6-216 leu1-32 ura4D-18 
loxP-pol1-ura4-loxM3 
 
 
This study. 
 
FMA53 
 
 
h90LEU2 ade6+ leu1-32 ura4+ spp1-GFP:: kanR 
This study. 
Derived from 
P903.  
(Yang et al., 
2005) 
 
FMA54 
 
 
h90LEU2 ade6+ leu1-32 ura4+ psf2-YFP:: kanR 
This study. 
Derived from 
P1411. 
(Yang et al., 
2005) 
 
FMA63 
 
 
h90LEU2 ade6+ leu1-32 ura4+ rpl42P56QcyhR  
 
 
Laboratory 
collection. 
 
FMA69 
 
 
h90LEU2 ade6-M210 leu1-32 ura4+ pol1-ts13 (ts) 
his3-D1 
This study. 
Derived from 
DBts131.  
(Bhaumik and 
Wang, 1998) 
 
FMA70 
 
 
h90LEU2 ade6+ leu1-32 ura4+ pol1-H4 (ts) 
This study. 
Derived from 
SP262.  
(Murakami and 
Okayama, 1995) 
 
FMA71 
 
 
h90LEU2 ade6-M216 leu1-32 ura4-D18 swi7-1 
 
This study. 
 
FMA72 
 
 
h90 ade6-216 leu1-32 ura4D-1  
loxP-pol1-loxM3  
 
This study. 
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FMA73 
 
h90 ade6-216 leu1-32 ura4D-18 
loxP-pol1G1116S-loxM3 
 
This study. 
 
FMA75 
 
 
h90 ade6-216 leu1-32 ura4D-18  
loxP-pol1G1116Q-loxM3 
 
 
This study. 
 
FMA76 
 
 
h90 ade6-216 leu1-32 ura4D-18  
loxP-pol1G1116D-loxM3 
 
 
This study. 
 
FMA78 
 
 
h90 ade6-216 leu1-32 ura4D-18 
loxP-pol1G1116E-loxM3 
 
 
This study. 
 
FMA85 
 
 
h90 ade6+ leu1-32 ura4-D18 
loxP-9His-5FLAG-pol1-loxM3 
 
 
This study. 
 
FMA86 
 
 
h90 ade6+ leu1-32 ura4-D18  
loxP-9His-5FLAG-swi7-1-loxM3 
 
 
This study. 
 
FMA93 
 
 
h90 ade6-M210 leu1-32 ura4-D18 swi1Δ::ura4+ 
 
 
Laboratory 
collection. 
 
FMA95 
 
 
h90 ade6-M210 leu1-32 ura4-D18 swi3Δ::kanMX 
 
 
Laboratory 
collection. 
 
FMA131 
 
 
h90LEU2 ade6+ leu1-32 ura4+ pol1-1 (ts) 
This study. 
Derived from 
SP246. 
(D’Urso et al., 
1995) 
 
FMA132 
 
 
h90LEU2 ade6+ leu1-32 ura4+ pol1-1 (ts) 
This study. 
Derived from 
SP246. 
(D’Urso et al., 
1995) 
 
FMA146 
 
h90LEU2 ade6+ leu1-32 ura4+ mcl1ΔToda::kanMX 
  
This study. 
Derived from 
YAP12. 
(Mamnun et al., 
2006) 
 
FMA155 
 
h90LEU2 ade6-M216 leu1-32 ura4+ 
mcl1ΔBioneer::kanMX 
 
This study. 
Parental strain: 
knockout 
collection. 
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Table 2.3. Recipe of media used in this study for yeast and bacterial growth. 
 
Medium Recipe 
YEA (Rich 
medium for Sz. 
pombe) 
 
0.5% (w/v) yeast extract (Difco)  
0.0225% (w/v) adenine 
3% (w/v) glucose  
Optional: 2% (w/v) Bacto agar (Difco) for solid medium. 
 
YEA + G418 0.5% (w/v) yeast extract (Difco)  
0.0225% (w/v) adenine 
3% (w/v) glucose  
0.2 mg/ml Geneticin (G418) (Invitrogen) 
2% (w/v) Bacto agar (Difco)  
 
YEA + HU 0.5% (w/v) yeast extract (Difco)  
0.0225% (w/v) adenine 
3% (w/v) glucose  
8 mM HU (Sigma) 
2% (w/v) Bacto agar (Difco)  
 
YEA + MMS 0.5% (w/v) yeast extract (Difco)  
0.0225% (w/v) adenine 
3% (w/v) glucose  
0.0075% (v/v) (Sigma) 
2% (w/v) Bacto agar (Difco)  
 
YE (Rich medium 
for Sz. pombe) 
 
 
0.5% (w/v) yeast extract (Difco)  
3% (w/v) glucose  
Optional: 2% (w/v) Bacto agar (Difco) for solid medium. 
 
PMA+ 
(Sporulation 
medium for Sz. 
pombe) 
0.3% (w/v) KH phthalate  
0.18% (w/v) Na2HPO4 
0.5% (w/v) NH4Cl 
1% (w/v) glucose 
0.2% (w/v) Kaiser SC  
0.1% (v/v) vitamin mix (see below) 
0.1% (v/v) minerals mix (see below) 
Optional: 2% (w/v) Bacto agar (Difco) for solid medium. 
pH adjusted to 6.0 
 
Selective medium 
(For both S. 
cerevisiae and Sz. 
pombe) 
0.17% (w/v) yeast nitrogen base (Difco) 
0.5% (w/v) NH4SO4 
0.2% (w/v) glucose  
0.2% (w/v) Kaiser SC single Drop-out (Formedium).  
Optional: 2% (w/v) Bacto agar (Difco) for solid medium. 
 pH adjusted to 6.0 
 
YPD (Rich 
medium for S. 
cerevisiae). 
1% (w/v) yeast extract (Bacto)  
2% (w/v) peptone (Oxoid) 
2% (w/v) glucose  
Optional: 2% (w/v) Bacto agar (Difco) for solid medium. 
 
YPD + G418 1% (w/v) yeast extract (Bacto)  
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2% (w/v) peptone (Oxoid) 
2% (w/v) glucose  
0.2 mg/ml Geneticin (G418) (Invitrogen) 
2% (w/v) Bacto agar (Difco) 
 
YPD + 
HygromycinB 
1% (w/v) yeast extract (Bacto)  
2% (w/v) peptone (Oxoid) 
2% (w/v) glucose  
0.3 mg/ml HygromycinB (Hygromycin B GoldTM, InvivoGen) 
2% (w/v) Bacto agar (Difco) 
 
YPD + HU 1% (w/v) yeast extract (Bacto)  
2% (w/v) peptone (Oxoid) 
2% (w/v) glucose  
50-100 mM HU (Sigma) 
2% (w/v) Bacto agar (Difco) 
 
YPD + MMS 1% (w/v) yeast extract (Bacto)  
2% (w/v) peptone (Oxoid) 
2% (w/v) glucose  
0.005- 0.0075% (v/v) (Sigma) 
2% (w/v) Bacto agar (Difco) 
 
RSM (Sporulation 
medium for S. 
cerevesiae) 
0.25% (w/v) yeast extract (Bacto) 
1.5% (w/v) K(C2H3CO2) 
0.1% (w/v) glucose 
2.5% (v/v) amino acid mix  
 
FOA plates (select 
against uracil 
autotrophy) (For 
both S. cerevisiae 
and Sz. pombe) 
0.7% (w/v) yeast nitrogen base (w/ NH4Cl) 
2% (w/v) glucose 
0.1% (w/v) 5-FOA  
0.005% (w/v) uracil 
0.225% (w/v) adenine 
0.225% (w/v) leucine 
0.225% (w/v) histidine 
2% agar 
   
Amino acid mix 0.4% (w/v) adenine 
0.2% (w/v) arginine 
0.4% (w/v) histidine 
0.2% (w/v) leucine 
0.2% (w/v) lysine 
0.2% (w/v) methionine 
1% (w/v) phenylalanine 
0.2% (w/w) tryptophan 
0.08% (w/w) tyrosine 
 
Vitamins mix 0.1% (w/v) pantothenic acid 
1% (w/v) nicotinic acid 
1% (w/v) inositol 
0.001% (w/v) biotin 
 
Minerals mix 5% (w/v) boric acid 
4% (w/v) MnSO4 
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4% (w/v) ZnSO4.7H2O 
2% (w/v) FeCl2.6H2O 
0.04% (w/v) molybdic acid 
0.1% (w/v) KI 
0.04% (w/v) CuSO4.5H2O 
1% (w/v) citric acid 
 
Luria-Bertani (LB) 
Broth 
1% (w/v) bacto-tryptone 
0.5% (w/v) yeast extract (Bacto) 
1% (w/) NaCl 
pH adjusted to 7.0 
 
Optional:2% (w/v) agar 
Optional: Supplemented with either 100 μg/ml ampicillin or 
50 μg/ml kanamycin. 
 
NZY+ Broth 1% (w/v) NZ amine (casein hydrolysate) 
0.5% yeast extract 
0.5% NaCl 
pH adjusted to 7.5 
12.5 mM MgCl2 
12.5 mM MgSO4 
0.4% glucose  
 
SOC medium  2% (w/v) tryptone 
0.5% (w/v) yeast extract 
10 mM NaCl 
2.5 mM KCl 
10 mM MgCl2 
10 mm MgSO4 
Final pH 6.8-7.0 
20 mM glucose (added prior to use) 
RF1 medium 1.2% (w/v) rubidium chloride 
0.99 % (w/v) MnCl2.4H2O  
3% (w/v) 1M potassium acetate pH 7.5 
0.15% (w/v) CaCl2.2H2O   
1.5% (v/v) glycerol  
Final pH 5.8 with acetic acid. 
RF2 medium 2% (v/v) 0.5M MOPS pH 6.8 
0.12% (w/v) RbCl  
10mM KCl  
1.1% (w/v) CaCl2.2H20  
1.5% (v/v) glycerol 
Final pH 6.8 with NaOH.  
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2.1.2 Crossing of strains 
 
Cells were grown from 25% (v/v) glycerol suspensions onto non-selective 
plates (either YPD or YEA) and grown at the appropriate temperatures. For S. 
cerevisiae strains, two parents of opposite mating-types were mixed in a ratio 
of about 20:1 in 50 μl of sterile deionized water to homogeneity. 10 μl of the 
resulting cell suspension was then plated onto a non-selective plate and grown 
overnight at the appropriate temperature. This allows enough time for the two 
parent strains to mate to form diploids. The mixture was then plated onto a 
selective medium so as to select against the parental strain found in excess 
and grown overnight at the appropriate temperature. The mixture was then 
plated onto sporulation medium and grown until the cells sporulated (typically 
3-5 days). The resulting asci were then treated with gluronidase from snails’ 
gut (Helix pomata) and their tetrads were aligned by micro-manipulation onto 
non-selective plates and allowed to germinate. The tetrads were scored by 
replica-plating on different selective media. 
 
Unlike S. cerevisiae, Sz. pombe cells prefer to be haploid and, upon 
diploidization, will undergo sporulation spontaneously. To cross strains, cells 
of compatible mating-type types were mixed onto sporulation medium. When 
crossing an h+ with an h- strain or two homothallic (switching or self-fertile) 
(h90) strains, equal quantities of each parent was used. When crossing a 
homothallic strain with a heterothallic strain, however, the heterothallic (non-
switching or non-self-fertile) strain was added in large excess (a ratio of about 
20:1). This is because cells from homothallic strains would tend to mate with 
their sister or cousin cells by virtue of cell-type switching and proximity. The 
mixture was left on sporulation medium for at least three days at the 
appropriate temperature. This allows for the formation of transient diploids 
(zygote) that undergo meiosis before undergoing sporulation. Mating was 
judged successful when zygotic asci were detected microscopically. The 
zygotic asci were treated with glucoronidase overnight at 37°C. This treatment 
simultaneously kills vegetative cells and liberate spores from their asci. The 
supernatant was separated from the pellet containing cell debris and spores 
by centrifugation and the pellet was re-suspended in 30% (w/v) ethanol. This 
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inactivates any vegetative cells and helps to deter bacterial growth. 1/100 and 
1/1000 dilutions of the pellets were then plated onto the appropriate selective 
media. 
 
For tetrad dissection, we made use of the ade6-M210 and ade6-M216 
markers. In brief, parents of compatible cell-types (see above) were mated 
onto sporulation medium. In addition, one parent carried the ade6-M210 
marker whilst the other parent carried the ade6-M216 marker. As such, both 
parents are auxotrophs for adenine. However, the ade6-M210 and ade6-M216 
alleles complement one another at an intragenic level within diploids. This 
enables isolation of stable diploids. The cell mixture was plated onto synthetic 
medium lacking adenine 1, 2 and 3 days after mixing the parental strains. The 
diploid colonies were then grown on fresh synthetic medium lacking adenine 
before being plated on sporulation medium. After sporulation, azygotic asci 
were left overnight at 16°C or 3-5 h at 37°C for their walls to be degraded. The 
liberated tetrads were then aligned by micro-manipulation onto non-selective 
plates and allowed to germinate. The tetrads were scored by replica-plating 
on different selective media. 
 
2.1.3 Dilution Spotting 
 
Cells were grown from 25% (v/v) glycerol suspensions onto non-selective 
medium and grown for at least two days at the required temperature (up to 
four days for strains grown at 25°C). Cells were diluted in sterile d.H2O water 
supplemented with 100 μg/ml of ampicillin to prevent growth of bacterial 
contaminants to a final concentration of 5 x106 cells/ml. This suspension was 
serially diluted ten-fold to produce suspensions of 5 x 105, 5 x 104 and 5 x103 
cells/ml. 10 μl of each suspension was pipetted onto either non-selective or 
selective media and grown for up to 5 days at the required temperatures. The 
colonies were imaged daily using an Epson Perfection V700 Scanner. 
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2.1.4 Transformation of Yeast Cells using the Lithium 
Acetate Method 
 
Cycling cells were grown to a density of 1 x 107 cells/ml. S. cerevisiae cells 
were washed with sterile d.H2O and re-suspended in a solution of 0.1 M lithium 
acetate (pH 7.5), 1 M Tris-HCl (pH 7.5) to a final concentration of 2.0 x 109 
cells/ml. To 100 μl of the cell suspension, 1-2 μg of target DNA (plasmid, PCR 
or restriction digest) and an excess (500 μg) of freshly denatured carrier 
ssDNA (extracted from salmon sperm) were added in a combined volume of 
10 μl. To this mixture, 40% (w/v) PEG 4000 in 0.1 M lithium acetate (pH 7.5) 
1 M Tris-HCl (pH 7.5) was added to a final concentration of 33.3% (w/v) PEG, 
vortexing to achieve homogeneity. The cell suspension was then incubated 
for 45 min at 25°C before addition of sterile DMSO to a final concentration of 
10%. After addition of DMSO, the cell suspension was heat-shocked at 42°C 
for 15 min before rapid cooling on ice for 2 min. The suspension was then 
centrifuged and the supernatant discarded. If the transformation involved 
autotrophic markers, the cells were re-suspended in sterile d.H2O and different 
quantities of the suspension were plated on the appropriate selective media. 
Had the transformation involved either the kanMX or hphNT markers, the cells 
were re-suspended in non-selective media and grown for a further 3 h at 25°C 
to allow for expression of the antibiotic before plating on the appropriate 
selective media.  
 
For Sz. pombe, a similar method was used with some modifications. In brief, 
cycling Sz. pombe cells were grown to a density of 1 x 107 cells/ml, washed in 
sterile d.H2O and re-suspended in a 0.1 M lithium acetate (pH 4.5) and 
dispensed in aliquots of 100 μl. The cells were incubated at 30°C for 2 h. 
Thereafter, 1 μg of target DNA in 15 μl of TE (pH 7.5) was added, vortexing to 
homogeneity. 50% (w/v) of PEG 4000 pre-warmed to 30°C was added to a 
final concentration of 35.8% (w/v). The mixture was incubated for another hour 
at 30°C. The mixture was them heat-shocked for 15 min at 43°C before rapid 
cooling on ice for 2 min. The suspension was then centrifuged with the 
supernatant discarded. The cells were re-suspended in non-selective media 
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and grown for a further 3 h at 30°C before plating on the appropriate selective 
media.  
 
2.1.5 Testing for the cell-type of haploids 
 
The mating/cell-type of S. cerevisiae cells was assessed by their reaction to 
exposure to the α-factor pheromone to a final concentration of 7.5 μg/ml for 2-
3 h and by their ability to mate with tester MATa and MATα strains to form 
diploids capable of sporulating on the appropriate media.  
 
The mating-type of Sz. pombe cells was also assessed by their ability to mate 
with tester strains (h+ and h-) to form diploids capable of sporulating on the 
appropriate media. Alternatively, the mating type was determined by colony 
PCR. In brief, single colonies of Sz. pombe were boiled in sterile d.H2O for 7 
min, releasing genomic DNA into the water. The water was used as template 
for PCR using a primer that is common to both mat1-P and mat1-M (NRT40) 
with primers specific to mat1-P (NRT41) and mat1-M (NRT42) respectively 
(Table 2.5). Strains harbouring the h+ mating-type are characterized by a PCR 
product of 987 bases long whilst h- strains are characterized by a product of 
729 bases long. Diploids or homothallic strains are characterized by both 
products.  
 
2.1.6 Testing the efficiency of cell-type switching in fission 
yeast 
 
Unlike S. cerevisiae, the spores of fission yeasts are characterized by the 
presence of an amylose-like polymer that stains with iodine. To determine 
whether cells were defective for cell-type switching, h90 or h90:: LEU2 cells 
freshly grown on non-selective media were first transferred onto sporulating 
malt-extract medium in such a way as to obtain isolated colonies. The cells 
were grown either for 4-5 days at 25°C for heat-sensitive strains or for 2-3 
days at 33°C (until colonies become sufficiently large) before growth for an 
additional day at 30°C. This allows haploids to diploidize and to sporulate. 
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Importantly, each plate used contained two strains; a strain under investigation 
and a wildtype strain (JZ1) as control.  
 
The plates containing the colonies were held then upside down over a dish 
containing iodine crystals at 25°C for 5-6 min. The iodine sublimes and the 
vapour stain the colonies. Colonies that can switch cell-type would stain darkly 
(dark purple/chocolate brown) whilst colonies that are defective for cell-type 
switching stain lightly or with a speckled phenotype. The colonies were then 
imaged at a magnification of X 5 using a Leica MZ FL Stereomicroscope using 
a top-light to illuminate the colonies.  
 
2.1.7 Harvesting of yeast strains for immuno-precipitations 
 
MATa strains were grown from 25% (v/v) glycerol suspensions onto solid non-
selective medium and grown for 1-3 days at the appropriate temperatures. 
Fresh YPD was inoculated with the cells and cycling cultures were grown to a 
cellular density of 0.7 x 107 cells/ml in volumes of either 250 ml or 1 l for dilute 
or concentrated samples respectively at 24°C. The cells were then arrested in 
G1 by addition of the α-factor pheromone to a final concentration of 7.5 μg/ml 
for at least 3 h. The cells could then be harvested in G1 if so required. 
Otherwise, the arrested cells were washed twice with fresh YPD (lacking α-
factor) and released in S phase at 24°C. Cells were harvested 30 min (S 
phase) or 60-65 min (G2) after release from G1-arrest. To ensure the cells were 
harvested in the correct phase of the cell cycle, 1 ml of cells were fixed in 70% 
(v/v) ethanol and stored at 4°C for FACS analysis.  
 
To harvest the cultures, cells were first washed in 20 mM Hepes-KOH (pH 7.9) 
(Sigma) and then washed in a solution of 100 mM Hepes-KOH (pH 7.9) 
(Sigma), 50 mM potassium acetate (Fischer), 10 mM magnesium acetate 
(Sigma) and 2 mM EDTA-KOH at 4°C. 
 
For dilute samples, 1.75 x 109 cells were then re-suspended in a solution of 
100 mM Hepes-KOH (pH 7.9), 50 mM potassium acetate, 10 mM magnesium 
acetate and 2 mM EDTA-KOH supplemented with 2 mM glycerophosphate 
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(Johnson Matthey), 2 mM sodium fluoride (Fischer), 1 mM DTT, 1% (v/v) 
Sigma protease inhibitor cocktail (for fungal and yeast extracts, Sigma) and 
0.24% (w/v) EDTA-free Complete Protease Inhibitor Cocktail (Roche) so that 
the ratio of the wet mass of the cells to the final mass of the suspension was 
1:4. For concentrated samples, 7 x 109 cells were also re-suspended in the 
same solution but so that the ratio of the wet mass of the cells to the final mass 
of the suspension was 4:5 and the final concentrations of the protease and 
phosphatase inhibitors were increased 1.2-fold. The samples were maintained 
at 4°C before careful pipetting into liquid nitrogen. This freezes the cells, 
completing harvesting. The frozen cells were then kept at −80°C until use for 
immuno-precipitation. After harvesting, left-over cells at 4°C were fixed in 70% 
(v/v) ethanol for FACS analysis. 
 
When using strains harbouring degron alleles (also carrying the GAL1-UBR1 
allele), cycling cells were grown to a density of 0.7 x 107 cells/ml at 25°C in 
250 ml of YP-Raff and arrested in G1 by addition of the α-factor pheromone to 
a final concentration of 7.5 μg/ml for at least 3 h. Before release in S phase, 
however, the cells were shifted first to YPGAL medium for 35 min to induce 
expression of the E3 ligase Ubr1 protein and then to 37°C for 1 h to allow for 
degradation of the degron-tagged proteins. Cells were then released in S 
phase. Harvesting was carried out 20 min after release. Likewise, when using 
slow-growing strains such as strains harbouring the ctf4Δ allele, cells were 
grown at 30°C and were harvested 20 min after release from G1 arrest.  
 
For cells harbouring constructs under control of the strong, inducible GAL1 
promoter, cultures were grown in YP-Raff or YPGAL. When using YP-Raff, 
cultures were arrested in G1 by addition of α-factor for 3 h before the medium 
was substituted with YPGAL already supplemented with the pheromone. Cells 
were maintained in YPGAL for 35 min to allow for expression of constructs 
under control of the GAL1 promoter before release in fresh YPGAL at 24°C. 
For experiments where YPGAL was used exclusively, the cells could be 
released in fresh YPGAL immediately upon reaching G1 synchronycity, similar 
to cultures using only YPD. 
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2.2 E. coli Specific Methods  
 
2.2.1 Preparation of chemically competent cells 
 
DH5α cells were woken from 25% (v/v) glycerol suspensions on solid LB 
medium and grown for ~ 16 h at 37°C until sufficiently big colonies were 
obtained. 5-10 individual colonies were used to inoculate a fresh aliquot of 10 
ml LB and the culture was grown at 37°C overnight. A portion of this inoculum 
was diluted in 100 ml of fresh LB medium that was incubated at 37°C with 
shaking until an OD600 of 0.5 was obtained (midlog phase). The culture was 
then transferred to sterile tubes and cooled by placing on ice for 10 min. The 
sample was centrifuged at 2700 g and the supernatant was removed by 
careful decantation. The pellet was re-suspended in 33 ml of RF1 solution to 
homogeneity and left to stand on ice for a further 10 min. The sample was 
centrifuged at 2700 g for 10 min and the RF1 solution was removed by 
decantation. The pellet was then re-suspended in 8 ml of RF2 to homogeneity 
and left to stand on ice for 10 min. 500 μl of cell suspension was aliquoted in 
Eppendorf tubes that were immediately flash-frozen in liquid nitrogen. The 
tubes were kept at −80°C until required. 
 
2.2.2 Transformation of E. coli cells 
 
Chemically-competent cells suspensions (DH5α cells prepared in-house or 
commercially-sourced XL Gold (Agilent) or BL21 StarTM (DE3) (Invitrogen)) 
were thawed from −80°C on ice for 5-10 min. If required, 100-200 μl of cell 
suspension were dispensed in chilled Eppendorfs to which plasmid DNA 
(unprocessed plasmid or derived from either mutagenesis or ligation reaction) 
was added. Gentle tapping ensures mixing and the cell suspensions were then 
left on ice for 30 min (1 h for commercially-sourced cells). The cells were then 
heat-shocked for 90 s (30 s for commercially-sourced cells), followed by rapid 
cooling on ice for 2 min. The suspensions were then immediately diluted in 
250-1000 μl of SOC medium (NZY+ for XL Gold cells) pre-warmed to 37°C 
and grown at 37°C with shaking for 1 h. This allows expression of the 
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appropriate antibiotics-resistance genes. The cells were then plated on the 
appropriate selective media at different dilutions and grown for ~ 16 h at 37°C.   
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2.3 Molecular Biology 
 
2.3.1 Genotyping by PCR 
 
To tag or delete genes, heterologous DNA with homology to the gene of 
interest and carrying DNA corresponding to the appropriate markers (and also, 
where appropriate, DNA corresponding to protein tags) were constructed by 
PCR. Yeast strains were transformed with purified DNA using the lithium 
acetate method (Section 2.1.4) and successful transformants were screened 
by growth on selective media. To check whether the novel DNA was 
introduced at the correct loci, we adopted a PCR-based approach where we 
designed oligoes that align upstream and downstream of the target loci and 
oligoes that align with the marker cassettes used. These oligoes were used to 
screen for correct transformants by colony-PCR or by PCR using genomic 
DNA extracted from those transformants. 
 
2.3.2 Cloning of inducible constructs of SEN1  
 
To clone inducible fragments of SEN1, we used the integrative pRS305 
plasmid. pRS305 is a derivative of pBLUESCRIPT, with a LEU2 marker and a 
multiple cloning site (MCS) cloned in (Sikorski and Hieter, 1989). 
 
We first amplified DNA encoding the GAL1 promoter followed by repeats of 
the haemagglutinin tag from pYM-N24 (pCS11 in our lab) (Janke et al., 2004) 
using oligoes CS355 and CS356. The PCR product was designed with a NotI 
restriction site at its 5’-end and a SalI restriction site at its 3’ end. The PCR 
product was introduced into the pRS305 plasmid by virtue of these sites to 
produce the pCS25 plasmid (pRS305-GAL1-3HA).  Fragments of SEN1 were 
amplified from genomic DNA extracted from strain CS1 (wildtype) to 
synthesize products with SalI sites at their 5’ end and XhoI sites at their 3’ 
ends. The fragments were then cloned in plasmid pCS25 and analysed by 
sequencing. 
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To tag constructs with the TAP tag instead, we used a derivative of pRS305, 
pKL935 that already had a GAL1 promoter cloned between the NotI and XBaI 
sites. DNA encoding the NTAP2 tag followed by a GAGAGAGAGA linker was 
amplified from pKL205 using oligoes CS446 and CS447. The product was 
designed with a XbaI and SalI sites at its 5’ and 3’ ends respectively enabling 
cloning into pKL935 to give the pCS14 plasmid (pRS305-GAL1-NTAP2). 
Fragments of SEN1 were amplified from genomic DNA extracted from strain 
CS1 (wildtype) to synthesize products with SalI sites at their 5’ end and PspXI 
sites at their 3’ ends. The fragments were then cloned in plasmid pCS14 and 
analysed by sequencing. 
 
Derivatives of pCS14 and pCS25 were linearized with the XcmI enzyme that 
cuts within the LEU2 marker and the purified digests were transformed into 
diploids cells homozygous for the leu2-3,112 mutation. Upon successful 
integration, the constructs reconstitute the LEU2 marker making the cells 
autotrophic for leucine. Integration was also checked by extracting genomic 
DNA from clones and using this DNA to perform diagnostic PCRs using 
oligoes CS28, CS29, CS32 and CS33. The clones were also screened by 
induction of protein expression in YPGAL and analysed by Western blotting. 
Haploids from clones adjudged to have the correct insert were obtained by 
tetrad dissection. 
 
  
	 129	
2.3.3 Promoter switching from GAL1 to ACT1 or SEN1 
 
To produce non-inducible constructs of SEN1, we decided to substitute the 
GAL1 promoter from pCS25-derivatives with either the SEN1 promoter or the 
strong ACT1 promoter. To introduce these promoters, the GAL1 promoter was 
first excised from the pCS25-derivatives using the NotI and SpeI 
endonucleases. The ACT1 promoter was amplified from genomic DNA using 
the oligoes CS953 and CS954 with a product encoding a NotI site at its 5’ end 
and a SpeI site at its 3’ end. Likewise, the SEN1 promoter was amplified from 
genomic DNA using the oligoes CS955 and CS956 with a product encoding a 
NotI site at its 5’ end and a SpeI site at its 3’ end. The ACT1 and SEN1 
promoters were then cloned into derivatives of the pCS25 plasmid. These 
plasmids were then linearized and introduced into diploids through 
transformation. The clones were analysed as described in Section 2.3.2. 
 
2.3.4 Creating SEN1 point mutants by site-directed 
mutagenesis 
 
The plasmid pCS120 was obtained by substituting the ACT1 promoter for the 
GAL1 promoter as described in Section 2.3.3. To obtain novel alleles of SEN1, 
we first identified conserved residues with the armadillo-repeat motifs within 
the Sen1 N-terminal domain that were predicted to be on the surface of the 
super-helix and that were conserved. We then mutated the bases encoding 
for these residues using an in vitro site-directed mutagenesis protocol 
(QuikChange Lightning, Qiagen). In brief, a pair of complimentary oligoes with 
the desired mutation was used to amplify the target DNA, here pCS120. The 
kit uses a blend that includes the high-fidelity Pfu DNA polymerase, reducing 
the incidence of unwanted mutations. Whilst PCR products are usually linear, 
the newly synthesized DNA is circular by virtue of being attached to template 
circular DNA and because enzymes within the blend seal nicks.  
 
After the amplification reaction, the product DNA is present in large excess 
compared to its template. Moreover, the template differs from the product DNA 
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by virtue of bacterial methylation of cytosine bases. As such, methylated and 
hemi-methylated DNA was digested using the DpnI nuclease. The DNA was 
then transformed without purification into XL-10 Gold Ultracompetent (Qiagen) 
cells to amplify the plasmids, according to the manufacturer’s guidelines. 
Plasmids were isolated from single colonies and analysed by sequencing. 
Plasmids with the correct mutations were linearized with XcmI and 
transformed in diploid cells as described in Section 2.3.2, except that 
SEN1/sen1∆ strains were used instead. Clones with the correct integration 
were placed on sporulation media and their tetrads were dissected. Haploids 
autotrophic for both uracil and leucine carried only the mutant copy of SEN1 
albeit under control of the ACT1 promoter cloned at an ectopic locus.  
 
2.3.5 Generating alleles of SEN1 lacking the N-terminus or 
with mini-truncations within their N-termini at their 
genomic locus 
 
To create the SEN1 (913-2231) allele, diploids were transformed with products 
amplified from plasmid pKL506 using oligoes CS898 and CS818. This disrupts 
the SEN1 allele upstream of its transcription start site to its 912th codon with a 
URA3 gene. This produces a SEN1/SEN1(1-912∆, 913-2231) diploid 
(CS2404). Oligoes CS898 and CS899 were used to amplify the HISMX marker 
from plasmid pKL230 and oligoes CS900 and CS901 were used to synthesize 
a PCR bridging the ATG of SEN1 to the 913th codon of the SEN1 gene was 
synthesized. The two PCRs were fused in another PCR reaction and this PCR 
was used to transform strain CS2404. To create the SEN (931-2231) allele, 
an identical approach was adopted where oligoes CS818 and CS901 were 
substituted with oligoes CS756 and CS902. This process is summarized in Fig 
2.1.
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Figure 2.1. Schematic of the stratagem used to generate alleles of SEN1 that lack the bases that encode for its N-terminal 
domain.
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Because both the SEN1 (913-2231) and SEN1 (931-2231) were sick 
compared to their wildtype counterpart, we resorted to generate alleles of 
SEN1 with mini-truncations within their N-termini. In order to do so, we first 
disrupted deleted the SEN1 gene from either its 411th or its 623rd codon to its 
2231st codon with the URA3 marker. This was done by amplification of the 
pKL506 plasmid using oligoes CS755 and CS291, and CS817 and CS291 
respectively, followed by transformation in a diploid. The resulting strains were 
heterozygous for SEN1: CS2334 (SEN1/SEN1(1-410, 411-2231∆)) and 
CS2335 (SEN1/SEN1 (1-622, 623-2231∆)).  
 
Genomic DNA was then extracted from strain CS1353 that harbours the 
SEN1-TAP allele. From this DNA, PCRs were generated using the CS291 
oligo as the reverse primer and different forward primers to generate PCR 
products that bridge either the 410th or 622nd codon to either 913th or 931st 
codon. Moreover, we attempted to bridge the codons by several strategies. 
We either included no linkers, or a short linker (GSGAGSGAGSG), or a 
somewhat longer linker to bridge the gap 
(GSGAGSGSGGAGAGSGSGAGGSG) or alternatively we used the CIP (Ctf4 
Interacting Peptide) (GGSGGSIDNFDDILGEFEGAGSG) from Pol1. We did 
so as it is known that the solubility and stability of proteins can be 
compromised upon intra-domain tinkering. 
 
The different PCRs were integrated into the appropriate diploid (either CS2334 
or CS2335) and successful transformations were screened initially by growth 
on YPD supplemented with G418 and then by growth on FOA plates, 
indicating the loss of the URA3 marker. The clones were then assessed by 
diagnostic PCRs and finally by Western blotting with strain CS1353 (that 
carries the SEN1-TAP allele) used as a control. For successful integration, not 
only would the TAP signal be detected but it would run at height of 220-250 
kDa whilst Sen1-TAP would run at around 280 kDa. The clones that integrated 
correctly were placed on sporulation medium and their tetrad were dissected. 
This process is summarized in Fig 2.2.
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Figure 2.2. Schematic of the stratagem used to generate alleles of SEN1 that encodes for variants of the protein with mini-
truncations within their respective N-terminal domain.
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2.3.6 Tagging of Pol1 at the N-terminus and creating pol1 
mutants by site-directed mutagenesis 
 
Both for tagging and for creating novel pol1 alleles in Sz. pombe, we used a 
cassette exchange protocol (Watson et al., 2008). In brief, a wildtype haploid 
cell (SV46) was used to construct a base strain. Initially, a heterologous DNA 
product was amplified from plasmid pAW41 using oligoes NRT14 and NRT15 
and this DNA was transformed upstream of the pol1 promoter using the lithium 
acetate method. Successful integration was checked by autotrophy for uracil 
and diagnostic PCRs of genomic DNA from transformants. The resulting strain 
(FMA3) was characterized by the loxP-ura4-loxP-pol1 allele. This strain was 
then transformed with the non-integrative plasmid pAW5 that expresses the 
Cre-recombinase as well as the LEU2 marker. Successful transformation was 
adjudged by virtue of autotrophy for leucine. The clones were grown for 4 days 
at 33°C on selective medium lacking YNB (yeast nitrogen base) to allow 
expression of the Cre-recombinase under control of the nmt1 promoter. The 
clones were then grown on FOA plates. Growth on FOA plates signals loss of 
the ura4 marker, by recombination between the two loxP sites previously 
introduced upstream of the pol1 gene. This leaves a loxP scar some 260 
bases upstream of pol1 whose presence was confirmed by diagnostic PCR. 
The corresponding strain (FMA4) was grown for several days on non-selective 
medium to lose the pAW5 plasmid and was then transformed by a 
heterologous DNA product amplified from plasmid pAW12 using oligoes 
NRT16 and NRT17.  This introduces the ura4 marker immediately 
downstream of the pol1 gene along with the loxM3 recombination site. 
Successful integration was checked by autotrophy for uracil and diagnostic 
PCRs of genomic DNA from transformants. The resulting strain (FMA8) was 
characterized by the loxP-pol1-ura4-loxM3 allele and was used as a base 
strain. 
 
To create tagged or mutant alleles of pol1, the gene was first amplified from 
genomic DNA of a wildtype strain (JZ1) using oligoes NRT18 and NRT19 and 
inserted into the pAW8 plasmid between the loxP and loxM3 sites to form the 
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pRA8 plasmid. The plasmid was checked for mutations by PCR. To tag pol1, 
we amplified two regions from plasmid pRA8. Using oligoes CS440 and 
CS441, a region immediately upstream of the pol1’s transcription start site was 
amplified whilst oligoes CS444 and CS445 were used to amplify a region 
immediately downstream of the transcription start. A final pair of oligoes 
(CS442 and CS443) was used to amplify a DNA region encoding for a 9XHIs-
5XFLAG tag from plasmid pKL712. This third oligo was used to bridge the two 
earlier PCRs using fusion PCR. The resulting product was cloned into pRA8 
using the SacI and XhoI sites to get the pRA22 plasmid. The newly cloned 
region was analysed by sequencing.  
 
To generate novel alleles of pol1, plasmids pRA8 or pRA22 were used as 
templates for site-directed mutagenesis as described in Section 2.3.4. 
Plasmids pRA8, pRA22 and their derivatives were then transformed into the 
base strain (FMA8) using the lithium acetate method. Successful 
transformation was adjudged by virtue of autotrophy for leucine. The clones 
were grown for 4 days at 33°C on selective medium lacking YNB (yeast 
nitrogen base) to allow expression of the Cre-recombinase under control of 
the nmt1 promoter. The clones were then grown on FOA plates. Growth on 
FOA plates signals loss of the ura4 marker. The loxP and loxM3 sites are not 
compatible and loss of ura4 cannot happen by looping out the pol1 gene from 
the genome. Instead loss of the ura4 gene can be achieved by recombinant 
exchange of the cassette in the base strain with cassettes found on the pRA8, 
pRA22 or their derivatives. The resulting strains were analysed by diagnostic 
PCRs, sequencing and (where appropriate) Western blotting. Figure 2.3 
summarizes this process.
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Figure 2.3. Schematic of the stratagem used to generate novel and 
tagged alleles of pol1 in Sz. pombe.
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2.3.7 List of plasmids and oligoes used in present study 
 
Table 2.4. List of plasmids used. 
 
Plasmid 
Name 
Insert Backbone Use Source 
Plasmids used for the Sz. pombe study 
pAW5 Empty pAW5 Cloning of loxp-pol1-loxM3 and its derivatives. (Watson et al., 2008) 
pAW8 Empty pAW8 Cloning of loxp-pol1-loxM3 and its derivatives. (Watson et al., 2008) 
pAW12 Empty pAW12 Cloning of loxp-pol1-loxM3 and its derivatives. (Watson et al., 2008) 
pAW41 Empty pAW41 Cloning of loxp-pol1-loxM3 and its derivatives. (Watson et al., 2008) 
pKL712 Empty 9His-5FLAG-
pRS306 
To amplify up the 9His-5FLAG tag. Kind gift from Dr K. Labib. The 
pRS306 vector was originally 
described by (Sikorski and 
Hieter, 1989) 
pRA1 Codon-optimized 
(Geneart®), truncated 
pol1 gene (Sz. pombe) 
pTWO-E (Based 
on p17-ET with 
an N-terminal 
His-tag) 
Express recombinant His6-Pol1. This study. The pTWO-E 
commercially sourced from 
Novagen. Described in 
(Garces et al., 2011)  
pRA2 Codon-opimized 
(Geneart®), truncated 
swi7-1 gene (Sz. 
pombe) 
pTWO-E (Based 
on p17-ET with 
an N-terminal 
His-tag) 
Express recombinant His6-Swi7-1. This study.  
pRA4 None pMCSG32 Express recombinant MBP-His6 (control). pMCSG32 sourced from 
DNASU (plasmid repository). 
Described in (Stols et al., 
2002)  
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pRA5 Codon-optimized 
(Geneart®), truncated 
pol1 gene (Sz. pombe) 
pMCSG32 Express recombinant MBP-Pol1-His6 (control). 
The pol1 gene was codon-optimized. 
This study. 
pRA6 Codon-opimized 
(Geneart®), truncated 
swi7-1 gene (Sz. 
pombe) 
pMCSG32 Express recombinant MBP-Swi7-1-His6 (control). 
The swi7-1 gene was codon-optimized. 
This study. 
pRA7 Full pol1 gene, 
amplified from 
genomic DNA from Sz. 
pombe. 
TOPO-Blunt II Quick access to pol1 gene. This study. 
pRA8 Full pol1 gene, 
amplified from 
genomic DNA from Sz. 
pombe. The gene is 
flanked by loxP and 
loxM3 sites. 
pAW8 To introduce pol1 into the donor FMA8 base 
strain. Used to quickly mutagenize the pol1 gene.  
This study. The pAW8 was 
described in (Watson et al., 
2008) 
pRA9 pol1G1116E. The 
gene is flanked by 
loxP and loxM3 sites. 
pAW8 To introduce pol1G1116E into the donor FMA8 
base strain.  
This study. 
pRA10 pol1G1116Q. The 
gene is flanked by 
loxP and loxM3 sites. 
pAW8 To introduce pol1G1116Q into the donor FMA8 
base strain.  
This study. 
pRA11 pol1G1116S. The 
gene is flanked by 
loxP and loxM3 sites. 
pAW8 To introduce pol1G1116S into the donor FMA8 
base strain.  
This study. 
pRA12 pol1G1116D. The 
gene is flanked by 
loxP and loxM3 sites. 
pAW8 To introduce pol1G1116D into the donor FMA8 
base strain.  
This study. 
pRA22 9HIS-5FLAG-pol1 pAW8 To tag pol1. This study. 
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pRA23 9HIS-5FLAG-swi7-1 pAW8 To tag swi7-1. This study. 
Plasmids used for the S. cerevisiae study 
pCS11 Empty. pYM-N24 To amplify the GAL1-3HA and insert in pRS305 to 
create pCS25. 
The pYM-N24 was first 
described in (Janke et al., 
2004) 
pCS14 GAL1-TAP-Ø pRS305 To integrate GAL1-TAP-Ø in the genome at 
LEU2. 
This study. The pRS305 vector 
was originally described by 
(Sikorski and Hieter, 1989) 
pCS25 GAL1-3HA-Ø pRS305 To integrate GAL1-3HA-Ø in the genome at 
LEU2. 
This study. 
pCS26 SEN1 (2-931) pRS305-GAL1-
3HA (pCS25) 
To integrate GAL1-3HA-SEN1 (2-931) in the 
genome at LEU2. 
This study. 
pCS30 SEN1 (2-931) pRS305-GAL1-
TAP (pCS14) 
To integrate GAL1-TAP-SEN1 (2-931) in the 
genome at LEU2. 
This study. 
pCS31 SEN1 (2-1103) pRS305-GAL1-
TAP (pCS14) 
To integrate GAL1-TAP-SEN1 (2-1103) in the 
genome at LEU2. 
This study. 
pCS32 SEN1 (931-2231) pRS305-GAL1-
TAP (pCS14) 
To integrate GAL1-TAP-SEN1 (931-2231) in the 
genome at LEU2. 
This study. 
pCS33 SEN1 (1095-2231) pRS305-GAL1-
TAP (pCS14) 
To integrate GAL1-TAP-SEN1 (1095-2231) in the 
genome at LEU2. 
This study. 
pCS39 SEN1 (2-2231) pRS305-GAL1-
TAP (pCS14) 
To integrate GAL1-TAP-SEN1 (2-2231) in the 
genome at LEU2. 
This study. 
pCS40 SEN1 (2-1901) pRS305-GAL1-
TAP (pCS14) 
To integrate GAL1-TAP-SEN1 (2-1901) in the 
genome at LEU2. 
This study. 
pCS42 SEN1 (2- 622) pRS305-GAL1-
3HA (pCS25) 
To integrate GAL1-3HA-SEN1 (2- 622) in the 
genome at LEU2. 
This study. 
pCS43 SEN1 (410- 931) pRS305-GAL1-
3HA (pCS25) 
To integrate GAL1-3HA-SEN1 (410- 931) in the 
genome at LEU2. 
This study. 
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pCS47 SEN1 (2-2231) pRS305-GAL1-
3HA (pCS25) 
To integrate GAL1-3HA-SEN1 (2-2231) in the 
genome at LEU2. 
This study. 
pCS56 SEN1 (410- 913) pRS305-GAL1-
3HA (pCS25) 
To integrate GAL1-3HA-SEN1 (410- 913) in the 
genome at LEU2. 
This study. 
pCS57 SEN1 (410- 761) pRS305-GAL1-
3HA (pCS25) 
To integrate GAL1-3HA-SEN1 (410- 761) in the 
genome at LEU2. 
This study. 
pCS58 SEN1 (410- 501) pRS305-GAL1-
3HA (pCS25) 
To integrate GAL1-3HA-SEN1 (410- 501) in the 
genome at LEU2. 
This study. 
pCS59 SEN1 (501- 931) pRS305-GAL1-
3HA (pCS25) 
To integrate GAL1-3HA-SEN1 (501- 931) in the 
genome at LEU2. 
This study. 
pCS60 SEN1 (761- 931) pRS305-GAL1-
3HA (pCS25) 
To integrate GAL1-3HA-SEN1 (761- 931) in the 
genome at LEU2. 
This study. 
pCS61 SEN1 (622-931) pRS305-GAL1-
3HA (pCS25) 
To integrate GAL1-3HA-SEN1 (622-931) in the 
genome at LEU2. 
This study. 
pCS115 SEN1 promoter pCS25 
(pRS305-
derivative) 
Switch SEN1 promoter for GAL1 promoter in 
pCS25. To integrate SEN1-3HA-Ø in the genome 
at LEU2. 
This study. 
pCS116 ACT1 promoter pCS25 
(pRS305-
derivative) 
Switch ACT1 promoter for GAL1 promoter in 
pCS25. To integrate ACT1-3HA-Ø in the genome 
at LEU2. 
This study. 
pCS117 SEN1 (931-2231) pRS305-SEN1-
3HA (pCS115) 
To integrate SEN1-3HA-SEN1 (931-2231) in the 
genome at LEU2. 
This study. 
pCS118 SEN1 (931-2231) pRS305-ACT1-
3HA (pCS116) 
To integrate ACT1-3HA-SEN1 (931-2231) in the 
genome at LEU2. 
This study. 
pCS119 SEN1 (2-2231) pRS305-SEN1-
3HA (pCS115) 
To integrate SEN1-3HA-SEN1 (2-2231) in the 
genome at LEU2. 
This study. 
pCS120 SEN1 (2-2231) pRS305-ACT1-
3HA (pCS116) 
To integrate ACT1-3HA-SEN1 (2-2231) in the 
genome at LEU2. 
This study. 
pCS123 SEN1 (2-2231) 
W773A E774A W777A 
pRS305-ACT1-
3HA 
To integrate SEN1 (2-2231) W773A E774A 
W777A in the genome at LEU2. Obtained by site-
directed mutagenesis of pCS120. 
This study. 
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pCS124 SEN1 (2-2231) L656A 
S657A K658A I659A 
L660A 
pRS305-ACT1-
3HA 
To integrate SEN1 (2-2231) L656A S657A K658A 
I659A L660A in the genome at LEU2. Obtained by 
site-directed mutagenesis of pCS120. 
This study. 
pCS125 SEN1 (2-2231) D850A 
E851G V852A L853G 
L854A 
pRS305-ACT1-
3HA 
To integrate SEN1 (2-2231) D850A E851G V852A 
L853G L854A in the genome at LEU2. Obtained 
by site-directed mutagenesis of pCS120. 
This study. 
pCS128 SEN1 (2-2231) V746G 
D747G P748G I749G 
pRS305-ACT1-
3HA 
To integrate SEN1 (2-2231) V746G D747G 
P748G I749G in the genome at LEU2. Obtained 
by site-directed mutagenesis of pCS120. 
This study. 
pKL205 TAP-Ø pRS306 To amplify the TAP tag to make a fusion PCR of 
GAL1-TAP. This PCR was then inserted in 
pRS305 to create pCS14. 
Kind gift from Dr K. Labib. 
pKL935 GAL1-Ø pRS306 To amplify the GAL1 promoter to make a fusion 
PCR of GAL1-TAP. This PCR was then inserted 
in pRS305 to create pCS14. 
Kind gift from Dr K. Labib. 
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Table 2.5. List of oligoes used in this study. 
 
Oligo Name 5'-3' Sequence Purpose 
Oligonucleotides used in the Sz. pombe study 
NRT1 AAAAAAAAACCCGGGGTGGTGGTGGTATGGATGGT
AGCCTGTTTTTCTTC 
Input XmaI site. For cloning swi7 in pMCSG32. 
NRT2 AAAAAAAAACTCGAGACCACCACCGCCTTGGAAAT
AGAGATTTTCACCACCACCGCTGGTTTCATGGCTAT
AGTATTT 
Remove STOP codon. Input XhoI site. For 
cloning swi7 in pMCSG32 
NRT3 TTCATTATCTTTAACCGCCTGGAAAAAAACCCGGAA
GATTATCCG 
Mutate glycine residue into glutamic acid (for 
codon-optimized swi7 gene). pTWO-E/ 
pMCSG32 GGC to GAA 
NRT4 CGGATAATCTTCCGGGTTTTTTTCCAGGCGGTTAAA
GATAATGAA 
Mutate glycine residue into glutamic acid (for 
codon-optimized swi7 gene). pTWO-E/ 
pMCSG32 GGC to GAA 
NRT5 TTGGTTGTAGCAGTCCGCAGAATAT Sequencing to ensure mutation of codon-
optimised swi7 gene to swi7-1 gene in vector. 
NRT6 TATAGCGTTCTGCTGAGTCGTCTGA Sequencing to ensure mutation of codon-
optimised swi7 gene to swi7-1 gene in vector. 
NRT7 TGGTAGTCTGTGCCTGTTTGGTAAA Sequencing to ensure mutation of codon-
optimised swi7 gene to swi7-1 gene in vector. 
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NRT8 GGTGCAGAAGATGGTCTGCAAGAAG Sequencing to ensure mutation of codon-
optimised swi7 gene to swi7-1 gene in vector. 
NRT9 CTGGCAGATCAGATGGGTCTGCAGG Sequencing to ensure mutation of codon-
optimised swi7 gene to swi7-1 gene in vector. 
NRT10 GTTCGTGTGGGTGATGTTATTCCGT Sequencing to ensure mutation of codon-
optimised swi7 gene to swi7-1 gene in vector. 
NRT11 TTAGCTGGTTTCATGGCTATAGTAT Sequencing to ensure mutation of codon-
optimised swi7 gene to swi7-1 gene in vector. 
NRT12 CGCTGCTGCTGCTCGGACGAGGCAG Sequencing to ensure mutation of codon-
optimised swi7 gene to swi7-1 gene in vector. 
NRT13 GTGCCGTAGCGCTGAAGTCTTACG Sequencing to ensure pol1 and swi7-1 genes are 
in frame with first ATG from maltose binding 
protein. 
NRT14 CTCGGGAGCAAAGATAGAGGCTACGCTAGGGACG
GTCGAGGAGGCAACCATTTTCGACGAGATAGTATT
CGTGCTTCAAGTATTTCCCGTTAGAATACTCAAGCT
TGGAC 
Integration of loxP site 162 bp upstream of swi7 
NRT15 ACAAGTAATACTGACCCTAGCTCACCACCACAAGA
GAGTTAAACCGGAATAGGTTAGGGTTGTAAAGACA
GTCACAAGATGTAAACTAATTTCACCACCCCCGCC
GCCCG 
Integration of loxP site 162 bp upstream of swi7 
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NRT16 CTTGGACTAATATGCCAAGCTTAAACCCTACCCTAA
ATTGACTGCTTTTTTATTAGAGAATTAAATTGCAAGC
ACATTTAGAATGTTAACAAGCTTAGCTACAAATCCC
A 
Integration of loxM3 immediately downstream of 
swi7 
NRT17 AACAAGCTCACCGGAACGAATTTGAGGCCCAACGT
TGGTTGCCATTTTGATATCTTTCCTCCCTACAGATG
CGTTTGAGACACTGCGCAAGAATTCGAGCTCGTTT
AAAC 
Integration of loxM3 immediately downstream of 
swi7 
NRT18 AAAAAAAGAGCTCTGAGAAGAGACTCGGGAGCAAA
GATAGAGGCTACGCTAGGGACGGTCGAGGAGGCA
ACCATTTTCGACGAGATAGTATTCGTGCTTCAAG 
PCR-amplify swi7 from genomic DNA and add a 
SacI cut site upstream 
NRT19 AAAAAAAACTAGTGTTAACATTCTAAATGTGCTTGC
AATTTAATTCTCTAATAAAAAAGCAGTCAATTTAGGG
TAGGGTTTAAGCTTGGCATATTAGTCCAAG 
PCR-amplify swi7 from genomic DNA and add a 
SpeI cut site downstream 
NRT20 CTCGGGAGCAAAGATAGAG Sequence and colony-PCR of Sz. pombe after 
transformation with products from product of 
pAW41. Also used after transformation with 
products from pAW5 and pAW12. 
NRT21 TGAAATTAAACGTGAGTA Sequence and colony-PCR of Sz. pombe after 
transformation with products from product of 
pAW41.  
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NRT22 CCTTATGTGTGTGCTCTGG Sequence and colony-PCR of S.pombe after 
transformation with pAW5. Also used after 
transformation pAW12-product.  
NRT23 AACTTGGTTATAAACATTG Sequence and colony-PCR of Sz. pombe after 
transformation with products from product of 
pAW12. Also usable with final product.  
NRT24 AACAAGCTCACCGGAACGA Sequence and colony-PCR of Sz. pombe after 
transformation with products from product of 
pAW12. Also usable with final product.  
NRT25 TAGGGTCAGTATTACTTGT Sequence and colony-PCR of S.pombe. Used 
along with CRELOX_seq_swi7_start (antisense)  
NRT26 ACGTTTTAAGTAAACGGTTCT Sequence and colony-PCR of mainly FMA8 but 
compatible with wildtype. 
NRT27 GTCGAGGATTCTCGCACAACC Sequence and colony-PCR of mainly FMA8 but 
compatible with wildtype. 
NRT28 TTCCATTTGGATAATCTTCTGGATTTTTTTCCAAACG
ATTGAATATTATAAATTTGTTA 
Site-directed mutagenesis of Pol1. G1116E 
(LoxP-LoxM3 system) 
NRT29 TAACAAATTTATAATATTCAATCGTTTGGAAAAAAAT
CCAGAAGATTATCCAAATGGAA 
Site-directed mutagenesis of Pol1. G1116E 
(LoxP-LoxM3 system) 
NRT30 GTCTTTCCATTTGGATAATCTTCTGGATTTTTCTGCA
AACGATTGAATATTATAAATTTGTTAGCCG 
Site-directed mutagenesis of Pol1. G1116Q 
(LoxP-LoxM3 system) 
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NRT31 CGGCTAACAAATTTATAATATTCAATCGTTTGCAGA
AAAATCCAGAAGATTATCCAAATGGAAAGAC 
Site-directed mutagenesis of Pol1. G1116Q 
(LoxP-LoxM3 system) 
NRT32 CTTTCCATTTGGATAATCTTCTGGATTTTTGCTCAAA
CGATTGAATATTATAAATTTGTTAGC 
Site-directed mutagenesis of Pol1. G1116S 
(LoxP-LoxM3 system) 
NRT33 GCTAACAAATTTATAATATTCAATCGTTTGAGCAAAA
ATCCAGAAGATTATCCAAATGGAAAG 
Site-directed mutagenesis of Pol1. G1116S 
(LoxP-LoxM3 system) 
NRT34 TCTTTCCATTTGGATAATCTTCTGGATTTTTATCCAA
ACGATTGAATATTATAAATTTGTTAGC 
Site-directed mutagenesis of Pol1. G1116D 
(LoxP-LoxM3 system) 
NRT35 GCTAACAAATTTATAATATTCAATCGTTTGGATAAAA
ATCCAGAAGATTATCCAAATGGAAAGA 
Site-directed mutagenesis of Pol1. G1116D 
(LoxP-LoxM3 system) 
NRT40 AGAAGAGAGAGTAGTTGAAG Determine mating type (common oligo) 
NRT41 ACGGTAGTCATCGGTCTTCC Determine mating type (specific to mat1P) 
NRT42 TACGTTCAGTAGACGTAGTG Determine mating type (specific to mat1M) 
MK01 TGACAGATCTCCTTCTAACTCTGATTCCGA Sequencing of pol1 gene in vivo. 
MK02 TAGTTCACTGTGAAATTGACACATTCTTTA Sequencing of pol1 gene in vivo. 
MK03 GTGAGAGGTCTGAAGTTTCGTTGCTTAATA Sequencing of pol1 gene in vivo. 
MK04 CTAATACCGCCTTATTCGAGCAGTTTGTCT Sequencing of pol1 gene in vivo. 
MK05 AAAAACATATGGATGGTTCTTTGTTTTTTTTTTGGAT
GGAT 
Sequencing of pol1 gene in vivo. 
Mk06 AAAAGGATCCTCAAGAAGTCTCATGTGAGTAGTATT
TTCGAGC 
Sequencing of pol1 gene in vivo. 
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MK07 CCATGCTCTTCGAATTGG Sequencing of pol1 gene in vivo. 
MK08 ATTTCTTGCGGACTATAAGC Sequencing of pol1 gene in vivo. 
CS440 GCATACATTATACGAAGTTATGCATGCGGAGAGCT
CTACGCTAGGGACG 
Tagging of Pol1 (fission yeast) at the amino-
terminal with a 5X FLAG, 9X His tag.  
CS441 GATAAGTTCACGAGAAGACTTTAAAGTCGAA Tagging of Pol1 (fission yeast) at the amino-
terminal with a 5X FLAG, 9X His tag.  
CS442 TTCGACTTTAAAGTCTTCTCGTGAACTTATCATGGG
TGCTCATCACCACCATCACCATCATCA 
Tagging of Pol1 (fission yeast) at the amino-
terminal with a 5X FLAG, 9X His tag.  
CS443 CGGCTTTATCCCCGCGTTTCTCTTTCTGGCACCCG
CTCCAGCGCCTGCACCAGCTCC 
Tagging of Pol1 (fission yeast) at the amino-
terminal with a 5X FLAG, 9X His tag.  
CS444 AGAAAGAGAAACGCGGGGATAAAGCCGTCT Tagging of Pol1 (fission yeast) at the amino-
terminal with a 5X FLAG, 9X His tag.  
CS445 ATTGGTTGACTGTCGACATTTTCTTCTGTCTCGAGT
GCAG 
Tagging of Pol1 (fission yeast) at the amino-
terminal with a 5X FLAG, 9X His tag.  
CS784 CGTATAGCATACATTATACG Aligns with loxP locus (either on pRA8 or pRA8-
derived plasmids or when integrated into the 
genome). Used to amplify pol1 (Sz. pombe) from 
progeny of the FMA12 strain. 
CS785 CGTATATAATACCATATACG Aligns with loxM3 locus (reverse complemented, 
either on pRA8 or pRA8-derived plasmids or 
when integrated into the genome). Used to 
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amplify pol1 (Sz. pombe) from progeny of the 
FMA12 strain. 
CS786 ATCGAAGAACGTTCTAGCTG Aligns to within the pol1 gene (4705-4724 in 
pRA8 and pRA8-derived plasmids). 
CS787 GCCGTACATCTCGGTATAATCC Aligns to within the pol1 gene (5407-5428 (RC) in 
pRA8 and pRA8-derived plasmids). 
CS788 CCTCAACCTGCTAGCAGTCTTCC Aligns within the pol1 gene (5009-5031 in pRA8 
and pRA8-derived plasmids). 
CS789 ACAAATTGGCTACTTCGTCG Aligns within the pol1 gene (5590-5609 in pRA8 
and pRA8-derived plasmids). 
Oligonucleotides used in the S. cerevisiae study 
CS290 TGTATGGCATCTATCTCTATATATATAAAAAAGCGC
ATCTGTTTATTATAACGTACGCTGCAGGTCGAC 
Tagging/gene deletion of the SEN1 gene in 
W303 (S. cerevisiae). 
CS291 TATACACCAATATATATGCAGGTATAATTCCTAACA
CTTTTACTTCAAGATCAATCGATGAATTCGAGCTCG 
Tagging/gene deletion of the SEN1 gene in 
W303 (S. cerevisiae). 
CS292 CGGAATGCTTCATCTAGCCCATTTATCCCAAAAAAA
AGAAAGCCTAGATCACGTACGCTGCAGGTCGAC 
Tagging/gene deletion of the SEN1 gene in 
W303 (S. cerevisiae). 
CS293 ATTATTATTATTAATGTTGTTGCTATTATTATTATCAG
GATTGTTGGAATTCATCGATGAATTCTCTGTCG 
Tagging/gene deletion of the SEN1 gene in 
W303 (S. cerevisiae). 
CS294 CTTCGCATATTTTAGGATCTTG Checking N- and C-terminal tagging of the SEN1 
gene in W303 strains. 
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CS295 CATTTATCACAAACAGAGAG Checking N- and C-terminal tagging of the SEN1 
gene in W303 strains. 
CS296 TCAAATAGTGTTTTATCCGG Checking N- and C-terminal tagging of the SEN1 
gene in W303 strains. 
CS297 AAACAGCCCTCGACTCCCTC Checking N- and C-terminal tagging of the SEN1 
gene in W303 strains. 
CS297 AAACAGCCCTCGACTCCCTC Checking N- and C-terminal tagging of the SEN1 
gene in W303 strains. 
CS355 TTACAGCGGCCGCGAGCTCTAGTACGGATTAG Cloning GAL1-3HA in pRS305 vector. 
CS356 AGATAAGTCGACACCGGCACCGGCACCAGC Cloning GAL1-3HA in pRS305 vector. 
CS361 TTACTGTCGACAATTCCAACAATCCTGATAAT Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS362 CAATGGCTCGAGTCACTTTTCTTTTCTGTAGTTTTC
AG 
Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS363 CAATGGCTCGAGTCATTCTAACTCCTGTTTAGCCAA
T 
Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
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CS364 CAATGGCTCGAGTCATACCTCATCGGGGCCTTG Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS365 CAATGGCTCGAGTCATGATCTAGGCTTTCTTTTTTT
TG 
Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS366 TTACTGTCGACAAGGAATTATCAAGACTTGGG Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS367 TTACTGTCGACGCTGAATTGGCTAAACAGGAG Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS368 ATGAATTCCAACAATCCTG Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS369 TAACATTTTGCACTTCCCT Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS370 GACATCGTATGCCAATGGA Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
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CS371 TCGAGATTACTACCGGTTT Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS372 ATGGCGTTCCTGCGTATAA Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS373 CATTGCTGGCCAAACAGCT Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS374 TCTGGTGTGTTTGCTAATT Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS375 CAGGCGAGTGAGATTCTAC Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS376 GACGATAGCAGTAGTGAGG Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS377 GTCGCTAAACAAGTCATAC Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
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CS378 TTTCTTTAATTCAGGGTCC Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS379 GGTAATCCAGAAAGTCCAA Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS380 CTGGATGTTCAATACCGTA Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS381 ACGAAATCTAGTGTCGGTT Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS382 CAGCACCTCATCTGGTACA Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS383 AGGTACCTGCTGCTATTAC Checking SEN1 constructs under GAL1-3HA/ 
GAL1-TAP in pRS305-derived vector by 
sequencing. 
CS446 GTTACTCTAGAATGAAAGCTGATGCGCAAC Expressing TAP-tagged SEN1 fragment under 
control of a GAL1 promoter. 
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CS447 CGAGGTCGACGGCACCCGCTC Expressing TAP-tagged SEN1 fragment under 
control of a GAL1 promoter. 
CS448 AATATCCTCGAGGTCACTTTTCTTTTCTGTAGTTTTC
AG 
Expressing fragments of SEN1.  
CS449 AATATCCTCGAGGTCATTCTAACTCCTGTTTAGCCA
AT 
Expressing fragments of SEN1.  
CS450 AATATCCTCGAGGTCATACCTCATCGGGGCCTTG Expressing fragments of SEN1.  
CS451 AATATCCTCGAGGTCATGATCTAGGCTTTCTTTTTTT
TG 
Expressing fragments of SEN1.  
CS581 TTATTATTAATGTTGTTGCTATTATTATTATCAGGAT
TGTTGGAATTGGCACCCGCTCCAGCGCCTG 
To construct a SEN1 Degron 
CS679 GTGAGGAGAGTGACAACGATATAG To make a full length construct of Sen1 under the 
control of the GAL1 promoter and tagged at the 
N-terminal with 3HA. 
CS680 AAAGGGAACAAAAGCTGGGTAC To make a full length construct of Sen1 under the 
control of the GAL1 promoter and tagged at the 
N-terminal with 3HA. 
CS687 TACACCTACAAAAAAGCTCTACTTTGTCATTTATTTT
CTACTTCATCTCTATTAAGGCGCGCCAGATCTG 
To construct a heat-inducible degron of SEN1. 
To be used with oligo CS 688. This oligo pair can 
also be used for other N-terminal modification of 
SEN1. 
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CS688 TTATTATTAATGTTGTTGCTATTATTATTATCAGGAT
TGTTGGAATTCATGGCACCCGCTCCAGCGCCTG 
To construct a heat-inducible degron of SEN1. 
To be used with oligo CS 687. This oligo pair can 
also be used for other N-terminal modification of 
SEN1. 
CS712 CAATGGCTCGAGTCACTCAACAATTGGATTGTCTT Cloning of SalI_SEN1 (2-410)_XhoI. 
CS713 CAATGGCTCGAGTCATGACGGTACTATCAAAAGAC Cloning of SalI_SEN1 (2-622)_XhoI. 
CS714 TTACTGTCGACGAGCATCAAACAGAAGTTTAC Cloning of SalI_SEN1(410-931)_XhoI 
CS747 AGCTGGTGCAGGCGCTGGAGCGGGTGCCGTCGAC
GAGCATCAAACAGAAGTTTAC 
Forward primer. Used to clone fragments of 
SEN1 starting with residue 410 in pCS14. Gibson 
compatible. Also includes the SalI restriction site. 
CS748 AGCTGGTGCAGGCGCTGGAGCGGGTGCCGTCGAC
ACAGTACTGTTGACTAAAACAG 
Forward primer. Used to clone fragments of 
SEN1 starting with residue 501 in pCS14. Gibson 
compatible. Also includes the SalI restriction site. 
CS749 AGCTGGTGCAGGCGCTGGAGCGGGTGCCGTCGAC
AAGAGCCAAAATACCGAAAAGG 
Forward primer. Used to clone fragments of 
SEN1 starting with residue 761 in pCS14. Gibson 
compatible. Also includes the SalI restriction site. 
CS750 CTAAAGGGAACAAAAGCTGGGTACCGGGCCCCTAC
TTTTCTTTTCTGTAGTTTTCAG 
Reverse primer. Used to clone fragments of 
SEN1 ending with residue 931 in pCS14. Gibson 
compatible. Also includes the PspXI restriction 
site. 
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CS751 CTAAAGGGAACAAAAGCTGGGTACCGGGCCCCTA
GAATATTTTAGCCTTTTGTAGAAT 
Reverse primer. Used to clone fragments of 
SEN1 ending with residue 913 in pCS14. Gibson 
compatible. Also includes the PspXI restriction 
site. 
CS752 CTAAAGGGAACAAAAGCTGGGTACCGGGCCCCTAC
AAAGTTTGGAAATTAGCAAACA 
Reverse primer. Used to clone fragments of 
SEN1 ending with residue 761 in pCS14. Gibson 
compatible. Also includes the PspXI restriction 
site. 
CS753 CTAAAGGGAACAAAAGCTGGGTACCGGGCCCCTAT
TCAAATTCATCATTCTTATAAAGC 
Reverse primer. Used to clone fragments of 
SEN1 ending with residue 501 in pCS14. Gibson 
compatible. Also includes the PspXI restriction 
site. 
CS754 AGCTGGTGCAGGCGCTGGAGCGGGTGCCGTCGAC
TCAAATACTGCCGTAGCTGAG 
Forward primer. Used to clone fragments of 
SEN1 starting with residue 622 in pCS14. Gibson 
compatible. Also includes the SalI restriction site. 
CS755 GAGATTCATTCCCAATCAAACTAATCAAAATTCAAG
ACAATCCAATTGTTATTAAGGCGCGCCAGATCTG 
To produce a PCR (with oligo CS756) from 
plasmid pKL506. This PCR is transformed into a 
diploid and causes a disruption mutation of 
SEN1.  
CS756 GCCGGCACAGAATCCGTTAAGTCGATCACCTTCCC
AAGTCTTGATAATTCATCGATGAATTCGAGCTCG 
To produce a PCR (with oligo CS755) from 
plasmid pKL506. This PCR is transformed into a 
	 156	
diploid and causes a disruption mutation of 
SEN1.  
CS757 GCAGTTTAGCATTAGCTGATG To check (by sequencing) whether the PCR 
generated from oligoes CS755 and CS756 
engendered the correct disruption in the SEN1 
gene in one of the chromatids (in a diploid). Oligo 
CS371 should also be used. 
CS758 GGATCTGGTGCTGGTTCAGGAGCAGGTTCAGGTGA
ATTATCAAGACTTGGGAAGGTG 
To produce a PCR product from gDNA (obtained 
from strain #1353 or other SEN1-TAP strains). 
This oligo aligns with bases 2794- 2814 in the 
SEN1 ORF (thus beginning with residue 931). To 
be used in combination with oligo CS291. The 
PCR will be used for a substrate of another PCR 
reaction. 
CS759 GAGATTCATTCCCAATCAAACTAATCAAAATTCAAG
ACAATCCAATTGTTGGATCTGGTGCTGGTTCAGG 
Using a PCR generated from gDNA coming from 
strain # 1353 (with oligoes CS758 and CS291), 
this oligo in tandem with oligo CS291 will be used 
to produce another PCR that aligns with bases 
1178-1228 in SEN1 ORF. It includes a linker, 
followed by another region that aligns with the 
SEN1 gene. This PCR will be used to loop out 
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the URA3 gene that had been used to disrupt the 
SEN1 gene previously, creating a gene that has 
lost bases that translate to residues 410-931. 
CS760 CACGTAATAGTCAAACTCTTTCACG To check (by sequencing, along with other 
oligoes) whether the bases encoding residues 
410- 931 have been successfully removed from 
SEN1. Designed by Giacomo. 
CS761 CCGTTAACGATAATACGGG To sequence SEN1. 
CS762 CCGCATATGTTGAGGCTT To sequence SEN1. 
CS769 GCGGATTACAGAGACACTCG To sequence SEN1. 
CS771 CAATCGACGGTTTCCAAGGTC To check SEN1 (1-1901) tagging. 
CS819 AAACAGCTGCTAGTATCTTTAAAAAATATTAATGGT
CTTTTGATAGTACCGGAATTATCAAGACTTGGGAAG 
To make SEN1 (622-931∆) with no linker. 
CS820 GGATCTGGTGCTGGTTCAGGAGCAGGTTCAGGTGA
ATTATCAAGACTTGGGAAGG 
To make SEN1 (622-931∆) with a short linker. 
CS821 AAACAGCTGCTAGTATCTTTAAAAAATATTAATGGT
CTTTTGATAGTACCGGGATCTGGTGCTGGTTCAG 
To make SEN1 (622-931∆) with a short linker. 
CS822 TGGATCTGGTGCAGGAGGCTCTGGTGAATTATCAA
GACTTGGGAAG 
To make SEN1 (622-931∆) with a long linker. 
CS823 GGATCTGGTGCTGGTTCAGGAAGTGGAGGCGCTG
GGGCAGGATCTGGATCTGGTGCAGGAGGCTC 
To make SEN1 (622-931∆) with a long linker. 
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CS824 AACAGCTGCTAGTATCTTTAAAAAATATTAATGGTCT
TTTGATAGTACCGGGTGGAAGCGGTGGCAGCATCG
ACAACTTCGAC 
To make SEN1 (622-931∆) with a CIP linker. 
CS825 AGCATCGACAACTTCGACGACATCCTGGGCGAGTT
CGAGGGTGCTGGATCTGGTGAATTATCAAGACTTG
GGAAG 
To make SEN1 (622-931∆) with a CIP linker. 
CS826 AGCATCGACAACTTCGACGACATCCTGGGCGAGTT
CGAGGGTGCTGGATCTGGTAAAGCACTCACGGAA
GAGG 
To make SEN1 (622-913∆) with a CIP linker. 
CS827 AACAGCTGCTAGTATCTTTAAAAAATATTAATGGTCT
TTTGATAGTACCGAAAGCACTCACGGAAGAGG 
To make SEN1 (622-913∆) with no linker. 
CS828 GGATCTGGTGCTGGTTCAGGAGCAGGTTCAGGTAA
AGCACTCACGGAAGAGG 
To make SEN1 (622-913∆) with a short linker. 
CS829 TGGATCTGGTGCAGGAGGCTCTGGTAAAGCACTCA
CGGAAGAGG 
To make SEN1 (622-913∆) with a long linker. 
CS830 GAGATTCATTCCCAATCAAACTAATCAAAATTCAAG
ACAATCCAATTGTTGGTGGAAGCGGTGGCAGCATC
GACAACTTCGACG 
To make SEN1 (410-931∆) with a CIP linker. 
CS831 GAGATTCATTCCCAATCAAACTAATCAAAATTCAAG
ACAATCCAATTGTTAAAGCACTCACGGAAGAGG 
To make SEN1 (410-913∆) with no linker. 
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CS832 GAGATTCATTCCCAATCAAACTAATCAAAATTCAAG
ACAATCCAATTGTTGGATCTGGTGCTGGTTCAG 
To make SEN1 (410-931∆) with a short linker. 
CS833 GAGATTCATTCCCAATCAAACTAATCAAAATTCAAG
ACAATCCAATTGTTGAATTATCAAGACTTGGGAAG 
To make SEN1 (410-931∆) with no linker. 
CS898 GTATGGCATCTATCTCTATATATATAAAAAAGCGCA
TCTGTTTATTATAAATTAAGGCGCGCCAGATCTG 
To make SEN1 starting from 912 or 930 
CS899 GACTCACTTAATTTTATCATTAAAAGTACAAAAAATA
TCGATGAATTCGAGCTCG 
To make SEN1 starting from 912 or 930 
CS900 ATTTTTTGTACTTTTAATGATAAAATTAAGTG To make SEN1 starting from 912 or 930 
CS901 TCTTTTCTGTAGTTTTCAGCTTCTGTAGCGACCTCT
TCCGTGAGTGCTTTATTCATTTATAATAAACAGATG
CGCTTTTT 
To make SEN1 starting from 912 or 930 
CS902 GGCACAGAATCCGTTAAGTCGATCACCTTCCCAAG
TCTTGATAATTCCTTCATTTATAATAAACAGATGCGC
TTTTTT 
To make SEN1 starting from 912 or 930 
CS929 ACGGCAGTATTTGACGGTACTATCCCACCACCACC
ACCATTTTTTAAAGATACTAGCAGCTGTTTGGCCAG
CAATGGACCGT 
SEN1_ SIte directed mutagenesis of LSKIL (614- 
618) to AAAAA 
CS930 ACGGTCCATTGCTGGCCAAACAGCTGCTAGTATCT
TTAAAAAATGGTGGTGGTGGTGGGATAGTACCGTC
AAATACTGCCGT 
SEN1_ SIte directed mutagenesis of LSKIL (614- 
618) to AAAAA 
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CS933 GTAAACTTATAAATCGTATCCAAGAATAACGCACAT
GATGCCGCGAATTTTAAAAATTCCTTTTCGGTATTTT
GGCTC 
SEN1_ SIte directed mutagenesis of WESCW 
(773-777) to AASCA 
CS934 GAGCCAAAATACCGAAAAGGAATTTTTAAAATTCGC
GGCATCATGTGCGTTATTCTTGGATACGATTTATAA
GTTTAC 
SEN1_ SIte directed mutagenesis of WESCW 
(773-777) to AASCA 
CS935 CAGACGTGCTTATAATTAATCTAACACAAGATTCCG
CACCTGCTCCGGCGCTCAATCTCAGCCAATACAAC
ATATTCTTA 
AAG 
SEN1_ SIte directed mutagenesis of DEVLL 
(850-854) to AGAGA 
CS936 CTTTAAGAATATGTTGTATTGGCTGAGATTGAGCGC
CGGAGCAGGTGCGGAATCTTGTGTTAGATTAATTAT
AAGCACGT 
CTG 
SEN1_ SIte directed mutagenesis of DEVLL 
(850-854) to AGAGA 
CS939 GTACTTGGCCATCATTTCTCCCAAGGAACCACCCA
CTTTCACATGCTTTTC 
SEN1_ SIte directed mutagenesis of DDSLV 
(876-880) to GGSLGEM 
CS940 GAAAAGCATGTGAAAGTGGGTGGTTCCTTGGGAGA
AATGATGGCCAAGTAC 
SEN1_ SIte directed mutagenesis of DDSLV 
(876-880) to GGSLGEM 
CS941 AAGTTTGGAAATTAGCAAACACACCAGAACCCCCG
CCTCCAAATGCACTCACTACGTCCATCAAAACA 
SEN1_ SIte directed mutagenesis of FVDPISGV 
(746-753) to FGGGGSGV(746-753) 
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CS942 TGTTTTGATGGACGTAGTGAGTGCATTTGGAGGCG
GGGGTTCTGGTGTGTTTGCTAATTTCCAAACTT 
SEN1_ SIte directed mutagenesis of FVDPISGV 
(746-753) to FGGGGSGV(746-753) 
CS953 ATCTAAGCGGCCGCACAAGCGCGCCTCTACCT Cloning ACT1 promoter instead of GAL1. 
CS954 TACAATACTAGTTGTTAATTCAGTAAATTTTCGAT Cloning ACT1 promoter instead of GAL1. 
CS955 ATCTAAGCGGCCGCCGTTATGTGACCAATGTATA Cloning SEN1 promoter instead of GAL1. 
CS956 TACAATACTAGTTTATAATAAACAGATGCGCTTT Cloning SEN1 promoter instead of GAL1. 
CS981 AGAAGATGATTATAAGCTACCC Clone TAP by Gibson in plasmid. 
CS982 GGAACAAAAGCTGGGTACCGAGGCCTTATACACCA
ATATATATGCAGG 
Clone TAP by Gibson in plasmid. 
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2.4 Biochemistry 
 
2.4.1 Genomic DNA Extraction 
 
Individual clones were grown overnight in 5 ml of either YPD or YEA medium. 
Cells were washed in sterile d.H2O and re-suspended in 200 μl of lysis buffer 
(10 mM Tris-HCl (pH 7.5), 1 mM EDTA, 3% (w/v) SDS) to which 200 μl of 
sterile d.H2O, 200 μl of phenol/chloroform/alcohol (25:24:1) and a small 
quantity of glass beads were added. The cells were lysed by vigorous shaking 
for 1 min. The mixture was then centrifuged at 12,000 g for 2 min. 380 μl of 
the clear supernatant was transferred to a tube containing 760 μl of 100% 
ethanol. The resulting solution is around 70% (v/v) ethanol and the DNA 
precipitates. The DNA is recovered by centrifugation and is washed in fresh 
70% (v/v) ethanol to remove any residual phenol/chloroform contaminant that 
may inhibit downstream applications and recovered again by centrifugation. 
The supernatant was discarded. The pellet was dried at 37°C for 30 min before 
resuspension in 50 μl of TE supplemented with 50 μg/ml RNAse A. The 
mixture was left to incubate at 37°C for at least 1 h before storage at −20°C. 
 
2.4.2 TCA Protein Extraction 
 
Individual clones were grown overnight in 5 ml of either YPD or YEA medium. 
Cells were washed in sterile d.H2O and re-suspended in 300 μl of 20% (w/v) 
TCA to which a small quantity of glass beads was added. The cells were then 
lysed by vigorous shaking for 1 min. The supernatant was then transferred to 
a new Eppendorf and left-over protein precipitates were fished out by washing 
the cell debris and glass beads with 300 μl 5% (w/v) TCA and this solution was 
then added to the 30% (w/v) TCA collected previously. The 600 μl combined 
solution was centrifuged for 10 min at 3000 g. The supernatant was discarded 
and the protein pellet was re-suspended in 100-200 μl of 1 x Laemmli buffer 
supplemented with 150 mM Tris base. The sample was boiled for 4 min before 
centrifugation at 3000 g for 10 min. The supernatant was then kept at −20°C 
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for long-term storage and analysed using electrophoresis on polyacrylamide 
gels. 
 
2.4.4 Immuno-precipitation of TAP-tagged proteins from 
Yeast Samples 
 
Dilute or concentrated yeast samples were prepared as described in section 
2.1.7. For dilute samples, frozen cell pellets were lysed using a mechanized 
pestle and mortar at −80°C (Spex Sample Prep, 6870). The resulting 
powdered yeast cells were thawed and kept at 4°C. 1 g of the lysate was 
assumed to be equivalent to 1 ml. To each volume of thawed lysate was added 
one quarter of volume plus 50 μl of a solution of 50% (v/v) glycerol, 100 mM 
Hepes-KOH (pH 7.9), 50 mM potassium acetate, 50 mM magnesium acetate, 
0.5% Igepal® CA-630 (Sigma), 2mM EDTA supplemented with 2 mM 
glycerophosphate, 2 mM sodium fluoride, 1 mM DTT, 1% (v/v) Sigma protease 
inhibitor cocktail and 0.24% (w/v) EDTA-free Complete Protease Inhibitor 
Cocktail (Roche). Pierce Universal Nuclease was added to a final 
concentration of 0.4 U/μl. The mixture was transferred to a centrifuge tube and 
left on a rotating platform for 30 min to allow degradation of nucleic species. 
The lysate was then clarified from cell debris by step-wise centrifugation first 
at 18,700 g and then at 126,600 g in a vacuum. The supernatant was isolated 
from the cell debris and 50 μl of this cell extract was added to 100 μl of 1.5 X 
Laemmli buffer, boiled for 4 min and flash-frozen on dry-ice. 
 
The remainder of the cell extract was incubated with 100 μl of TAP beads (M-
270 Dynabeads® Epoxy beads (Invitrogen) bound to rabbit anti-sheep IgG 
(S1265, Sigma)) in two separate Eppendorfs. The mixture was placed on a 
rotating platform at 4°C for 2 h before washing the beads with solutions of 100 
mM Hepes-KOH (pH 7.9), 50 mM potassium acetate, 50 mM magnesium 
acetate, 2 mM EDTA, 0.1% (v/v) Igepal® CA-630 thrice. Importantly, the first 
wash was supplemented with 2 mM glycerophosphate, 2 mM sodium fluoride, 
1 mM DTT, 1% (v/v) Sigma protease inhibitor cocktail and 0.24% (w/v) EDTA-
free Complete Protease Inhibitor Cocktail (Roche). After the three washes, 50 
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μl of 1 x Laemmli buffer was added to each 50 μl of beads, homogenized by 
vigorous vortexing and boiled for 4 min. 50 μl from each duplicate was added 
to one another in order to average the samples, split again in volumes of 50 
μl in two Eppendorfs and flash-frozen on dry-ice. The cell extracts and IP 
samples were then kept at −80°C for long-term storage. 
 
For concentrated samples, frozen cell pellets were also lysed using the 
mechanized pestle and mortar at −80°C and the powdered lysate was allowed 
to thaw at 4°C. Again 1 g of the lysate was deemed to be equivalent to 1 ml 
and to each volume of thawed lysate was added a quarter of volume plus 50 
μl of a solution of 50% (v/v) glycerol, 100 mM Hepes-KOH (pH 7.9), 50 mM 
potassium acetate, 50 mM magnesium acetate, 0.5% Igepal® CA-630 
(Sigma), 2mM EDTA supplemented with 2 mM glycerophosphate, 2 mM 
sodium fluoride, 1 mM DTT, 1% (v/v) Sigma protease inhibitor cocktail and 
0.24% (w/v) EDTA-free Complete Protease Inhibitor Cocktail (Roche). In 
addition, 1 ml of a solution of 10% (v/v) glycerol, 50 mM potassium acetate, 
50 mM magnesium acetate, 0.1% (v/v) Igepal® CA-630, 1 mM DTT, 2mM DTT 
supplemented with 2 mM glycerophosphate, 2 mM sodium fluoride, 1 mM 
DTT, 1% (v/v) Sigma protease inhibitor cocktail and 0.24% (w/v) EDTA-free 
Complete Protease Inhibitor Cocktail (Roche). Pierce Universal Nuclease was 
added to a final concentration of 1.6 U/μl. The mixture was transferred to a 
centrifuge tube and left on a rotating platform for 40 min to allow degradation 
of nucleic acid species. The samples were then clarified by centrifugation and 
incubated with TAP beads, similar to dilute samples. 
 
2.4.5 Recombinant Expression of Sz. pombe Pol1 in Escherichia 
coli BL21(DE3) 
 
Individual clones of E. coli BL21 (DE3) carrying either the pRA4 (pMCSG32), 
pRA5 or pRA6 were inoculated in LB (lysogeny broth) medium consisting of 
10% (w/v) tryptone, 5% (w/v) yeast extract and 10% (w/v) NaCl. Ampicillin to 
a final concentration of 100 μg/ml was used to prevent contamination and to 
prevent plasmid loss. To trigger expression of the recombinant genes, IPTG 
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was added to logarithmically-growing cultures to a final concentration of 1 mM. 
Upon addition of IPTG, the cultures were grown at 20°C for 6 h to favour 
transcription, translation and folding of the recombination proteins. Thereafter, 
cells were harvested by centrifugation at 4,000 × g for 20 min at 4°C. The cells 
were lysed by addition of lysozyme (to a final concentration of 1.5 mg/ml) and 
sonication. EDTA-free protease inhibitor tablets (Roche) and 10 mM PMSF 
(Fischer) were used to reduce digestion of the recombinant proteins during 
cell lysis. The resulting crude extract were centrifuged at 10,000 × g for 25 min 
at 4°C. The supernatant (cleared lysate) contained the recombinant proteins.  
 
The cleared lysates were then diluted 1:6 in column buffer (20 mM Tris-HCl, 
pH 7.5, 200 mM NaCl, 1 mM EDTA, pH 8, 1mM DTT) supplemented with 1 
tablet of EDTA-free Complete Protease Inhibitor Cocktail (Roche) and 10 mM 
PMSF. The diluted samples were then mixed with three volumes of amylose 
resin (NEB) pre-washed with 5 column volumes of column buffer. The diluted 
lysate and resin were incubated at 4°C for 2 h on a rotary shaker. After 
incubation, the mixture was packed in an empty gravity flow column (Econo-
Pac® Chromatography Columns, Biorad) and the column buffer was allowed 
to separate from the resin by gravity flow at 4°C, ensuring that the resin did 
not dry. The resin was then washed with 12 columns volumes of column buffer 
by gravity flow and the flow-through was collected for analysis on acrylamide 
gels. The MBP-tagged proteins were then eluted by using 10 successive 1/5th 
column volumes fractions of elution buffer supplemented (20 mM Tris-HCl, pH 
7.5, 200 mM NaCl, 1 mM DTT, 10 mM maltose). A small quantity of each 
elution was saved for analysis on acrylamide gels.  
 
The first three fractions were pooled and diluted 1:10 in 50 mM Hepes buffer 
with no additional salt (pH 7). The diluted samples were then fed manually 
through a syringe into separate 1 ml pre-packed HiTrapTM Heparin HP 
columns (GE Healthcare) pre-washed with 10 column volumes of 50 mM 
Hepes buffer (pH 7). Once the samples were applied, the columns were 
washed with 5 column volumes of 50 mM Hepes buffer (pH 7). The flow-
through was collected for analysis on acrylamide gels. The proteins were 
eluted by washing successively with 3 column volumes of 50 mM Hepes buffer 
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(pH 7) with 0.5 M NaCl, 3 column volumes of 50 Hepes buffer (pH 7) with 1 M 
NaCl, 3 columns volumes of 50 mM Hepes buffer (pH 7) with 1.5 M NaCl and 
3 columns volumes of 50 mM Hepes buffer (pH 7) with 2 M NaCl. The different 
elutions were pooled according to the concentration of NaCl used and small 
quantities of the pooled samples were analysed on an acrylamide gel. The 
samples eluted with 0.5 and 1 M NaCl solutions contained the highest quantity 
of fusion proteins. The first two elutions for either concentrations were pooled 
together (4 ml of material) and diluted 1:10 in a solution of 50 mM NaH2PO4, 
300 mM NaCl, 20 mM imidazole and 0.2% (v/v) IGEPAL CA-630. 
 
2 ml of of 50% Ni-NTA slurry was then washed twice with one column volume 
of 50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole and 0.2% (v/v) IGEPAL 
CA-630 to remove the preservatives. The slurry was resuspended in a solution 
of 50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole and 0.2% (v/v) IGEPAL 
CA-630 to a final volume of 2 ml. The elutions from the heparin column were 
then added to the slurry and allowed to incubate on a rocking platform at 4°C 
for 2 h. Thereafter, the mixture was packed in an empty gravity flow column 
(Econo-Pac® Chromatography Columns, Biorad) and the column buffer was 
allowed to separate from the resin by gravity flow at 4°C, ensuring that the 
resin did not dry. The flow-through was collected for analysis on acrylamide 
gels. The column was washed with 8 column volumes of 50 mM NaH2PO4, 
300 mM NaCl, 20 mM imidazole and 0.2% (v/v) IGEPAL CA-630. The 
recombinant proteins were eluted using 4 column volumes of elution buffer (50 
mM NaH2PO4, 300 mM NaCl, 250 mM imidazole and 0.2% (v/v) IGEPAL CA-
630). The 4 column volumes were collected separately. The first two elutions 
contained the highest levels of the recombinant proteins, for both the wildtype 
and mutant proteins. The recombinant proteins were kept in 50% (v/v) glycerol 
at −20°C and in 25% (v/v) glycerol at −70°C for long-term storage. 
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2.4.6 Detection of proteins by Western blotting, Coomassie 
Blue or Silver Staining 
 
Protein were separated according to size by running protein samples through 
5, 6, 7, 8 or 10% denaturing polyacrylamide gels (National Diagnostics) in 
electrophoretic reactions. For IP samples used for mass spectrometric 
analysis, pre-cast NovexTM WedgewellTM 4-12% Tris-Glycine polyacrylamide 
gels were used to separate proteins to minimize human contamination of the 
samples. To simply assess the presence or relative quantities of proteins, the 
proteins were stained either with Coomassie or silver. For Coomassie staining, 
gels were rinsed in deionized water before staining with InstantBlue Protein 
Stain (Expedeon) at 25°C for at least 1 h whilst, for silver staining, gels were 
fixed for 10 min in a solution of 40% (v/v) methanol and 13.5% (v/v) 
formaldehyde before rehydration in deionized water. The gels were then 
sensitized in a solution of 0.02% (w/v) sodium thiosulphate for 1 min before 
briefly rinsing in deionized water. Finally, the gels were then incubated in a 
solution of 0.1% (w/v) Ag(NO3) for 10 min, rinsed with deionized water before 
development in a solution of 3% (w/v) sodium carbonate, 0.05% formaldehyde 
and 0.0004% (w/v) sodium thiosulphate. Upon achieving satisfactory signal to 
noise ratios, the reaction was stopped by adding an excess of citric acid to the 
solution.  
 
In order to quickly identify or relatively quantify specific proteins within a 
sample, proteins were transferred to either a PVDF or a nitrocellulose 
membrane using a semi-dry method after separation on polyacrylamide gels. 
The membranes were blocked in 5% (w/v) skimmed-milk at 25°C for 1 h to 
reduce unspecific binding. Thereafter, the membranes were incubated either 
at 4°C overnight or at 25°C for 1 h in 5% (w/v) milk supplemented with the 
appropriate primary antibody (Table 2.6). The membranes were then washed 
thrice in TBST for 5 min. If the primary antibody was conjugated to the HRP 
(horseradish peroxidase) enzyme, the membranes were then treated with the 
Western blotting Reagents (ECL). Otherwise, the membranes were treated 
with 5% milk supplemented with a secondary antibody conjugated to the HRP 
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enzyme. The membranes were then washed thrice in TBST for 5 min and 
treated with the Western blotting Reagents (ECL). The chemiluminescent 
signal was detected by exposing chemiluminescent films (HyperfilmTM, ECL) 
to them. The secondary antibodies used were all commercially sourced. These 
are anti-sheep IgG-HRP (Sigma, A3415), anti-rabbit IgG-HRP (Rockland, 18-
8816-33) and anti-mouse IgG-HRP (Cell Signaling Technology, #7076). 
Unless otherwise stated, all primary antibodies recognize S. cerevisiae 
proteins specifically.  
 
Table 2.6. Primary antibodies used in this study. * The antibody used against 
MBP was used as a primary antibody. After probing with this antibody, 
membranes were washed and incubated with secondary anti-mouse antibody. 
 
Antibody Typical 
concentrations 
Host Provenance 
anti-Pol2 1:1,000 Sheep Kind gift from K. Labib. 
anti-Pol1 1:1,000 Sheep Kind gift from K. Labib. 
anti-Mcm6 1:20,000 Sheep Kind gift from K. Labib. 
anti-Mcm5 1:1,000 Sheep Kind gift from K. Labib. 
anti-Mcm4 1:1,000 Sheep Kind gift from K. Labib. 
anti-Mcm3 1:1,000 Sheep Kind gift from K. Labib. 
anti-Ctf4 1:20,000 Sheep Kind gift from K. Labib. 
anti-Pob3 1:1,000 Sheep Kind gift from K. Labib. 
anti-Cdc45 1:2,500 Sheep Kind gift from K. Labib. 
anti-Dpb2 1:1,000 Sheep Kind gift from K. Labib. 
anti-Csm3 1:1,000 Sheep Kind gift from K. Labib. 
anti-Sld5 1:500 Sheep Kind gift from K. Labib. 
anti-Psf1 1:500 Sheep Kind gift from K. Labib. 
anti-TAP-HRP 
(PAP) 
1:1,000,000- 
1:25,000 
Rabbit Sigma 
(P1291) 
anti-c-MYC 
(9E10) 
1:5,000- 1:500 Mouse Sigma 
(M4439) 
anti-FLAG  
(M2) 
1:5,000- 1:500 Mouse Sigma 
(F3165) 
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anti-HA 
(12CA5) 
1:5,000- 1:500 Mouse Sigma 
(11 583 816 001) 
anti-MBP-HRP* 
 
1:30,000 Mouse Commercially available from 
NEB (E8038). Kind gift from 
M.	Balasubramanian. 
  
 
2.4.7 FACS analysis by flow cytometry 
 
Yeast cells at a density of 0.7 x 107 cells/ml were fixed in 70% (w/v) ethanol. 
The suspension could be kept at 4°C for long-term storage. To process the 
samples, 200 μl of suspension was added to 1 ml of fresh 50 mM sodium 
citrate solution and vortexed vigorously. The cells were pelleted by 
centrifugation at 3000 g for 3 min, re-suspended in 1 ml of fresh sodium citrate 
and vortexed vigorously. This removes any alcohol and allows the cells to 
rehydrate. To remove any RNA molecules, the cells were then pelleted and 
re-suspended in fresh 50 mM sodium citrate supplemented with 0.1 mg/ml 
RNase A. The suspension was then allowed to incubated at 37°C overnight. 
The cells were again recovered by pelleting and re-suspended in 500 μl of 
pepsin in 50 mM HCl. The suspension was centrifuged and the pellet was re-
suspended in 1 ml of 50 mM sodium citrate supplemented with 2 μg/ml 
propidium iodide. Before processing using a FACScan (BD), the cells were tip-
sonicated to prevent clumping and vortexed to promote homogeneity within 
the suspension. Excitation of fluorophores is carried with a 488 nm laser light 
and the emission photons were detected using a 650 nm long pass filter. 
 
2.4.8 Primer Extension Assay 
 
Polymerase activity from purified protein samples was measured using a 
hairpin DNA/RNA hybrid oligonucleotide. The DNA/RNA hybrid oligo mimics 
the in vivo substrate of Polymerase α where RNA acts as the primer and DNA 
as the template. The oligonucleotide was labelled at the 5’ end with radioactive 
32P using T4 Polynucleotide kinase (PNK) and 32P- γ-ATP. Reaction mixtures 
(20 μl) contained 50 mM Hepes medium (adjusted to pH 7.0), 1.0 mM 
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magnesium acetate, 75 mM KCl, 50 mM sodium glutamate, 0.05% (v/v) 
IGEPAL CA-630, 1 mM DTT, 0.1 mg/ml BSA, 20 μM dNTPs and 10-40% (v/v) 
extract of interest to assess the latter’s polymerase activity. The reactions 
were allowed to run for 0.5- 256 min at either 25°C, 30°C or 37°C before 
termination with 20 μl of formamide loading buffer. The samples were heated 
to 92°C to denature the DNA and were run on 8 or 10% polyacrylamide 
sequencing gels (7 M urea). The radioactive fragments separated on the gel 
were detected using films. Exposure times varied from overnight to seven days 
at −70°C.  
 
2.4.9 Electrophoretic motility shift assay (EMSA) 
 
Standard electrophoretic mobility shift assay reactions were conducted with 
the 5’ radioactively-labelled primer used in Section 2.4.8. In brief, equal 
amounts of nucleic acid substrate were incubated with different quantities of 
different protein samples in a 20 μl reaction of 10 mM Tris-HCl (pH 7.5), 25 
mM NaCl, 2.5% (v/v) glycerol, 0.5 mM EDTA and 2 mM DTT. Non-specific 
competitor DNA (sonicated salmon sperm) was added to a final concentration 
of 0.1 mg/ml. The protein samples were allowed to bind to the substrate for 30 
min at 4°C. 3 μl of sucrose dye solution (0.25% (w/v) bromophenol blue, 0.25% 
(w/v) xylene cyanol FF and 40% (w/v) sucrose) was added to each 20 μl 
reaction. The reaction was then separated on 6% native polyacrylamide gel. 
The gel was pre-run at 100 V for 30 min and subsequently run at 100 V after 
sample loading in 0.5× TBE buffer (89 mMTris-acetate, 89 mM boric acid, 2 
mM EDTA) at 4°C until the dye end was close to the end of the gel. The gel 
was then dried and the radioactive fragments separated on the gel were 
detected using films. Exposure times varied from overnight to seven days at 
−70°C. 
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2.4.9 Determining Protein Concentrations using the 
Bicinchoninic acid Assay 
 
The bicinchoninic acid (BCA) protein assay is a two-component and highly 
precise colorimetric assay used to quantify proteins. Unlike the Bradford 
assay, it is compatible with most ionic and non-ionic detergents and other 
contaminants. The first step involves the reduction of copper ions (Cu2+) to 
cuprous ions (Cu+) in an alkaline environment by protein side-chains (cysteine, 
tyrosine and tryptophan). However, contrary to the Bradford reagent, the 
peptide backbone also contributes to the reduction of copper ions. This 
minimizes the variability across samples with different protein compositions, 
making the BCA assay superior to the Bradford assay. The contribution of the 
peptide backbone increases at higher temperatures (37°C and 60°C), 
increasing the sensitivity of the assay. The second step involves the chelation 
of cuprous ions by BCA (two BCA molecules chelate one cuprous ion), leading 
to colour formation. A strong purple product is formed and the assay exhibits 
a strong linear absorbance at 562 nm with increasing protein concentrations. 
The concentration of recombinant protein samples was measured using a 
commercially-sourced PierceTM BCA Protein Assay Kit (ThermoFischer), 
using serial dilutions of bovine serum albumin (BSA) as standards. 
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2.5 Mass Spectrometric Analysis 
 
2.5.1 Immuno-precipitation and Mass Spectrometric Methods 
 
To obtain sufficiently concentrated protein samples for mass spectrometric 
analysis, four independent harvest of 7 x 109 cells carrying the GAL1-TAP-
SEN1 (2-931) allele and grown in YPGAL were conducted for each phase of 
the cell cycle (G1, S and G2). For the control (no bait), four independent 
harvests of 2 x 1010 cycling cells, encoding the GAL1-TAP-Æ allele, were 
carried out. The cycles of the cell population at each different harvest were 
verified by FACS. The samples were lysed by using a motorized pestle and 
mortar cooled to −80°C using liquid nitrogen. The lysate was thawed to 4°C 
and clarified by centrifugation at 12,500 rpm in a high speed centrifuge and at 
32,500 rpm in an ultra-centrifuge. TAP-Sen1 (2-931) was immuno-precipitated 
using IgG bound to Dynabeads in a 100 mM Hepes, 50 mM potassium acetate 
solution. After three washes, TAP-Sen1 (2-931) and its co-precipitates were 
cleaved off the Dynabeads using AcTEV protease at 24°C for 2 h. After 
cleavage, the resulting CBP-Sen1 (2-931) and its co-precipitates were 
incubated with pre-washed calmodulin beads at 4°C for 2 h and, after washing, 
the proteins were removed from the calmodulin resin by boiling in 30 µl of 1 x 
Laemmli buffer. This simultaneously concentrates the proteins. The samples 
from the four biological replicates were then pooled together. Thereafter, the 
samples were run for a small distance on a commercially-sourced 4-12% 
acrylamide gel to reduce the potential for contamination especially from 
keratin. The gel was then cut in thin slices and processed using a robot (MS 
Bioworks, USA). The protein samples were successively washed, reduced, 
alkylated and digested by trypsin. The reaction was then analysed using a 
nanoLC/MS/MS (Waters NanoAcquity HPLC/ThermoFischer Q Exactive). Of 
the ions identified, the fifteen most abundant were selected for tandem MS. 
To process the data, the spectra obtained were compared to the spectra of in 
silico trypsinized Saccharomyces cerevisiae proteins (SGD database).  
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2.5.2 Analysis of Raw data 
 
The raw data obtained from the mass spectrometric screen is presented in 
Table S1 (Supplementary Data). The raw data (number of peptides) for 
selected proteins is presented in graphical form in Figures 4.10, 4.13 and 4.15. 
For Figure 4.11, the data were processed as indicated below. 
 
Firstly, it was assumed that the mass spectrometry apparatus was not 
saturated with ions. Then, for both the bait and every protein identified in the 
screen, the molecular weight (M), length of primary sequence of the protein 
(L) and the number of tryptic sites + 1 (T) was determined using the SGD 
database and the ExPASy PeptideCutter software 
(http://web.expasy.org/peptide_cutter/). For each protein, the following 
variable (X) was calculated: [X=M*(T/L)]. The number of specific peptides (N) 
was calculated by subtracting the number of non-specific peptides in the 
control sample from the total number of peptides in each of the test samples. 
The number of specific peptides (N) was then divided by the X variable. The 
resulting variable (Y) gives an output value normalized for both the molecular 
weight of the protein and the number of tryptic sites dispersed along its length. 
Finally, the value of the Y variable was normalized to that of Sen1 (2-931) 
(Y/YSen1 (2-931)) in that specific test sample. For instance, the Y value of Pol1G1 
was divided by the Y value of Sen1 (2-931)G1.    
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2.6 Image Acquisition and Processing 
 
2.6.1 Image acquisition of films 
 
Films were exposed to chemiluminescent or radioactive signals for the 
appropriate length of time. The films were then developed and scanned using 
with an Epson V700 Scanner. The image was acquired in 8-bit grayscale at a 
resolution of 300 dpi (dots/pixels per inch). 
 
2.6.2 Image acquisition of colonies growing on plates 
 
Cells were grown on the appropriate medium for the required number of days. 
When required, plates were placed upright on an Epson V700 Scanner to be 
scanned. The image was acquired in 8-bit grayscale at a resolution of 600 dpi 
(dots/pixels per inch). 
 
2.6.3 Image Processing 
 
Acquired images were opened with Adobe Photoshop CS6 image software. 
The images were adjusted for brightness and contrast, then rotated and 
cropped as required. The images were processed to remove dust and 
scratches and despeckled to 1 pixel. Finally, the images were formatted to 
widths of 3 or 6 cm (without altering the width to length ratio) and the resolution 
was set to 508 dpi. 
 
2.6.4 Image Generation 
 
Data were analysed with Microsoft Excel and R Studio (ver 1.0.153). Graphical 
figures were created using R Studio. Images were created in Adobe Illustrator 
CS6. 
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Chapter 3: Investigating the Role of 
Polymerase a in the Imprinting Process at the 
MPS1 locus in the model organism 
Schizosaccharomyces pombe.  
 
3.1 Background 
 
The imprinting process in Schizosaccharomyces pombe is essential for cell-
type switching and is dependent on a number of cis-regulatory elements and 
trans-acting (protein) factors. Several of these trans-acting factors were 
isolated by screening for mutants with reduced frequencies for cell-type 
switching (Gutz and Schmidt, 1985). Others were identified at later dates, 
using a multitude of genetic screens (Codlin and Dalgaard, 2003, Holmes et 
al., 2012, Zech et al., 2015).  
 
Among the genes required for the imprinting process, components of the fork 
protection complex (swi1TOF1, swi3CSM3 and mrc1) are required for both fork 
stalling at the MPS1 locus and for fork arrest at the RTS1 locus. In addition, 
swi7 is necessary for imprinting at MPS1 in an ill-characterized but pausing-
independent manner (Dalgaard and Klar, 2000, Dalgaard and Klar, 2001, 
Singh and Klar, 1993, Zech et al., 2015). Importantly, to date, only one 
switching-defective mutant of the swi7 gene (swi7-1) has been isolated, 
suggesting that this defect is specific to this one mutant and not to some 
general disruption of the gene. Work in the Klar lab have since shown that 
swi7-1 is allelic to the pol1 gene and carries a missense mutation (G3347A) 
(Singh and Klar, 1993). The resulting protein (Pol1G1116E) is thought to have 
reduced affinity for its DNA substrate by virtue of the increased negative 
charge at the mutated residue (Perera et al., 2013). How this translates to 
reduced frequency of cell-type switching is uncertain and represents a gap in 
scholarship. 
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Here, I have used in vitro assays to characterize the defects of swi7-1. The 
Swi7-1 protein was found to have reduced affinity for a DNA/RNA hairpin 
substrate that mimics the natural substrate of Pol1. This reduced affinity also 
severely affected the polymerase activity of the protein. These observations 
provide some clues about the role of Polymerase α at the MPS1 locus during 
the imprinting process. I have also identified an allele of spp1PRI1 that is 
characterized by reduced cell-type switching. Spp1 is the catalytic primase 
subunit of Polymerase α, suggesting that the catalytic activity of the primase 
subunit of Polymerase α may be required for the imprinting process at the 
MPS1 locus. The nature of the imprint at MPS1 itself is still disputed. It is either 
a nick (Kaykov and Arcangioli, 2004) or two ribonucleotides (Vengrova and 
Dalgaard, 2004, Vengrova and Dalgaard, 2006). Involvement of primase in the 
imprinting process could be interpreted as evidence of the RNA-nature of the 
imprint. 
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3.2 swi7-1 is uniquely switching-defective amongst 
pol1 mutants  
 
To date, only the swi7-1 allele of pol1 has been shown to be defective for cell-
type switching, suggesting a very specific defect. To test the specificity of this 
phenotype, I have crossed strains carrying different mutants of pol1 with the 
h90+ :: LEU2 marker (referred henceforth to as h90LEU2), including swi7-1, pol1-
1 (D’Urso et al., 1995), pol1-ts13 (Bhaumik and Wang, 1998) and pol1-H4 
(Murakami and Okayama, 1995) (Table 3.1). Here, the 1.1 kb S. cerevisiae 
LEU2 marker replaces a stretch of 1.5 kb DNA distal (with cen2 as a reference 
point) to the mat1 locus so that the distance between the mat1 and mat2P loci 
is not substantially altered and that the imprinting at MPS1 is unaffected (Fig 
3.1). This not only ensures that autotrophy for leucine is a marker for 
homothallism (the ability to switch cell-types) but also that recombination 
between the receptor mat1 locus and either of its donor loci (mat2P and 
mat3M) is not compromised (Zech et al., 2015) 
 
 
 
Figure 3.1. The h90LEU2 marker allows simple selection of homothallism 
by genetically linking it to leucine autotrophy. This marker has been 
described in Zech et al. (2015). 
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Table 3.1. Summary of pol1 alleles tested for defects in cell-type switching. 
Allele Residues 
Mutated 
Brief Overview Phenotype Reference 
 
pol1-1 
 
Not 
characterized. 
Temperature-sensitive allele with an 
elongated cell (cdc) phenotype at 
non-permissive temperatures and 
following HU treatment. A small 
proportion of the cell population 
undergoes abnormal mitosis at non-
permissive temperatures. The allele 
confers a mutator phenotype. 
Disrupted catalytic activity. 
Temperature-sensitive. 
Sensitive to hydroxyurea. 
Mutator phenotype. 
 
 
(D’Urso et al., 1995) 
 
pol1-ts13 
 
470-472Δ 
Temperature-sensitive allele that 
leads to arrest in early to mid S 
phase at non-permissive 
temperatures. The allele also confers 
a mutator phenotype. 
Disrupted catalytic activity. 
Temperature-sensitive. 
Cut phenotype. 
 
Decreased silencing of mating 
donor loci. 
Mostly insensitive to 
hydroxyurea. 
 
Mutator phenotype 
 
 
(Bhaumik and Wang, 
1998) 
(Ahmed et al., 2001) 
	 179	
 
pol1-H4 
 
G889D 
Temperature-sensitive allele with an 
elongated cell (cdc) phenotype. Cells 
cannot undergo DNA replication at 
non-permissive temperatures. Has a 
similar phenotype to mcl1-101/cos1 
mutants with reduced propagation of 
centromeric DNA. This allele confers 
a mutator phenotype. 
Disrupted catalytic activity 
Temperature-sensitive 
Cut phenotype. 
 
Decreased silencing of mating 
donor loci. 
Increased duration of mitotic S 
phase. 
 
 Mutator phenotype 
 
 
(Murakami and 
Okayama, 1995) 
(Ahmed et al., 2001) 
 
swi7-1 
 
G1116E 
Viable mutant. Leads to impaired 
response to alkylation damage (such 
as MMS) in S phase. Confers a 
mutator phenotype. 
Cut phenotype. 
 
Decreased silencing of mating 
donor loci. 
Hypersensitive to hydroxyurea 
and MMS. 
Mutator	phenotype.	
 
(Singh and Klar, 1993) 
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The cell-type switching efficiency of each mutant was tested by growth on 
sporulation medium at 25°C (permissive temperature), followed by staining 
with iodine vapour. In homothallic (self-fertile or switching) strains, individual 
cells of complementary cell-types will mate, producing a transient diploid that 
quickly undergoes sporulation. The walls of these spores contain α-glucans 
and β-glucans starch molecules (Manners and Meyer, 1977) that can be 
stained with iodine vapours (Forsburg and Rhind, 2006). On the other hand, 
heterothallic (non-self-fertile or non-switching) strains exist as a homogeneous 
population cell-type-wise and these cells cannot mate with one another. 
Exposure to iodine vapour leads to light staining, producing uniformly 
yellow/white colonies. Switching-defective strains adopt an intermediate 
phenotype where cells switch cell-type inefficiently, allowing for localized 
mating and sporulation. Upon iodine staining, this leads to a characteristic 
speckled (or mottled) phenotype. 
 
As shown previously (Zech et al., 2015), h90LEU2 cells have a phenotype similar 
to wildtype h90 cells. Cells carrying the swi7-1 allele stained with the 
characteristic speckled (or mottled) phenotype and cells carrying both h90LEU2 
and swi7-1 also presented the same phenotype. Thus, the h90LEU2 construct 
does not interfere with the cell-type switching process. When present in cells 
carrying this h90LEU2 marker, the other mutant alleles of pol1 led to dark staining 
after exposure to iodine vapour, indicating efficient cell-type switching (Fig 
3.2). This suggests that swi7-1 is uniquely switching-defective amongst pol1 
mutants.  
 
However, cells carrying the pol1-1 allele were characterized by some minor 
defects in cell-type switching. The extent of this defect was much lower 
compared to that of the swi7-1 allele. The pol1-1 mutant was initially isolated 
in a screen for temperature-sensitive mutations of pol1 with checkpoint defects 
(D’Urso et al., 1995). However, at non-permissive temperatures, only a 
subpopulation of cells underwent aberrant mitoses and because of this low 
penetrance, the allele was deemed unsuitable. This low penetrance could also 
underpin the iodine staining pattern in h90LEU2 pol1-1 cells where limited defects 
in Pol1-1 stochastically result in some cells switching inefficiently whilst, in 
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most cells, this defect is muted. This contrasts to swi7-1 colonies where 
colonies stain with a homogeneous speckled phenotype. This suggests that 
the switching-defective phenotype of swi7-1 arise from a specific defect and 
not some generalized loss of function of Pol1. 
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Figure 3 2. Iodine staining reveals that the swi7-1 allele is uniquely switching-defective. However, the pol1-1 allele has some 
mild switching-defects as well.
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However, as the staining pattern of the pol1-1 colonies could reflect unstable 
proteins, the switching- and imprinting-defects in swi7-1 cells could be a result 
of differences in protein levels or in protein stability with wildtype cells. Given 
that the relative levels of Pol1 and Swi7-1 have not been assayed previously 
(Singh and Klar, 1993), we constructed strains carrying the 9His-5FLAG-pol1 
and 9His-5FLAG-swi7-1 alleles using a recombinase mediated cassette 
technique (Watson et al., 2008). These strains were grown in non-selective 
medium and were then treated with cycloheximide to inhibit translation of new 
protein molecules. Prior to cycloheximide treatment, there was no difference 
in the levels of Pol1 and Swi7-1 (Fig 3.3). The levels of the two proteins were 
also indistinguishable up to 4 h after addition of cycloheximide to the medium. 
This suggests that Swi7-1 is expressed at similar levels to Pol1 and that the 
Swi7-1 protein is no more unstable than its wildtype counterpart. 
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Figure 3.3. Strains carrying either the wildtype pol1 or the swi7-1 allele express similar levels of the protein and the mutant 
variant is no more unstable than Pol1. Strains of Sz. pombe were grown to a density of 0.7 x 107 cells/ml in YEA medium and 
treated with cycloheximide to a final concentration of 100 µg/ml up to 4 h. Samples were collected every hour for TCA analysis and 
run on a 6% acrylamide gel. Strains used: FMA85 and FMA86. 
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3.3 Characterizing the Differences between Pol1 and 
Swi7-1 in vitro 
 
Having established that the decreased cell-type switching in strains carrying 
the swi7-1 allele was not reflective of decreased protein stability, we then 
undertook a reductive approach to characterize the differences between pol1 
and swi7-1. We first expressed truncated versions (G976-C3684, that 
encodes for residues 326 to 1228) of pol1 and swi7-1 tagged at the N-terminus 
with a hexa-histidine tag in the bacterial strain BL21 (DE3). Truncated proteins 
were used as the full-length enzymes are susceptible to degradation in the 
absence of their co-enzymes (Spb70, Spp1 and Spp2) (Perera et al., 2013). 
However, insufficiently high yields of proteins were obtained using this 
approach, perhaps as a result of mis-folding (not shown). We optimized 
expression of the proteins by codon-optimizing the genes for expression in 
bacteria and by using the E. coli maltose binding protein tag fused to the N-
terminus of the constructs and a hexa-histidine tag at their C-termini. The MBP 
is known to enhance the solubility of its fusion partners either spontaneously 
or by acting as a magnet for chaperones (Raran-Kurussi and Waugh, 2012). 
 
The resulting yields of the recombination proteins were markedly higher. 
These were purified from cleared bacterial lysate by successive passage 
through amylose, heparin and Ni-NTA columns. Samples from each 
purification steps were saved for analysis using Coomassie stain and Western 
blotting (Fig 3.4).  
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Figure 3.4. Similar amounts of recombinant Pol1 and Swi7-1 proteins were purified for use in in vitro assays. Cleared bacterial 
lysate from BL21 (DE3) E. coli strains carrying either an empty vector (pRA4), a vector with the codon-optimized pol1 gene (pRA5) 
or the codon-optimized swi7-1 allele (pRA6) were purified by passage through three successive columns (amylose, heparin and Ni-
NTA). Here, the samples for the last column purification (Ni-NTA) is shown. (A) Coomassie stain of the recombinant proteins. The 
arrows indicate the presence of either MBP-HIS6, MBP-Pol1-HIS6 or MBP-Swi7-1-HIS6. Comparable amounts of recombinant Pol1 
and Swi7-1 were recovered. (B) Western blot against MBP for the first three elutions obtained from the Ni-NTA column purification. 
The signals shown are from identical exposure times.  
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We then used the samples recovered after Ni-NTA purification to extend a 
DNA/RNA hairpin that mimics the natural substrate of Pol1 at 37°C (for 
increased enzymatic activity) for 1 h. The samples purified from bacteria 
carrying the empty control were unable to extend the substrate, nor were they 
able to degrade the nucleic species suggesting that the purification strategy 
used was stringent enough to remove any contaminating polymerases, 
helicases and nucleases of bacterial origin. Samples purified from bacteria 
carrying the truncated pol1 gene were able to fully extend the hairpin DNA, 
beyond the extent achieved by the Klenow Polymerase (NEB). By contrast, no 
detectable polymerization of the DNA/RNA hairpin was observed when 
substituting the Swi7-1 protein for its wildtype counterpart (Fig 3.5). In order to 
better characterize the difference in activity of the mutant compared to the 
wildtype, different concentrations of the two proteins were used to extend the 
same DNA/RNA substrate at 37°C. Only at the highest concentration was 
discernible polymerizing activity observed with the Swi7-1 protein. 
Comparison between the enzymatic activities of the Pol1 and Swi7-1 proteins 
also suggests that Swi7-1 has around 2.5-5% polymerase activity compared 
to the wildtype enzyme (Fig 3.6).  
 
We then used the primer extension assay at the highest concentration 
assayed for each enzyme to carry time-course experiments at 37°C. Although 
the swi7-1 allele does not confer temperature-sensitivity, the time-course 
experiment was also carried at more physiological temperatures (24°C and 
30°C) to ensure that the stability of the recombinant proteins were not 
compromised. These assays revealed that the Swi7-1 protein is much less 
functional than its wildtype counterpart at all three temperatures tested (Fig 
3.7). The mutated residue does not correspond to the active site of the protein 
and a catalytic dead variant of the protein (Pol1D894N) renders cells inviable 
(Bhaumik and Wang, 1998). It is unlikely then that the decreased functionality 
associated with Swi7-1 is based on a reduction in catalytic activity. Instead, 
based on crystallographic data, the phenotype observed in Swi7-1 can be 
attributed to a predicted decreased affinity of the protein for its substrate 
(Perera et al., 2013). To test this hypothesis, the relative affinities of the 
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recombinant Pol1 and Swi7-1 for their substrates were compared, using the 
same DNA/RNA substrate used previously (in the primer extension assays) in 
an electrophoretic mobility shift assay (EMSA). In brief, the recombinant Pol1 
and Swi7-1 proteins were allowed to interact with the primer substrate at 4°C 
and the sample reactions were immediately run on native gels at 4°C. The 
substrate on its own, or in the presence of a non-interacting protein, will run a 
certain distance, based on its size. However, binding to the substrate causes 
an upward shift as the resulting protein-DNA complex is heavier and migrates 
at a slower rate through the native gels.  
 
Using the Klenow fragment, we first tested whether the primer substrate was 
suitable for use in a mobility shift assays. We found that, contrary to BSA, the 
Klenow fragment was able to bind to the substrate, causing a mobility shift (Fig 
3.8A). In fact, under the conditions used, 1.9 pmol of Klenow (in a 20 μl 
reaction mix) was sufficient to cause an upward shift. The recombinant Pol1 
construct also caused a shift, observable from 4.7 pmol of protein used. Unlike 
results from the Klenow fragment, two distinctive shifted bands were 
observable (Fig 3.8B). These bands may correspond to sequential loading of 
Pol1 molecules on the substrate, mutually exclusive occupancy state of the 
substrate (for example a substrate could either accommodate two protein 
molecules of Pol1 at either extreme of its DNA/RNA stretch, but only one 
molecule of Pol1 should the latter bind centrally to a permissible DNA/RNA 
region) or formation of protein-protein complexes. This contrasts to the Klenow 
fragment. Whilst titrating the Klenow down leads to a gradual loss of nucleic 
acid-protein complexes (reflecting an excess of substrate), no intermediate 
shifts were observable. The difference between the two proteins reflect the 
difference in substrate preference of the two proteins. Indeed, whilst the 
Klenow fragment binds to single-stranded DNA immediately past a primer 
(Turner et al., 2003), Pol1 binds almost exclusively to DNA/RNA hybrid 
substrates (Perera et al., 2013). Interestingly, we did not detect a shift 
indicating nucleic acid-protein interaction when substituting Swi7-1 for Pol1. 
This indicates that the mutant protein has reduced affinity for its substrate in 
vitro (Fig 3.8B, C).   
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The mutated residue in Swi7-1 aligns to the Ser1134 residue in budding 
yeast’s Pol1 (Perera et al., 2013). Crystallographic data places this residue in 
the thumb domain of Pol1 and this domain is important for interaction with the 
RNA component of its DNA/RNA substrate.   In line with the crystallographic 
data, the in vitro results presented here suggests that the G1116E mutation in 
Swi7-1 leads to decreased affinity for its substrate. Given the striking 
differences in activity between Pol1 and the mutant Swi7-1, it is remarkable 
that swi7-1 cells are viable and show few signs of sickness unless when 
challenged by DNA damaging agent. This contradiction may suggest that, in 
vivo, the limitations of the Swi7-1 protein are compensated by the other 
subunits of Pol α and perhaps other components of the replisome.    
 
Like Pol1, the Klenow fragment adopts a right-handed conformation where the 
analogous thumb domain is required for interaction with its substrates. 
Removal of 24 residues from the tip of the Klenow fragment’s thumb domain 
triggers a 100-fold decrease in its affinity for its templates, as well as a 70-fold 
increase in the number of +1 frameshifts (Minnick et al., 1996). It is noteworthy 
then, that the swi7-1 allele confers a mutator phenotype in Sz. pombe 
(Koulintchenko et al., 2012). It should also be noted that the Pol1-1, Pol1-H4 
and Pol1-ts13 proteins have never been tested for either their ability to extend 
a DNA/RNA hybrid in vitro or for their ability to bind to such a substrate in vitro. 
Thus, there is a paucity of data to which to compare the results generated 
using the Pol1 and Swi7 proteins. However, given that the mutation in Pol1-
ts13 is located in a different domain to that of the mutation found in Swi7-1 
(Fig S.1), it is unlikely that Pol1-ts13 has any defects in binding to DNA/RNA 
hybrids or to extend them. By contrast, the Pol1-H4 has a mutation in the 
polymerase domain of Pol1, similar to Swi7-1 (Fig S.1). However, the mutated 
residue in Pol1-H4 (G889E) aligns to Gly904 in the S. cerevisiae homolog. 
This residue is not involved in binding of the protein to its substrates (Perera 
et al., 2013), suggesting that Pol1-H4 will behave differently from Swi7-1 
although this would need to be investigated empirically. Finally, the mutation 
in Pol1-1 has yet to be characterized. Should the mutation occur within the 
polymerase domain, it is possible that Pol1-1 may have some defects in 
substrate binding and in polymerase activity.   
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Figure 3.5. Primer extension assay used to measure the polymerase activity of the purified recombinant proteins. The first 
three elution samples from the third purification column (Ni-NTA) for Pol1 (pRA5) and Swi7-1 (pRA6) were used to extend a hairpin 
substrate that has an RNA strand annealed to DNA, mimicking the natural substrate of Pol1. The reaction was carried out at 37°C 
for 1 h. The Klenow fragment (NEB) and water were used as positive and negative controls respectively. Purified samples from E. 
coli carrying an empty vector (that contains MBP-His6) (pRA4) were also used as controls. Protein samples from E. coli carrying the 
pRA4 plasmid did not display any polymerase, nuclease or helicase activities, suggesting that our purification strategy was sufficiently 
stringent. The recombinant Pol1 was able to extend the hairpin, more competently than the Klenow fragment. However, the 
recombinant Swi7-1 protein was unable to extend the primer template within the duration of the reaction. RNAseOUT was used to 
inactivate ribonuclease activity whilst an excess of RNAse A was used to determine what effect contaminating ribonucleases would 
have on the reaction mixture. 
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Figure 3.6. Under the experimental conditions used, the recombinant Swi7-1 protein has around 2.5-5% activity of its 
wildtype counterpart. This experiment is similar to the one presented in Figure 3.5 but with modifications. The reaction was still 
carried out at 37°C for 1 h but the protein samples purified from the strain carrying the empty vector (pRA4) were not used. Moreover, 
the levels of the recombinant Pol1 and Swi7-1 proteins were titrated up. The concentrations of the protein samples were determined 
using the BCA protein assay (Pierce) and the amounts of the proteins used for each reaction was calculated from this concentration. 
The relative quantities of the proteins used was also assayed via Western blotting. For Swi7-1, polymerase activity was detected only 
in the reaction mixture containing the highest amount of the protein (7.3 pmol). Given that 7.3 pmol of Swi7-1 could only extend the 
primer to the same extent as 0.18-0.35 pmol of Pol1 (under identical conditions), Swi7-1 is judged to have between 2.5-5% activity. 
The percentage activity was calculated by dividing the appropriate concentration of Pol1 (0.18 or 0.35 pmol) with the highest 
concentration of Swi7-1 used (7.3 pmol) (because they have comparable activities) multiplied by 100%. 
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Figure 3.7. The primer extension assay was used to carry out time-
course experiments at the physiological temperatures of fission yeast. 
5.6 pmol of recombinant Pol1 and 7.3 pmol of Swi7-1 were used to extend the 
primer substrate at 24°C, 30°C and 37°C, temperatures that are routinely used 
to grow Sz. pombe strains. For each condition, parallel reactions were initiated 
at a single time and stopped at different time points. 
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Figure 3.8. Gel shift assays reveal that Swi7-1 has a much reduced affinity for its template. This provides a rationale for the 
difference in polymerase activity in our primer extension assays. (A) The Klenow fragment was used as a positive control to determine 
whether the primer substrate used previously would be adequate as a substrate for gel shifts assays. At quantities as low as 1.9 
pmol, the Klenow fragment was able to produce a shift, indicating nucleic acid-protein interaction. 45 pmol of BSA was not able to 
produce any shift. (B) At 4.7 pmol of Pol1, gel shifts were detectable whilst for Swi7-1, no shifts were detected even when using 8.8 
pmol of the protein. (C) Summary of the difference between binding of the Klenow fragment and the recombinant Pol1 and Swi7-1 
proteins to the substrate. 
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3.4 Generating new swi7 mutants to test the 
relationship between the DNA binding affinity of 
Pol1 and its switching defects. 
 
Results thus far suggest that the Swi7-1 protein has a reduced affinity for its 
substrates. We wanted to confirm whether this was also the case in vivo. We 
decided to adopt an indirect approach where we targeted the incriminating 
residue in the switching- and imprinting-defective swi7-1 for mutagenesis. In 
particular, we wanted to generate mutants of pol1 that were switching-
defective, but to a lesser extent that swi7-1. For that purpose, we chose to 
mutate the Gly1116 residue in the wildtype allele to an aspartic residue. 
Aspartate and glutamate are comparable residues and both lose protons at 
neutral pH. However, aspartic acid also has a lesser potential for steric 
hindrance compared to glutamic acid. As such, Pol1G1116D would be 
predicted to have an affinity for its substrate that is intermediate between those 
of Pol1 and Swi7-1 (Pol1G1116E). As controls, we also aimed to mutate the 
Gly1116 residue to either serine (Ser1134 in Pol1 from S. cerevisiae aligns 
with Gly1116 in Pol1 from Sz. pombe) or glutamine (a residue that offers 
similar steric hindrance compared to glutamic acid, but is polar and not 
negatively charged). Both Ser1116 and Gln1116 could serve to strengthen the 
interaction between Pol1 and its substrate (Perera et al., 2013). 
 
When generating mutant alleles, it is customary to delete the endogenous 
gene and use a vector expressing the mutant alleles to complement it. 
However, given that small differences in the levels of Pol1 could affect the 
read-out (iodine staining) of the mutants, an alternative approach was 
adopted. We chose to use a cassette-exchange method (Watson et al., 2008), 
coupled to a commercial site-directed mutagenesis kit (QuikChange, Agilent) 
to generate mutant alleles of pol1 at the genomic loci.  
 
The novel alleles carry loxP and loxM3 scars. To ensure that these scars do 
not affect gene expression, loxP-pol1-loxM3 and loxP-swi7-1-loxM3 alleles 
that differ from pol1 and swi7-1 respectively only with respect to those scars 
	 199	
were also created. The novel alleles were tested for their efficiency to switch 
cell-types by iodine staining. Strains encoding the loxP-pol1-loxM3 allele had 
an indistinguishable phenotype from strains carrying the wildtype pol1 gene. 
Likewise, no phenotypic differences could be seen between cells carrying the 
swi7-1 and the and loxP-swi7-1-loxM3 alleles. This suggests that the loxP and 
loxM3 scars have no physiological consequences. The novel loxP-
pol1G1116S-loxM3 and loxP-pol1G1116Q-loxM3 alleles did not behave 
dissimilarly to wildtype upon staining, indicating that cells carrying these alleles 
form the Pol1-dependent imprint at wildtype levels and, thus, switch cell-type 
efficiently. On the other hand, the loxP-pol1G1116D-loxM3 allele (henceforth 
referred to as swi7-2) had an intermediate phenotype between those of the 
wildtype and the swi7-1 allele upon iodine staining (Fig 3.9), fitting the 
hypothesis that Pol1’s interaction with its nucleic acid substrate is critical for 
stable imprinting at MPS1.  
 
It has been reported that the swi7-1 allele confers increased sensitivity to both 
HU and MMS, perhaps highlighting a role for Pol1 in alkylation damage repair 
(Koulintchenko et al., 2012). The hypersensitivity of cells carrying the swi7-1 
allele to both HU and MMS could be attributed to decreased affinity of the 
mutant Pol1 for its DNA/RNA substrates. We wanted to see whether cells 
carrying the swi7-2 allele were also sensitive to both HU and MMS. We found 
that sen1-2 did confer increased sensitivity to both HU and MMS but, 
importantly, cells carrying the swi7-2 allele were less sensitive to both HU and 
MMS than cells with the swi7-1 allele (Fig 3.10). Should the Pol1-dependent 
sensitivity to HU and MMS for this class of mutants inversely correlate with 
the affinity of the enzyme for its substrates, these results fits with the 
hypothesis that Swi7-2 has an intermediate affinity for its DNA/RNA substrate 
between those of Pol1 and Swi7-1. However, the binding affinity of Swi7-2 
compared to that of Pol1 and Swi7-1 needs to be tested empirically (e.g by 
using EMSA assays). It also supports the notion that Pol1’s affinity for its 
substrates is important for the imprinting process at MPS1. 
	 200	
 
	 201	
Figure 3.9. Iodine staining demonstrates that the novel swi7-2 (pol1G1116D) mutant allele is switching-defective but to a 
lower extant than swi7-1 (pol1G1116E). Iodine was used to first assess whether the loxP and loxM3 scars occurring on either side 
of the pol1 gene impact switching efficiency. This was found not to be the case. Iodine staining was then used to determine whether 
the novel alleles of pol1 alleles were defective for switching. The loxP-pol1G1116S-loxM3 and loxP-pol1G1116Q-loxM3 alleles 
behaved similarly to wildtype upon staining. The third mutant allele, pol1G1116D was found to be switching-defective, but to a lower 
extent that swi7-1. Consequently, this allele was then renamed swi7-2. 
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Figure 3.10. The swi7-2 allele has an intermediate phenotype between those of pol1 and swi7-1 in relation to sensitivity to 
HU and MMS. Fission yeast strains were grown from frozen for 2 days at 33°C. The cells were then diluted in water to obtain cell 
suspensions of 5 x106, 5 x 105, 5 x 104 and 5 x 103 cells/ml. 10 μl of each suspension was pipetted onto either non-selective medium 
(with or without exposure to UV) or non-selective medium supplemented with either HU or MMS. Cells were grown up to 4 days and 
imaged daily. Strains used (top to bottom): JZ1, FMA72, FMA73, FMA75, FMA76, FMA78, FMA40, FMA93 and FMA95. 
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3.5 A mutant of spp1PRI1, apparently defective for 
catalysis, and deletion mutants of mcl1CTF4 lead 
to defects in Cell-type Switching 
 
Given the interaction between Pol1 and its substrate seem to be a requisite 
for stable imprinting at MPS1, we wondered whether the binding partner of 
Pol1, Mcl1Ctf4, was also required for the stability of the imprint at MPS1. Mcl1 
is known to tether Pol1 to the rest of the replisome. We first tested whether 
mcl1 was required for cell-type switching. We acquired mcl1∆ mutants from 
two sources: (i) from the Bioneer deletion library and (ii) from Prof Takashi 
Toda (Mamnun et al., 2006) and crossed them with the h90LEU2 homothallic 
marker. Both mcl1∆ alleles were marked with the kanamycin reporter cassette 
and the homothallic marker was marked with the LEU2 reporter gene from S. 
cerevisiae. After crossing, random spores were allowed to germinate and 
haploids with both the kanamycin and LEU2 marker were selected for. Two 
independent clones from each cross that carried both the mcl1∆ and h90LEU2 
alleles were grown on sporulation medium for two days at 30°C. After 
sporulation, the plates were stained with iodine vapour and imaged. Colonies 
carrying the h90LEU2 and mcl1∆Toda alleles (FMA146) stained darkly, without the 
speckled/mottled phenotype characteristic of switching-defective mutants. 
However, some colonies stained lightly (as seen with some pol1-1 colonies), 
suggesting a stochastic loss of switching. Meanwhile, some colonies of cells 
carrying the h90LEU2 and mcl1∆Bioneer alleles (FMA155) also stained lightly. 
However, the remaining colonies stained less darkly than wildtype. As such, 
this strain is characterized by a majority of cells switching cell-type inefficiently 
with some cells unable to switch at all. 
 
The difference between the mcl1∆Toda and mcl1∆Bioneer alleles could reflect the 
different strategies used to generate the different mutants. We tested cells 
carrying either of the mcl1∆ alleles by PCR and confirmed that the mcl1 gene 
was either completely deleted or deleted by disruption. We note however that 
mcl1∆ has been shown to be both viable (Mamnun et al., 2006) or recessive 
lethal (Williams and McIntosh, 2002). These data can be reconciled by the 
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presence of unaccounted for synthetic defects or suppression. Perhaps, the 
difference between the phenotypes observed for mcl1∆Toda and mcl1∆Bioneer 
can also be accounted for by some unknown genetic interaction. Common to 
these two alleles, however, are colonies that do not stain with iodine vapour 
at all. This phenotype is dissimilar to those of cells that are defective in 
imprinting such as swi7-1. 
 
The imprint at MPS1 has been shown to be made up of two ribonucleotides 
(Vengrova and Dalgaard, 2004, Vengrova and Dalgaard, 2006) (Fig 3.12). It 
seems likely then that the primase subunit of Polymerase α (Spp1Pri1) has a 
role in imprinting at the MPS1 locus. Importantly, spp1∆ is lethal and no cell-
type switching- or imprinting-defective mutants of spp1 have yet been 
identified. In the present study, we have noticed that a tagged allele of swi7 
(swi7-1-TAP) but not pol1-TAP confers cold-sensitivity (not shown). It is known 
that a conserved motif at the extreme C-terminus of Pol1 is required for 
interaction with the primase subunits of Polymerase α (Kilkenny et al., 2012). 
The swi7-1-TAP allele then may be defective for interaction with primase. 
Interestingly, we also noticed that a tagged allele of spp1 (spp1-GFP) (Yang 
et al., 2005) confers a similar cold-sensitivity presumably through having 
impaired enzymatic ability. We wondered whether these two alleles also 
shared switching-defects. To do so, the spp1-GFP was crossed in cells 
carrying the h90LEU2 marker and we assessed the ability of the resulting cells 
to switch cell-type and hence to stain with iodine vapour. Colonies carrying the 
spp1-GFP allele stained lightly, similar to heterothallic strains (Fig 3.11). This 
could indicate that the primase subunit of Polymerase α is required for the 
imprinting at MPS1 and that the GFP tag interferes with this process. To 
ensure that the phenotype seen was specific to the spp1-GFP allele and not 
some general result of tagging replisome components with some bulky 
fluorescent protein, we also tested the ability of cells carrying both the psf2-
YFP (Yang et al., 2005) and h90LEU2 alleles to switch cell-types. Unlike spp1-
GFP colonies, psf2-YFP colonies stained darkly suggesting that the spp1-GFP 
allele has specific defects in cell-type switching.  It is interesting to note that 
spp1-YFP behaves like a heterothallic strain and not like switching-defective 
	 205	
mutants such as swi1∆ or swi7-1. This suggests a stronger imprinting-defect 
in cells carrying the spp1-GFP allele. 
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Figure 3.11. Iodine staining demonstrates that both the mcl1∆ and spp1-GFP alleles present some defects in cell-type 
switching. Iodine staining was used to assess defects in cell-type switching in strains carrying either the mcl1∆ or spp1-GFP allele. 
A wildtype strain and a strain carrying the psf2-YFP allele were used as controls. 
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Figure 3. 12. The imprint is made up of two ribonucleotides. It is likely that 
the switching-deficient phenotypes associated with mcl1∆, swi7-2 and spp1-
GFP are linked to inefficient imprinting.  
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Chapter 4: Unravelling the Role of Sen1 as a 
Modulator at the Interface of DNA 
Replication and Transcription 
 
4.1 Background 
 
The DNA double helix is the common substrate of both DNA replication and 
transcription. Temporal overlap of the two processes is possible as, unlike 
DNA replication that is confined to the S phase, transcription occurs 
throughout the cell cycle. This can lead to collisions between the transcription 
and replication machineries (Aguilera and García-Muse, 2012). Head-on 
collisions between those two processes are more problematic than rear-end 
(or co-directional) collisions (Hamperl et al., 2017, Prado and Aguilera, 2005). 
In addition, transcription produces an intermediate that antagonizes the 
replication process. This intermediate, known as the R-loop, is a three-
stranded nucleic species composed of the nascent mRNA bound to the 
template strand with the non-template strand displaced. R-loops are 
thermodynamically more stable than the equivalent dsDNA by virtue of the 
hybrid interaction between RNA and DNA molecules (Lesnik and Freier, 1995, 
Roberts and Crothers, 1992) and need to be removed through the activity of 
specific enzymes such as the RNase H endonucleases.   
 
Unresolved collisions between the DNA replication and transcription 
machineries have been shown to trigger genetic instability in a wide array of 
organism, from S. cerevisiae (Wellinger et al., 2006) to B-lymphocytes (Barlow 
et al., 2013). Given the short window of time during which chromosomes need 
to be fully and faithfully duplicated and the dire consequences of failing to 
complete DNA replication in a timely fashion, it has been hypothesized that 
cells have evolved mechanisms to avert or quickly resolve such conflicts by 
forcibly disengaging the transcription machinery from DNA, favouring fork 
progression. This would cause premature transcription termination 
(transcription attenuation). Such a model dictates that enzymes capable of 
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resolving R-loops can be quickly enriched at sites of collisions between 
replication forks and transcribing RNA polymerases (or R-loops). Alternatively, 
these enzymes might travel with either the replication or transcription 
machinery allowing efficient recruitment at sites of collisions. In the model 
organism Saccharomyces cerevisiae, a possible candidate for this role is the 
DNA/RNA helicase, Sen1. The latter participates in premature transcription 
termination although the precise mechanism through which it does so has not 
been fully characterized yet. It is known that Nab3 and Nrd1, that form a 
hetero-trimer with Sen1, bind to nascent mRNA molecules (Jamonnak et al., 
2011) whilst full-length Sen1 is able to disengage the transcription machinery 
in a manner reminiscent of the bacterial Rho termination factor in vitro (Porrua 
and Libri, 2013). Sen1 also associates with forks (Alzu et al., 2012). Sen1, 
then, is an ideal candidate to rid the genome of R-loops at actively transcribing 
loci in favour of replication forks. Such a mechanism would help to resolve 
problematic collisions between forks and transcribing complexes. 
 
This project originated from the observation that Sen1 co-precipitates with the 
replisome in a mass spectrometric screen of S phase GINS IP (De Piccoli, 
unpublished data). Here, I have sought to characterize this interaction and to 
investigate its biological relevance. I have found that Sen1 interacts with the 
replisome by virtue of its N-terminal domain and one interactor of Sen1 (Ctf4) 
has been identified. By screening point mutants of SEN1, one mutant that is 
unable to bind to the replisome has been isolated. This mutant is healthy in 
isolation but is synthetically lethal in the absence of both RNase H1 and H2.  
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4.2 Sen1 co-precipitates with Replisome components 
in S phase  
  
Mass spectrometric screens are highly sensitive and thus prone to 
misidentification of peptides as false-positives. In order to validate Sen1’s 
ability to co-precipitate with GINS, Sen1 was C-terminally tagged with 9MYC 
and crossed with a strain carrying the TAP-SLD5 allele (Sld5 being a 
component of the GINS complex). We grew the cells at 24°C and harvested 
them either arrested in G1 or synchronized in S phase. These samples were 
then used for GINS IPs followed by Western blotting. Pierce Universal 
nuclease was added to a final concentration of 1.6 U/μl to remove any DNA or 
RNA molecules within the extracts. In G1, Sld5 is known to interact with Ctf4 
but not to other non-GINS components of the replisome. At the onset of S 
phase, both Cdc45 and GINS are recruited to origins where the MCM2-7 
double hexamer was already loaded in G1. This leads to the formation of the 
CMG helicase that is required for complete formation of the replisome (Fig 
4.1). We found that, in G1, Ctf4 but neither Cdc45 nor any MCMs co-
precipitated with GINS (Fig 4.2), fitting the established pattern of CMG 
assembly (Gambus et al., 2009). 
 
Sen1 also did not co-precipitate with the GINS in G1. In S phase, however, 
several components of the replisome co-precipitated with GINS. Moreover, 
Sen1 also co-precipitated with GINS, validating the results from the earlier 
mass spectrometric screen (De Piccoli, unpublished data) (Fig 4.2). This 
suggests that Sen1 interacts with the replisome after assembly in S phase but 
does not interact with GINS directly in G1. We then used a strain encoding a 
SEN1-TAP allele to immuno-precipitate Sen1 in G1, S and G2. Replisome 
components co-precipitated with Sen1 only in S phase, suggesting that Sen1 
forms an integral part of the replisome (Fig 4.3). Tellingly, none of the proteins 
we probed against co-precipitated with Sen1 outside of S phase. Whilst this 
could be indicative of an absence of physical interaction between Sen1 and 
the proteins probed for, an alternative interpretation is that the interaction 
between Sen1 and its binding partner(s) is strictly cell cycle dependent.
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Figure 4.1. Sequence of events leading to CMG assembly at the onset of S phase. During origin-licensing two MCM2-7 hexamers 
are recruited sequentially at origins in G1 by the concerted efforts of ORC1-6, Cdc6 and Cdt1. At this point in the cell cycle, GINS 
(Sld5, Psf1, Psf2 and Psf3) cannot interact with MCM2-7. It is only at the onset of S phase that Cdc45 and GINS are recruited to 
origins, forming the replicative CMG helicase at the centre of the eukaryotic replisome.  
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Figure 4.2. Sen1 interacts with components of the replisome in S phase but not in G1. Cells carrying the SEN1-9MYC allele 
with or without the TAP-SLD5 allele were grown in YPD at 24°C to a density of 0.7 x 107 cells/ml in 1 l cultures. The cells were 
arrested in G1 using a-factor to a final concentration of 7.5 µg/ml for 3 h. After successful arrest (> 90% of cells shmooing and/or 
unbudded), the cells were either harvested and sample-prepared as described in Section 2.4.4 or the cells were released from a-
factor arrest by washing twice in fresh YPD, re-suspended in 1 l YPD and released in S phase at 24°C. The cells were harvested 30 
min post-release and sample-prepared. FACS samples were taken for asynchronous cultures (Asyn), at G1 arrest (G1), after 
preparation of the G1 sample (G1 + SP), at point of harvest in S phase (30 min), after preparation of the S phase sample (30 min +SP) 
and 30 min after S phase harvest (60 min). The samples were used for IPs using TAP beads. (A)  Westerns of TAP, MYC and several 
replisome components for both cell extracts and TAP IPs. (B) FACS samples of the experiment. Strains used in this experiment: 
CS1125 and CS1126. 
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Figure 4 3. Sen1 interacts with several sub-complexes of the replisome in S phase. Cells carrying the SEN1-TAP allele were 
grown in YPD at 24°C to a density of 0.7 x 107 cells/ml in 1 l cultures. The cells were arrested in G1 using a-factor to a final 
concentration of 7.5 µg/ml for 3 h. After successful arrest, the cells were either harvested and sample-prepared or the cells were 
released from a-factor arrest by washing twice in fresh YPD, re-suspended in 1 l YPD and released in S phase at 24°C. The cells 
were then harvested and sample-prepared either 30 or 60 min after release in S phase. FACS samples were taken for asynchronous 
cultures (Asyn), at G1 arrest (G1), after preparation of the G1 (G1 + Sample Prep) sample, at point of harvest in S phase (30 min), after 
preparation of the S phase sample (30 min +Sample Prep), at point of harvest in G2 (60 min) and after preparation of the G2 phase 
sample (60 min +Sample Prep). The samples were used for IPs using TAP beads. (A).  Westerns of TAP and several replisome 
components for both cell extracts and TAP IPs. (B). FACS samples of the experiment. Strains used in this experiment: CS74 and 
CS1353. 
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4.3 The N-terminal Domain of Sen1 is required for 
Interaction with the Replisome 
 
Having established that Sen1 interacts with replisome components, we then 
sought to determine what domain of the protein is required for this interaction. 
Sen1 is made of two domains, both of which are conserved albeit to different 
extents (Fig 4.4). Residues 1327-1656 encode a helicase domain that has 
been shown to be essential for viability (DeMarini et al., 1992). The sen1-1 
allele (Fig S.2) encodes a substitution in this helicase domain that reduces the 
extent of ATP hydrolysis and transcription termination in vitro (Porrua and 
Libri, 2013). Residues 106-859 encode an N-terminal domain of which Sen1 
is the prototype. It is required for several protein-protein reactions, including 
with Rad2 (Ursic et al., 2004). Deletion of this domain is not lethal but its 
ablation leads to dysregulation of gene expression, shorter chronological life 
span and loss of mitochondrial DNA (Sariki et al., 2016). 
 
We cloned N-terminally TAP-tagged constructs of Sen1 (Fig S.2) that spanned 
either one or both of these domains under the strong inducible GAL1 promoter. 
We also took into consideration the predicted location of unstructured 
stretches of amino acids to determine the ends of the fragments (Fig 4.5). 
These fragments were cloned at an ectopic site in the genome at the LEU2 
locus on chromosome III. Strains carrying the different fragments were grown 
in YP-Raff to prevent premature expression of the constructs. When the 
required cell density was reached (0.7 x 107 cells/ml), the cells were 
synchronized in G1 using α-factor and the medium was then switched to 
YPGAL, still in the presence of α-factor, triggering gene expression of the 
constructs for 35 min. The α-factor was removed by repeated washing with 
fresh YPGAL and cells were released in S phase in YPGAL at 24°C. Samples 
were then harvested in S phase (30 min after release at 24°C).  
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Figure 4.4. Sen1 is made up of two domains that are conserved in eukaryotes. Sen1 is made up of the Sen1 N-terminal domain 
at its N-terminus and a helicase domain at its C-terminus. These two domains are conserved in Sen1 orthologues although the Sen1 
N-terminal domain is conserved to a lower extent, perhaps because it is not necessary for viability (Adapted from Interpro). 
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Figure 4.5. Schematic of Sen1 Constructs used to determine the domain through which the protein interacts with the 
replisome. Constructs of N-terminally TAP-tagged Sen1 fragments were cloned ectopically at the LEU2 locus under control of the 
strong, inducible GAL1 promoter. 
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This experiment revealed that fragments expressing the essential helicase 
domain were prone to quick degradation (Section 5.4). Why this is the case is 
uncertain but is congruent with the difficulty to overexpress the full-length 
protein in yeast (DeMarini et al., 1995). This also suggests the presence of 
some regulatory mechanism that ensures levels of Sen1 do not exceed a 
certain threshold. In order to achieve appreciable levels of the constructs 
expressing the essential helicase domain, we attempted to scale up the 
amount of yeast harvested from 1.75 x 109 cells to 7.0 x 109 cells. In addition, 
the cells were grown in YPGAL throughout the experiment to allow for 
continuous expression of the constructs. With these modifications, we were 
able to detect appreciable levels of Sen1 constructs expressing the helicase 
domain.  
 
Immunoprecipitating the different constructs from cells harvested in S phase 
reveals that replisome components co-purified with constructs expressing the 
Sen1 N-terminal domain (Fig 4.6). To control for the possibility that the N-
terminal domain of Sen1 might interact non-specifically with the TAP beads 
used for immuno-precipitation, two isogenic yeast strains were generated with 
the GAL1-3HA-SEN1 (2-931) allele and with or without TAP-MCM3. The cells 
were harvested in S phase after expression of the GAL1-3HA-SEN1 (2-931) 
allele and these samples were then used to generate cell extracts from which 
TAP-tagged proteins were immuno-precipitated. Results from this experiment 
confirmed that the N-terminal domain of Sen1 does not interact non-
specifically with TAP beads. To ensure that the constructs expressing the 
helicase domain were folding correctly, we crossed the different fragments in 
a strain carrying the td-MYC-sen1-1 and GAL1-UBR1 genes and tested the 
ability of the different constructs to complement the temperature sensitivity of 
the td-MYC-sen1-1 allele at the non-permissive temperatures (37°C) in the 
presence of galactose. The td-MYC-sen1-1 allele (Fig S.2) was constructed 
by tagging the sen1-1 (kind gift from Prof Proudfoot) with a heat-sensitive 
degron and the MYC tag. The sen1-1 allele confers temperature-sensitivity 
and is characterized by increased transcription read-through, increased 
presence of R-loops in the genome and associated hyper-recombination 
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(Mischo et al., 2011). We found that constructs not expressing the helicase 
domain could not complement the td-MYC-sen1-1 allele at 37°C, in line with 
the established literature. By contrast fragments Sen1 (2-1901), Sen1 (2-
2231), Sen1 (931-2231) and Sen1 (1095-2231) all complemented the 
temperature-sensitive allele upon degradation of endogenous TD-MYC-Sen1-
1 proteins at 37°C and in the presence of Ubr1 (the latter is the E3 ligase 
required for degradation of proteins tagged with the TD degron), indicating that 
these constructs folded properly (Fig 4.7). As such, the inability of both the 
Sen1 (931-2231) and Sen1 (1095-2231) constructs to interact with replisome 
components is not a result of mis-folding. Taken together, these observations 
suggest that the first 931 residues of Sen1 are both sufficient and necessary 
for the interaction of the protein with the replisome.
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Figure 4.6. Residues spanning 2-931, that include the Sen1 N-terminal domain, are responsible for interaction with the 
replisome. (A) Cells carrying different N-terminally tagged Sen1 fragments under the GAL1 promoter were grown in YP-Raff at 24°C 
to a density of 0.7 x 107 cells/ml in 250 ml cultures. The cells were arrested in G1 using a-factor to a final concentration of 7.5 µg/ml 
for 3 h. After successful arrest, the YPGAL medium was substituted for YP-Raff, keeping a-factor at a concentration of 7.5 µg/ml for 
a further 35 min. The galactose in the new medium triggers expression of the constructs. The a-factor was removing by washing with 
fresh YPGAL and the cells were released in S phase in YPGAL at 24°C. Cells were harvested 30 min after release. The samples 
were used for IPs using TAP beads. (B) Similar to (A) but with modifications. Cells were grown in 1 l cultures and YPGAL was used 
throughout the experiment. Arrows indicate the correct position of proteins blotted against (here, Pol1 and Ctf4) whilst the star symbol 
(*) indicates the position of the TAP-tagged protein that is recognized by the Ctf4 antibody. (C) Cells carrying the GAL1-3HA-SEN1 
(2-931) allele with or without the TAP-MCM3 allele were grown in YP-Raff at 24°C to a density of 0.7 x 107 cells/ml in 250 ml cultures. 
The cells were arrested in G1 using a-factor to a final concentration of 7.5 µg/ml for 3 h. After successful arrest, the YPGAL medium 
was substituted for YP-Raff, keeping a-factor at a concentration of 7.5 µg/ml for a further 35 min. The cells were then released from 
G1 arrest by washing out the a-factor with fresh YPGAL, followed by release in S phase in YPGAL at 24°C. Cells were harvested 30 
min after release. FACS samples were taken for asynchronous cultures (Asyn), at G1 arrest (G1), after preparation of the G1 (G1 + 
SP) sample, at point of harvest in S phase (30 min), after preparation of the the S phase sample (30 min +SP) and 30 min after S 
phase harvest (60 min). The samples were used for IPs using TAP beads. The arrow indicates the correct position of the 3HA-Sen1 
(2-931) construct. Strains used in this experiment: CS1711, CS1714, CS1852, CS1933, CS1941, CS1942, CS1943, CS1957 and 
CS1958.
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Figure 4.7. The last 1136 residues of Sen1 are sufficient to complement the temperature-sensitive of the td-MYC-sen1-1 
allele. To determine whether the different constructs of Sen1 folded correctly, they were crossed into cells carrying the td-MYC-sen1-
1 and GAL1-UBR1 alleles. The td-MYC-sen1-1 allele is temperature-sensitive at 37°C and induction of Ubr1 with galactose quickly 
leads to degradation of the TD-MYC-Sen1-1 protein by virtue of its temperature degron (TD). The strains were grown at either 24°C 
or 37°C, in either YPD to suppress expression of both Ubr1 and the Sen1 fragments or in YPGAL to trigger their expression. Strains 
used in this experiment: CS1, CS2056, CS2058, CS2061, CS2062, CS2184, CS2188 and CS2451. 
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4.4 Yeast-Two-Hybrid Analysis reveals Rad5 as a 
novel Interactor of Sen1 
 
Having determined that the N-terminal of Sen1 is required for interaction with 
the replisome, we then wanted to identify the preferred interactor or interactors 
through which this interaction is achieved. There are two ways to identify novel 
physical interactors of a protein of interest. These are the yeast-two-hybrid 
(Y2H) and immuno-precipitation followed by mass spectrometric analysis. In 
both assays, either the entire protein of interest or its fragment(s) may be used 
as bait. 
 
We initially attempted to identify the preferred interactor of Sen1 by using a 
high-throughput, optimized variant of the yeast-two-hybrid (Y2H) assay, 
conducted by Hybrigenics. In brief, SEN1 (2-931) was cloned juxtaposed to 
the GAL4 DNA binding domain. We chose this fragment and not the full-length 
gene based on our earlier observations that the full-length protein is more 
labile and less well expressed than Sen1 (2-931). Additionally, given the role 
of Sen1 in transcription termination, we reasoned that expressing the full 
length protein as a second copy (as bait) could impair global levels of proteins, 
including those of the candidate preys. Moreover, because of the nature of 
Y2H screens, the helicase domain of Sen1 could also impair expression of the 
reporter genes. The SEN1 (2-931) construct was cloned in MATa yeast cells 
that were then mated to a collection of MATα cells of the same background 
that had been previously transformed with a library of yeast (S. cerevisiae) 
genomic DNA cloned in proximity and in frame with a GAL4 activating domain. 
The resulting diploids were tested for grown on synthetic medium lacking 
histidine. Of the 97 million interactions tested, 380 positive clones were 
obtained. The different positive hits were scored for non-specificity and false-
negatives and the clones were sequenced to identify the prey proteins. Twelve 
potential interactors were identified (Table 4.1). 
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Table 4.1. List of potential Interactors of Sen1 Identified in the Commercial 
Y2H Screen (Hybrigenics) 
Potential 
Interactors 
of Sen1 
 
Function Number of 
Clones 
Prs2 Involved in amino acid and nucleotide biosynthesis 96 
Prs3 Involved in amino acid and nucleotide biosynthesis 39 
Prs4 Involved in amino acid and nucleotide biosynthesis 28 
Rad2 Nucleotide excision repair 8 
Rad5 Involved in DNA damage tolerance pathway 1 
Msh6 Mismatch repair during mitosis and meiosis 1 
Nap1 Histone chaperone 15 
Lro1 Triglyceride synthesis 12 
Dal81 Involved in nitrogen degradation pathways 1 
Sco1 Required for cytochrome C oxidase activity and 
Respiration 
3 
Flo8 Transcription factor required for flocculation 1 
Nrd1 Involved in Sen1-dependent transcription termination 23 
 
 
No replisome component was identified in the Y2H screen. Although no screen 
can claim to be exhaustive, the failure to detect any replisome component 
could indicate that the preferred interactor of Sen1 within the replisome is not 
expressed at significantly high levels to achieve detectable levels of interaction 
with Sen1 in the screen. The tags used for the bait and prey proteins could 
also interfere with physiological interactions. Alternatively, it is possible that 
such an interaction is too transient to be detected by the screen. Sen1 could 
also interact with the replisome through a sub-complex made up of either 
distinct or identical proteins (such as Polymerase e and the Ctf4-trimer 
respectively) in such a way that it would not be possible to recreate this 
interaction artificially in a Y2H screen (Simon et al., 2014). Finally, post-
translational modifications of either the bait or prey may be important for 
interaction and the constructs used in the screen may not be modified 
adequately.  
 
Of the possible interactors of Sen1 identified in the screen, Rad2 and Prs3 (a 
protein involved in both nucleotide and amino acid biosynthesis) had been 
identified previously in a Y2H screen using the Sen1 (2-975) construct as bait, 
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closely corresponding to the bait used here (Ursic et al., 2004). Because of 
the high-throughput nature of the commercial screen, we wanted to test 
whether Msh6, Nap1, Nrd1 and Rad5 were true interactors of Sen1. To do so, 
I obtained bait and prey plasmids that I transformed in a Y2H tester strain 
(CS114). In brief, cells were transformed simultaneously with either an empty 
bait plasmid or a bait plasmid expressing the SEN1 (2-931) construct together 
with either an empty prey plasmid or plasmids expressing fragments of either 
MSH6, NAP1, NRD1 or RAD5. As an internal control, we also used prey 
plasmids expressing fragments of Prs2 (related to Prs3) and Rad2. Cells 
expressing different pairs of bait and prey plasmids were then growth on 
selective medium with or without 3-amino- 1,2,4-triazole (3-AT), a competitive 
inhibitor of the HIS3 gene in S. cerevisiae. Cells expressing NAP1 and MSH6 
constructs as prey did not grow on selective medium suggesting that the 
proteins they encode for do not interact physically with Sen1. On the other 
hand, cells expressing SEN1 (2-931) and RAD5 (13-265) grew on selective 
medium (Fig 4.8). Importantly, these cells grew better on selective medium 
compared to cells expressing both the SEN1 (2-931) bait and the RAD2 (501-
869) prey. This indicates that Rad5 genuinely interacts with the first 931 
residues of Sen1 and that the Rad5 (13-265) construct is sufficient for this 
interaction. This observation merits further investigation in the future. 
 
The Y2H results also indicate that Sen1 and Nrd1 interact through their own 
respective N-termini (Fig 4.8). Previously, Sen1 was thought to only interact 
physically with Nab3 and not Nrd1 (Nedea et al., 2008). Given that Nab3 and 
Nrd1 form a hetero-dimer, these observations indicate that all three 
components of the NNS complex can form direct physical contact with one 
another.  
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Figure 4.8. Yeast-two-hybrid screen using the GAL4-Sen1 (2-931) as bait. 
Diploid cells were transformed with a pair of bait and prey plasmids. The bait 
vector encoded either a GAL4-binding domain on its own or for the GAL4-
bindind domain bound to the Sen1 (2-931) fragment. The prey plasmids 
encoded either for the GAL4-activation domain on its own or the activation 
domain bound to candidates binding partners of Sen1 (2-931). The diploids 
were then grown on either non-selective medium or in selective media 
(synthetic medium with amino acids lacking histidine with or without the 
histidine inhibitor, 3AT.  Strain used in this experiment: CS114.
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4.5 Mass Spectrometric Analysis of Sen1 (2-931) IPs in 
different phases of the cell cycle reveal either 
Ctf4 or GINS to be the interactor of Sen1 within 
the Replisome 
 
As the Y2H screen did not reveal the identity of the replisome interactor(s) of 
Sen1, we decided to carry immuno-precipitations of Sen1 (2-931) followed by 
mass spectrometric analysis. We aimed to exploit the dynamic nature of 
replisome assembly, expecting that Sen1 (2-931) would interact with all or 
most of the components of the replisome in S phase but would interact 
uniquely with one or a few replisome components throughout the cell cycle. 
The latter interactors would be identified as the preferred interactor(s) of Sen1 
vis-à-vis the replisome.  
 
To obtain sufficiently concentrated protein samples for mass spectrometric 
analysis, four independent harvests of 7 x 109 cells, grown in YPGAL, and 
carrying the GAL1-TAP-SEN1 (2-931) allele were conducted for each phase 
of the cell cycle (G1, S and G2). For the control (no bait), four independent 
harvests of 2 x 1010 cycling cells, carrying the GAL1-TAP-Æ allele, were 
carried out. For each biological replicate, FACS profile were run to ensure that 
cells were harvested in their correct respective cycles (Fig 4. 9). The samples 
were lysed by using a motorized pestle and mortar cooled to −80°C using 
liquid nitrogen and thawed to 4°C. Universal nuclease (Pierce) was added to 
a final concentration of 1.6U/μl and the resulting mixture was incubated at 4°C 
for 40 min. Thereafter, the mixture was clarified by centrifugation at 12,500 
rpm in a high speed centrifuge and at 32,500 rpm in an ultra-centrifuge. TAP-
Sen1 (2-931) was immuno-precipitated using IgG bound to Dynabeads in a 
100 mM Hepes, 50 mM potassium acetate solution. After three washes, TAP-
Sen1 (2-931) and its co-precipitates were cleaved off the Dynabeads using 
AcTEV protease at 24°C for 2 h. After cleavage, the resulting CBP-Sen1 (2-
931) and its co-precipitates were incubated with pre-washed calmodulin beads 
at 4°C for 2 h and, after washing, the proteins were removed from the 
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calmodulin resin by boiling in 30 µl of 1 x Laemmli buffer. This simultaneously 
concentrates the proteins. The samples from the four biological replicates 
were then pooled together.  
 
Thereafter, the samples were run for a small distance on a commercially-
sourced 4-12% acrylamide gel that was then cut in thin slices and processed 
using a robot (MS Bioworks, USA). The protein samples were successively 
washed, reduced, alkylated and digested by trypsin. The reaction was then 
analysed using a nanoLC/MS/MS (Waters NanoAcquity HPLC/ThermoFischer 
Q Exactive). Of the ions identified, the fifteen most abundant were selected for 
tandem MS. To process the data, the spectra obtained were compared to the 
spectra of in silico trypsinized S. cerevisiae proteins (SGD database).  
 
The raw data is presented in Table S1 at the very end of this thesis. There 
was a total of 1778 unique (non-specific) peptides identified using the control 
samples whilst 4343, 8066 and 5826 unique peptides were identified using the 
Sen1 (2-931) bait in G1, S and G2 respectively. This was reflected in 
Coomassie and silver staining of the IP samples (Fig 4.9). As a first 
approximation, this indicates that the mass spectrometric screen successfully 
identified specific interactors of CBP-Sen1 (2-931) and that more protein 
molecules interact with the bait in S phase than either in G1 or G2. Proteins for 
which the number of peptides identified in the control was at least 2-fold 
smaller compared to at least one of the experimental samples were 
considered specific interactors of Sen1 (2-931). The remaining proteins were 
considered non-specific hits.  
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Figure 4.9. The Sen1 (2-931) fragment was used as a bait to fish for 
interactors using IPs followed by tandem mass spectrometry. Cells 
carrying the GAL1-TAP-SEN1 (2-931) allele were grown in YPGAL at 24°C to 
a density of 0.7 x 107 cells/ml in 4 x 1 l cultures. 4 l of samples were harvested 
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in either G1, S or G2 corresponding to 2.8 x 1010 cells for each cycle. As a 
control, cells carrying the GAL1-TAP-Ø allele were grown in YPGAL at 24°C 
to a density of 2 x 107 cells/ml in 4 x 1 l cultures. Here, asynchronous cultures 
of the untagged control were used as it more cost-effective than using 
synchronized cultures for the untagged control. However, it should be 
recognized that this is not a perfect control for this experiment as the test 
samples consist of IPs of synchronized cultures. This can lead to bias, 
especially for non-specific interactors that would have fluctuating signals 
throughout the different phases of the cell cycle, complicating the 
interpretation of the results. Nonetheless, this control was adjudged to be 
satisfactory for the purpose of screening for interactors prior to verification by 
Western blotting. The total number of cells harvested for the control was 8 x 
1010 cells. After a two-step IP, the biological replicates were pooled together 
and the IPs were analysed via mass spectrometric analysis. FACS samples 
were taken for asynchronous cultures (Asyn), at G1 arrest (G1), after 
preparation of G1 (G1 + SP) sample, at point of harvest in S phase (30 min), 
after preparation of S phase sample (30 min + SP), at point of harvest in G2 
(65 min) and after preparation of G2 sample (65 min + SP). (A) Schematic of 
the experiment. (B) The FACS samples for each biological replicate was run 
and this shows that the cells were harvested in their correct respective cycles. 
(C) A small quantity of the IPs from the experiment were run on polyacrylamide 
gels and the bands visualized using Coomassie or Silver stains. Strains used 
in this experiment: CS1852 and CS1957. 
	 230	
We observed that several replisome components co-precipitate with CBP-
Sen1 (2-931) in S phase, including with all the components of the fork 
protection complex (Mrc1, Tof1 and Csm3), all components of the Polymerase 
a holoenzyme (Pol1, Pol12, Pri1 and Pri2), two components of the 
Polymerase e holoenzyme (Pol2 and Dpb2), the topoisomerase Top1, the Ctf4 
interaction hub (Villa et al. 2016), and all 11 subunits of the CMG helicase 
(Cdc45, Mcm2, Mcm3, Mcm4, Mcm5, Mcm6, Mcm7, Sld5, Psf1, Psf2, Psf3). 
The inability to detect two proteins within the Polymerase e holoenzyme (Dpb3 
and Dpb4) could be reflective of technical limitations of the experiments to 
detect ions from smaller proteins. The screen also revealed the presence of 
Pob3 and Spt16 (members of the FACT complex that acts as a histone 
chaperone). Peptides of the F-box protein Dia2 and the cullin protein Cdc53 
that are required for replisome disassembly (Maric et al., 2014) were also 
detected in S phase IPs of CBP-Sen1 (2-931). Histone proteins were also 
detected (HTA2, HTB2, HHF1) (Fig 4.9). Taken together, this indicates that 
several sub-complexes of the replisome can co-purify with CBP-Sen1 (2-931) 
in S phase (Fig 4.10).  
 
By contrast, few peptides corresponding to replisome proteins were detected 
in the screen for the G1 phase, except for Ctf4 and GINS (Sld5, Psf1, Psf2 and 
Psf3). The signal for the GINS complex in G1 is more convincing when 
normalizing for the molecular weight and number of tryptic sites within the 
proteins (Fig 4.11). Sen1 (2-931) then could potentially interact directly with 
both Ctf4 and GINS. However, given that Ctf4 is known to interact directly with 
Sld5 (Gambus et al., 2009, Tanaka et al., 2009a), another plausible scenario 
is that either Ctf4 or GINS interact directly with Sen1 in G1. Interaction with 
GINS and Ctf4 could also be seen in the G2 screen although peptides from 
other components of the replisome could also be seen. Since replisomes 
disassemble at the onset of G2, this could be indicative of some late forks still 
going through the replication process.  
 
Of interest, earlier experiments indicated that Sen1-TAP did not co-purify with 
replisome components outside of S phase (Fig 4.2 and 4.3). These apparently 
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contradictory findings can be reconciled if the last 1300 residues of Sen1 were 
to regulate the interaction of the protein to replisome components, perhaps 
through some self-inhibitory mechanism. Thus, had the full-length Sen1 been 
used as bait instead, the interaction with Ctf4 and GINS in G1 might have gone 
undetected.  
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Figure 4.10. The mass spectrometric screen reveals that Ctf4, can interact specifically with Sen1 (2-931) throughout the cell 
cycle. Here, the raw data of the number of peptides from replisome components that were identified in the mass spectrometric screen 
is represented graphically. The identity of the different proteins is indicated for the S phase plot. For simplicity, the corresponding 
identifiers for the control, G1 and G2 plots are masked.  
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Figure 4.11. Normalizing the data from the mass spectrometric screen 
reveals both Ctf4 and GINS as likely interactors of Sen1. The data from 
the mass spectrometric screen was normalized (Section 2.5.2), taking in 
account the number of likely number of tryptic fragments and the molecular 
weights of the different proteins identified. 
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4.6 Sen1 (2-931) co-purifies with components of RNA 
Pol I, II and III throughout the cell cycle 
 
In addition to replisome components, other proteins were identified as bona 
fide interactors of Sen1 (2-931). This includes several subunits of RNA Pol I, 
II and III (Table 4.2, Fig 4.12 and 4.13). Whilst subunits of RNA polymerases 
have previously been shown to co-purify with full-length Sen1 (Yüce and West, 
2013), here we show that Sen1 (2-931) construct interacts with RNA 
polymerases throughout the cell cycle. It would be interesting to determine 
whether this also holds true for the full-length Sen1 protein and how this affects 
its function. Another addition to the scholarship is the way through which Sen1 
interacts with RNA Pol I and III. It has previously been shown that Sen1 
interacts with the CTD terminal of RNA Pol II by virtue of its N-terminal domain 
(Chinchilla et al., 2012). In fact, the Sen1R302W protein is characterized by 
loss of interaction with RNA Pol II. However, it was previously unknown 
through which domain Sen1 interacted with either RNA Pol I or III. Here, mass 
spectrometric data indicate that the first 931 residues of Sen1 are sufficient for 
interaction with several subunits of both RNA Pol I and III (Table 4.2, Fig 4.12 
and Fig 4.13). 
 
The peptides identified included those from the largest subunits of all three 
RNA polymerases (Rpa190, Rpb1 and Rpc160). Peptides from the second 
largest subunit was observed for both RNA Pol II (Rpb2) and RNA Pol III 
(Rpc128) whilst the third largest subunit common to RNA Pol I and III (Rpc40) 
was detected. Subunits from the stalk sub-complex were only detected for 
RNA Pol III (Rpc17 and Rpc25). Given that RNA Pol I, II and III share a 
common ancestor, it is possible that the N-terminal domain of Sen1 interacts 
with some common features between the RNA polymerases. However, we 
cannot rule out that the 1400 other residues of Sen1 have no role in interaction 
with the RNA polymerases. 
 
It is also interesting to note that more peptides from RNA Pol III subunits were 
detected compared to RNA Pol I and II (Fig 4.13). This possibly indicates that 
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although Sen1 interacts with all three RNA polymerases, RNA Pol III might 
have the highest affinity for the N-terminal domain of Sen1. Our results could 
also indicate that some of the defects reported in strains carrying the sen1-2 
allele [Sen1 (976-2231)] could be a result of loss of interaction with the RNA 
polymerases (Sariki et al., 2016). 
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Table 4.2. Subunits of the RNA polymerases in S. cerevisiae. RNA 
polymerases are made up of four to six sub-complexes and each sub-complex 
is made up of a number of subunits. Some of these subunits are shared across 
all three RNA polymerases. The architecture of the different subunits within 
the different RNA polymerases is depicted in Figure 4.12. The numbers within 
the brackets are unique identifiers for each subunit.  
 
Structures RNA Polymerase 
Pol I Pol II Pol III 
Sub-structures 
 
Core 
 
 
Subassembly 
including the 
largest subunit 
Rpa190 (190) Rpo21/Rpb1 
(1) 
Rpo31/Rpc160 
(160) 
Rpb5/ Abc27 (5) Rpb5/ Abc27 
(5) 
Rpb5/ Abc27 
(5) 
Rpo26/Rpb6/ 
Abc23 (6) 
Rpo26/Rpb6/ 
Abc23 (6) 
Rpo26/Rpb6/ 
Abc23 (6) 
Rpb8/ Abc14.5 (8) Rpb8/ 
Abc14.5 (8) 
Rpb8/ Abc14.5 
(8) 
Subassembly 
including the 
second largest 
subunit 
Rpa135 (135) 
 
Rpb2 (2) Ret1/ Rpc128 
(128) 
Rpa12/ A12.2 
(12.2) 
Rpb9 (9) Rpc11 (C11) 
Third 
subassembly 
Rpc40 (40) Rpb3 (3) Rpc40 (40) 
Rcp19 (19) Rpb11 (B11) Rcp19 (19) 
Rpb10/ Abc10 
(10) 
Rpb10/ 
Abc10 (10) 
Rpb10/ Abc10 
(10) 
Rpc10/ 
Rpb12/Abc10 (12) 
Rpc10/ 
Rpb12/Abc10 
(12) 
Rpc10/ 
Rpb12/Abc10 
(12) 
Stalk Rpa14 (14) Rpb4 (4) Rpc17 (17) 
Rpa43 (43) Rpb7 (7) Rpc25 (25) 
TFIIF-like subcomplex Rpa49 Not 
applicable 
Rpc37 (37) 
Rpa34/ A34.5 
(34.5) 
Rpc53 (53) 
TFIIE-related subcomplex Not applicable Not 
applicable 
Rpc82 (82) 
Rpc34 (34) 
Rpc31 (31) 
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Figure 4.12.The subunits of RNA Polymerase I, II and III. Upper panel: Eukaryotic RNA polymerases are made up of four to six 
sub-complexes. Here, a schematic of the architecture of the three RNA polymerases from yeast are shown. The identity of the 
different subunits is indicated by unique numerical identifiers (Table 4.2). Lower panel: The different subunits that have been identified 
in the mass spectrometric screen as interactors of Sen1 (2-931) are depicted in red. The subunits that were not detected are shown 
in light grey. Adapted from (Wild and Cramer, 2012). 
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Figure 4.13. The mass spectrometric screen reveals that Sen1 (2-931) 
can bind to several subunits of the RNA polymerases. Here, the raw data 
of the number of peptides from subunits of the RNA polymerases identified in 
a mass spectrometric screen using Sen1 (2-931) as bait is depicted. The 
identity of the different subunits is indicated by unique numerical identifiers 
(Table 4.2). The plot also shows peptides from the Spt5 protein. 
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4.7 Several Ty1 Copia-like Retrotransposons co-
purify with Sen1 (2-931)  
 
Transposons (or transposable elements, TEs) are mobile genetic sequences 
within the genome. Class I TEs (retrotransposons) encode for a reverse 
transcriptase in their ‘pol’ gene that they use to synthetize their cDNA anew 
from their own RNA transcripts. They can insert the new copies of DNA at 
some distance to their previous locus. This allows for amplification of the gene 
in the wider genome. Retrotransposons can be classified as long terminal 
repeat (LTR) retrotransposons, non-LTR retrotransposons and endogenous 
retroviruses. LTR-retrotransposons can be sub-divided into several groups, 
including the Ty1-copia retrotransposons (these include Ty1 and Ty2 
retrotransposons that differ by their ‘gag’ genes that code for their virus-like 
particle (VLP)) (Fig 4.14). It had previously been reported that R-loops 
associate to Ty1 retrotransposons sites at low incidences in wildtype cells but 
this association is enriched in the absence of the RNase H enzymes and the 
topoisomerase, Top1 (El Hage et al., 2014). R-loops then are an intermediate 
of the Ty1 life cycle and their targeted removal by the RNase H enzymes and 
Top1 would seem to silence this life cycle. Results here indicate that Sen1 
interacts specifically with the protein products of several Ty1 and Ty2 
retrotransposons throughout the cell cycle (Fig 4.15). How this observation 
would fit with the broader literature is not obvious. We use a universal 
nuclease in our IPs and this would suggest that identification of the 
retrotransposons proteins was not an artefact of protein-nucleic acid 
interaction but genuine protein-protein interactions. Thus, our results indicate 
a possible role of Sen1 in retrotransposon biology, possibly distinct from those 
of the RNase H enzymes and Top1. 
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Figure 4.14. Schematic of the life cycle of retrotransposons, including Ty1 retrotransposons.
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Figure 4.15. The mass spectrometric screen reveals that Sen1 (2-931) 
can bind to Ty1 retrotransposons. Here, we depict the raw data of the 
number of peptides from Ty retrotransposons that were identified in the mass 
spectrometric screen using Sen1 (2-931) as bait. 
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4.8 Sen1 (2-931) requires Ctf4 to bind to the GINS 
complex in G1 but retains interaction with 
replisome components in the absence of Ctf4 
 
Our mass spectrometric screen of IPs of Sen1 (2-931) revealed that the 
construct interacted with several components of the replisome in S phase but 
it interacted with both Ctf4 and GINS throughout the cell cycle. This contrasts 
with results of IPs of full length Sen1 where neither Ctf4 nor GINS co-
precipitate with Sen1 outside of S phase. To validate the results from the mass 
spectrometric screen, we performed IPs of the Sen1 (2-931) construct in both 
G1 and S phase and analysed their co-precipitates by Western blotting. Using 
this approach, we confirmed that Sen1 (2-931) can interact with both Ctf4 and 
GINS outside of S phase (Fig 4.16). This suggests that Sen1 (2-931) interacts 
with other components of the replisome either through one of Ctf4 or GINS 
alone, or through both of them. To differentiate between these two 
possibilities, we carried out IPs of TAP-Sen1 (2-931) in the absence of Ctf4 in 
both G1 and S phase. We found that, in cells carrying the ctf4D mutation, no 
replisome components (including GINS) co-precipitated with Sen1 (2-931) in 
G1 (Fig 4.16). This strongly suggested that Sen1 (2-931) interacts with the 
replisome through Ctf4 and not GINS. 
 
However, whilst ctf4D did lead to a substantial reduction in the levels of 
replisome components co-precipitating with Sen1 (2-931) in S phase, it did not 
lead to a complete loss of interaction between Sen1 (2-931) and the rest of 
the replisome. In fact, the S phase results from the ctf4D mutant are difficult to 
interpret as these cells are characterized by fewer forks, naturally leading to 
reduced numbers of replisomes (Tanaka et al., 2009a), potentially hampering 
the read-out of the IPs in S phase. Taken together however, these results 
could be indicative of two models. Either Ctf4 is one of at least two replisome 
interactors of Sen1 where the other putative interactors of Sen1 associate with 
Sen1 (2-931) solely in S phase. Or the reduction of Sen1 in S phase GINS IPs 
in the absence of CTF4 simply correlates with fewer replisomes in ctf4D cells.
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Figure 4.16. Sen1 (2-931) interacts with both Ctf4 and GINS throughout the cell cycle but Sen1 (2-931) cannot interact with 
GINS in G1 in the absence of Ctf4. Cells carrying the GAL1-TAP-SEN1 (2-931) allele with or without ctf4Δ were grown in YPGAL 
to a density of 0.7 x 107 cells/ml in 250 ml cultures at 30°C. The cells were arrested in G1 using a-factor to a final concentration of 7.5 
µg/ml for 3 h. After successful arrest, the cells were either harvested and sample-prepared or were released from a-factor arrest by 
washing twice in fresh YPGAL, re-suspended in 250 ml YPGAL and released in S phase at 30°C. The cells were harvested 20 min 
post-release. The samples were then used for IPs using TAP beads. Strains used in this experiment: CS1852, CS1957 and CS2603.  
For the panel corresponding to the Ctf4 signal, two bands are visible. The slower-running band corresponds to the TAP-Sen1 (2-931) 
construct (~128 kDa) whilst the faster-running protein corresponds to Ctf4 (~104 kDa). For the panel corresponding to the Pob3 
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signal, two bands are also visible. The slower-running signal is an unknown protein. The latter is unlikely to be a non-specific interactor 
as it is not present in IPs of the untagged control and, in the absence of Ctf4, its retention in Sen1 (2-931) IPs is reduced in both G1 
and S phase. The faster running protein corresponds to Pob3 (~63 kDa). For both Ctf4 and Pob3 panels, the arrows indicate the 
position of the specific signals for these two proteins.  
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4.9 Ctf4 interacts with Sen1 by virtue of its C-
terminal domains 
 
Ctf4 is made up of a WD40 domain in its N-terminus, a central β-propeller 
domain and an α-helical structure at its C-terminus. A second WD40 was also 
found in its C-terminal region (Simon et al., 2014). Replisome-associated 
proteins that bind to Ctf4 do so at the C-terminal WD40 by virtue of CIP boxes. 
We wondered whether Sen1 also binds to this domain. We carried out IPs of 
the Sen1 (2-931) construct in G1 encoding either Ctf4-9MYC, 9MYC-Ctf4 or 
N- or C-terminally MYC-tagged truncated variants of Ctf4. In the absence of 
TAP-Sen1 (2-931) protein, no MYC-tagged proteins were detected in the IPs. 
On the other hand, N- and C-terminally MYC tagged Ctf4 co-precipitated with 
the Sen1 construct with identical intensities suggesting that tagging of Ctf4 at 
either of its termini does not affect its interaction with the Sen1 construct (Fig 
4.17). The 9MYC-Ctf4 (351-927) construct also interacted with TAP-Sen1 (2-
931) indistinguishably from both 9MYC-Ctf4 and Ctf4-9MYC, suggesting that 
the N-terminal WD40 is not required for this interaction. 
 
Absence of the last 544 residues of Ctf4, that corresponds to loss of both the 
central β-propeller domain and the C-terminal α-helical, completely abrogated 
its interaction with the Sen1 construct in G1 whilst truncation of the last 86 
residues led to a marked reduction but not a complete loss of this interaction. 
This result suggests that Ctf4 interacts with Sen1 mainly by virtue of its C-
terminal WD40 domain, but even when this domain is ablated, Ctf4 can still 
bind weakly to Sen1. 
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Figure 4.17. Sen1 interacts with Ctf4 by virtue of the C-terminal domains within Ctf4. Isogenic yeast cells encoding MYC-tagged 
alleles of either full-length or truncated CTF4 with or without the GAL1-TAP-SEN1 (2-931) allele were grown in YPGAL at 24°C to a 
density of 0.7 x 107 cells/ml. The cells were synchronized in G1 by addition of α-factor to a final concentration of 7.5 μg/ml for 3 h. The 
cells were harvested at −80°C and ground using a motorized pestle and mortar at −80°C. The liberated proteins were immuno-
precipitated using magnetic beads conjugated to IgG antibodies. (A) Whole cell extracts and IP samples immunoblotted with 
antibodies that recognize MYC-tagged proteins. (B) Schematic summarising the constructs of Ctf4 that can bind to Sen1 (2-931) in 
G1. Strains used in this experiment: CS2798, CS2799, CS2800, CS2801, CS2802, CS2803, CS2804, CS2805 and CS2806. 
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To determine the importance of Ctf4 on Sen1’s interaction with the replisome, 
we carried out IPs of GINS in S phase with or without Ctf4. As a control, we 
also carried out GINS IPs in the absence of other non-essential components 
of the replisome, including Top1 and subunits of the fork protection complex 
(Csm3, Mrc1 or Tof1). We saw reduced retention of Sen1 in GINS IPs in the 
absence of Ctf4 but not with in the absence of Top1 or of individual subunits 
of the FPC. In the absence of Ctf4, the GINS IP also retained fewer 
components of other replisome components as expected given that ctf4D 
leads to a reduction in the number of active replication forks per unit mass (Fig 
4.18). This suggests that Sen1, like Sen1 (2-931) interacts with Ctf4 but that 
either this interaction is redundant for Sen1’s interaction with the rest of the 
replication machinery or that, Sen1 can somehow compensate for the absence 
of Ctf4 by binding to some other protein(s). 
 
We then decided to exploit the fact that different sub-complexes of the 
replisome interact with one another with different affinities. We investigated 
the retention of full length Sen1 in S phase IPs of the MCM2-7 complex (TAP-
Mcm3), Polymerase a (Pol12-TAP) and Polymerase e (Dpb2-TAP). We 
reasoned that should Ctf4 be the sole interactor of Sen1, the amount of Sen1 
co-precipitating with replisome components should be proportional to the 
amount of Ctf4 also co-precipitated. Interestingly, this particular ratio was not 
constant, suggesting that Ctf4 is not the sole replisome interactor of Sen1. 
Interestingly, the amount of Sen1 co-precipitating was higher in IPs of 
Polymerase a and e, compared to IPs of MCM2-7 (effectively IPs of the CMG) 
(Fig 4.19).
	 248	
 
 
	 249	
Figure 4.18. Sen1 interacts with replisome components in S phase independently of Ctf4. Cells carrying the TAP-SLD5 and 
SEN1-9MYC alleles with or without deletion mutations of non-essential replisome components were grown in YPD to a density of 0.7 
x 107 cells/ml in 1 l cultures at 30°C. The cells were arrested in G1 using a-factor to a final concentration of 7.5 µg/ml for 3 h. After 
successful arrest, the cells were released from a-factor arrest by washing twice with fresh YPD, re-suspended in 1 l YPD and released 
in S phase at 30°C. The cells were harvested 20 min post-release and sample-prepared. FACS samples were taken for asynchronous 
cultures (Asyn), at G1 arrest (G1), at point of harvest in S phase (20 min), after preparation of S phase sample (20 min +SP) and 30 
min after S phase harvest (50 min). The samples were used for IPs using TAP beads. (A) Cell extracts, IPs and FACS profiles of 
wildtype cells and cells carrying either the ctf4D , tof1D or mrc1D mutants. (B) Cell extracts, IPs and FACS profiles of wildtype cells 
and cells carrying either the top1D, tof1D or csm3D mutants. Strains used in this experiment: (A) CS1125, CS1187, CS1217 and 
CS1534 (B) CS1125, CS1217, CS1561 and CS1676. 
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Figure 4.19. The ratio of Sen1 and Ctf4 levels co-precipitating with different sub-complexes of the replisome is not constant. 
Cells carrying the SEN1-9MYC allele and either one of TAP-MCM3, POL12-TAP or DPB2-TAP alleles were grown in YPD to a density 
of 0.7 x 107 cells/ml in 1 l cultures at 24°C. The cells were arrested in G1 using a-factor to a final concentration of 7.5 µg/ml for 3 h. 
After successful synchronization, the cells were released from a-factor arrest by washing twice with fresh YPD, re-suspended in 1 l 
YPD and released in S phase at 24°C. The cells were harvested 30 min post-release and sample-prepared for use in IPs. Strains 
used in this experiment: CS1134, CS1403 and CS1416. Note: The anti-Ctf4 antibody recognizes both Ctf4 specifically (arrow) and 
also recognizes the TAP tag non-specifically (marked as a single* or double stars**).
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4.11 Abrogation of Origin Firing Interferes with the 
Interaction of Sen1 (2-931) with the Replisome 
 
CMG assembly requires activation of both the CDK and DDK kinases (Labib, 
2010). Once activated, CDK phosphorylates Sld3 (and other proteins) and this 
enables recruitment of Cdc45 to licensed origins (Kamimura et al., 2001, 
Heller et al., 2011, Takayama et al., 2003, Tanaka et al., 2007). As such, 
degradation of Sld3 in G1 prevents CMG assembly (and subsequent DNA 
replication) without interfering with other CDK-dependent cellular events. 
 
Having established that Sen1 binds to at least another replisome component 
besides Ctf4, we wanted to determine whether the Sen1 (2-931) construct 
could co-purify with components of the replisome other than Ctf4 and GINS in 
the absence CMG assembly, but without interfering with the activity of either 
CDK and DDK. The Sen1 (2-931) construct was chosen instead of the full-
length protein for two reasons. First, this construct is less labile than its full-
length counterpart. This allows for harvesting of smaller volumes of culture 
(250 ml) and, hence, practical harvesting at different time-points within a single 
experiment. Secondly, given that the Sen1 (2-931) construct is both sufficient 
and necessary for binding to the replisome in S phase, it was deemed that the 
construct is an adequate substitute to the full-length protein as far as its 
interaction with replisome components is concerned.  
 
In order to prevent CMG assembly, we used a temperature-degron of SLD3, 
sld3-7-td that can quickly be degraded upon shifting to non-permissive 
temperatures (37°C) (Kanemaki and Labib, 2006). We tested four strains: a 
control strain expressing GAL1-TAP-Ø, a positive control expressing GAL1-
TAP-SEN1 (2-931) and two sld3-7-td strains expressing GAL1-TAP-SEN1 (2-
931) and GAL1-UBR1 either with or without CTF4. Cells were grown in YP 
medium supplemented with 2% (w/v) raffinose to a density of 0.7 x 107 cells/ml 
at a temperature of 24°C. In raffinose, neither the Sen1 construct nor the Ubr1 
protein are expressed. The cultures were then synchronized in G1 by addition 
of α-factor. Upon synchronization, half of the culture was harvested at −80°C. 
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The remainder of the cells was shifted to YPGAL supplemented with α-factor 
to maintain cells in G1. The cells were left in YPGAL for 35 min to promote 
synthesis of both TAP-Sen1 (2-931) and Ubr1. Ubr1 is the E3 ligase required 
for degradation of proteins tagged with the TD degron. The cells were then 
shifted to 37°C for 1 h. This enables the degradation of Sld3-7 (Kanemaki and 
Labib, 2006). Finally, the cells were released in S phase (in YPGAL) at 37°C 
and were harvested 20 min post-release. Samples harvested both after 
synchronization in G1 (in YP-Raff) and 20 min after release in S phase were 
used for TAP IPs. IPs of both the negative and positive controls correlated well 
with comparable experiments conducted at 24°C, suggesting that the 
interaction between the Sen1 construct and the replisome is not significantly 
affected at 37°C (Fig 4.20). However, in the absence of Sld3, Sen1 (2-931) 
was seen to co-precipitate only with GINS (this interaction with GINS is 
mediated by Ctf4) in S phase. As such, Sen1 (2-931) requires intact CMG 
complexes to bind to other component of the replisome. In the absence of both 
Sld3 and Ctf4, Sen1 (2-931) did not co-precipitate with any component of the 
replisome for which we tested. 
 
These observations confirm that Sen1 can bind to GINS through Ctf4. 
However, from this experiment, we have also shown that when an intact CMG 
is present, Sen1 (2-931) can co-precipitate with replisome components 
besides Ctf4 and GINS. Absence of both Sld3 and Ctf4 would seem to 
completely abrogate Sen1’s interaction with replisome components not only in 
S phase but throughout the cell cycle. In addition, this experiment suggests 
that the interaction between Sen1 and DNA polymerases is not simply 
dependent on the activity of CDK and DDK.
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Figure 4.20. Intact CMG is required for Sen1 (2-931) to interact with replisome components, besides Ctf4 and GINS. We grew 
cultures of four MATa strains: a negative control expressing GAL1-TAP-Ø, a positive control expressing GAL1-TAP-SEN1 (2-931) 
and two sld3-7-td strains expressing GAL1-TAP-SEN1 (2-931) and GAL1-UBR1 with or without CTF4. Cells were grown in YP-Raff 
at 24°C to a density of 0.7 x 107 cells/ml. The cultures were then synchronized in G1 by addition of α-factor to a final concentration of 
7.5 μg/ml for 3 h. Half of the cells were then immediately harvested. The remainder of the cells was centrifuged out of solution, re-
suspended in YPGAL supplemented with 7.5 μg/ml of α-factor and left to incubate at 24°C for 35 min to induce expression of both 
TAP-SEN1 (2-931) and Ubr1. Thereafter the cultures were transferred to 37°C for 1 h to degrade Sld3-7-TD to prevent CMG 
assembly. The cells were released in S phase by re-suspension in fresh YPGAL pre-warmed to 37°C. 20 min after release, the cells 
were harvested. The cultures were sampled for FACS analysis before addition of α-factor, upon synchronization in G1 (at first point 
of harvest), after induction of the TAP-SEN1 (2-931) and Ubr1, 1 h after shifting the cultures to 37°C and at 20 min (at second point 
of harvest) and 40 min after release in S phase. (A) Schematic of origin-licensing and firing in wildtype and sld3-7-td strains. (B) 
FACS profiles of the experiment. (C) Whole cell extracts and IPs samples.  Strains used in this experiment: CS1852 (1), CS1957 (2), 
CS2791 (3) and CS2903 (4). 
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4.12 Residues 622-931 within the N-terminus of Sen1 is 
sufficient for its Interaction with the Replisome 
 
Given that Sen1 seems to interact independently with at least two components 
of the replisome, we decided to focus on Sen1 itself to further characterize this 
interaction in order to eventually break it. Our results thus far suggest that 
mutants of Sen1 lacking the first 931 amino acids are unable to interact with 
replisome components. However, the sen1-2 allele that lacks the first 945 
amino acids displays a plethora of aberrant phenotypes, including 
mitochondrial defects (Sariki et al., 2016). Results here and elsewhere also 
indicate that first 931 residues of Sen1 are responsible for interaction with 
proteins not involved in DNA replication (Ursic et al., 2004, Nedea et al., 2008). 
Unsurprisingly then, ablation of the first 912 or 930 residues leads to slow-
growth phenotypes, reminiscent of strains encoding the sen1-2 allele (Fig 
4.21). As such, simply removing the N-terminal domain of Sen1 is not a viable 
strategy to study the physiological importance of its interaction with the 
replisome.  
 
For this reason, we wanted to identify the smallest domain of Sen1 within its 
N-terminal domain that is sufficient for its interaction with the replisome and 
we aimed to construct an allele of the gene lacking the corresponding bases. 
We cloned several constructs of Sen1 spanning residues 2-931 tagged at the 
N-terminus with 3HA (Fig S.2) and under control of the strong, inducible GAL1 
promoter at the LEU2 locus in strains also carrying the TAP-MCM3 allele. We 
then carried S phase TAP IPs for the different clones. In silico analysis of the 
N-terminal domain of Sen1 revealed that residues 913-931 house a coiled-coil 
domain. We wondered whether the latter was important for the interaction 
between Sen1 and the replisome. The Sen1 (410-913) construct was poorly 
expressed compared to the Sen1 (410-931) construct, suggesting that this 
coiled-coil domain was required to stabilize the protein. On the other hand, the 
results from the screen indicate that the first 621 amino acids of Sen1 are 
dispensable for its interaction with the replisome. Indeed, we found that a 
construct of Sen1 spanning residues 622-931 was sufficient to co-precipitate 
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with the replisome in S phase (Figs 4.22 and 4.23). However, attempts to use 
the Sen1 (761-931) construct in IPs was unsuccessful as the construct was 
poorly expressed, indicating that we had reached the technical limitations of 
the screen in trying to clone ever smaller fragments of Sen1 capable of co-
precipitating with the replisome. 
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Figure 4.21. The SEN1 (931-2231) and SEN1 (913-2231) alleles lead to 
slow-growth phenotypes. Diploids of either SEN1/SEN1 (931-2231) or 
SEN1/ SEN1 (913-2231) were generated as described in Section 2.3.5. After 
sporulation, asci were treated with glucoronidase and individual asci were 
separated by microscopic manipulation into their constituent spores onto solid 
YPD medium. The spores were allowed to germinate at 30°C and scored by 
growth on selective media. Strains used in the experinent: CS2457 and 
CS2458.  Donor strains: CS2403 and CS2404. 
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Figure 4.22. Residues spanning 622-931 within the N-terminus of Sen1 are sufficient for interaction with the replisome. Cells 
carrying the TAP-MCM3 allele and different N-terminally tagged Sen1 fragments under the GAL1 promoter were grown in YP-Raff at 
24°C to a density of 0.7 x 107 cells/ml in 250 ml cultures. The cells were arrested in G1 using a-factor to a final concentration of 7.5 
µg/ml for 3 h. After successful arrest, YPGAL medium was substituted for YP-Raff, keeping a-factor at a concentration of 7.5 µg/ml 
for a further 35 min. The cells were then released from G1 arrest by washing out the a-factor with fresh YPGAL, followed by release 
in S phase in YPGAL at 24°C. Cells were harvested 30 min after release. The harvests were used for IPs using TAP beads. (A- D) 
Westerns of cell extracts and IPs of TAP for four different experiments. Strains used in this experiment:  CS1711, CS1714, CS2030, 
CS2032, CS2145, CS2146, CS2147, CS2148, CS2149 and CS2150. Two non-specific bands are observable upon blotting against 
the HA tag. These are indicated as either * or **.  
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Figure 4.23. Schematic summarizing the different constructs of Sen1 tested and their abilities to interact with 
replisome components in S phase. 
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4.13 Mini-truncations within the N-terminus of Sen1 
lead to Synthetic Defects 
 
Having established that residues 622-931 were sufficient for Sen1’s 
interaction with the replisome, we then designed the SEN1 (410-931D)-TAP 
and SEN1 (622-931D)-TAP alleles in an attempt to construct alleles of SEN1 
that encode for proteins that do not bind to the replisome whilst leaving large 
portions of the N-terminal domain untouched. 
 
The cloning was done in a diploid with one of the copy of SEN1 previously 
disrupted with the URA3 gene (Section 2.3.5). Integration of PCRs 
simultaneously substituted the URA3 gene with the novel allele of SEN1 whilst 
also tagging it with the TAP tag at its C-terminus and marking it with the 
reporter kanMX gene. The resulting clones were grown on FOA plates to 
select for URA auxotrophy. Colonies were then selected for growth on YPD 
supplemented with kanamycin and screened for integration at the correct 
locus by PCR. Individual clones were also screened by Western blotting. In 
brief, had the PCR integrated correctly, the TAP signal would be visible for the 
clone showing that there were no frameshifts introduced. Additionally, the TAP 
signal would run below that of a control Sen1-TAP clone. Clones that were 
judged to have integrated correctly were sequenced for the SEN1 gene and if 
the correct truncation mutation was present, the clones would be transferred 
onto sporulation medium and the resulting tetrads scored.  
 
Surprisingly, the SEN1 (410-931D)-TAP and SEN1 (622-931D)-TAP alleles 
caused a greater defect compared to either SEN1 (913- 2231) or SEN1 (931-
2231) (Fig 4.24). In fact, the SEN1 (410-931Δ) allele led to micro-colonies at 
30°C whilst cells encoding the SEN1 (622-931Δ) allele were distinguished by 
terminal arrest in G2 after germination, similar to sen1Δ cells. This suggests 
that the additional amino acid regions render SEN1 mutants unstable 
compared to SEN1 (931-2231) making them unsuitable mutants. We also tried 
to bridge the 409th or 623rd residues to the 932nd residue with either a small or 
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long linker or with a region of DNA coding for the Ctf4 Interacting Peptide from 
Pol1 (CIP). None of these strategies led to viable mutants (not shown). 
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Figure 4.24. The SEN1 (410-931D)-TAP and SEN1 (622-931D)-TAP alleles 
lead to micro-colonies and terminal arrest in G2 respectively. Diploids of 
either SEN1/SEN1 (410-931D)-TAP or SEN1/SEN1 (622-931D)-TAP were 
generated as described in Section 2.3.5. After sporulation, asci were treated 
with glucoronidase and individual asci were separated by microscopic 
manipulation into their constituent spores onto solid YPD medium. The spores 
were allowed to germinate at 30°C and scored by growth on selective media.  
Donor strains: CS2334 and CS2335.
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4.14 Identifying point mutants to disrupt the 
Interaction between Sen1 and the replisome 
 
The residues spanning 622-931 in Sen1 did not reveal any CIP box that could 
help mediate the interaction between Sen1 and Ctf4 (Samora et al., 2016). 
However, secondary structure analysis of those residues using the Jpred4 
software (Drozdetskiy et al., 2015) predicted several α-helices and, 
accordingly, several residues were predicted to be buried with at most 25% 
solvent accessibility. The Jpred4 software uses multiple-alignment of the input 
sequence (here residues spanning 501-1200 in Sen1) with several of its close 
orthologues to predict secondary structures. Moreover, analysis of the protein 
structure (using residues spanning 622-931) by the Phrye2 suggested that the 
N-terminal domain of Sen1 contained several Armadillo (ARM) repeats, similar 
to the human β-catenin protein (Kelley et al., 2015). ARM repeats are 
characterized by degenerate primary sequences but conserved tertiary 
structures made of three a-helices spanning around 40 residues collectively. 
Several ARMs fold and interact with one another in such a way as to produce 
a rigid super-helix of a-helices (Fig 4.25). The inner concave surface of the 
super-helix is positively-charged and it can promote protein-protein 
interactions (Tewari et al., 2010). To construct a mutant of Sen1 that is 
incapable of interacting with the replisome, we chose to conduct a screen of 
Sen1 mutants where residues of the protein that are both conserved (Fig 4.26) 
and that are predicted to occur on the surface of the super-helix (Yachdav et 
al., 2014) were mutated. The Jpred4 software was used to identity the various 
residues predicted to occur on the surface. These have a predicted solvent 
accessibility above 25%. We did so by adopting a site-directed mutagenesis 
approach (Qiagen). The residues targeted are depicted in Table 4.3.  
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Table 4.3. The residues that were targeted for mutagenesis to disrupt Sen1’s 
interaction with the replisome is depicted here. 
Mutant name Point Mutations 
sen1-3 W773A E774A W777A 
sen1-4 L656A S657A K658A I659A L660A 
sen1-5 D850A E851G V852A L853G L854A 
sen1-6 V746G D747G P748G I749G 
 
 
For the screen, we first cloned the 3HA-SEN1 (2-2231) allele at an ectopic 
locus (LEU2) under its own promoter whilst the endogenous SEN1 allele was 
deleted. We found that, at the ectopic locus, the 3HA-SEN1 (2-2231) was able 
to counter the lethal phenotype associated with sen1∆ (Fig 4.27). However, 
these cells grew poorly, suggesting the ectopic allele cannot fully complement 
sen1∆. Cloning the 3HA-SEN1 (931-2231) allele at the ectopic locus led to 
spores that germinate but terminally arrest in G2, similar to sen1∆. Thus, this 
allele cannot complement sen1∆ when cloned under the SEN1 promoter at 
the LEU2 locus. However, we have previously cloned cells with the SEN1 
(931-2231) allele at its endogenous locus and these cells were sick but viable. 
Taken together, these observations suggest that either the 3HA tag or an 
incomplete SEN1 promoter was introducing a synthetic defect. We then 
substituted the strong constitutive ACT1 promoter for the SEN1 promoter. 
Under the ACT1 promoter, 3HA-SEN1 (2-2231) cloned at the LEU2 locus was 
able to fully complement sen1∆ and cells carrying the 3HA-SEN1 (931-2231) 
allele at the ectopic locus in sen1∆ cells behaved similarly to cells carrying the 
SEN1 (931-2231) allele cloned at its endogenous locus. Thus, we chose to 
use SEN1 alleles cloned under the ACT1 promoter for our screen. Upon 
cloning of the mutant SEN1 alleles, we found that none of the mutants 
generated displayed any significant growth defects (Fig 4.28). 
 
We then carried out S phase IPs in strains carrying the TAP-MCM3 allele 
along with wildtype 3HA-SEN1 (2-2231) or the novel mutant alleles. A strain 
carrying an untagged SEN1 allele was used as a negative control. We found 
that cells carrying the sen1-3 allele did not co-precipitate with the replisome 
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(Fig 4.29). The sen1-3 allele is characterized by the W773A E774A W777A 
substitutions and the two mutated tryptophans correspond to the most 
conserved residues within the ARM repeats (Fig 5.7). Also notable was that 
MCM2-7 IPs in strains carrying the sen1-4, sen1-5 and sen1-6 alleles were 
characterized by stronger interaction between the replisome and Sen1. This 
could arise by morphing of the surface of the super-helix in such a way as to 
alter the strength of protein-protein interactions. As such, the strategy utilized 
in this study could be used as a blueprint to study interactions between ARM 
repeats proteins and their binding partners. The levels of the Sen1-3 protein 
were lower than that of its wildtype counterpart.  This was also true for the 
Sen1-4 and Sen1-5 proteins. This could indicate that these mutants are less 
stable than wildtype Sen1 (the mutations are unlikely to affect transcription 
downstream of the ACT1 promoter).  It is possible that the reduced levels of 
Sen1-3 could contribute to its lowered affinity for replisome components. On 
the other hand, Sen1-4 and Sen1-5 seem to interact more strongly with 
replisome components. As such any decreased stability of the Sen1-3 mutant 
cannot, on its own, account for the lowered affinity of the mutant for replisome 
components. 
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Figure 4.25. Armadillo repeats fold and interact with one another to form 
a super-helix of a-helices. The positively charged groove at its concave 
surface in thought to be responsible for protein-protein interactions. 
Importantly, the N-terminal domain of Sen1 does not contain a CIP box, but 
instead is predicted to encode for armadillo repeats. 
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Figure 4.26. Conservation scores of Sen1 residues spanning 622-931 against a consensus sequence. Armadillo repeats are 
conserved structurally but show less conservation at the primary sequence. Nonetheless, by comparing close orthologues of Sen1 
(via BLASTP), a consensus sequence was built against which the different residues of Sen1 (622-931) was be scored for 
conservation. In brief, residues 622-931 was analysed by PSI-BLAST (Position-Specific Iterative Basic Local Alignment Search Tool) 
(Altschul et al., 1997). The first iteration of the algorithm works as a normal BLASTp where the query amino acid sequence is 
compared to protein sequences in an unbiased database in order to identify regions of local alignment. The output of this first iteration 
is a multiple alignment of the highest scoring pairs as well as a position specific score matrix (PSSM) or profile generated from the 
multiple alignment of the query sequence. The PSSM captures the extent of conservation at individual amino acid positions. The 
second iteration of the algorithm then uses this PSSM as a query sequence against an unbiased database. Sequences that score 
above a set threshold are added to the multiple alignment and the PSSM is refined accordingly. Subsequent iterations are then used 
until no new sequences are added to the multiple alignment. This leads to generation of a final PSSM to which the residues of the 
original query sequence (here, Sen1 (622-931)) are scored. The higher the score, the more conserved are the individual residues. 
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Figure 4.27. Expressing SEN1 at an ectopic locus. Viable strains derived from the dissections: CS2582, CS2584, CS2586.
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Figure 4.28. Mutants of SEN1 used in the screen. None of the four mutants used to screen for loss of interaction with the replisome 
presented any significant growth defects and were able to complement sen1∆ fully. Viable strains derived from the dissections: 
CS2607, CS2609, CS2617, CS2623.
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Figure 4.29. Novel alleles of SEN1 abrogate or reinforce the interaction of the protein with the replisome. Cells carrying the 
TAP-MCM3 allele with novel alleles of SEN1 tagged at the N-terminus with the 3HA tag were grown in YPD to a density of 0.7 x 107 
cells/ml in 1 l cultures at 24°C. The cells were arrested in G1 using a-factor to a final concentration of 7.5 µg/ml for 3 h. After successful 
arrest, the cells were released from a-factor arrest by washing twice with fresh YPD, re-suspended in 1 l YPD and released in S 
phase at 24°C. The cells were harvested 30 min post-release and sample-prepared for use in IPs. Strains used in this experiment: 
CS2636, CS2638, CS2640, CS2642, CS2669 and CS2670. In this particular experiment, the protein levels of Sen1-3, Sen1-4 and 
Sen1-5 appear lower than that of the wildtype protein, as observed on Western blots. 
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4.15 Biological Consequences of Abrogating the 
Interaction between Sen1 and the Replisome 
 
Having established biochemically that Sen1-3 is defective for interaction with 
the replisome, we then set out to characterize the phenotypic consequences 
of such a loss of interaction in vivo. In isolation, none of the novels alleles of 
SEN1 were especially sensitive to non-optimal temperatures (25°C or 37°C), 
compared to wildtype. This contrasts to cells carrying the ACT1-3HA-SEN1 
(931-2231) allele that are slow-growing at both 25°C and 37°C (Fig 4.30). Nor 
did we detect any slow growth on non-fermentable sources of carbon (either 
glycerol or ethanol) that is characteristic of mitochondrial defects. Again, this 
contrasts with cells carrying the ACT1-3HA-SEN1 (931-2231) allele. Growth 
in either the dNTP-depleting agent hydroxyurea (HU) or the alkylating agent 
methylmethanosulfate (MMS) did not reveal any defect of the novel alleles of 
Sen1 compared to wildtype cells (Fig 4.30). Taken together, these results 
suggest that the point mutations used here do not grossly affect the 
functionality of the N-terminal domain of the protein. 
 
Given that depletion of Sen1 leads to increased levels of R-loops (Mischo et 
al., 2011), we wondered whether the sen1-3 mutant interacted genetically with 
mutants of proteins that either prevent the formation of R-loop (such as Top1) 
or with mutants that actively remove R-loops (such as the RNase H enzymes) 
(Aguilera and García-Muse, 2012). As a control, the other novel alleles of 
SEN1 were also used to detect synthetic interactions. Cells carrying the novel 
SEN1 alleles were not characterized by noticeable growth defects in the 
absence of Top1 (Fig 4.30). On the other hand, the sen1-3 allele conferred 
temperature-sensitivity at 37°C when grown in cells deleted for both RNH1 
and RNH201, demonstrating a synthetic defect that is not observable in rnh1D 
rnh201D cells. Moreover, the sen1-3 allele conferred increased susceptibility 
to both HU and MMS in rnh1D rnh201D cells (Fig 4.30). Given the role of 
RNases H1 and H2 in the removal of R-loops, these observations suggest that 
the association of Sen1 with replisomes helps cells to efficiently remove R-
loops. It is known that failure of nascent mRNA to be processed via the 
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THO/TREX complex also leads to stable R-loops (Huertas and Aguilera, 
2003). To confirm whether the synthetic defects in rnh1D rnh201D sen1-3 cells 
were indicative of stabilized R-loops, we crossed the sen1-3 allele into hrp1D 
cells. Hrp1 is a component of the THO/TREX complex. This double mutant 
also showed increased susceptibility to both HU and MMS, again suggesting 
that cells carrying the sen1-3 allele are not fully proficient in R-loop removal. 
Taken together, this suggests that loss of interaction between Sen1 and the 
replisome in sen1-3 cells leads to more stable R-loops.  
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Figure 4.30. The novel alleles of SEN1 show synthetic defects in the absence of RNH1 and RNH201. Strains were grown from 
frozen on fresh YPD at 30°C for 2 days. The cells were then diluted in water to obtain cell suspensions of 5 x106, 5 x 105, 5 x104 and 
5 x103 cells/ml. 10 µl of each suspension was pipetted onto either non-selective medium or non-selective medium supplemented with 
either HU or MMS. Cells were grown up to 4 days and imaged daily. For each condition, images from the same day are presented.  
Strains used (top to bottom): (topmost panel) CS1, CS2582, CS2584, CS2607, CS2623, CS2609; (second panel from top) CS44, 
CS2656, CS2659, CS2661, CS2668; (third panel from top) CS2734, CS2736, CS2738; (bottom panel) CS2276, CS2696, CS2702 
and CS2729. 
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Given that we had cloned the novel alleles of SEN1 under the strong and 
constitutive ACT1 promoter, the increased levels of the Sen1 molecules could 
mask some of the defects associated with the sen1-3 allele. To test this 
possibility, we generated the sen1-3 mutation at the endogenous SEN1 locus. 
We also tagged the gene with the TAP-tag. Using this strain, we carried out S 
phase IPs of TAP and found that Sen1-3-TAP, unlike its wildtype counterpart, 
did not co-purify with replisome components in S phase, including Ctf4 (Fig 
4.31). As such, cloning sen1-3 at its endogenous locus recaptures the loss of 
interaction when the allele is cloned at an ectopic site. We then constructed 
triple mutants of rnh1D rnh201D sen1-3-TAP. As a control, we found that cells 
carrying the rnh1D rnh201D SEN1-TAP alleles grew at similar rates to cells 
carrying only rnh1D rnh201D alleles, suggesting that the C-terminal TAP tag 
did not affect growth. By contrast, the rnh1D rnh201D sen1-3-TAP genotype 
was inviable (Fig 4.32). This confirms the genetic interaction between the 
RNase H enzymes and Sen1, suggesting that Sen1’s interaction with the 
replisome is required for the removal of DNA/RNA hybrids. In addition, 
overexpressing sen1-3 under control of the ACT1 promoter can mask some 
of defects linked to this allele. 
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Figure 4.31. The sen1-3 allele abrogates the interaction between Sen1 and the rest of the replisome when expressed at the 
genomic locus. Yeast cells carrying either the untagged SEN1 allele or SEN1-TAP or sen1-3-TAP were grown in YPD at 24°C to a 
density of 0.7 x 107 cells/ml. The cells were synchronized in G1 by addition of α-factor to a final concentration of 7.5 μg/ml for 3 h and 
the α-factor was washed out with fresh YPD and cells were released in S phase at 24°C. 30 min after release, cells were harvested 
at −80°C and the samples were used to generate cell extracts. The liberated proteins were immuno-precipitated using magnetic 
beads conjugated to IgG antibodies. The cultures were also harvested for FACS profile when asynchronous, once synchronized in 
G1, 30 min after release (at point of harvest) and 60 min after release. WCE and IPs are shown on the left hand and the FACS 
samples are shown on the right. Strains used: CS74, CS2853, CS2854.
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Figure 4.32. The triple rhn1Δ rhn201Δ sen1-3 mutant is inviable for 
growth. A strain carrying the rhn1Δ rhn201Δ deletion mutations was crossed 
with strains carrying either the SEN1-TAP or sen1-3-TAP alleles. The resulting 
diploids were transferred on sporulation medium and upon formation of asci, 
the spores within individual asci were aligned by micro-manipulation. The 
spores were allowed to germinate and grow on rich YPD medium at 24°C 
before being scored by replica-plating on selective media. Parental strains 
used: CS2735, CS2853 and CS2854
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Chapter 5: Discussion 
 
5.1 The Role of Polymerase α during Imprinting at 
MPS1 in Sz. pombe  
 
Fission yeast relies on the asymmetric nature of DNA replication to imprint and 
switch cell-types (Dalgaard and Klar, 1999). Efficient imprinting requires 
unidirectional replication of the mat1 locus which is itself dependent on forks 
to terminate at RTS1 (Dalgaard and Klar, 2001) and to pause at MPS1 
(Dalgaard and Klar, 2000). Several protein factors are required for the 
imprinting process. Amongst them, Pol1 is unique in that it is not required for 
the barrier activity at either MPS1 or RTS1. Instead, Pol1 is able to respond to 
competent fork stalling at MPS1 to imprint at that locus. Interestingly, a single 
switching- and imprinting-defective allele of pol1 (swi7-1) has been isolated to 
date.  
 
Here, I have used gel shifts assays to show that recombinant Swi7-1 has 
decreased affinity for a DNA/RNA substrate compared to its wildtype 
counterpart. Perhaps as a direct consequence of this reduced affinity, Swi7-1 
was also seen to be a less processive enzyme compared to Pol1. 
Crystallographic data of Pol1 suggests that the Gly1116 residue (Ser1134 in 
S. cerevisiae) that is mutated in swi7-1 is located in the thumb domain of the 
polymerase and is required for strengthening the grip of this domain on the 
RNA portion of a DNA/RNA substrate (Fig 5.1). Substituting the glycine to a 
glutamic acid increases both the steric hindrance and negative charge at that 
particular residue and is predicted to weaken the interaction between the 
enzyme and its substrate (Perera et al., 2013). Given that Swi7-1 carries this 
G1116E substitution, our data fits this prediction.
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Figure 5.1. Crystallographic data predicts that the swi7-1 mutant has reduced affinity for its DNA/RNA substrates because 
of the G1116E substitution. (A) The Pol1 protein from Sz. pombe was aligned to its orthologues from S. cerevisiae, H. sapiens, X. 
laevis and C. elegans using Clustal Omega and the image was generated using T-Coffee (Li et al., 2015). The alignment scores are 
given in terms of colour; blue/purple denotes residues that are not conserved whilst red/pink marks residues that are conserved. 
Additionally, the strength of conservation is highlighted from strongly conserved (.), to more conserved (:), to invariant (*). The residue 
mutated in swi7-1 (and the corresponding residues in the orthologues of the protein) is highlighted.  (B) The Ser1134 residue in Pol1S. 
cerevisiae (that aligns with Gly1116 in Pol1Sz. pombe) (highlighted) interacts with the phosphate backbone of the DNA/RNA hybrid (Perera 
et al., 2013).
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This suggests that the efficiency of imprinting correlates with the ability of Pol1 
to bind to its nucleic acid substrate at MPS1. According to such a model, 
replacing the incriminating Gly1116 residue with an aspartic acid would result 
in a mutant that has intermediate affinity for DNA/RNA substrates between 
those of Pol1 and Swi7-1. In addition, this Pol1G1116D mutant would also 
have imprinting and cell-type switching efficiencies intermediate between 
those of Pol1 and Swi7-1. We constructed a novel allele of pol1 (swi7-2) that 
is characterized by this G1116D substitution and found that cells carrying it 
indeed had cell-type switching defects intermediate to those of pol1 and swi7-
1. This result would suggest that the affinity of Pol1 (and consequently of 
Polymerase α) for its nucleic acid substrate at MPS1 is important for 
imprinting. However, given that neither the binding affinity of Swi7-2 for its 
substrate nor its polymerase activity has been tested empirically, we cannot 
at this time exclude the possibility that the defect in the swi7-2 cells may not 
be linked to a reduced affinity of Pol1 for its substrates.  
 
The imprint itself is RNase-sensitive and has been shown to consists of up to 
two ribonucleotides (Vengrova and Dalgaard, 2004, Vengrova and Dalgaard, 
2006). Some controversy surrounds the nature of the imprint as it has 
alternatively been characterized as a nick (Kaykov and Arcangioli, 2004). 
However, data from both groups are compatible with the imprint being RNA in 
nature (Vengrova and Dalgaard, 2005). In this study, we have identified a 
primase allele, spp1-GFP, that is completely defective for cell-type switching. 
We have also shown that mcl1Δ mutants are also defective for cell-type 
switching. However, the switching-defective pattern of mcl1Δ mutants is 
similar to that of pol1-1 and not to that of swi7-1, suggesting a stochastic loss 
of imprinting in some cells. Mcl1 is known to tether Pol1 to the replisome. 
Taken together, the characterization of the switching-defects of these mutants, 
especially of the spp1-GFP allele, further strengthens the case for the imprint 
to be RNA in nature. It should be noted however that iodine staining assesses 
the ability of cells to switch cell-types and not their imprinting directly. As such, 
the ability of cells carrying the swi7-2, spp1-GFP and mcl1Δ alleles to imprint 
need to be assessed formally by Southern blotting. Furthermore, the fact that 
cells carrying mcl1Δ from two sources have non-identical staining phenotypes 
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need to be reconciled. Importantly, the presence of genetic interactors need 
to be assessed. 
 
From the literature, it is clear that imprinting is regulated both spatially and 
temporally. Indeed, at the mat1 locus, three distinct priming sites have been 
identified. Two priming sites exist 30 and 350 bases past the MPS1 locus 
respectively (Vengrova and Dalgaard, 2004) and a priming site occurs at 
MPS1 itself (Sayrac et al., 2011). This unusual arrangement of priming sites 
is thought to contribute to the formation of the imprint at MPS1 by using an 
RNA primer as a precursor. In addition, Pol1 is required for the imprinting 
process, downstream of a fork pausing event at MPS1. 
 
Our results suggest that Pol1 participates in imprinting in one of two ways. It 
is possible that Pol1 participates in imprint formation by recruiting factors 
necessary for processing the RNA primer at MPS1. This would need to 
happen during pausing so that Pol δ does not remove the DNA/RNA primer 
synthesized by Pol α. In fact, it is possible that the pausing event at the MPS1 
locus enables remodelling of a part of the mat1 chromatin that includes the 5’-
end of the RNA primer into heterochromatin. This would prevent both the 
synthesis of the mat1 locus by Pol δ and removal of the RNA primer originating 
from MPS1 (Devbhandari et al., 2017), allowing time for the primer to be 
processed into the imprint. Given that Swi7-1 has reduced affinity for its 
DNA/RNA substrate, it might disengage from the substrate too quickly to 
recruit factors that are required to process the primer into the imprint (Fig 5.2). 
This would lead to temporal dysregulation of the imprinting process.  
 
Another scenario reflects the fact that the Swi7-1 is defective in polymerizing 
nucleotides in vitro. Here, the primase subunit of Polymerase α still 
synthesizes a primer that is converted post-replicatively into the imprint in 
wildtype cells. The primer is then converted in a Polymerase α- independent 
manner into the imprint. However, because of the reduced affinity of Swi7-1 
for its substrates, it is possible that upon intramolecular hand-off of the 
substrate from Spp1Pri1 to Swi7-1, the latter can only synthesize DNA 
inefficiently so that Spp1Pri1 needs to prime more frequently as a 
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consequence. This would lead to atypical primers that are either inappropriate 
precursors for formation of the imprint or that are efficiently removed by Pol δ 
(Devbhandari et al., 2017). An alternative to atypical priming in swi7-1 cells 
could be abortive priming, where Swi7-1 can only synthesize a few bases 
before falling off its substrate. The DNA/RNA substrate are not processed 
quickly enough so that RNases (or Pol δ) might remove the ribonucleotides in 
these hybrids. This antagonizes the formation of the imprint at MPS1 (Fig 5.3). 
Both high frequency and abortive priming can be thought as spatial 
dysregulation of imprinting. 
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Figure 5.2. Pol1 could participate in maturation of the imprint from a precursor RNA primer. In wildtype cells, the imprint could 
be generated from an RNA primer at MPS1. Pol1 could be important in this process by recruiting a protein that processes the primer 
into the imprint at the junction of the mat1 cassette and its H1 locus. By contrast, the Swi7-1 mutant has reduced affinity for its 
substrates and this would preclude formation of the imprint.
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Figure 5.3. Proper synthesis of DNA/RNA hybrids by Polymerase α could be important for imprinting at MPS1. In wildtype 
cells, proper synthesis of the DNA/RNA hybrid could enable processing of the RNA primer at MPS1 into the imprint. However, it is 
possible that Swi7-1 is not a good polymerase in vivo. To compensate, the primase subunit needs to synthesize more frequently. 
These atypical primers are not suitable precursors for imprint formation. Alternatively, once primase hands the primer over, inefficient 
activity by Swi7-1 may eventually lead RNases to remove the RNA primer prematurely so that the imprint is not synthesized. 
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5.2 Exploiting the swi7-1 mutant as a tool to study 
responses to fork barriers and to understand 
origin usage 
 
Here, I have demonstrated that Swi7-1 has reduced affinity for its template. 
Whether this also occurs in vivo has not been addressed. To do so, chromatin 
binding assays (Donovan et al., 1997, Liang and Stillman, 1997) could be used 
whereby spheroplasted cells are lysed and chromatin pellets and soluble 
fractions are collected separately. The relative binding of Pol1 and Swi7-1 to 
chromatin could thus be compared. Alternatively, the relative affinities of these 
two variants for nucleic acid substrates could be assessed by chromatin-
immuno-precipitation. In fact, these experiments would be critical to determine 
whether the decreased affinity of Swi7-1 for its substrates is compensated in 
vivo by other components of the replisome, such as Mcl1 (Mcl1 could increase 
the local concentration of the enzyme at forks). Should Swi7-1 also have 
defects in binding to nucleic acids in vivo, this would be in agreement with the 
model of imprinting proposed here. In addition, this would open new avenues 
for research.  
 
For instance, if swi7-1 cells are characterized by abortive priming, this could 
be a useful tool to study origin usage. Unlike origins in S. cerevisiae that 
contain an 11-17 base consensus sequence (Theis and Newlon, 1997), 
origins in Sz. pombe lack consensus, although they are AT-rich. However, 
both the location and firing efficiency of these origins have been systematically 
characterized (Heichinger et al., 2006). Thus, systematic analysis of origin 
firing in swi7-1 cells could inform us about the protein requirement for efficient 
origin firing in an in vivo setting. In this highly speculative scenario, it would 
also be interesting to determine whether some origins are more or less 
refractory to the swi7-1 mutation and whether this putative feature would be 
sequence specific. 
 
Should swi7-1 cells be characterized by high frequency priming instead, it can 
be hypothesized that such priming would not be restricted to the vicinity of the 
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MPS1 locus. It is also known that stalled forks can eventually skip barriers by 
re-priming immediately past them (Elvers et al., 2011, Lopes et al., 2006, 
Yeeles and Marians, 2013). It would be interesting to see if excessive priming 
can confuse replisomes, thus effecting a poor response to fork stalling.   
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5.3 Reassessing the posttranscriptional control of 
SEN1 expression 
 
The earliest attempt to characterize the enzymatic function of Sen1 in vitro 
was made in the Hochstrasser lab where the full-length gene (SEN1) was 
cloned in a high-copy vector plasmid and transformed in an S. cerevisiae host 
(DeMarini et al., 1995). For comparison, the authors also cloned a truncated 
allele (sen1-2) in the high-copy plasmid that they transformed in an S. 
cerevisiae host. This sen1-2 allele encodes for the Sen1 (976-2231) protein. 
However, whilst the Sen1-2 protein was highly visible on Western blots, the 
wildtype protein was not (DeMarini et al., 1995). On the other hand, Northern 
blots showed that the two genes were expressed at comparable levels 
(DeMarini et al., 1995). The authors also cloned SEN1 constructs fused to lacZ 
from E. coli in a high-copy vector and found that both Sen1 (1-1742)-LacZ and 
Sen1 (433-1742)-LacZ were expressed poorly whilst both Sen1 (571-1742)-
LacZ and Sen1 (857-1742)-LacZ were highly expressed. This suggested that 
residues 434- 570 of Sen1 negatively auto-regulated its protein levels by post-
transcriptional control of its transcript.  
 
In the present study, the TAP-SEN1 (2-931), TAP-SEN (2-1103) and TAP-
SEN1 (2-1901) constructs were expressed under control of the strong GAL1 
promoter. Although the mRNA levels of these different constructs were not 
formally assessed, appreciable amounts of proteins were recovered. This 
suggests that residues 434-570 of Sen1 are required but are insufficient to 
dampen the protein levels of Sen1 by post-transcriptional control of SEN1 
transcripts. Instead it suggests one of two likely models. Either a second 
stretch of residues within the Sen1 protein co-operatively mediates post-
transcriptional control of its transcript. Alternatively, residues 434-570 alone 
are involved in this post-transcriptional control but the target within the SEN1 
transcript is located beyond the first 3309 bases. Given Sen1’s ability to 
moderate its expression by affecting gene dosage dependence, it would be 
interesting to investigate whether Sen1 also affects the regulation of 
transcription at other loci. 
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Here, we generated a yeast strain with the following genotype: MATα td-MYC-
sen1-1 (klTRP1+) GAL1-UBR1 (HISMX) GAL1-TAP-SEN1 (2-2231) (LEU2+) 
(CS2188). The isogenic MATa strain was first created as a control where Sen1 
could be depleted at non-permissive temperatures and replaced with TAP-
Sen1 (2-2231). However, the TAP-Sen1 (2-2231) was seen to suppress sen1-
1 lethality at 37°C on YPD. This was seen in all clones with this genotype (the 
GAL1-TAP-SEN1 (2-2231) was fully sequenced and independently cloned at 
the LEU2 locus thrice). Given that the marker for both td-MYC-sen1-1 and 
GAL1-TAP-SEN1 (2-2231) (both markers were present C-terminally to their 
respective gene) were not compromised, it is unlikely that the leaky expression 
of GAL1-TAP-SEN1 (2-2231) arose as a result of meiotic recombination 
between those two alleles to generate a wildtype SEN1 gene. Instead, this 
observation suggests that the td-MYC-sen1-1 allele is defective in repression 
of the GAL1 promoter. The fact that the other SEN1 constructs did not 
suppress the lethality of td-MYC-sen1-1 at 37°C on YPD could indicate that 
the other constructs are not as well suited to complement Sen1’s depletion at 
low concentrations.   
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5.4 Stability of Sen1 constructs 
 
When overexpressed, Sen1 (2-931), Sen1 (2-1103) and Sen1 (2-1901) were 
easily detected in both TCA protein samples and cell extracts upon rupturing 
of the cell walls and membranes. This contrasted with Sen1 (2-2231), Sen1 
(931-2231) and Sen1 (1095-2231). These constructs were detected in TCA 
samples but underwent rapid lysis in cell extracts. In fact, when using 1.75 x 
109 cells to generate the extracts, these constructs could not be detected by 
Western blotting (Fig 5.4). This was independent of the protein tag used. This 
observation suggests that the last 330 residues of Sen1 contain a degron that 
can be targeted for rapid proteolysis. Constructs carrying these 330 residues 
were only visible in cell extracts prepared from 7 x 109 cells. This would 
suggest that the protein levels of Sen1 are maintained beneath a certain 
threshold, both by posttranscriptional control of its mRNA (DeMarini et al., 
1995) and by rapid proteolysis. The implication is evident. Although Sen1 is 
necessary for viability, excessive levels of the protein would cause global 
problems in transcription termination and gene expression, affecting growth.
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Figure 5.4. Constructs of Sen1 encoding the last 330 residues were especially liable. Sen1 constructs were cloned under the 
GAL1 promoter. To assess expression after addition of galactose, cells were collected for protein extraction by TCA. Cells were also 
collected to make cell extracts. Comparison between TCA samples and cell extracts showed that constructs of Sen1 carrying the last 
330 residues were very liable. By contrast, constructs carrying the first 1901 residues and endogenous proteins were relatively stable. 
This suggests that the last 300 residues of Sen1 encode for a degron that cells use to keep Sen1 levels beneath a certain threshold. 
(A) Constructs tagged with the TAP tag collected in S phase. (B) Constructs tagged with 3HA collected in S phase.  The arrows show 
the positioning of the different Sen1 constructs [black arrow: Sen1 (2- 931), light grey arrow: Sen1 (931-2231) and dark grey arrow: 
Sen1 (1095-2231)].
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5.5 Sen1 Interacts physically with Nrd1, Rad5 and RNA 
Polymerases 
	
In order to identify novel interactors of Sen1, a Y2H screen was employed with 
Sen1 (2- 931) used as bait. From the screen, two novel physical interactors 
of Sen1 were identified. The first one was Nrd1. It has previously been shown 
that Nab3, Nrd1 and Sen1 form a complex, and that Sen1, via residues 1890- 
2092, makes direct physical contact with Nab3 (Nedea et al., 2008). Here, the 
first 282 residues of Nrd1 was sufficient for the interaction with Sen1 (2-931), 
at least in the Y2H screen. If this interaction can be verified biochemically, it 
would suggest that the individual components of the NNS complex can form 
direct physical contacts with one another. This would also suggest that this 
trimer can toggle between an open and a closed conformation. This may have 
interesting implications for our understanding of the structure and assembly of 
the complex. This putative ability to open or close could also be important 
functionally (Fig 5.5). 
 
Figure 5.5. Identification of Nrd1 as a direct interactor of Sen1 suggests 
that the NNS complex can toggle between an open and a closed 
conformation. 
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It has previously been shown that Sen1 interacts physically with Rad2 (Ursic 
et al., 2004), a protein involved in nucleotide excision repair (Ursic et al., 
2004). NER is one of the pathways that cells use to remove pyrimidine dimers 
upon UV-mediated damage (Mao et al., 2016) and Sen1 was later found to 
play an important role in NER itself by virtue of its N-terminal domain (Li et al., 
2016). Importantly, the triple rad7∆ rad26∆ SEN1(1089-1929) mutant was 
more susceptible to UV treatment than the double rad7∆ rad26∆ mutant. 
Deletion of both RAD7 and RAD26 prevents repair of UV-mediated lesions 
using either branch (global genomic NER and transcription-coupled repair) of 
the nucleotide excision repair. Taken together, these observations suggest 
that Sen1 participates in the removal of UV-induced lesions in an NER-
independent pathway. 
 
One alternative way through which UV damage can be dealt with is the DNA-
damage tolerance (DDT) pathway where lesions can simply be skipped during 
DNA replication (Xu et al., 2015). Within DDT, a sub-pathway known as error-
free DDT is thought to use the newly replicated ‘sister’ strand as an 
undamaged template to bypass the damage site (Xu and Clayton, 1996). This 
is not dissimilar to replication between the RTS1 and MPS1 loci in imprinted 
fission yeast strains lacking the donor loci (Klar and Miglio, 1986). Error-free 
DDT requires the poly-ubiquitination of PCNA that is mediated by three 
proteins: Rad5, Mms2 and Ubc13. Rad5 is the E3 ligase. Here, in the Y2H 
assay, Rad5 has been identified as a physical interactor of Sen1. Notably, a 
Rad5 (12-265) construct was sufficient for this interaction. Taken together with 
observations in rad7∆ rad26∆ SEN1(1089-1929) cells, this suggests that Sen1 
may be involved in error-free DTT by virtue of its N-terminal domain.  
 
It should be noted that strains used in this study were all isogenic to W303 that 
carries the rad5-535 mutation. In the W303 background, cells carrying the 
sen1-3 mutation did not show any defect compared to SEN1 cells. Moreover, 
there was no observable difference between cells with the sen1-3 RAD5 and 
sen1-3 rad5-535 genotypes (not shown). Thus, the sen1-3 and rad5-535 
mutants do not interact genetically. Identifying alleles of SEN1 and RAD5 that 
would interact genetically with one another would be useful to discern the 
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biological relevance of Sen1’s interaction with Rad5. This constitutes an 
interesting avenue for future research. 
 
By mass spectrometric analysis of proteins that co-precipitate with Sen1 (2-
931), the N-terminal domain of Sen1 was also shown to interact with RNA Pol 
I, II and Pol III. RNA Pol I and III lack a CTD (Wild and Cramer, 2012), 
suggesting that the interaction between Sen1 (and the NNS complex) and 
these two RNA polymerases is different to the interaction between the NNS 
complex and RNA Pol II. Importantly, the number of peptides detected for the 
two largest subunits of RNA Pol III in the mass spectrometric screen was at 
least 10-fold higher than the number of peptides for the corresponding 
subunits of RNA Pol I and II. This suggests that Sen1 has a preference for 
RNA Pol III and that the protein has a critical role in the homeostasis of transfer 
RNA. Consequently, Sen1 is involved in regulation of the translation process. 
 
No replisome components were identified with the Y2H screen. This could be 
a result of either the technical limitations of the screen or of the physiological 
aspects of Sen1’s interaction with the replisome or a combination of the two. 
For example, should the trimerization of Ctf4 be necessary for interaction with 
Sen1, it would be possible that the Ctf4 fragments used in the Y2H screen 
were not able to trimerize or, alternatively, trimerized in such a way as to 
prevent interaction with the Sen1 construct. It should be noted however that 
Rad5 is required for fork progression following MMS treatment. Moreover, 
Rad5 also forms subnuclear foci upon MMS treatment and its protein levels 
peak in S phase (Ortiz-Bazán et al., 2014). Consequently, whilst not strictly 
involved in DNA replication, Rad5 is nonetheless required for fork progression 
under certain conditions.    
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5.6 The DNA/RNA helicase Sen1 is a bona fide 
component of the Replisome in the model 
organism S. cerevisiae 
 
It has previously been shown that Sen1 travels with forks in S. cerevisiae (Alzu 
et al., 2012). In fact, depletion of Sen1 by shifting cells containing the 
temperature-sensitive sen1-1 allele to non-permissive temperatures leads to 
a lengthening of S phase and terminal arrest in G2. These observations hint at 
a role of Sen1 during DNA replication. Here, using IPs from synchronous 
cultures, I have shown that Sen1 is a component of the replisome in yeast. It 
is perhaps surprising that Sen1 had yet to be recognized as such. Although 
no screen can claim to be exhaustive, one plausible explanation for this delay 
is the liability of the protein (DeMarini et al., 1995). Indeed, in this study IPs 
from cell extracts of 1.75 x 109 cells did not reveal any interaction between 
Sen1 and other replisome components, although this is sufficient to show 
interaction amongst other replisome components. It is only when I raised the 
yield to 7 x 109 cells that physical interaction between Sen1 and replisome 
components could be visualized. Importantly, full-length Sen1 would not seem 
to interact with any component of the replisome outside of S phase. 
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5.7 Posttranslational modifications of Sen1 or its 
binding Partners may affect the interaction 
with the Replisome 
 
On Western blots, Sen1 is often seen as a smear rather than a discrete band. 
This is more evident in immuno-precipitated samples. Sen1 is a 
phosphoprotein and residues spanning positions 2125 to 2144 
(ILTASDYGEPNQNGQNGANR) were identified in a mass spectrometric 
screen of the phosphoproteome of S. cerevisiae (Bodenmiller et al., 2010). By 
employing similar proteomics techniques, several other residues have been 
shown to be phosphorylated (Table 5.1). 
 
 
Table 5.1. Phosphorylated sites within Sen1 
Position of Residue Reference 
S863 (Swaney et al., 2013)  
S1047 (Swaney et al., 2013) 
S1053 (Swaney et al., 2013) 
S1055 (Swaney et al., 2013) 
S1058 (Swaney et al., 2013) 
T1487 (Bodenmiller et al., 2010)  
S1505 (Swaney et al., 2013) 
S2218 (Helbig et al., 2010) 
 
It is as yet unknown whether phosphorylation is a requirement for Sen1 to 
interact with the rest of the replisome. Our immuno-precipitation assays 
include two phosphatase inhibitors: sodium fluoride (that inhibits acidic, 
phosphoseryl and phosphothreonyl phosphatases) and sodium β-
glycerophosphate (that inhibits phosphoseryl and phosphothreonyl 
phosphatases). It would be relatively straightforward to assess whether 
phosphorylation is important for the interaction between Sen1 and other 
replisome components. To do so, a two-step S phase IP of TAP-Sen1 can be 
employed where, after cleaving Sen1 from TAP beads, the elute would then 
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be split and treated with either an inactivated or a functional phosphatase prior 
to incubation with calmodulin beads. However, it would not be possible to 
distinguish whether phosphorylation of Sen1 or the phosphorylation of some 
other replisome component (such as Ctf4) is important for the interaction using 
this method. 
 
Interestingly, I have shown that full-length Sen1 does not interact with any 
replisome components outside of S phase. However, a truncated variant of 
the protein, Sen1 (2-931) is able to interact with Ctf4 and GINS throughout the 
cell cycle. Absence of the first 931 residues abrogates the interaction with the 
replisome in S phase, suggesting that the last 1300 residues of the protein are 
dispensable for interaction with the replisome. The difference between Sen1 
and Sen1 (2-931) suggests that the last 1300 residues regulate the interaction 
between Sen1 (2-931) and Ctf4 and GINS in a cell cycle-dependent manner. 
This regulatory role could be dependent on posttranslational modification(s). 
Alternatively, a cell cycle dependent interactor of Sen1 that antagonizes its 
interaction with replisome components may require some post-translational 
modification as a cue to break its interaction with Sen1. 
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5.8 Identifying Replisome Interactors of Sen1 
 
By immunoprecipitation, the Sen1 (2-931) construct was seen to interact with 
both Ctf4 and GINS throughout the cell cycle. Deletion of Ctf4 abrogates 
interaction with GINS, suggesting that Sen1 interacts with Ctf4 only and not 
with GINS. However, it is also possible that Sen1 straddles both Ctf4 and 
GINS. To determine whether this is the case, GINS can be degraded 
specifically by shifting cells carrying the temperature-sensitive psf1-1 allele to 
non-permissive temperatures. IPs in the absence of Psf1 can then be carried 
out. Should Sen1 (2-931) not interact with Ctf4 in the absence of Psf1, this 
would suggest that Sen1 requires both Ctf4 and GINS to interact with the rest 
of the replisome. Moreover, the results presented here do not exclude the 
possibility that Ctf4 interacts with Sen1 through some other unknown 
interactor(s). To show that Ctf4 and Sen1 directly interact with one another, 
the two proteins need to be expressed and purified in isolation (for example, 
in an E. coli host or in a cell-free translation system) and the two proteins can 
then be mixed. Formation of Sen1-Ctf4 complexes would conclusively support 
the ability the two proteins to directly interact with one another. 
 
Ctf4 is made of three domains: an N-terminal WD40 domain, a central β-
propeller domain (required for trimerization) and a C-terminal α-helical domain 
that houses a second WD40 region. The first 350 residues of Ctf4 on their own 
cannot interact with Sen1 whilst deletion of the first 383 residues does not 
affect the interaction with Sen1. This suggests that the N-terminal domain of 
Ctf4 is dispensable for its interaction with Sen1. Truncation of the α-helical 
domain leads to a pronounced reduction in the levels of Ctf4 binding to Sen1 
(2-931), suggesting that this domain is required for optimal interaction. 
However, given that Sen1 (2-931) still interacts with Ctf4 (1-841), this suggests 
that either Sen1 (2-931) binds to at least two different regions of Ctf4 or that 
Ctf4 trimerization is sufficient for the Sen1 to interact with the protein. 
 
In cells deleted for Ctf4, subpopulations of Sen1 and Sen1 (2-931) can still 
interact with other components of the replisome in S phase. This suggests that 
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Sen1 interacts with replisome components other than Ctf4 and GINS. An 
alternative explanation is that ctf4∆ can lead to various changes in the cell 
(including changes in protein levels) that could contribute to Sen1 being able 
to artificially bind to the replisome in the absence of Ctf4. One way to test this 
hypothesis is to substitute a mutant of Ctf4, ctf4-4E [ctf4 (L867E A871E A897E 
I901E)] (Villa et al., 2016) for ctf4∆ in Sen1 or Sen1 (2-931) IPs. The ctf4-4E 
mutation abrogates the interaction between CIP-containing proteins (such as 
Pol1 and Sld5) and Ctf4 but it lacks many of the phenotypes of ctf4∆.  
 
Besides Ctf4 and GINS, no other replisome components co-precipitated with 
Sen1 (2-931) outside of S phase. Either there is an additional regulatory 
mechanism that prevents this Sen1 construct from binding to its other putative 
partners outside of S phase or there is a cell cycle dependent restriction to 
such interactions. As such, to test whether Sen1 interacted directly with other 
components of the replisome, I have used an in vitro reconstitution assay. In 
brief, strains carrying either the TAP-MCM3, POL12-TAP, DPB2-TAP alleles 
or an untagged control strain were harvested in S phase. In parallel, a strain 
carrying the SEN1-5FLAG allele and another untagged control strain were 
also harvested in S phase. Cell extracts were generated for the TAP-tagged 
strains (and the control) and a modified two-step TAP IP was carried out. After 
incubation with cell extracts, the TAP beads were washed successively with a 
solution containing 700 mM potassium acetate to remove weak interactors and 
a solution containing 50 mM potassium acetate, followed by cleavage of the 
proteins off the beads using the AcTEV protease. Simultaneously, cell extracts 
were generated using the cells carrying the SEN1-5FLAG allele (and the 
control) and FLAG IPs were carried out. The FLAG beads were washed 
successively with a solution of 700 mM potassium acetate and a solution of 
50 mM potassium acetate. The CBP-tagged proteins (and their strong 
interactors) cleaved from TAP beads were then split in half. One half was 
incubated with FLAG beads to which SEN1-5FLAG were bound whilst the 
other half was incubated with FLAG beads incubated previously in cell extracts 
with no tagged protein. Unfortunately, results from this in vitro assay were not 
fully reproducible and the assay needs to be optimized further. 
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However, if results from this assay were to be correct (Fig 5.6), it would show 
that Sen1 is able to bind independently to several replisome components. This 
would not fit with observations that Sen1 (2-931) cannot interact with 
replisome components in S phase (other than Ctf4 and GINS) upon 
degradation of Sld3-7-TD in G1. (Fig 4.20). There are a couple of plausible 
explanations for the discrepancies between the two assays. 
 
Firstly, it is possible that, within an assembled replisome, its individual 
components are modified in such a way that allows Sen1 to bind to them. 
When replisomes are not assembled at origins, the necessary modifications 
are not present so that some replisome components can no longer interact 
with Sen1. A second possibility is that Sen1 interacts with some replisome 
components indirectly through histones or nucleosomes. The inability to form 
replisomes would interfere with the interaction between histones or 
nucleosomes with replisome components, also interfering with the ability of 
these components to interact with Sen1. Finally, some interaction between 
Sen1 and replisome components could reflect nucleic acid-protein 
interactions. Indeed, although we use a universal nuclease in our IP 
experiments, some ssDNA could be trapped in polymerases. Sen1, but not 
Sen1 (2-931), would then be able to bind to these nucleic acid species by 
virtue of its helicase domain. 
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Figure 5.6. Summary of the in vitro assay to test phase-specific protein-protein interactions. Cells growing in S phase were 
harvested. These cells were used to generate cell extracts. Cell extracts from TAP-tagged strains (and an untagged control) were 
incubated with TAP beads and washed stringently to ensure only TAP-tagged preys and their strong interactors remained on the 
beads. These proteins were then cleaved from beads using the AcTEV protease. Simultaneously, cells extracts from Sen1-5FLAG 
strains (and a control) were incubated with FLAG beads. The beads were stringently washed to ensure only FLAG-tagged preys and 
their strong interactors remained on the beads. Calmodulin-tagged protein samples cleaved from the TAP beads were then split in 
two and incubated with either the empty FLAG-beads or FLAG-beads bound to Sen1-5FLAG. The left panel gives a schematic of this 
assay whilst the right panel gives an example output generated. However, results from the screen were not fully reproducible and the 
screen needs to be optimized further. 
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5.9 Mutation of Armadillo repeat motifs as a 
strategy to study protein-protein interaction 
 
The armadillo (ARM)-repeat is evolutionarily ancient and has evolved to 
mediate diverse functions (Tewari et al., 2010). In yeast, the Vac8 protein (that 
shares ~22% identity with the first identified ARM-repeat protein, β-catenin) 
also has an ARM-repeat motif that serves as a hub for interaction with several 
proteins. This contributes to the functional versatility of the protein. By 
performing S phase IPs of MCM2-7 in cells carrying progressively smaller 
constructs of Sen1, I have identified residues 622-931 of Sen1 that were 
sufficient for interaction with replisome components. Analysis of these 
residues revealed that they were predicted to encode several ARM-repeats. 
Sen1, like Vac8, is a versatile protein with several functions. It is possible that 
the ARM-repeats contribute to the plethora of activities of the protein. Thus, to 
create a mutant of Sen1 that no longer interacts with replisome components, 
I have mutated residues within the ARM-repeats that were predicted to occur 
on the surface of the secondary structures formed by those repeats and that 
were highly conserved. Conservation was assessed by comparing the 
sequence of Sen1 to its close orthologues in other yeasts (Fig 5.7). A single 
mutant (sen1-3) abrogated the interaction between Sen1 and the replisome in 
S phase. Moreover, several other mutants, including Sen1-4, Sen1-5 and 
Sen1-6, seemed to interact more strongly with the replisome. These 
observations suggest that the mutations used effectively altered the 
conformation of the N-terminal domain of Sen1 without affecting its overall 
stability. As such the strategy devised to create mutants of Sen1 is a viable 
one to study protein-protein interactions in ARM-repeat proteins, with the 
caveat that weakening the interaction with a particular partner could 
strengthen interaction with other partners and vice-versa. This potential 
artefact was not tested here but could be assessed by IPs, followed by mass 
spectrometric analysis. 
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Figure 5.7. Alignment of Sen1 with its close fungal orthologues. In order 
to generate mutants of Sen1 that do not interact with the replisome, residues 
were selected based on their conservation status and whether or not they were 
predicted to be localized on the surface of the secondary structures formed by 
ARM-repeats. Conservation was determined by comparison with fungal 
orthologues of the protein. The figure above highlights the residues (sen1-3, 
sen1-4, sen1-5 and sen1-6) that were chosen for mutagenesis. 
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5.10 Assessing the Specificity of the sen1-3 allele 
	
Sen1 is diverse in its functioning and it is involved in transcription termination 
(Mischo et al., 2011) and transcription-coupled repair (Li et al., 2016). The N-
terminal domain of the protein is thought to be primarily important for protein-
protein interactions and several proteins have been shown to bind to it, 
including Rad2, Rnt1, as well as RNA Pol II (Ursic et al., 2004, Yüce and West, 
2013). In this study, I have identified that Sen1 also interacts with the 
replisome through this N-terminal domain. To understand the biological 
relevance of this interaction, it was necessary to generate mutants of Sen1 
that lose the interaction with the replisome whilst not interfering with its other 
interactions and functions. To maximize the likelihood of isolating such a 
specific mutant, I generated point mutants of SEN1 and screened them for 
loss of interaction with the replisome. Using this strategy, the sen1-3 mutant 
was isolated. The latter is characterized by three substitutions (W773A E774A 
W777A).  
 
This novel allele does not present several of the phenotypes associated with 
the sen1-2 allele (that encodes for a protein that lacks the N-terminal domain), 
including slow growth and growth defects on non-fermentable carbon sources 
such as ethanol and glycerol (Sariki et al., 2016). Nor is it temperature-
sensitive, unlike the sen1-1 allele. Importantly, cells carrying the sen1-1 allele 
are also characterized by transcription defects. As such, it would be especially 
important to assess the transcription termination efficiency in cells carrying the 
sen1-3 allele. We are collaborating with Prof Domenico Libri (Institut Jacques 
Monod, CNRS, France) to assess whether sen1-3 is characterized by any 
transcription termination defects. The Libri lab will use Northern blots of 
reporter genes to assess whether transcription proceeds beyond the PAS sites 
in cells carrying the sen1-3 allele. They will also use a method known as CRAC 
(in vivo crosslinking and analysis of cDNA to RNA Pol II) to determine whether 
the substrate utilization of RNA Pol II is altered (Granneman et al., 2009), 
indirectly assessing the transcription termination efficiency in sen1-3 cells. 
Preliminary result from the Libri lab suggests that sen1-3, unlike sen1-1, has 
no defects in transcription termination of RNA Pol II genes. Moreover, recent 
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experiments from our lab has demonstrated that the Sen1-3 protein interacts 
with RNA Pol II, similar to its wildtype counterpart. Cells carrying the sen1-3 
mutation will also be tested against wildtype and sen1-1 cells for their ability 
to spontaneously form R-loops, using antibodies that specific recognize R-
loops (S9.6).  
 
Another feature of the sen1-3 allele that needs addressing is to determine to 
what extent the corresponding mutant protein affects DNA replication 
specifically. In fact, the lethality of sen1-3 rnh1Δ rnh201Δ cells might not be 
indicative of obstructed forks. To formally test the effect of the sen1-3 mutation 
on the progression of DNA replication, genetic assays will be used to 
investigate whether head-on and co-directional collisions between replication 
forks and RNA Pol II transcription complexes trigger increased genomic 
instability (Prado and Aguilera, 2005). On the other hand, cells carrying the 
sen1-3 allele and also deleted for MRC1 are both temperature-sensitive and 
hyper-sensitive to hydroxyurea (Section 5.11). This suggests that, in the 
presence of Sen1-3, replication forks require the Mrc1 protein (and the fork 
protection complex) during replication under stressful conditions. This can be 
interpreted as a replication-specific defect in sen1-3 cells.   
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5.11 The sen1-3 allele interacts genetically with MRC1 
 
The sen1-1 allele is synthetically lethal with several mutants that provoke fork 
instability and in the absence of genes involved in homologous recombination 
(Alzu et al. 2012). Consequently, the sen1-3-TAP allele was tested for its 
genetic interaction with some of the mutants that trigger sen1-1 lethality 
(Lones & De Piccoli, unpublished). Moreover, synthetic defects in the absence 
of the Pif1 helicases that are involved in DNA replication were also assessed. 
Most of the mutants tested did not interact genetically with sen1-3-TAP. 
However, mrc1∆, tof1∆ and rad50∆ interacted with the sen1-3-TAP allele (Fig 
5.8). The interaction with Rad50 suggests that R-loops that are not removed 
by Sen1 can lead to the formation of DSBs whilst interactions with the tof1∆ 
and mrc1∆ alleles suggest that Sen1 functions at forks. Because the defects 
observed in the sen1-3-TAP mrc1∆ double mutant at 37ºC and in 50 mM 
hydroxyurea were more profound than those seen in the sen1-3-TAP tof1∆ 
double mutant in 100 mM HU, it was thought that the defects associated with 
sen1-3 led to defects in the S phase checkpoint. Strikingly, however, sen1-3 
presented a more obvious defect in the absence of CTF18 and MRC1 than in 
the absence of RAD53 (Fig 5.8). As Rad53 is the effector kinase of the S 
phase checkpoint, these results suggest that the defects observed in the sen1-
3 cells only partially reflects defects in the S phase checkpoint.  
 
The temperature-sensitivity of the sen1-3-TAP mrc1∆ double mutant could 
indicate that, at higher temperatures and in the absence of Mrc1, collisions 
between replication forks and transcription complexes are increased to such 
an extent that excessive levels of R-loops are enriched on the genome. Given 
that the Sen1-3 protein is not enriched locally at forks, the RNase H1 and H2 
enzymes would seem unable to remove the corresponding excess of R-loops 
on their own. In order to investigate the phenotype of the sen1-3-TAP mrc1∆ 
double mutant further, cell cycle progression experiments were conducted 
(Lones & De Piccoli, unpublished). In brief, control and mutant strains were 
grown at 24ºC, arrested in G1 and shifted to 37ºC whilst still arrested. The cells 
were then released in S phase at 37ºC (Fig 5.9). Upon release from G1-arrest, 
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SEN1-TAP cells completed S phase within 40 min, where a major G2 peak 
can be seen. sen1-3-TAP cells also completed S phase within 40 min, 
indicating that this mutant does not undergo a prolonged S phase. By contrast, 
SEN1-TAP mrc1∆ took 60 min to complete S phase whilst sen1-3-TAP mrc1∆ 
cells only completed DNA replication 70 min post-release from G1. In the 
absence of Rad53, SEN1-TAP completed DNA replication in 50 min whilst 
sen1-3-TAP cells did so in 60 min. Interestingly, sen1-3-TAP mrc1∆ strains 
had a significant population of cells stalled in G2 after S phase completion. 
Taken together, this suggests that Sen1 associates with replisomes to remove 
barriers that otherwise trigger continued checkpoint arrest. Given the known 
functions of Sen1, the barriers in question are probably R-loops or actively 
transcribing complexes. This reinforces the notion that the transcription 
process and its intermediates can impede fork progression with dangerous 
consequences for genome integrity. 
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Figure 5.8. Sen1 interacts with MRC1. (A) Unlike sen1-1, sen1-3 does not interact genetically with several deletion mutants. 
However, sen1-3 interacts profoundly with mrc1∆ at 37ºC. (B) sen1-3 displays synthetic defects in the absence of RAD53 and CTF18. 
However, the synthetic defect with ctf18∆ and mrc1∆ is stronger than the corresponding defect seen with rad53∆. Lones and De 
Piccoli (unpublished). 
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Figure 5.9. The sen1-3 mrc1∆ double mutant has a delayed progression in S phase with a large population of cells arrested 
in G2. Cells were grown in YPD at 24ºC and synchronized in G1. Once arrested, the cells were shifted to 37ºC for 1 h and then 
released in S phase at 37ºC. FACS samples were collected at the stated time points. The blue bars indicate the duration of replication 
in minutes. Lones and De Piccoli (unpublished). 
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5.12 Sen1 uses the replisome to remove R-loops and is 
required for response to fork barriers 
	
In budding yeast, R-loops are removed by Sen1, RNase H1 and RNase H2 
(Aguilera and García-Muse, 2012). Here, we have shown that the triple rnh1∆ 
rnh201∆ sen1-3 mutant is inviable. Double mutants in any combination 
however are not. Given the overlapping roles of RNase H1 and RNase H2 in 
the removal of R-loops and the enrichment of these nucleic species upon Sen1 
depletion, it is tempting to suggest that Sen1’s interaction with replisome 
components serves to quickly recruit Sen1 at sites where forks encounter R-
loops. This localized enrichment of Sen1 facilitates the removal of R-loops. 
 
Overexpression of the sen1-3 allele using the strong ACT1 promoter is able 
to suppress the lethality associated with the triple rnh1∆ rnh201∆ sen1-3 
mutant. Overexpression of Sen1-3 then must somehow recapitulate (at least 
partially) the local enrichment of Sen1 at forks. To further characterize the role 
of Sen1 at forks, a strain encoding the sen1-3 mutant as well as degron alleles 
of RNH1 and RNH201 is being constructed. This would also help to investigate 
the role of Sen1 at forks in the absence of RNase H1 and H2 in a single cell 
cycle. Alternatively, the rnh1∆ rnh201∆ ACT1-3HA-sen1-3 that is inviable at 
37ºC could be used where cells synchronized in G1 could be shifted to non-
permissive temperatures before release in S phase. It would also be 
interesting to see whether a sen1-3 allele with a cloned CIP-tag that 
recapitulates its interaction with Ctf4 would still lead to synthetic lethality in the 
absence of both RNH1 and RNH201. The sen1-3 allele also interacts 
genetically with both ctf18∆ and mrc1∆ (Lones and De Piccoli, unpublished).  
Taken together, these observations strongly suggest that the Sen1 DNA/RNA 
helicase is required at forks (Fig 5.10). 
 
To further characterize the role of Sen1 at forks, we can exploit the genetic 
interactions between the sen1-3 allele and either ctf18∆ or mrc1∆, and the fact 
that overexpression of the RNase H1 gene has been shown to decrease levels 
of R-loops in several organisms, including yeast (Mischo et al., 2011). Indeed, 
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should overexpression of RNase H1 suppress the temperature-sensitivity of 
sen1-3 ctf18∆ double mutants and both the temperature-sensitivity and 
hypersensitivity to HU of sen1-3 mrc1∆ double mutants (Fig 5.8), it would 
strongly suggest that the sole role of Sen1 at forks is R-loop homeostasis. On 
the other hand, should overexpression of RNase H1 not suppress these 
phenotypes, it would indicate that Sen1 may have alternative roles at forks. 
 
The fact that Sen1 is required at forks raises an important question on the 
recruitment process of the protein to forks. It is possible the Sen1 associates 
with forks at the onset of S phase, irrespective of conditions. Alternatively, it is 
possible that Sen1 is only recruited when forks encounter R-loops. The latter 
scenario requires some pathway that would signal Sen1’s recruitment at the 
impeded forks. To differentiate between those two possibilities, 
immunoprecipitations can be used to monitor the affinity of Sen1 for replisome 
components in S phase whilst varying the levels of R-loops. For instance, IPs 
can be carried out in wildtype strains, in strains deleted for both RNase H1 
and RNase H2 (favouring stable R-loops) and in strains where RNase H1 is 
overexpressed (thus quickly removing R-loops). If the affinity of Sen1 for the 
replisome is independent on the levels of R-loops, it would suggest that Sen1 
associates to replisomes, irrespective of whether forks encounter R-loops. 
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5.13 Conservation of the function of Sen1 at Forks 
 
In this study, I have shown that Sen1 interacts with replisome components. 
The utility of this interaction is explored in Sections 5.11 and 5.12. It remains 
to be seen whether the binding of Sen1 to replisomes and its functioning at 
forks is conserved. In fungal orthologues of yeast Sen1, of the three residues 
mutated in sen1-3, two tryptophans are invariant (Fig 5.7). This includes the 
two fission yeast orthologues of Sen1, Dbl8 and Sen1Sz.pombe. This suggests 
that the interaction with replisomes is conserved. In higher eukaryotes, the N-
terminal of Senataxin has undergone strong divergence at the level of the 
primary sequence. However, given that the N-terminal domain of the protein 
is not separate from its essential, conserved helicase domain, it is possible 
that mutations that significantly alter the functioning of the protein were 
selected against. In fact, in human and HeLa cells, Senataxin forms foci upon 
treatment with aphidicolin, suggesting that Senataxin, like Sen1, also functions 
at forks (Yüce and West, 2013). 
 
Mutations in the SETX gene causes one of two neurological disorders. One of 
these disorders, AOA2, can be reconciled with defective transcription 
termination by Senataxin (Chen et al., 2014). The second disorder, ALS4, has 
a more obscure pathophysiology. Importantly, ALS4 sufferers are 
characterized by degeneration of motor neurons but other tissues appear 
unaffected (Bennett and La Spada, 2015). It is possible that, in human cells, 
Senataxin travels with forks enabling rapid removal of R-loops, much like 
Sen1. Moreover, in non-neuronal cells, SenataxinALS4 molecules would appear 
to compensate for their putative defect in R-loop removal by virtue of still being 
able to travel with forks, thus providing a localized concentration of the protein 
where R-loops block fork progression. However, neurons do not replicate their 
DNA. As such, a similar localized concentration of Senataxin mediated by 
forks would not be possible in these cells. Consequently, they would 
accumulate R-loops and DNA damage over time. This would correlate with the 
progressive nature of the disease. Of the paralogues of Senataxin, mutations 
in IGHMBP2 has been linked to neuropathy (Guenther et al., 2009) whilst 
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exogenous RENT1 expression improves survival in nerves harvested from 
murine models of ALS (Barmada et al., 2015).   
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Figure 5.10. The role of the Sen1 DNA/RNA helicase at forks. Results in this study have shed light on the mechanism of action of 
Sen1 at forks and complement previous studies on the subject (Mischo et al., 2011). In wildtype cells, Sen1 interacts with the 
replisome by virtue of its N-terminal domain. Sen1 uses this domain to bind to Ctf4 and, perhaps, other replisome components. This 
enables Sen1 to be quickly recruited at sites of head-on collisions between forks and transcribing complexes, that are favourable to 
the formation of R-loops (Hamperl et al., 2017). In this study, I have generated a mutant of Sen1, Sen1-3 that does not bind to 
replisomes. In isolation, this mutant is indistinguishable from wildtype, suggesting that enzymes are able to complement fully the loss 
of interaction between Sen1 and the replisome. However, in the absence of both RNase H1 and H2, sen1-3 cells are not viable, 
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suggesting that the RNase H1 and H2 enzymes can compensate for the loss of interaction between Sen1 and forks. Given the roles 
of the RNase H enzymes in R-loop removal, this suggests that Sen1 travels with forks to rid the genome of R-loops. Interestingly, 
overexpression of Sen1-3 using the ACT1 promoter is able to suppress the lethality of the sen1-3 allele in the absence of the RNase 
H enzymes. This suggests that Sen1 can be recruited to sites of collisions between forks and transcribing complexes independently 
of the replisome.
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5.14 Conclusion and perspectives 
 
The work in this thesis described the efforts to characterize how eukaryotic 
cells deal with DNA/RNA hybrids especially in the context of DNA replication. 
To this end, the role of Pol1 in imprinting in Sz. pombe and the role of the 
DNA/RNA helicase Sen1 at forks in S. cerevisiae have been investigated.  
 
For the Pol1 part of the study, a reductive approach was used whereby 
recombinant proteins were used to differentiate between wildtype Pol1 and its 
mutant counterpart (Swi7-1) that is defective for imprinting and, thus, cell-type 
switching in Sz. pombe (Gutz and Schmidt, 1985). The in vitro results suggests 
that the mutant protein has reduced affinity for its substrates. Whether this 
also holds true in an in vivo setting remains to be seen but can be determined 
empirically (Donovan et al., 1997, Liang and Stillman, 1997). An interesting 
question that arises from these experiments is how do cells cope with a Pol1 
variant that has a markedly reduced affinity for its substrates? It is possible 
that in an in vivo context, components of the replisome (such as Mcl1Ctf4) serve 
to alleviate the defect associated with Swi7-1. Alternatively, there might be a 
mechanism that allows for decoupling of priming by the primase subunit of Pol 
α and DNA synthesis by its Pol1 subunit where DNA synthesis is instead 
dependent on Pol δ or ε. In such a situation, the processive polymerases 
would affect imprinting at the MPS1 locus. It would be interesting to see 
whether this potential decoupling also occurs in other eukaryotes.  
 
Meanwhile, in this study we also provide evidence that the DNA/RNA helicase 
Sen1 travels with replication forks in S phase. We have shown that Sen1 
interacts with at least two components of the replisome, including Ctf4 
although we have yet to show that Sen1 interacts directly with these proteins. 
To that end, we need to purify Sen1 and its replisome interactors separately 
(perhaps from two different host organisms) and reconstitute the putative 
interaction in vitro. Having established that the N-terminal domain of Sen1 is 
required for interaction with the replisome, we then generated a mutant of 
Sen1, Sen1-3, that no longer interacts with the replisome. Importantly, the 
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residues mutated in Sen1-3 are conserved in close homologs of Sen1, 
including in the Sen1 and Dbl8 proteins from Sz. pombe, suggesting that the 
interaction between Sen1 and the replisome in conserved.  
 
In cells carrying the sen1-3 allele, absence of both RNase H1 and H2 is lethal, 
suggesting that Sen1 is required at forks to remove R-loops. This lethality can 
be suppressed if the sen1-3 allele is expressed from a strong constitutive 
(ACT1) promoter instead of the endogenous SEN1 promoter, suggesting that 
Sen1 can also be recruited in a replisome-independent manner to loci where 
forks encounter R-loops. There is also synthetic interaction between both 
mrc1Δ and ctf18Δ and the sen1-3 allele, further indicating a role for Sen1 in 
fork progression. It should be noted that the human homolog of Sen1, 
Senataxin has been shown to form foci in S phase and upon treatment of the 
cells with aphidicolin (Yüce and West, 2013). As such, it seems that the role 
of Sen1 at forks is at least partially conserved in eukaryotes, whereby the 
replisome actively makes use of the DNA/RNA helicase to remove R-loops. At 
present, it is also evident that patients with AOA2 and ALS4 present few non-
neuronal symptoms. Perhaps this selective penetrance of these diseases 
reflect the fact that neurons do not undergo DNA replication. It would be 
interesting to see whether non-neuronal quiescent cells in AOA2 or ALS4 
individuals also present defects associated to prolonged presence of R-loops 
on chromosomes.  
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Supplementary Data 
	
Table S.1. Raw data from Mass Spectrometric screen of Sen1 (2-931) IPs (Refer to Sections 4.5- 4.7). Strains used: CS1852 and 
CS1957. 
 
Prey Bait 
TAP-Ø TAP-Sen1 (2-931) 
Gene Name/ Identifier Accession Number Molecular 
Weight 
Asynchronou
s 
G1 S G2 
SEN1 YLR430W 253 kDa 0 348 509 340 
Retrotransposon TYA Gag and TYB Pol genes YPL257W-B 199 kDa 13 290 314 248 
RPO31 YOR116C 162 kDa 0 282 328 228 
RET1 YOR207C 129 kDa 0 183 190 180 
CTF4 YPR135W 104 kDa 0 93 243 107 
SSB2 YNL209W (+1) 67 kDa 84 76 119 149 
TEF2 YBR118W (+1) 50 kDa 86 79 106 106 
CDC19 YAL038W 55 kDa 59 57 93 103 
SPT16 YGL207W 119 kDa 0 16 233 54 
MCM4 YPR019W 105 kDa 0 5 244 45 
MCM6 YGL201C 113 kDa 0 0 254 51 
RPC82 YPR190C 74 kDa 0 99 90 95 
TOF1 YNL273W 141 kDa 0 0 235 42 
MRC1 YCL061C 124 kDa 0 8 231 36 
MCM5 YLR274W 86 kDa 0 0 192 66 
SSA1 YAL005C 70 kDa 63 57 63 82 
MCM2 YBL023C 99 kDa 0 0 202 37 
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POL1 YNL102W 167 kDa 0 2 212 22 
MCM3 YEL032W 108 kDa 0 5 184 38 
URA2 YJL130C 245 kDa 57 42 55 37 
MCM7 YBR202W 95 kDa 0 2 145 29 
RPG1 YBR079C 110 kDa 28 30 48 44 
ACC1 YNR016C 250 kDa 39 45 38 25 
DIA2 YOR080W 85 kDa 0 0 106 34 
POL2 YNL262W 256 kDa 0 0 122 10 
RPL3 YOR063W 44 kDa 23 20 49 37 
PAB1 YER165W 64 kDa 24 26 41 32 
GUS1 YGL245W 81 kDa 28 31 28 35 
RPS3 YNL178W 27 kDa 27 30 28 30 
RPS4B YHR203C (+1) 29 kDa 20 28 36 33 
HSP60 YLR259C 61 kDa 31 27 24 30 
SCP160 YJL080C 135 kDa 18 22 45 26 
CDC53 YDL132W 94 kDa 0 0 73 33 
RPL7A YGL076C 28 kDa 21 30 27 26 
RPC53 YDL150W 47 kDa 0 33 33 35 
RPB2 YOR151C 139 kDa 0 28 43 33 
CDC45 YLR103C 74 kDa 0 0 80 16 
YEF3 YLR249W 116 kDa 23 20 26 26 
TDH3 YGR192C 36 kDa 14 24 29 26 
RPC40 YPR110C 38 kDa 0 38 27 29 
POB3 YML069W 63 kDa 0 2 74 16 
RPL4A YBR031W 39 kDa 19 21 24 29 
RPS1B YML063W 29 kDa 19 21 26 26 
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DEF1 YKL054C 84 kDa 33 21 24 12 
RPL8A YHL033C 28 kDa 16 20 29 27 
RPL26B YGR034W (+1) 14 kDa 14 20 23 30 
RPO21 YDL140C 192 kDa 0 24 38 24 
RPC34 YNR003C 36 kDa 0 33 24 29 
PRT1 YOR361C 88 kDa 19 19 19 30 
SSE1 YPL106C 77 kDa 17 19 14 34 
RPS7A YOR096W 22 kDa 16 20 22 22 
Retrotransposon TYA Gag and TYB Pol genes YCL019W (+5) 202 kDa 0 127 138 109 
DED1 YOR204W 66 kDa 19 17 16 25 
RPL11B YGR085C (+1) 20 kDa 21 18 20 15 
RPL2A YFR031C-A (+1) 27 kDa 14 16 20 24 
RPS24A YER074W (+1) 15 kDa 14 15 20 21 
RPL17A YKL180W 21 kDa 12 17 20 19 
RPS11B YBR048W (+1) 18 kDa 18 10 21 22 
RPS5 YJR123W 25 kDa 16 17 16 21 
RPL9B YNL067W 22 kDa 19 19 18 13 
ASC1 YMR116C 35 kDa 3 21 23 21 
RPL20A YMR242C (+1) 20 kDa 14 15 15 26 
CYS4 YGR155W 56 kDa 7 17 20 24 
RPL13A YDL082W (+1) 23 kDa 13 13 20 19 
MKT1 YNL085W 94 kDa 13 17 17 19 
RPL6A YML073C 20 kDa 8 19 15 22 
UGP1 YKL035W 56 kDa 6 14 18 25 
PRI2 YKL045W 62 kDa 0 0 53 5 
ATP1 YBL099W 59 kDa 8 13 5 18 
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RPS6B YBR181C (+1) 27 kDa 9 12 18 23 
RPL10 YLR075W 25 kDa 7 8 18 21 
RPS9B YBR189W (+1) 22 kDa 10 13 24 13 
RPL5 YPL131W 34 kDa 12 14 18 17 
RPS2 YGL123W 27 kDa 9 10 25 14 
TIF3 YPR163C 49 kDa 15 11 17 17 
RPS19A YOL121C 16 kDa 12 12 15 16 
RPC17 YJL011C 19 kDa 0 27 13 18 
RPC37 YKR025W 32 kDa 0 22 20 16 
ACT1 YFL039C 42 kDa 7 15 12 18 
SSC1 YJR045C 71 kDa 17 17 12 12 
RPP0 YLR340W 34 kDa 8 16 15 14 
RPC25 YKL144C 24 kDa 0 23 17 12 
RPS13 YDR064W 17 kDa 8 11 16 14 
RPL16B YNL069C 22 kDa 10 10 18 13 
CAM1 YPL048W 47 kDa 15 7 12 18 
RPS0B YLR048W 28 kDa 10 13 10 16 
RPL21A YBR191W 18 kDa 6 12 14 16 
RPB5 YBR154C 25 kDa 0 21 11 18 
SHM2 YLR058C 52 kDa 7 8 16 20 
RPL31A YDL075W 13 kDa 6 8 15 19 
ACS2 YLR153C 75 kDa 12 7 11 15 
RPL32 YBL092W 15 kDa 7 8 13 15 
HTB2 YBL002W 14 kDa 4 3 26 10 
ILV2 YMR108W 75 kDa 12 9 9 18 
PIL1 YGR086C 38 kDa 6 13 15 16 
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TFP1 YDL185W 119 kDa 13 9 9 16 
POL12 YBL035C 79 kDa 0 0 43 4 
GFA1 YKL104C 80 kDa 0 9 19 16 
RPS16B YDL083C (+1) 16 kDa 10 14 13 9 
RPL14B YHL001W (+1) 15 kDa 6 12 13 14 
HSC82 YMR186W 81 kDa 11 5 13 16 
TOP1 YOL006C 90 kDa 0 0 45 0 
RPL33B YOR234C (+1) 12 kDa 7 8 13 13 
OKP1 YGR179C 47 kDa 0 12 16 14 
ARO1 YDR127W 175 kDa 0 11 16 12 
RPL35B YDL136W (+1) 14 kDa 5 2 15 15 
RPN2 YIL075C 104 kDa 9 7 14 11 
ADE3 YGR204W 102 kDa 6 8 17 11 
RPS25A YGR027C (+1) 12 kDa 9 9 9 13 
PSF2 YJL072C 25 kDa 0 9 12 21 
RPL19B YBL027W (+1) 22 kDa 7 7 16 11 
EFT2 YDR385W (+1) 93 kDa 6 10 11 15 
LSP1 YPL004C 38 kDa 9 10 18 16 
RPL24B YGR148C 18 kDa 7 6 12 15 
RPS20 YHL015W 14 kDa 6 12 10 11 
PSF1 YDR013W 24 kDa 0 9 22 8 
PFK2 YMR205C 105 kDa 5 7 18 10 
PRI1 YIR008C 48 kDa 0 0 35 5 
NIP1 YMR309C 93 kDa 0 12 10 17 
RPL36B YPL249C-A 11 kDa 4 4 11 14 
GAL10 YBR019C 78 kDa 7 8 8 12 
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PDC1 YLR044C 61 kDa 7 8 7 14 
KAR2 YJL034W 74 kDa 8 16 14 15 
RPL12B YDR418W (+1) 18 kDa 10 11 9 7 
SPT5 YML010W 116 kDa 0 12 14 6 
SUP35 YDR172W 77 kDa 9 10 6 10 
STM1 YLR150W 30 kDa 11 9 8 8 
RPL18B YNL301C (+1) 21 kDa 3 7 12 12 
RPL23A YBL087C (+1) 14 kDa 11 6 8 9 
THS1 YIL078W 85 kDa 7 5 9 14 
RPL27A YHR010W 16 kDa 5 8 12 7 
TIF4631 YGR162W 107 kDa 5 7 14 8 
TEF4 YKL081W 47 kDa 9 4 9 15 
NPL3 YDR432W 45 kDa 7 9 8 8 
RPL40A YIL148W (+1) 15 kDa 3 6 12 3 
KGD1 YIL125W 114 kDa 7 6 6 9 
RPS27B YHR021C (+1) 9 kDa 7 4 8 8 
MIF2 YKL089W 62 kDa 0 13 8 8 
ADH1 YOL086C (+1) 37 kDa 4 10 8 9 
CCT8 YJL008C 62 kDa 3 11 4 14 
RPS14A YCR031C 15 kDa 8 8 7 7 
RPL25 YOL127W 16 kDa 4 5 8 11 
PFK1 YGR240C 108 kDa 5 4 11 14 
RPS18A YDR450W (+1) 17 kDa 3 7 11 8 
RPL43B YJR094W-A (+1) 10 kDa 3 3 9 14 
GCD11 YER025W 58 kDa 7 5 4 13 
RPN1 YHR027C 109 kDa 0 10 14 6 
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RPS8A YBL072C (+1) 22 kDa 0 6 8 14 
RPA190 YOR341W 186 kDa 0 4 16 12 
DBP2 YNL112W 61 kDa 2 10 5 13 
BDP1 YNL039W 68 kDa 0 25 0 3 
RPS15 YOL040C 16 kDa 4 7 10 6 
SLD5 YDR489W 34 kDa 0 7 13 7 
YGR054W YGR054W 71 kDa 8 4 4 11 
RPC31 YNL151C 28 kDa 0 9 7 10 
PBP1 YGR178C 79 kDa 14 4 0 7 
ILS1 YBL076C 123 kDa 2 5 10 10 
NOP58 YOR310C 57 kDa 0 7 2 2 
RPS30A YLR287C-A (+1) 7 kDa 3 4 9 5 
SBP1 YHL034C 33 kDa 4 7 6 9 
SYP1 YCR030C 96 kDa 0 3 10 11 
CSM3 YMR048W 36 kDa 0 0 21 6 
FAS1 YKL182W 229 kDa 0 13 7 3 
CSE4 YKL049C 27 kDa 0 2 10 13 
NOP1 YDL014W 34 kDa 0 5 12 9 
SUP45 YBR143C 49 kDa 2 5 7 11 
HHT1 YBR010W (+1) 15 kDa 4 0 11 3 
BCY1 YIL033C 47 kDa 3 4 9 9 
RPA135 YPR010C 136 kDa 2 4 8 10 
Retrotransposon TYA Gag and TYB Pol genes YPR137C-B 199 kDa 0 132 110 67 
RPL28 YGL103W 17 kDa 3 0 11 4 
RPS10A YOR293W 13 kDa 3 7 7 4 
RPL15A YLR029C 24 kDa 2 4 4 9 
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LAT1 YNL071W 52 kDa 3 6 5 8 
FKS1 YLR342W 215 kDa 2 6 4 7 
RPC19 YNL113W 16 kDa 0 8 4 8 
DPB2 YPR175W 78 kDa 0 0 18 5 
RPL1B YGL135W (+1) 24 kDa 0 2 6 6 
RPL30 YGL030W 11 kDa 2 5 7 6 
RPS23A YGR118W (+1) 16 kDa 3 2 10 5 
GAL1 YBR020W 58 kDa 0 7 4 9 
FUN12 YAL035W 112 kDa 2 5 7 6 
UTP10 YJL109C 200 kDa 0 0 10 8 
SRP54 YPR088C 60 kDa 0 9 4 8 
CCT2 YIL142W 57 kDa 3 5 3 8 
NEW1 YPL226W 134 kDa 0 6 7 8 
ENO1 YGR254W (+1) 47 kDa 2 7 6 5 
RPS26B YER131W (+1) 13 kDa 2 2 4 4 
RPS12 YOR369C 15 kDa 0 3 5 3 
RPS1A YLR441C 29 kDa 12 21 26 20 
SEC21 YNL287W 105 kDa 3 3 7 6 
EFB1 YAL003W 23 kDa 6 0 9 5 
GCN1 YGL195W 297 kDa 3 3 3 0 
RPL8B YLL045C 28 kDa 15 0 35 26 
RVS161 YCR009C 30 kDa 0 2 4 11 
SHM1 YBR263W 54 kDa 5 6 5 8 
HRP1 YOL123W 60 kDa 5 7 4 2 
TIM44 YIL022W 49 kDa 4 2 2 11 
CPR6 YLR216C 42 kDa 0 5 4 9 
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SSA2 YLL024C 69 kDa 0 48 20 41 
HTA2 YBL003C (+1) 14 kDa 0 2 6 5 
HHF1 YBR009C (+1) 11 kDa 0 0 10 3 
SRV2 YNL138W 58 kDa 6 3 2 4 
RRP5 YMR229C 193 kDa 0 2 5 5 
RPS17B YDR447C (+1) 16 kDa 3 4 5 6 
Retrotransposon TYA Gag and TYB Pol genes YMR045C 199 kDa 0 41 30 12 
RPB8 YOR224C 17 kDa 0 5 9 4 
IMD3 YLR432W 57 kDa 3 6 3 6 
LYS21 YDL131W 49 kDa 2 3 3 10 
VMA2 YBR127C 58 kDa 0 8 3 6 
RPS22A YJL190C (+1) 15 kDa 2 3 6 5 
HSP104 YLL026W 102 kDa 2 2 4 8 
NBA1 YOL070C 56 kDa 0 9 4 3 
TIF34 YMR146C 39 kDa 0 3 4 8 
UTP4 YDR324C 88 kDa 3 0 4 5 
ENP1 YBR247C 55 kDa 0 4 3 9 
CAJ1 YER048C 45 kDa 4 4 4 4 
FAS2 YPL231W 207 kDa 0 7 5 0 
Retrotransposon TYA Gag and TYB Pol genes YMR050C 199 kDa 0 143 0 62 
NTH1 YDR001C 86 kDa 3 4 3 5 
SEC27 YGL137W 99 kDa 0 2 8 5 
FAF1 YIL019W 39 kDa 0 2 0 0 
TCP1 YDR212W 60 kDa 0 7 0 7 
NOP56 YLR197W 57 kDa 0 4 8 3 
COP1 YDL145C 136 kDa 0 0 6 4 
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RPA49 YNL248C 47 kDa 0 0 4 11 
KEM1 YGL173C 175 kDa 2 2 5 4 
DHH1 YDL160C 58 kDa 4 2 3 6 
YMR315W YMR315W 38 kDa 0 2 6 6 
RNR1 YER070W 100 kDa 3 0 6 4 
RPB10 YOR210W 8 kDa 0 0 4 2 
FAA1 YOR317W 78 kDa 2 3 2 7 
MES1 YGR264C 86 kDa 5 0 4 5 
RRM3 YHR031C 82 kDa 0 2 0 0 
VMA4 YOR332W 26 kDa 2 0 4 4 
RPL34A YER056C-A (+1) 14 kDa 2 2 7 2 
RPL16A YIL133C 22 kDa 0 5 18 10 
GPM1 YKL152C 28 kDa 2 0 2 7 
SIS1 YNL007C 38 kDa 0 2 4 6 
KES1 YPL145C 49 kDa 2 2 5 5 
RPL37A YLR185W 10 kDa 0 0 6 6 
IKI3 YLR384C 153 kDa 0 2 3 6 
BFR1 YOR198C 55 kDa 0 5 4 3 
HIS4 YCL030C 88 kDa 2 0 6 5 
IDP1 YDL066W 48 kDa 0 0 3 10 
TAL1 YLR354C 37 kDa 4 0 0 7 
ARC1 YGL105W 42 kDa 0 2 5 5 
MDH3 YDL078C 37 kDa 3 2 4 4 
PDA1 YER178W 46 kDa 0 2 2 7 
NAB3 YPL190C 90 kDa 0 4 3 4 
RPT1 YKL145W 52 kDa 0 2 3 5 
	 332	
LSG1 YGL099W 73 kDa 2 0 0 8 
AME1 YBR211C 37 kDa 0 6 0 6 
TYS1 YGR185C 44 kDa 0 0 3 8 
BRF1 YGR246C 67 kDa 0 9 0 3 
RPS29B YDL061C 7 kDa 0 2 0 5 
RPC10 YHR143W-A 8 kDa 0 5 2 2 
RHO1 YPR165W 23 kDa 0 2 4 3 
Retrotransposon TYA Gag gene co-transcribed with TYB Pol YGR109W-A (+4) 34 kDa 0 5 2 3 
RPS28A YOR167C 8 kDa 0 2 0 7 
TSL1 YML100W 123 kDa 4 2 4 0 
PAT1 YCR077C 88 kDa 5 2 2 0 
TRM1 YDR120C 64 kDa 0 3 2 4 
GVP36 YIL041W 37 kDa 2 0 2 8 
VPS1 YKR001C 79 kDa 4 3 0 5 
RPT3 YDR394W 48 kDa 0 3 3 6 
CCT4 YDL143W 58 kDa 0 6 0 6 
CDC3 YLR314C 60 kDa 2 3 2 3 
KRE33 YNL132W 119 kDa 0 2 5 2 
SEC26 YDR238C 109 kDa 0 2 4 2 
RPL6B YLR448W 20 kDa 7 0 8 17 
CTF19 YPL018W 43 kDa 0 2 3 4 
VAS1 YGR094W 126 kDa 0 4 5 2 
GLO3 YER122C 55 kDa 0 0 0 3 
MCK1 YNL307C 43 kDa 0 0 2 4 
SRP1 YNL189W 60 kDa 0 4 2 4 
TIF35 YDR429C 31 kDa 0 2 2 5 
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FBA1 YKL060C 40 kDa 0 0 4 3 
ABF2 YMR072W 22 kDa 0 0 3 4 
PYC1 YGL062W 130 kDa 0 2 5 0 
MSC6 YOR354C 80 kDa 0 3 0 3 
RPT6 YGL048C 45 kDa 0 0 6 5 
CKA2 YOR061W 39 kDa 0 0 3 7 
ATP2 YJR121W 55 kDa 0 6 0 3 
QCR2 YPR191W 40 kDa 0 0 2 8 
WRS1 YOL097C 49 kDa 0 2 0 8 
MDN1 YLR106C 559 kDa 0 0 0 5 
PGM1 YKL127W 63 kDa 0 0 0 6 
PUF4 YGL014W 98 kDa 0 2 0 4 
ARB1 YER036C 68 kDa 2 3 0 3 
RPS7B YNL096C 22 kDa 0 0 0 14 
FAA4 YMR246W 77 kDa 0 2 0 6 
Retrotransposon TYA Gag and TYB Pol genes YDR098C-B 199 kDa 0 0 51 66 
RVB1 YDR190C 50 kDa 0 0 2 6 
GPH1 YPR160W 103 kDa 5 0 0 2 
GAL7 YBR018C 42 kDa 0 0 2 6 
RPO26 YPR187W 18 kDa 0 5 0 2 
SPT15 YER148W 27 kDa 0 3 0 5 
CHL4 YDR254W 53 kDa 0 0 0 7 
TUB1 YML085C 50 kDa 0 3 0 2 
KGD2 YDR148C 50 kDa 2 2 0 3 
LSC2 YGR244C 47 kDa 0 2 0 4 
PIM1 YBL022C 127 kDa 0 0 4 2 
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PSF3 YOL146W 22 kDa 0 0 7 0 
VIP1 YLR410W 130 kDa 0 3 3 0 
RFA1 YAR007C 70 kDa 0 0 6 0 
CCT7 YJL111W 60 kDa 0 5 0 0 
TUB2 YFL037W 51 kDa 0 3 0 5 
ATG9 YDL149W 115 kDa 0 6 0 0 
RTN1 YDR233C 33 kDa 2 0 2 2 
TSR1 YDL060W 91 kDa 0 0 2 2 
CDC12 YHR107C 47 kDa 0 2 0 4 
YRA1 YDR381W 25 kDa 0 0 2 3 
ARX1 YDR101C 65 kDa 2 0 0 2 
RVS167 YDR388W 53 kDa 2 0 0 0 
IDH1 YNL037C 39 kDa 2 0 0 3 
CDC33 YOL139C 24 kDa 0 0 0 4 
ARO80 YDR421W 108 kDa 0 0 3 2 
PDB1 YBR221C 40 kDa 0 0 0 4 
CCT3 YJL014W 59 kDa 0 3 0 3 
DPB3 YBR278W 23 kDa 0 0 3 2 
YPK1 YKL126W 76 kDa 0 0 2 3 
RPT2 YDL007W 49 kDa 0 0 2 4 
RLI1 YDR091C 68 kDa 0 3 0 3 
MCM21 YDR318W 43 kDa 0 2 0 4 
CLU1 YMR012W 145 kDa 0 0 0 3 
PUF6 YDR496C 75 kDa 0 0 2 4 
CCT6 YDR188W 60 kDa 0 0 0 2 
BNI1 YNL271C 220 kDa 0 0 0 3 
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SVL3 YPL032C 92 kDa 4 0 0 0 
CTF3 YLR381W 84 kDa 0 4 0 0 
TPS2 YDR074W 103 kDa 0 0 4 0 
HEM15 YOR176W 45 kDa 0 0 0 5 
EHT1 YBR177C 51 kDa 0 0 0 5 
NET1 YJL076W 129 kDa 0 0 5 0 
MEC1 YBR136W 273 kDa 0 0 5 0 
SSZ1 YHR064C 58 kDa 2 0 0 2 
EGD2 YHR193C 19 kDa 0 0 2 3 
ETR1 YBR026C 42 kDa 0 0 2 3 
RTT103 YDR289C 46 kDa 0 0 0 4 
INP53 YOR109W 125 kDa 0 0 3 2 
PWP2 YCR057C 104 kDa 0 2 0 2 
NFS1 YCL017C 54 kDa 0 0 2 3 
NAN1 YPL126W 101 kDa 0 0 0 3 
UTP8 YGR128C 80 kDa 0 0 0 2 
HSP42 YDR171W 43 kDa 0 2 0 0 
RPL38 YLR325C 9 kDa 0 0 0 3 
RPL29 YFR032C-A 7 kDa 0 0 5 0 
GAL80 YML051W 48 kDa 0 0 2 3 
VPS72 YDR485C 91 kDa 0 0 0 2 
YHR020W YHR020W 77 kDa 3 0 0 3 
GLT1 YDL171C 238 kDa 0 0 3 3 
SPC105 YGL093W 105 kDa 0 2 0 4 
CDC14 YFR028C 62 kDa 0 0 3 0 
YLH47 YPR125W 52 kDa 0 0 0 2 
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UBP3 YER151C 102 kDa 0 2 0 0 
YDJ1 YNL064C 45 kDa 0 0 0 5 
CBF2 YGR140W 112 kDa 0 0 0 5 
SST2 YLR452C 80 kDa 0 0 0 5 
RUB1 YDR139C 9 kDa 0 0 5 0 
RNR2 YJL026W 46 kDa 0 0 0 5 
TDH1 YJL052W 36 kDa 0 0 0 15 
KRE2 YDR483W 51 kDa 0 3 0 3 
SUI3 YPL237W 32 kDa 2 0 0 2 
RFC3 YNL290W 38 kDa 0 0 3 2 
YGR207C YGR207C 29 kDa 3 0 0 2 
ISW1 YBR245C 131 kDa 3 0 2 0 
CMK2 YOL016C 50 kDa 0 0 2 3 
MOT2 YER068W 65 kDa 3 0 0 2 
SEC18 YBR080C 84 kDa 0 0 0 3 
SIR2 YDL042C 63 kDa 0 0 2 3 
NAB2 YGL122C 58 kDa 2 0 0 0 
GND1 YHR183W 54 kDa 0 0 0 3 
ABD1 YBR236C 50 kDa 0 0 0 3 
TAF5 YBR198C 89 kDa 4 0 0 0 
MSH6 YDR097C 140 kDa 0 0 3 0 
YGR250C YGR250C 90 kDa 2 0 0 0 
NCL1 YBL024W 78 kDa 2 0 0 0 
CIT1 YNR001C 53 kDa 0 0 0 3 
VPS70 REV_YJR126C 92 kDa 0 0 2 0 
TID3 YIL144W 80 kDa 0 0 0 4 
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POL3 YDL102W 125 kDa 0 0 4 0 
NDE1 YMR145C 63 kDa 0 0 0 2 
ARO4 YBR249C 40 kDa 0 0 0 2 
RSP5 YER125W 92 kDa 2 0 0 0 
DIS3 YOL021C 114 kDa 0 2 0 0 
TIF5 YPR041W 45 kDa 0 0 0 2 
RPT5 YOR117W 48 kDa 0 0 2 2 
RFC5 YBR087W 40 kDa 0 0 2 2 
CEP3 YMR168C 71 kDa 0 0 0 3 
TMA46 YOR091W 40 kDa 0 2 0 0 
MIS1 YBR084W 106 kDa 4 0 0 0 
TPA1 YER049W 74 kDa 0 0 0 2 
NOG1 YPL093W 74 kDa 0 0 0 3 
RPL42B YHR141C (+1) 12 kDa 0 0 0 2 
UTP5 YDR398W 72 kDa 0 0 0 3 
ZUO1 YGR285C 49 kDa 0 3 0 0 
NOG2 YNR053C 55 kDa 0 0 0 2 
AMD1 YML035C 93 kDa 0 0 2 0 
YSC84 YHR016C 51 kDa 2 0 0 0 
DBP8 YHR169W 48 kDa 0 0 0 2 
LTE1 REV_YAL024C 163 kDa 0 0 0 3 
SMC1 YFL008W 141 kDa 0 0 0 2 
RPC11 YDR045C 13 kDa 0 0 0 3 
HOC1 YJR075W 46 kDa 0 0 0 2 
RPT4 YOR259C 49 kDa 0 4 0 0 
KAP123 YER110C 123 kDa 0 0 3 0 
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CHC1 YGL206C 187 kDa 0 0 0 4 
IML3 YBR107C 28 kDa 0 0 0 4 
SHS1 YDL225W 63 kDa 0 4 0 0 
RAD3 YER171W 90 kDa 0 0 0 4 
RVB2 YPL235W 52 kDa 0 0 0 2 
PRS1 YKL181W 47 kDa 0 0 0 2 
BUD27 YFL023W 91 kDa 0 0 2 0 
MGM101 YJR144W 30 kDa 2 0 0 0 
ELP3 YPL086C 64 kDa 0 0 0 2 
DPB4 YDR121W 22 kDa 0 0 2 0 
RPN3 YER021W 60 kDa 0 0 0 2 
GLN4 YOR168W 93 kDa 0 0 2 0 
POL32 REV_YJR043C 40 kDa 0 0 2 0 
PGK1 YCR012W 45 kDa 0 2 0 0 
ATP3 YBR039W 34 kDa 0 0 0 2 
ALD6 YPL061W 54 kDa 0 2 0 0 
ARP2 YDL029W 44 kDa 0 0 0 2 
IDH2 YOR136W 40 kDa 0 0 0 2 
PRP43 YGL120C 88 kDa 0 0 0 3 
NUG1 YER006W 58 kDa 0 0 0 2 
ASK10 YGR097W 127 kDa 0 0 2 0 
MNN11 YJL183W 48 kDa 0 0 0 2 
UTP15 YMR093W 58 kDa 0 0 0 2 
MRT4 YKL009W 27 kDa 0 0 0 2 
CHS1 YNL192W 130 kDa 0 2 0 0 
APL2 YKL135C 82 kDa 0 0 0 2 
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MAE1 YKL029C 74 kDa 0 0 0 3 
GCD10 YNL062C 54 kDa 0 0 0 3 
COR1 YBL045C 50 kDa 0 0 0 3 
PSA1 YDL055C 40 kDa 0 0 0 3 
NAR1 YNL240C 54 kDa 0 0 0 3 
CHA1 YCL064C 39 kDa 0 0 0 3 
NUF2 YOL069W 53 kDa 0 0 0 3 
RFC2 YJR068W 40 kDa 0 0 0 2 
YLR225C YLR225C 46 kDa 0 0 0 2 
GCN20 YFR009W 85 kDa 0 0 0 3 
RMD9 YGL107C 75 kDa 0 2 0 0 
IRC24 YIR036C 29 kDa 0 0 0 2 
FAR1 YJL157C 95 kDa 0 2 0 0 
SKP1 YDR328C 22 kDa 0 0 2 0 
RAD27 YKL113C 43 kDa 0 0 0 2 
FRS1 YLR060W 67 kDa 0 0 0 2 
ADE12 YNL220W 48 kDa 0 0 0 2 
TFB1 YDR311W 73 kDa 2 0 0 0 
ACO1 YLR304C 85 kDa 0 0 0 2 
MSS51 YLR203C 51 kDa 0 0 0 2 
SFI1 YLL003W 113 kDa 2 0 0 0 
BRE1 YDL074C 81 kDa 2 0 0 0 
MDN1 REV_YLR106C 559 kDa 0 0 0 2 
NUP2 YLR335W 78 kDa 2 0 0 0 
ILV1 YER086W 64 kDa 0 0 0 2 
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Figure S.1. Schematic of Pol1 mutants and constructs used in this study. Empty circles indicate position of mutations. The 
mutation in the pol1-1 allele has not been characterized.  
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Figure S.2. Schematic of Sen1 mutants and constructs used in this study. Empty circles indicate position of point mutations 
whilst red boxes depict mini-truncations. 
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 Abbreviations 
 
AGS: Aicardi-Goutières syndrome 
 
ATP: Adenosine triphosphate 
 
APC/C: Anaphase promoting complex/ cyclosome 
 
BLAST: Basic local alignment search tool 
 
BLASTp: Protein-protein BLAST 
 
BSA: Bovine serum albumin 
 
CBP: Calmodulin binding protein 
 
CDK: Cyclin-dependent protein kinase 
 
CF: Cleavage factor 
 
CFS: Common fragile site 
 
ChIP: Chromatin immuno-precipitation 
 
CIP: Ctf4 interacting peptide 
 
CMG: Cdc45 MCM2-7 GINS 
 
CMGE: Cdc45 MCM2-7 GINS Polymerase ε 
 
CPA: Cleavage and polyadenylation 
 
CPF: Cleavage and polyadenylation factor 
 
CPSF: Cleavage and polyadenylation specificity factor 
 
CTD: Carboxyl-terminal domain 
 
CUT: Cryptic unstable transcript 
 
DDK: Dbf4-dependent kinase 
 
DSB: Double-stranded break 
 
dsDNA: Double-stranded DNA 
 
FLC: FLOWERING LOCUS C 
 
GAL: Galactose 
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GINS: Sld5 (Go), Psf1 (Ichi), Psf2 (Ni), Psf3 (San) 
 
HU: Hydroxyurea 
 
KSHV: Kaposi's sarcoma-associated herpesvirus 
 
MAT: Mating-type 
 
MBP: Maltose binding protein 
 
MCM: Minichromosome maintenance 
 
MCS: Multiple cloning site 
 
MPS1: mat1 pausing site 1 
 
MMS: Methyl methanesulfonate 
 
mtDNA: Mitochondrial DNA 
 
NER: Nucleotide excision repair 
 
PAS: Polyadenylation signal 
 
PIP: PCNA interacting peptide 
 
PMSF: Phenylmethane sulfonyl fluoride 
 
PSI-BLAST: Position-specific iterative BLAST 
 
PSSM: Position specific score matrix 
 
Raff: Raffinose 
 
RFB: Replication fork barrier 
 
RFC: Replication factor C 
 
RPA: Replication protein A 
 
RPC: Replication progression complex 
 
RTS1: Replication termination site 1 
 
SDSA: Synthesis-dependent strand annealing 
 
ssDNA: Single-stranded DNA 
 
TAM: Transcription-associated mutagenesis 
 
TAR: Transcription-associated recombination 
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TCR: Transcription coupled repair 
 
TD (or td): Temperature degron 
 
TE: Transposable elements 
 
VLP: Virus-like particle 
 
Y2H: Yeast-2-hybrid
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